{"meta":{"query_hash":"2d0850d8eead","filters":{"venue":"Journal of clinical lipidology"},"cohort_total":227,"direct_labels_cover":0,"predictions_cover":227,"exported":227,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2d0850d8eead","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+clinical+lipidology"},"results":[{"id":"W1113293211","doi":"10.1016/j.jacl.2015.07.011","title":"Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; Hospital for Sick Children; University of British Columbia; Université du Québec à Chicoutimi; University of Toronto","funders":"Pfizer","keywords":"Rosuvastatin; Medicine; Discontinuation; Adverse effect; Familial hypercholesterolemia; Internal medicine; Gastroenterology; Rosuvastatin Calcium; Cholesterol; Endocrinology","score_opus":0.06207042970551783,"score_gpt":0.3633206977396602,"score_spread":0.30125026803414234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1113293211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922536,0.0054235295,0.00007623166,0.00006739576,0.000021447384,0.0001545576,0.0013399356,0.0000091800075,0.00065426773],"genre_scores_gemma":[0.9950584,0.0019154713,0.00021408952,0.00011362545,0.00004924364,0.00017733587,0.0022058096,0.0000066096263,0.00025940753],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99760723,0.0012034746,0.000276855,0.0002129221,0.000498982,0.00020045068],"domain_scores_gemma":[0.99673307,0.00081439345,0.0013660406,0.0001953903,0.00035389693,0.00053730415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003842197,0.00046934123,0.0015452044,0.00050296437,0.0002962688,0.0006368637,0.00034604917,0.000654062,0.0006175343],"category_scores_gemma":[0.0029456317,0.00025047795,0.0026144127,0.0009609739,0.00031599554,0.00040456132,0.00034440128,0.00077949493,0.00011328362],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21605971,0.0021115178,0.7341774,0.0011574891,0.007968576,0.00027403384,0.0003979002,0.0006805647,0.0013893076,0.00013046552,0.0017003234,0.03395269],"study_design_scores_gemma":[0.021794535,0.017083757,0.95321417,0.00017762855,0.0045253616,0.00021819597,0.00017511283,0.00035720697,0.0004655638,0.000028466548,0.0019243392,0.000035597714],"about_ca_topic_score_codex":0.004885855,"about_ca_topic_score_gemma":0.00731273,"teacher_disagreement_score":0.004885855,"about_ca_system_score_codex":0.0011287577,"about_ca_system_score_gemma":0.0012286713,"threshold_uncertainty_score":0.0203197},"labels":[],"label_agreement":null},{"id":"W1423581981","doi":"10.1016/j.jacl.2015.08.006","title":"Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":467,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Amarin Corporation; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; CSL Behring; Danone; Amarin Pharma; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Esperion Therapeutics; GlaxoSmithKline","keywords":"Medicine; Alirocumab; Ezetimibe; Statin; Internal medicine; Pharmacology; Cholesterol; Total cholesterol","score_opus":0.0757458802216295,"score_gpt":0.3849540900123038,"score_spread":0.3092082097906743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1423581981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910945,0.0053923447,0.0003662232,0.0008240745,0.00028532045,0.00022424167,0.00053311995,0.000029454639,0.001250654],"genre_scores_gemma":[0.99545765,0.0014780127,0.0005073963,0.0006655774,0.00027062744,0.00021104625,0.0004542239,0.000008699545,0.0009467864],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99940014,0.0002974387,0.00004494504,0.00012450016,0.00005024091,0.000082743085],"domain_scores_gemma":[0.99913883,0.0002865149,0.00021547379,0.00008624785,0.00004097392,0.00023191134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013093144,0.0013489197,0.0034540782,0.00030406026,0.00038458395,0.0014041394,0.0006585781,0.0011742533,0.004332014],"category_scores_gemma":[0.0017232314,0.0005109783,0.0022031676,0.00026750859,0.0011340135,0.0011581221,0.00073642714,0.002604965,0.00043423646],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98674184,0.0007799407,0.0017925928,0.00040332362,0.00197206,0.00004186251,0.00003812374,0.00018518351,0.0011756532,0.0001585718,0.00031902327,0.006391815],"study_design_scores_gemma":[0.9603225,0.023197116,0.0101378225,0.00007636449,0.0037175776,0.000079470075,0.0000960872,0.0008155048,0.00031701775,0.00056062534,0.0006459211,0.000034009336],"about_ca_topic_score_codex":0.0012985527,"about_ca_topic_score_gemma":0.0027075834,"teacher_disagreement_score":0.004332014,"about_ca_system_score_codex":0.0007233522,"about_ca_system_score_gemma":0.0006595845,"threshold_uncertainty_score":0.014491975},"labels":[],"label_agreement":null},{"id":"W1542603599","doi":"10.1016/j.jacl.2015.06.012","title":"The apoB-to-PCSK9 ratio: A new index for metabolic risk in humans","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Endocrinology; Internal medicine; PCSK9; Apolipoprotein B; Medicine; Kexin; Postprandial; Lipoprotein; Hyperinsulinemia; Insulin resistance; Type 2 diabetes; Insulin; Cholesterol; LDL receptor; Diabetes mellitus","score_opus":0.13075347700927287,"score_gpt":0.4440603937341583,"score_spread":0.3133069167248854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1542603599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91404295,0.02627836,0.033320922,0.0021126622,0.0012345721,0.000242415,0.007065621,0.0010445996,0.014657909],"genre_scores_gemma":[0.97481596,0.0033617404,0.01617013,0.0004292676,0.00071395334,0.00015736157,0.0017320036,0.000104941435,0.0025146464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987375,0.00031262092,0.00017636034,0.00022232314,0.00050982955,0.000041410705],"domain_scores_gemma":[0.9977996,0.0005070472,0.0008526946,0.00022872289,0.00030533035,0.0003065266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013965486,0.0015847643,0.0015063157,0.0045195217,0.0006193308,0.002464072,0.00079858646,0.0017299431,0.0016853261],"category_scores_gemma":[0.0040477486,0.0004990472,0.000798999,0.0023181338,0.0005980891,0.0012341365,0.0014619039,0.0021025874,0.0011563363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036833016,0.00034247938,0.90703726,0.00032732918,0.0016798065,0.0004016919,0.00017628707,0.0011238792,0.013360381,0.0010638407,0.0022537601,0.06854992],"study_design_scores_gemma":[0.0001628094,0.001249969,0.9607727,0.00011503833,0.000859614,0.0056237876,0.00028193867,0.013401497,0.007856654,0.003336878,0.0061944467,0.00014472644],"about_ca_topic_score_codex":0.0009632073,"about_ca_topic_score_gemma":0.0010204735,"teacher_disagreement_score":0.0045195217,"about_ca_system_score_codex":0.00058291614,"about_ca_system_score_gemma":0.00039179894,"threshold_uncertainty_score":0.0073857307},"labels":[],"label_agreement":null},{"id":"W1754892304","doi":"10.1016/j.jacl.2015.10.003","title":"JCL roundtable: Apolipoproteins as causative elements in vascular disease","year":2015,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Apolipoprotein B; Medicine; Cholesterol; Lipoprotein; Internal medicine; Disease; Bioinformatics; Endocrinology; Genetics; Computational biology; Biology","score_opus":0.21400066480712102,"score_gpt":0.5073236104021006,"score_spread":0.2933229455949796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1754892304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015730211,0.9137473,0.00019200795,0.017108256,0.065127134,0.000056491055,0.00035452907,0.000078186604,0.0031787343],"genre_scores_gemma":[0.0015930185,0.9088883,0.00056136906,0.02585198,0.053823646,0.000059373724,0.0007463768,0.000029334104,0.008446596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989737,0.0001375895,0.0001784341,0.000103076294,0.00042945181,0.00017777829],"domain_scores_gemma":[0.9957808,0.0012479702,0.00066240487,0.00010294379,0.0014661092,0.00073973427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002316186,0.0015202377,0.0025807202,0.005639309,0.00068228436,0.0029271634,0.002052241,0.0049378914,0.02548692],"category_scores_gemma":[0.0055811424,0.0005272263,0.0013974446,0.0034316857,0.0006765972,0.0038948948,0.0038126407,0.0038584343,0.00872818],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016309916,0.000039839895,0.00017549879,0.0087323515,0.00012703448,0.00017555669,0.000031628802,0.00006567073,0.00034712028,0.0009062815,0.72049576,0.26874024],"study_design_scores_gemma":[0.00010140823,0.00015594623,0.0010038018,0.011441168,0.00036337614,0.00044426048,0.00007515514,0.00007482938,0.00016859121,0.001767672,0.9843731,0.000030838404],"about_ca_topic_score_codex":0.0016276737,"about_ca_topic_score_gemma":0.0044156564,"teacher_disagreement_score":0.02548692,"about_ca_system_score_codex":0.001344966,"about_ca_system_score_gemma":0.0038570908,"threshold_uncertainty_score":0.08526224},"labels":[],"label_agreement":null},{"id":"W1934277520","doi":"10.1016/j.jacl.2015.08.005","title":"Familial hypercholesterolemia: PCSK9 InsLEU genetic variant and prediabetes/diabetes risk","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; McGill University","funders":"Fondation Leducq","keywords":"PCSK9; Prediabetes; Medicine; Internal medicine; Diabetes mellitus; Familial hypercholesterolemia; Endocrinology; Impaired fasting glucose; Glucose homeostasis; Impaired glucose tolerance; Type 2 diabetes; Cholesterol; LDL receptor; Lipoprotein; Insulin resistance","score_opus":0.06823566948672859,"score_gpt":0.3567780784363165,"score_spread":0.2885424089495879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934277520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978448,0.00032326806,0.00024765712,0.00018719885,0.000040965482,0.0000061886212,0.0002425853,0.000017029677,0.0010903568],"genre_scores_gemma":[0.99900585,0.000074454205,0.0001774515,0.000036362846,0.000037553,0.0000039146757,0.00014325198,0.0000043699606,0.00051690015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997106,0.000069618065,0.000050526935,0.0000714516,0.000046825462,0.00005092667],"domain_scores_gemma":[0.9994185,0.00014040153,0.00017661107,0.000044502372,0.000055000386,0.00016500516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028798525,0.0006185032,0.00043333048,0.0009913344,0.00079299085,0.00066221284,0.00030257882,0.0010242888,0.0049556145],"category_scores_gemma":[0.0013592519,0.00027825052,0.0006796997,0.0011877408,0.00028578783,0.0002609011,0.00034615607,0.00077815267,0.00058667007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002135952,0.00019329676,0.9843725,0.000022930326,0.00024957795,0.0049182093,0.00013163616,0.000103607774,0.0039120936,0.00016070271,0.0003522568,0.0034471937],"study_design_scores_gemma":[0.000098708166,0.00029902378,0.9853823,0.000025260746,0.0004283825,0.009914687,0.0002907454,0.001350054,0.0010337895,0.00041331374,0.0007358683,0.000027952194],"about_ca_topic_score_codex":0.0041606217,"about_ca_topic_score_gemma":0.003503743,"teacher_disagreement_score":0.0049556145,"about_ca_system_score_codex":0.0002518472,"about_ca_system_score_gemma":0.00027240254,"threshold_uncertainty_score":0.016578197},"labels":[],"label_agreement":null},{"id":"W1938664023","doi":"10.1016/j.jacl.2015.05.005","title":"Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Dyslipidemia; Medicine; Internal medicine; Triglyceride; Cholesterol; Endocrinology; High-density lipoprotein; Percentile; Lipoprotein; Disease","score_opus":0.08302288987089383,"score_gpt":0.3538103416122137,"score_spread":0.27078745174131985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1938664023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5161659,0.0033384846,0.001362247,0.0003083525,0.00006858502,0.00017619213,0.47633126,0.00012661915,0.002122328],"genre_scores_gemma":[0.40643558,0.0012894503,0.002165955,0.0002960038,0.000085910615,0.0004367347,0.58789635,0.00009093461,0.0013030989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972338,0.0005270247,0.0007138151,0.00079164305,0.00048053506,0.00025318217],"domain_scores_gemma":[0.99376523,0.00097122876,0.0020007817,0.0016796852,0.00087673654,0.00070629333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018379557,0.0008067552,0.0019522625,0.003925776,0.0006244965,0.0019313111,0.0014695312,0.0011064722,0.0030353076],"category_scores_gemma":[0.006470049,0.0005406845,0.0011961699,0.0063553923,0.00026398175,0.0010165598,0.0019255246,0.0009143348,0.0021727122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002599833,0.00009042716,0.9576944,0.00035080445,0.0013129254,0.00044354337,0.0001552124,0.00026315163,0.001492416,0.00035358197,0.024387985,0.01085569],"study_design_scores_gemma":[0.0002580611,0.00006355911,0.987672,0.00009505614,0.0003408503,0.00068950537,0.00018181092,0.0002467081,0.00028502254,0.00021153946,0.009924731,0.00003116668],"about_ca_topic_score_codex":0.009911527,"about_ca_topic_score_gemma":0.014963937,"teacher_disagreement_score":0.009911527,"about_ca_system_score_codex":0.00057629304,"about_ca_system_score_gemma":0.0013689846,"threshold_uncertainty_score":0.01970768},"labels":[],"label_agreement":null},{"id":"W1967534708","doi":"10.1016/j.jacl.2013.12.002","title":"Education for lifestyle-based management of hyperlipidemia in children enhanced by a collaborative approach","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Dyslipidemia; Hyperlipidemia; Motivational interviewing; Percentile; Physical therapy; Physical activity; Anthropometry; National Cholesterol Education Program; Internal medicine; Obesity; Metabolic syndrome; Endocrinology; Randomized controlled trial","score_opus":0.027590071466116826,"score_gpt":0.37553977842228553,"score_spread":0.3479497069561687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967534708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96121997,0.002788929,0.008011192,0.008747367,0.0005937214,0.0012142402,0.00019754858,0.00036523596,0.016861785],"genre_scores_gemma":[0.94113255,0.0050590946,0.04546901,0.0014364116,0.00038121862,0.0018686501,0.00030409082,0.000030953524,0.004318045],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99925905,0.00027843541,0.000049897873,0.00007907449,0.00013248334,0.00020101194],"domain_scores_gemma":[0.998884,0.0002254846,0.00012483656,0.000037302823,0.00007159448,0.0006568491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011538365,0.0004694486,0.0004402765,0.0005167402,0.00089061406,0.000469723,0.0007830235,0.0007423367,0.0029581646],"category_scores_gemma":[0.002393066,0.0002268192,0.0007140825,0.00024080469,0.0002044299,0.00049125246,0.0021553647,0.0013698968,0.00030241557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010334675,0.06225787,0.16798528,0.0016804087,0.000358266,0.003979872,0.010078837,0.0016811498,0.0037551345,0.0016834402,0.03345226,0.71205395],"study_design_scores_gemma":[0.0056089535,0.016585222,0.8471607,0.006544062,0.0012040637,0.00764722,0.013590688,0.007932695,0.0048670173,0.00465553,0.08392237,0.0002814928],"about_ca_topic_score_codex":0.0073664603,"about_ca_topic_score_gemma":0.014335562,"teacher_disagreement_score":0.0073664603,"about_ca_system_score_codex":0.00086507545,"about_ca_system_score_gemma":0.0029367595,"threshold_uncertainty_score":0.014647126},"labels":[],"label_agreement":null},{"id":"W1968586354","doi":"10.1016/j.jacl.2012.04.004","title":"Health benefits of high-density lipoproteins in preventing cardiovascular diseases","year":2012,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Antithrombotic; Cardiovascular health; High-density lipoprotein; Reverse cholesterol transport; Cholesterol; Lipoprotein; Function (biology); Internal medicine; Bioinformatics; Disease; Cell biology; Biology","score_opus":0.12686894208898988,"score_gpt":0.4081531610127706,"score_spread":0.28128421892378075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968586354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010835654,0.9993494,0.00004890901,0.00014550447,0.00006685636,0.0000028697316,0.000014693579,0.0000026735297,0.00026065097],"genre_scores_gemma":[0.0007231816,0.9987538,0.00013652878,0.00013635065,0.000113592614,0.0000037929797,0.000017179222,5.086032e-7,0.00011507604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997826,0.00004880968,0.000037940077,0.000032798223,0.00008023057,0.000017677712],"domain_scores_gemma":[0.999491,0.00030636933,0.00007520724,0.000010279772,0.00009140643,0.000025733605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092261034,0.00090980076,0.0022957057,0.0019050264,0.00023193595,0.0007647575,0.0008371665,0.0010292178,0.0033816772],"category_scores_gemma":[0.0010216662,0.00031885382,0.0007619137,0.0020761914,0.00039269507,0.0008134352,0.000636442,0.0017449005,0.0010443536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022549469,0.00012930659,0.00039577813,0.03244562,0.00060508685,0.00018073378,0.000043010732,0.00022908613,0.00085437956,0.0021617268,0.016103135,0.94662666],"study_design_scores_gemma":[0.00026012637,0.00035979284,0.0068742693,0.024294613,0.0030333793,0.0019814176,0.00018087916,0.0002302415,0.0008230087,0.0044021006,0.95748115,0.00007913095],"about_ca_topic_score_codex":0.0014951605,"about_ca_topic_score_gemma":0.0033253995,"teacher_disagreement_score":0.0033816772,"about_ca_system_score_codex":0.0004080964,"about_ca_system_score_gemma":0.0007733009,"threshold_uncertainty_score":0.011312783},"labels":[],"label_agreement":null},{"id":"W1976199573","doi":"10.1016/j.jacl.2014.08.004","title":"The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Disease; Atherosclerotic cardiovascular disease; Primary prevention; Intensive care medicine; Statin; Blood pressure; Vascular disease; Risk assessment; Cardiology; Cardiovascular event; Internal medicine; Physical therapy","score_opus":0.03317201517271609,"score_gpt":0.3407055560705636,"score_spread":0.30753354089784746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976199573","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053661168,0.03712151,0.22874288,0.62976706,0.011805887,0.00097031647,0.0009709292,0.00018242454,0.036777835],"genre_scores_gemma":[0.77799046,0.018629346,0.050109826,0.106404886,0.0401597,0.0011115469,0.00027145405,0.000121576995,0.0052012117],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.94726944,0.042047672,0.001745121,0.0034123214,0.004732118,0.0007932958],"domain_scores_gemma":[0.8486614,0.13889009,0.0035185174,0.0041661793,0.0031724407,0.0015913424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08263936,0.002422575,0.004907075,0.0030328482,0.0015565598,0.0041761855,0.0053436817,0.01167556,0.009650103],"category_scores_gemma":[0.10912893,0.0015186896,0.00356386,0.0012983679,0.013502132,0.011077398,0.0030263958,0.017168524,0.00090285524],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009355728,0.0012357961,0.017432455,0.0037207096,0.0076080575,0.0013664113,0.0008914842,0.006782388,0.0015293657,0.8582717,0.0119053,0.079900555],"study_design_scores_gemma":[0.0039696964,0.0009571896,0.004173013,0.0006282014,0.0038725703,0.0007552154,0.00040200618,0.01837508,0.00040604162,0.95919883,0.0071417917,0.000120249904],"about_ca_topic_score_codex":0.0025796203,"about_ca_topic_score_gemma":0.0024883754,"teacher_disagreement_score":0.08263936,"about_ca_system_score_codex":0.0030392334,"about_ca_system_score_gemma":0.0040050875,"threshold_uncertainty_score":0.4370439},"labels":[],"label_agreement":null},{"id":"W1977959614","doi":"10.1016/j.jacl.2013.08.004","title":"Is the superiority of apoB over non–HDL-C as a marker of cardiovascular risk in the INTERHEART study due to confounding by related variables?","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Confounding; Apolipoprotein B; Internal medicine; Cholesterol","score_opus":0.03019220161012818,"score_gpt":0.3558608782901012,"score_spread":0.325668676679973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977959614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90399814,0.059671354,0.0062927697,0.017313225,0.003968333,0.00015813271,0.001770696,0.00010542392,0.0067219287],"genre_scores_gemma":[0.9858803,0.0032691641,0.002860057,0.0038204945,0.0029760443,0.000043799137,0.00051074795,0.000070773385,0.0005686663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96642345,0.022383865,0.003116303,0.0039369757,0.0031332697,0.0010060197],"domain_scores_gemma":[0.89336634,0.073789135,0.00833439,0.01819421,0.0031857903,0.0031301598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08000796,0.0011082366,0.002875366,0.00080374116,0.0008734771,0.0027497434,0.003630337,0.003854671,0.0023346783],"category_scores_gemma":[0.07558327,0.0011314506,0.0041166055,0.0018444599,0.002402293,0.0018350161,0.0011741404,0.0031369615,0.00060876826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039874174,0.00024061264,0.8901957,0.0009233183,0.02006547,0.00039111607,0.0006410306,0.0004941662,0.0044307974,0.001241371,0.0021596998,0.0393424],"study_design_scores_gemma":[0.0042843143,0.0049111573,0.9579216,0.00038654005,0.016401833,0.00086776406,0.00036063354,0.0020242813,0.0024369967,0.00502581,0.0052457387,0.00013337132],"about_ca_topic_score_codex":0.0018452589,"about_ca_topic_score_gemma":0.0030317137,"teacher_disagreement_score":0.08000796,"about_ca_system_score_codex":0.00030218644,"about_ca_system_score_gemma":0.0009429205,"threshold_uncertainty_score":0.4231276},"labels":[],"label_agreement":null},{"id":"W1981819062","doi":"10.1016/j.jacl.2010.05.001","title":"Complete Apo AI Deficiency in an Iraqi Mandaean Family: Case studies and review of the literature","year":2010,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital; St. Paul's Hospital","funders":"","keywords":"Medicine; Internal medicine; Apolipoprotein B; Nonsense mutation; Nonsense; Genotype; Pediatrics; Endocrinology; Phenotype; Cholesterol; Missense mutation; Gene; Genetics","score_opus":0.19020067112110933,"score_gpt":0.49957950437791115,"score_spread":0.3093788332568018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981819062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046408786,0.99406755,0.0001203386,0.00032327673,0.00007519596,0.0000059867543,0.000036741614,0.000007694699,0.0007223247],"genre_scores_gemma":[0.019533072,0.9791235,0.00039859864,0.00028840703,0.0002627484,0.000006832081,0.00006468407,0.000002341988,0.00031979114],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99972004,0.000035643458,0.000106232124,0.000053247248,0.000058866135,0.000025972176],"domain_scores_gemma":[0.9993167,0.0003590431,0.00019459169,0.000018888744,0.00007013249,0.000040737206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035592995,0.00083962746,0.0019471797,0.003502878,0.00033326735,0.0009605185,0.0012570083,0.0012405614,0.0016287534],"category_scores_gemma":[0.0012128269,0.00032369807,0.0005478765,0.003521728,0.0005829189,0.0013566266,0.0005093383,0.00056182,0.0005757613],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002950534,0.00020085745,0.01733757,0.04211031,0.0008350818,0.25602666,0.00062174065,0.00033319197,0.0049871607,0.00081713556,0.022140704,0.65429455],"study_design_scores_gemma":[0.000064313426,0.0001503236,0.026545973,0.011650257,0.0019166974,0.817163,0.0012628235,0.00024099316,0.0009685109,0.0009771883,0.13896999,0.00008993988],"about_ca_topic_score_codex":0.0014598103,"about_ca_topic_score_gemma":0.0025920223,"teacher_disagreement_score":0.003502878,"about_ca_system_score_codex":0.00034206346,"about_ca_system_score_gemma":0.00089365465,"threshold_uncertainty_score":0.0054487586},"labels":[],"label_agreement":null},{"id":"W1985705515","doi":"10.1016/j.jacl.2011.04.006","title":"Can conclusions that seem discordant be concordant after all?","year":2011,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Scopus; Medicine; Disease; Internal medicine; MEDLINE","score_opus":0.14278335019877653,"score_gpt":0.3949998836364707,"score_spread":0.2522165334376942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985705515","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002276402,0.0021978845,0.0007055146,0.9628187,0.028279278,0.000028759243,0.00005872757,0.000041171046,0.0035934797],"genre_scores_gemma":[0.023817563,0.0012951335,0.0020475376,0.8741345,0.097320706,0.000055029475,0.00006987441,0.000050278373,0.0012093923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.94091785,0.024544733,0.012199092,0.0052638496,0.013897191,0.003177356],"domain_scores_gemma":[0.67804056,0.24197134,0.021017037,0.014326566,0.034726992,0.009917502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05104815,0.0011079352,0.004458373,0.003501335,0.0064604003,0.009104173,0.0057793064,0.061995294,0.006512227],"category_scores_gemma":[0.4831833,0.0018564995,0.0029091104,0.0028691157,0.011105704,0.010446664,0.004937376,0.045143098,0.006160242],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009281651,0.00017317427,0.029947197,0.0008988495,0.0010974363,0.053878896,0.0034566387,0.00029174663,0.0005029593,0.023318268,0.8342517,0.051255047],"study_design_scores_gemma":[0.0013539898,0.00029475405,0.018881015,0.0050338646,0.0015953961,0.0897703,0.00880704,0.003698984,0.0016611197,0.28057885,0.5875892,0.00073556346],"about_ca_topic_score_codex":0.0022126746,"about_ca_topic_score_gemma":0.0040649106,"teacher_disagreement_score":0.061995294,"about_ca_system_score_codex":0.0048757303,"about_ca_system_score_gemma":0.00482446,"threshold_uncertainty_score":0.2699716},"labels":[],"label_agreement":null},{"id":"W1989736439","doi":"10.1016/j.jacl.2013.02.003","title":"Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care Research Institute; University of British Columbia; Heart and Stroke Foundation; St. Paul's Hospital","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Medicine; Diabetes mellitus; Internal medicine; Percentile; Cohort; Body mass index; Coronary artery disease; Type 2 Diabetes Mellitus; Incidence (geometry); Population; Cohort study; Type 2 diabetes; Retrospective cohort study; Cholesterol; Endocrinology; Environmental health","score_opus":0.023211957163326365,"score_gpt":0.28251050700187486,"score_spread":0.2592985498385485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989736439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882346,0.00016950548,0.00006132797,0.00006849196,0.000014011475,0.000004211435,0.0001535496,0.0000047571457,0.00070065],"genre_scores_gemma":[0.99962187,0.000043057036,0.0000343977,0.0000426845,0.000019073783,0.000003472216,0.00011677949,0.0000019036775,0.00011671212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994165,0.00018928654,0.00008603593,0.00012272097,0.00008862176,0.00009692385],"domain_scores_gemma":[0.99744725,0.0009183127,0.00071111147,0.00017535916,0.00025557348,0.00049241097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006218223,0.0003217413,0.00068969076,0.0012384008,0.0008190833,0.0011511649,0.0004614864,0.0009358096,0.0040899515],"category_scores_gemma":[0.0042829034,0.00044409113,0.0005164583,0.0012440225,0.00045215333,0.0008797806,0.00042741117,0.0007845172,0.0005715232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028876882,0.000065840046,0.9982299,0.000010503659,0.000044581986,0.00009048777,0.000082768696,0.000010082002,0.00024562597,0.0000128489455,0.000073194155,0.0008454106],"study_design_scores_gemma":[0.000021308288,0.00012283785,0.9989944,0.000004282366,0.000045088098,0.0003533109,0.00023580153,0.00008931599,0.000026641685,0.000027066808,0.000075279204,0.0000047652666],"about_ca_topic_score_codex":0.0033321336,"about_ca_topic_score_gemma":0.003520286,"teacher_disagreement_score":0.0040899515,"about_ca_system_score_codex":0.00022738262,"about_ca_system_score_gemma":0.0003262998,"threshold_uncertainty_score":0.013682246},"labels":[],"label_agreement":null},{"id":"W1990092121","doi":"10.1016/j.jacl.2011.07.005","title":"Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists","year":2011,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health; National Lipid Association; Abbott Laboratories; Merck; AstraZeneca; Genzyme; Pfizer","keywords":"Medicine; National Cholesterol Education Program; Hypertriglyceridemia; Residual risk; Apolipoprotein B; Internal medicine; Population; Cholesterol; Lipoprotein; Biomarker; Intensive care medicine; Metabolic syndrome; Physical therapy; Obesity; Environmental health; Triglyceride","score_opus":0.17471571907754718,"score_gpt":0.40713855426934764,"score_spread":0.23242283519180046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990092121","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.088420466,0.058028482,0.062204123,0.7098097,0.008825766,0.0017138915,0.0018931424,0.0015322635,0.0675722],"genre_scores_gemma":[0.53330946,0.027705742,0.19929634,0.20268881,0.019468393,0.0015960672,0.0025446212,0.0006859642,0.012704574],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901495,0.0033889564,0.0022954608,0.00076551124,0.0027698872,0.0006306431],"domain_scores_gemma":[0.9487199,0.02532798,0.0018069313,0.0011311186,0.01825607,0.004757995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018821934,0.00148037,0.003145849,0.0036046803,0.0020288841,0.0034935973,0.0026421505,0.010528237,0.004810451],"category_scores_gemma":[0.064215876,0.0009189471,0.002353459,0.0012703992,0.0011429263,0.0026617493,0.0015119697,0.00666992,0.0038600233],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011362255,0.0008012519,0.14490929,0.000919127,0.00083256967,0.010759651,0.0021586441,0.003328175,0.003417056,0.0014289576,0.5537794,0.27652967],"study_design_scores_gemma":[0.0035135855,0.0018087182,0.28501514,0.013158331,0.0036696575,0.05461903,0.014818084,0.03934964,0.006604993,0.034612425,0.54133576,0.0014945952],"about_ca_topic_score_codex":0.0063110865,"about_ca_topic_score_gemma":0.009965569,"teacher_disagreement_score":0.018821934,"about_ca_system_score_codex":0.0017517771,"about_ca_system_score_gemma":0.0044884314,"threshold_uncertainty_score":0.09954113},"labels":[],"label_agreement":null},{"id":"W2009075342","doi":"10.1016/j.jacl.2014.03.006","title":"Dramatic lowering of very high Lp(a) in response to niacin","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Niacin; Medicine; Lipoprotein(a); Myocardial infarction; Statin; Internal medicine; Cardiology; Lipoprotein; Gastroenterology; Pharmacology; Endocrinology; Cholesterol","score_opus":0.04193391566992468,"score_gpt":0.38808481098635605,"score_spread":0.3461508953164314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009075342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98488575,0.0031420917,0.0026778989,0.0018305038,0.0007272774,0.00012961643,0.0006024304,0.00046212436,0.0055423384],"genre_scores_gemma":[0.9933014,0.00080973405,0.00097319763,0.00053893845,0.00017941682,0.000059363654,0.000597282,0.00004494498,0.0034957402],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997253,0.00006588738,0.000032833268,0.00002815125,0.00006002193,0.000087690925],"domain_scores_gemma":[0.99957496,0.000099842866,0.000056403955,0.0000890921,0.000038020564,0.00014172775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035881955,0.00058386807,0.0010379367,0.00022643416,0.000317059,0.0006383994,0.00039748166,0.00077860337,0.0038627726],"category_scores_gemma":[0.00084339344,0.00030904321,0.000565767,0.00018953209,0.0005849127,0.00033237576,0.0004838615,0.0024377261,0.0006450625],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.110589825,0.0028348188,0.0039136303,0.00028992188,0.00022278317,0.0025447262,0.00017086529,0.00040888073,0.82247704,0.0003330504,0.0025274358,0.053687077],"study_design_scores_gemma":[0.005909536,0.055696525,0.16525869,0.0000468495,0.00040437566,0.006592809,0.000790403,0.0020993236,0.7446548,0.000791056,0.017652364,0.00010338051],"about_ca_topic_score_codex":0.00095567544,"about_ca_topic_score_gemma":0.0013798065,"teacher_disagreement_score":0.0038627726,"about_ca_system_score_codex":0.00028317812,"about_ca_system_score_gemma":0.00040125242,"threshold_uncertainty_score":0.012922227},"labels":[],"label_agreement":null},{"id":"W2010076356","doi":"10.1016/j.jacl.2012.10.005","title":"Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects","year":2012,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Nuts composition and effects","field":"Nursing","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Karadeniz Teknik Üniversitesi","keywords":"Medicine; Lipoprotein; Cholesterol; Internal medicine; Lipid profile; Endocrinology; Food science; Biology","score_opus":0.027139954960286428,"score_gpt":0.34298803815401496,"score_spread":0.31584808319372853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010076356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99836904,0.0010249283,0.000099472694,0.00008467198,0.000034018005,0.0000098278315,0.00004709879,0.000012406518,0.00031848723],"genre_scores_gemma":[0.9961392,0.0013378795,0.0005132266,0.00017165692,0.000025356829,0.000009420571,0.00012503036,0.000005460211,0.0016727027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993896,0.00001645321,0.0000058236615,0.00001177977,0.000011524046,0.000015380076],"domain_scores_gemma":[0.99990845,0.000019082418,0.000015255411,0.000009576136,0.000013767061,0.000033915272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002376321,0.00042409735,0.0006060705,0.00022224487,0.0002952731,0.00025153812,0.00019799174,0.00032671538,0.0016259243],"category_scores_gemma":[0.0003132495,0.00020699897,0.0003110396,0.00016648538,0.00015470288,0.00021401363,0.00024709784,0.00063278124,0.00016023306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2647177,0.037701234,0.09426408,0.0019625109,0.004198599,0.00067314657,0.0010328409,0.0006623515,0.36244914,0.00041486468,0.0017170165,0.23020649],"study_design_scores_gemma":[0.010359531,0.0869755,0.84272504,0.0002742603,0.0067676497,0.00038157537,0.00095886603,0.0017999513,0.042153873,0.00069924066,0.0068262285,0.000078362114],"about_ca_topic_score_codex":0.0035566082,"about_ca_topic_score_gemma":0.007841037,"teacher_disagreement_score":0.0035566082,"about_ca_system_score_codex":0.00014039937,"about_ca_system_score_gemma":0.00025764285,"threshold_uncertainty_score":0.007071793},"labels":[],"label_agreement":null},{"id":"W2011950080","doi":"10.1016/j.jacl.2009.10.001","title":"Acquired severe hypercholesterolemia and hypoalphalipoproteinemia","year":2009,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"McGill University Health Centre","keywords":"Medicine; Body mass index; Diabetes mellitus; Obesity; Myocardial infarction; Pediatrics; Internal medicine; Coronary artery disease; Family history; Nephropathy; Endocrinology","score_opus":0.05398766015217993,"score_gpt":0.3847052830784341,"score_spread":0.3307176229262542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011950080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894895,0.00033020868,0.0005187565,0.00068259396,0.00007383617,0.00004886047,0.00023326973,0.000035550343,0.008587446],"genre_scores_gemma":[0.99842286,0.00013347101,0.0002025694,0.00014870724,0.0001337442,0.0000068170416,0.00014333628,0.000005189754,0.00080322166],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99955934,0.000085405874,0.00006766406,0.0000493133,0.00010246848,0.00013580722],"domain_scores_gemma":[0.9991769,0.00015170728,0.00019670332,0.000082506835,0.000066309134,0.0003258516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044262526,0.0011373856,0.00078017486,0.0008797487,0.00094344304,0.00059293397,0.00055061845,0.0014463795,0.005602136],"category_scores_gemma":[0.002209955,0.00045483655,0.00048448087,0.00059396203,0.0013851501,0.0007384458,0.0010708158,0.001732407,0.0005522691],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037796616,0.0011950952,0.53347296,0.00014451677,0.00019189616,0.4427265,0.00027815244,0.00023289128,0.007943956,0.0021030684,0.0012945761,0.0066366834],"study_design_scores_gemma":[0.0002538683,0.0019427,0.39409128,0.000024615862,0.00007778952,0.59895533,0.00035292286,0.0008328202,0.0013214429,0.0011310756,0.0009865053,0.000029652016],"about_ca_topic_score_codex":0.0013875741,"about_ca_topic_score_gemma":0.0015799602,"teacher_disagreement_score":0.005602136,"about_ca_system_score_codex":0.00042700412,"about_ca_system_score_gemma":0.0008279691,"threshold_uncertainty_score":0.018740952},"labels":[],"label_agreement":null},{"id":"W2012985550","doi":"10.1016/j.jacl.2014.03.007","title":"Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; McGill University; McGill University Health Centre","funders":"Baxter Healthcare Corporation; Astellas Pharma","keywords":"Medicine; Peritoneal dialysis; Internal medicine; Endocrinology; Gastroenterology","score_opus":0.059987654421789015,"score_gpt":0.4067866544839812,"score_spread":0.3467990000621922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012985550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95133483,0.040505197,0.000458969,0.0015881532,0.0004851855,0.00087189634,0.0008286415,0.000044835168,0.0038823432],"genre_scores_gemma":[0.99157083,0.0047664936,0.0006810151,0.00073297834,0.0002228344,0.0008114762,0.0005028686,0.0000067286373,0.0007047219],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99723023,0.0021405474,0.00017516542,0.00017400213,0.00009336321,0.0001868302],"domain_scores_gemma":[0.9976199,0.0010589004,0.0005995105,0.00019388428,0.00014244049,0.00038533387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004936179,0.0008199184,0.0020535844,0.0002693728,0.0003388985,0.0011558495,0.0007814532,0.001172345,0.002915323],"category_scores_gemma":[0.005407731,0.00035040634,0.0022191396,0.00040350002,0.00060785166,0.0008270429,0.0005990452,0.0019081843,0.00021719748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97222406,0.0014411121,0.0032043424,0.0012218325,0.0037936992,0.00003610767,0.000027318007,0.00023586197,0.00046176315,0.00016179249,0.00045886362,0.016733278],"study_design_scores_gemma":[0.9090636,0.056848545,0.02157485,0.000398196,0.008288642,0.00008773029,0.00005480678,0.00055554695,0.0006778764,0.0004738493,0.001946492,0.000029954352],"about_ca_topic_score_codex":0.00044716988,"about_ca_topic_score_gemma":0.0010017357,"teacher_disagreement_score":0.004936179,"about_ca_system_score_codex":0.00051336846,"about_ca_system_score_gemma":0.0005941825,"threshold_uncertainty_score":0.026105285},"labels":[],"label_agreement":null},{"id":"W2019242604","doi":"10.1016/j.jacl.2012.02.006","title":"Cholesterol trapping in Niemann-Pick disease type B fibroblasts can be relieved by expressing the phosphotyrosine binding domain of GULP","year":2012,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer research","score_opus":0.09243287201142239,"score_gpt":0.4098723468506847,"score_spread":0.31743947483926227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019242604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953962,0.0008391549,0.0012986405,0.0002908065,0.00006431683,0.000020554247,0.0006343057,0.00009417131,0.0013618277],"genre_scores_gemma":[0.99469006,0.0004855678,0.0015256843,0.00007885622,0.000016630183,0.00003613718,0.0007942655,0.00003954415,0.0023333074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975675,0.000056237004,0.000049359085,0.000024293759,0.00006397044,0.000049402694],"domain_scores_gemma":[0.999723,0.00006769703,0.00005856204,0.000052060732,0.000021025871,0.00007767663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029005963,0.00046826247,0.0003020652,0.00030343505,0.0004527669,0.0005519939,0.00041516218,0.00052352913,0.0014614689],"category_scores_gemma":[0.00022919093,0.0002823841,0.00028656542,0.00020667337,0.00041313845,0.00030071725,0.0003633534,0.0008014697,0.00090383465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019249454,0.0000433032,0.0000881532,0.000029539311,0.000007048453,0.00021889216,0.00002885765,0.000056718858,0.99865156,0.00012606464,0.00007588526,0.00048151682],"study_design_scores_gemma":[0.0000893247,0.0001873129,0.0018338956,0.000009036293,0.000021829668,0.00076584856,0.0000809851,0.001095803,0.9928504,0.000069800335,0.0029850856,0.000010683158],"about_ca_topic_score_codex":0.001758258,"about_ca_topic_score_gemma":0.0021146145,"teacher_disagreement_score":0.001758258,"about_ca_system_score_codex":0.00037102838,"about_ca_system_score_gemma":0.0003830901,"threshold_uncertainty_score":0.0048891306},"labels":[],"label_agreement":null},{"id":"W2024423016","doi":"10.1016/j.jacl.2010.08.018","title":"Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?","year":2010,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Atheroma; Clinical endpoint; Antithrombotic; Placebo; Internal medicine; Acute coronary syndrome; Apolipoprotein B; Cardiology; Lipoprotein; Endothelium; Clinical trial; Urology; Cholesterol; Gastroenterology; Endocrinology; Myocardial infarction; Pathology","score_opus":0.06535762871334946,"score_gpt":0.3973418951462419,"score_spread":0.33198426643289247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024423016","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074745836,0.44352007,0.0147441635,0.52158624,0.006392524,0.000055976598,0.00030008686,0.00011506175,0.0058112442],"genre_scores_gemma":[0.12283807,0.649711,0.030866418,0.1389732,0.054166414,0.00026730367,0.00038321922,0.00010787137,0.002686556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9852202,0.009946058,0.0014737394,0.001269351,0.0016855111,0.00040520413],"domain_scores_gemma":[0.79599005,0.16597089,0.010813926,0.0061606728,0.01657676,0.004487727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05145413,0.0013548867,0.0053268215,0.0025450967,0.0016221822,0.011060106,0.0024977801,0.0076948716,0.008295563],"category_scores_gemma":[0.09159739,0.0009986032,0.001617955,0.0024624693,0.0077592437,0.026264464,0.00365219,0.014354932,0.0014097677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017530371,0.0008524221,0.0681478,0.005239517,0.0012982154,0.00039663797,0.0007352649,0.0014206136,0.0011873883,0.12403419,0.05671632,0.73821855],"study_design_scores_gemma":[0.0018116898,0.0028086733,0.04454584,0.024199916,0.0028194955,0.0019340214,0.0069635925,0.010101812,0.0014285189,0.5177416,0.38481012,0.00083465985],"about_ca_topic_score_codex":0.0034895146,"about_ca_topic_score_gemma":0.008754798,"teacher_disagreement_score":0.05145413,"about_ca_system_score_codex":0.0028517437,"about_ca_system_score_gemma":0.009817282,"threshold_uncertainty_score":0.2721187},"labels":[],"label_agreement":null},{"id":"W2024620867","doi":"10.1016/j.jacl.2008.01.005","title":"Dietary agents that target gastrointestinal and hepatic handling of bile acids and cholesterol","year":2008,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Gastroenterology; Cholesterol; Internal medicine","score_opus":0.1426209594706047,"score_gpt":0.38248280189601014,"score_spread":0.23986184242540542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024620867","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611879,0.0203604,0.00412958,0.0021884004,0.0006711446,0.00032051874,0.0004349313,0.0002059708,0.0105012],"genre_scores_gemma":[0.96246886,0.017661756,0.009154449,0.0014356219,0.00039610578,0.00018600255,0.00036073875,0.000061804414,0.00827474],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998456,0.000036155412,0.000023595867,0.00002210022,0.000034699293,0.00003784663],"domain_scores_gemma":[0.99981266,0.000035394052,0.000050473765,0.000014298526,0.000033802433,0.000053383217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018981386,0.00048854284,0.00082666,0.0005668595,0.00029842329,0.00046734608,0.00022245962,0.00079464144,0.00402601],"category_scores_gemma":[0.00061147084,0.00022550469,0.00031765414,0.00029784342,0.00031252642,0.0004144767,0.00030570923,0.0012670519,0.00061706215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039178878,0.0046218494,0.003947757,0.0015815061,0.00046606135,0.00072146417,0.00011965948,0.0004349115,0.8182325,0.0018472124,0.0022041965,0.12664405],"study_design_scores_gemma":[0.011454882,0.031248722,0.026927045,0.0004862362,0.0012705817,0.0019732572,0.0004981973,0.0016370254,0.8720506,0.0016135758,0.05076256,0.0000773815],"about_ca_topic_score_codex":0.0009949304,"about_ca_topic_score_gemma":0.0019154149,"teacher_disagreement_score":0.00402601,"about_ca_system_score_codex":0.00028667747,"about_ca_system_score_gemma":0.0004722297,"threshold_uncertainty_score":0.013468325},"labels":[],"label_agreement":null},{"id":"W2034588349","doi":"10.1016/j.jacl.2010.01.005","title":"When is equal not equal?","year":2010,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Royal Victoria Regional Health Centre; McGill University Health Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Apolipoprotein B; Converse; Cholesterol; Hazard ratio; Disease; Hazard; Internal medicine; Lipoprotein; Confidence interval; Biology","score_opus":0.28010152918002335,"score_gpt":0.5100878414208259,"score_spread":0.22998631224080252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034588349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045409615,0.99460983,0.00006801971,0.0030959907,0.001246867,0.0000021710932,0.000007093287,0.0000020604625,0.00092258485],"genre_scores_gemma":[0.0011794695,0.9920695,0.00020764928,0.00441637,0.0014363927,0.000007209199,0.000013568005,0.0000025976021,0.0006672848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865603,0.000492806,0.00026383213,0.0001405124,0.00034009307,0.00010665945],"domain_scores_gemma":[0.996834,0.0022932568,0.00030441416,0.0000685708,0.00036167147,0.00013805709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003561167,0.00071671064,0.0029085695,0.002329392,0.0006365157,0.0025326118,0.0011233033,0.0026346259,0.0063403393],"category_scores_gemma":[0.008993606,0.00038059228,0.00062970666,0.0027142756,0.0026216977,0.005100709,0.0016316397,0.0038719173,0.0012280623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017553187,0.00004182102,0.00019103476,0.022123037,0.00022518351,0.00019121375,0.00019196013,0.00009837661,0.00017059257,0.01834012,0.09410487,0.86414623],"study_design_scores_gemma":[0.00007734038,0.00004786641,0.0005334492,0.023515904,0.00035727842,0.000993171,0.00033159083,0.000036966747,0.00008343697,0.013629607,0.9603703,0.000023030601],"about_ca_topic_score_codex":0.0026343702,"about_ca_topic_score_gemma":0.0070869406,"teacher_disagreement_score":0.0063403393,"about_ca_system_score_codex":0.0016847253,"about_ca_system_score_gemma":0.004843251,"threshold_uncertainty_score":0.021210492},"labels":[],"label_agreement":null},{"id":"W2039357029","doi":"10.1016/j.jacl.2013.06.010","title":"Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; McMaster University; University of Toronto; Hospital for Sick Children","funders":"AstraZeneca","keywords":"Medicine; Rosuvastatin; Familial hypercholesterolemia; Baseline (sea); Pediatrics; Internal medicine; Physical therapy; Cholesterol","score_opus":0.1438911063031317,"score_gpt":0.4072582887311235,"score_spread":0.26336718242799184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039357029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973361,0.00030515535,0.00046026823,0.000067812594,0.00001211462,0.0005874201,0.0008205833,0.0000059064755,0.00040463643],"genre_scores_gemma":[0.9940773,0.00036374317,0.0018433395,0.00016456941,0.00005174886,0.0013574245,0.0016651438,0.000014096054,0.00046254921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967514,0.0019869856,0.00021118174,0.00046890532,0.00022502423,0.00035654003],"domain_scores_gemma":[0.99818206,0.00037543057,0.0005039542,0.0002629302,0.00032754947,0.0003480802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026279893,0.0012519783,0.001291994,0.0006054046,0.0010083296,0.0006599718,0.000595566,0.00074115087,0.0019241936],"category_scores_gemma":[0.0035300024,0.00062328816,0.0009095616,0.001537177,0.0008637086,0.00066253036,0.00045486604,0.00074755907,0.00033743968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05582126,0.005908459,0.92269784,0.00016804607,0.0007277866,0.0010603056,0.0007025096,0.00054837234,0.003983876,0.00033814137,0.00055184035,0.0074915024],"study_design_scores_gemma":[0.011827065,0.05645219,0.92026705,0.00007021589,0.0011607686,0.0015779376,0.0019543625,0.00070697896,0.0022458148,0.0002552387,0.0034188246,0.000063552725],"about_ca_topic_score_codex":0.010322744,"about_ca_topic_score_gemma":0.008892078,"teacher_disagreement_score":0.010322744,"about_ca_system_score_codex":0.0015712394,"about_ca_system_score_gemma":0.0024292725,"threshold_uncertainty_score":0.020525336},"labels":[],"label_agreement":null},{"id":"W2042953537","doi":"10.1016/j.jacl.2012.12.004","title":"Counterpoint: Statins do reduce fatal events","year":2013,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Simvastatin; Scopus; Statin; Placebo; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Meta-analysis; Cholesterol lowering; MEDLINE; Cholesterol; Alternative medicine; Pathology","score_opus":0.08235070885245235,"score_gpt":0.41377649927365573,"score_spread":0.33142579042120335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042953537","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005382078,0.0009729086,0.000091706424,0.9809724,0.014014247,0.000011168953,0.0000836522,0.000035809877,0.0032799267],"genre_scores_gemma":[0.0070083085,0.001253819,0.00035653583,0.90707505,0.0785747,0.000043270757,0.00006442658,0.000024810986,0.005599191],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785197,0.00071413605,0.00027390945,0.00027679617,0.00058024307,0.00030294995],"domain_scores_gemma":[0.9896288,0.0062044566,0.0009487129,0.0002988793,0.0014558679,0.001463251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025939557,0.0010072029,0.002268278,0.0008483325,0.0027178016,0.003145559,0.0017083236,0.051730577,0.012577011],"category_scores_gemma":[0.028785946,0.0006100679,0.0015747629,0.0008366143,0.0021072628,0.0023407103,0.0012260221,0.03782389,0.010164907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030618205,0.00008520096,0.001234833,0.00008523274,0.000072482835,0.002086712,0.000055961053,0.00012768303,0.00022557875,0.0030304915,0.9729524,0.019737279],"study_design_scores_gemma":[0.0019736467,0.0006435473,0.0056208256,0.0011600306,0.00044756423,0.006479082,0.00048239104,0.0025893536,0.00097626355,0.03403565,0.9453839,0.00020769928],"about_ca_topic_score_codex":0.003904432,"about_ca_topic_score_gemma":0.007340394,"teacher_disagreement_score":0.051730577,"about_ca_system_score_codex":0.003552374,"about_ca_system_score_gemma":0.0032509333,"threshold_uncertainty_score":0.042074263},"labels":[],"label_agreement":null},{"id":"W2053837632","doi":"10.1016/j.jacl.2014.02.092","title":"Targeting Visceral Adiposity Loss as a Mean to Optimize Vitamin D Levels? Results From a Lifestyle Intervention Study in Viscerally Obese Men*","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Sainte Foy","funders":"","keywords":"Medicine; Obesity; Vitamin D and neurology; Intervention (counseling); Vitamin; Internal medicine; Physical therapy; Gerontology; Endocrinology; Psychiatry","score_opus":0.0704602800755001,"score_gpt":0.4379381268401353,"score_spread":0.3674778467646352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053837632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939084,0.0034823408,0.0004039326,0.0009170067,0.000112667956,0.00025241467,0.00018767903,0.000014137948,0.00072146347],"genre_scores_gemma":[0.9950117,0.0018381813,0.0010109193,0.00085253944,0.00017013008,0.00018723877,0.00021964939,0.0000059954186,0.0007035973],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991542,0.0004825545,0.00010930862,0.00008851254,0.00006923182,0.000096129304],"domain_scores_gemma":[0.998302,0.0007944281,0.00032240115,0.00018038542,0.00015302688,0.0002477718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00422186,0.00081074104,0.0011324061,0.00027106388,0.00050375675,0.0010113622,0.00047885656,0.0013376597,0.0021041199],"category_scores_gemma":[0.0034151266,0.0004890999,0.001888946,0.00051440566,0.00070781464,0.0005454427,0.00032496272,0.0014038313,0.00030969857],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69169587,0.04111556,0.13712378,0.002146324,0.01588375,0.00030357984,0.0010917301,0.00052855886,0.017950336,0.00036089265,0.0010682556,0.09073138],"study_design_scores_gemma":[0.13268645,0.28281143,0.5235644,0.00059120945,0.04654786,0.00020223556,0.0014065173,0.0008929883,0.005817365,0.00053035317,0.004834332,0.00011483356],"about_ca_topic_score_codex":0.005217152,"about_ca_topic_score_gemma":0.0067111133,"teacher_disagreement_score":0.005217152,"about_ca_system_score_codex":0.00037220737,"about_ca_system_score_gemma":0.00090009364,"threshold_uncertainty_score":0.022327602},"labels":[],"label_agreement":null},{"id":"W2062834072","doi":"10.1016/j.jacl.2007.12.006","title":"Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice","year":2008,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Ezetimibe; Apolipoprotein B; Internal medicine; Percentile; Cholesterol; Population; Endocrinology; Lipoprotein; Statistics; Environmental health; Mathematics","score_opus":0.24887842144101638,"score_gpt":0.47160715150342325,"score_spread":0.22272873006240687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062834072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9243537,0.036276795,0.006142426,0.01747187,0.0010516483,0.0001678859,0.00048946164,0.00013332172,0.013912928],"genre_scores_gemma":[0.9892105,0.0021300688,0.00440066,0.003115734,0.00057288486,0.000063195206,0.0001034414,0.000022319075,0.00038119892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98786515,0.007076589,0.0014398841,0.0013846868,0.0019684327,0.00026525557],"domain_scores_gemma":[0.95652115,0.033539124,0.0031678039,0.0021736834,0.003515086,0.0010832013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016378118,0.00067427335,0.0027034804,0.0013485138,0.0006837662,0.0024326977,0.0011678337,0.0026763768,0.0016994592],"category_scores_gemma":[0.069460325,0.0004560913,0.00057870365,0.0015650062,0.001278671,0.001445298,0.00092164346,0.002140013,0.0005615564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014292844,0.0011222358,0.74924016,0.0009724431,0.0015302895,0.0006210867,0.0014206489,0.00092669757,0.005666844,0.0014814913,0.0030150895,0.21971025],"study_design_scores_gemma":[0.0011374766,0.003821081,0.9691078,0.00040927433,0.0011035238,0.0017039516,0.0015685088,0.004547944,0.0037680506,0.007764344,0.0049518184,0.00011628803],"about_ca_topic_score_codex":0.0014414919,"about_ca_topic_score_gemma":0.0023368795,"teacher_disagreement_score":0.016378118,"about_ca_system_score_codex":0.00081554276,"about_ca_system_score_gemma":0.00088221126,"threshold_uncertainty_score":0.086616814},"labels":[],"label_agreement":null},{"id":"W2065290896","doi":"10.1016/j.jacl.2014.02.013","title":"An assessment by the Statin Cognitive Safety Task Force: 2014 update","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute for Aging; McMaster University; University of Waterloo","funders":"Genentech; National Institutes of Health; H. Lundbeck A/S; Bayer HealthCare; Amarin Corporation; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Relevance (law); MEDLINE; Cognition; Evidence-based medicine; Association (psychology); Task (project management); Task force; Systematic review; Statin; Alternative medicine; Medical education; Applied psychology; Psychology; Psychiatry; Pathology; Psychotherapist","score_opus":0.31391922341651357,"score_gpt":0.5586072982250093,"score_spread":0.24468807480849575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065290896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036164183,0.36891833,0.017599527,0.27292222,0.04701008,0.0030100846,0.20758739,0.0010559761,0.04573231],"genre_scores_gemma":[0.12627776,0.43033963,0.0357921,0.08231169,0.032239545,0.0077693905,0.26702753,0.00075414486,0.01748816],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98488635,0.0026936964,0.004143397,0.0006921099,0.0071007325,0.0004836742],"domain_scores_gemma":[0.9006616,0.018834077,0.014528393,0.0023777778,0.060702812,0.002895347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03413462,0.0020163553,0.002704971,0.009401898,0.0006580596,0.0029792942,0.002872427,0.0029479617,0.0034750192],"category_scores_gemma":[0.092239425,0.0009018148,0.0033001897,0.009218899,0.0005934838,0.003244094,0.0030825224,0.0034487871,0.0032235198],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007898112,0.00021187846,0.031802054,0.0037653367,0.0012234474,0.00006844058,0.0001762407,0.00079302676,0.00017322824,0.00083747186,0.67001593,0.2901431],"study_design_scores_gemma":[0.0014369258,0.00041567982,0.17052513,0.024131477,0.0049124304,0.0004273431,0.00046698202,0.0013295427,0.0008943402,0.0021614367,0.7930357,0.00026298987],"about_ca_topic_score_codex":0.043257516,"about_ca_topic_score_gemma":0.067148626,"teacher_disagreement_score":0.043257516,"about_ca_system_score_codex":0.0041782623,"about_ca_system_score_gemma":0.015679656,"threshold_uncertainty_score":0.18052322},"labels":[],"label_agreement":null},{"id":"W2065408044","doi":"10.1016/j.jacl.2008.04.006","title":"Elevated atherogenic lipoproteins in childhood: Risk, prevention, and treatment","year":2008,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Ezetimibe; Overweight; Childhood obesity; Internal medicine; Obesity; Insulin resistance; Endocrinology; Pediatrics; Cholesterol","score_opus":0.06556603295755499,"score_gpt":0.370928531869825,"score_spread":0.30536249891227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065408044","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8568114,0.12941577,0.0010580444,0.0073506352,0.0003227801,0.0000520596,0.0006903146,0.00006182154,0.0042372015],"genre_scores_gemma":[0.9324623,0.06318826,0.001954585,0.00048268284,0.0004577439,0.00006365695,0.00043020822,0.00001128905,0.0009493134],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961996,0.00011460915,0.000042247724,0.000035658795,0.00008238527,0.00010508385],"domain_scores_gemma":[0.9994424,0.00012223533,0.00014589625,0.000019007863,0.00009316358,0.00017727932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006356915,0.0004909559,0.0010614687,0.00073790306,0.00062432274,0.0005492946,0.0002933197,0.00088418677,0.0006169519],"category_scores_gemma":[0.0016507526,0.00029459008,0.0004618081,0.0008648097,0.00038194802,0.0003183235,0.00040273875,0.0011939246,0.00011469109],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002557548,0.0014187525,0.8880584,0.00052195525,0.00028451325,0.0015092073,0.00029425803,0.00056125433,0.0019235753,0.0016351113,0.0039717196,0.09726361],"study_design_scores_gemma":[0.00043230187,0.0016311883,0.97819716,0.00081086793,0.00069190096,0.0066164075,0.00092231296,0.0010324811,0.0022787217,0.0014596521,0.005885257,0.00004190079],"about_ca_topic_score_codex":0.0074933474,"about_ca_topic_score_gemma":0.009068769,"teacher_disagreement_score":0.0074933474,"about_ca_system_score_codex":0.00091687177,"about_ca_system_score_gemma":0.0016139784,"threshold_uncertainty_score":0.014899433},"labels":[],"label_agreement":null},{"id":"W2068685982","doi":"10.1016/j.jacl.2012.10.011","title":"HDL deficiency due to a new insertion mutation (ApoA-INashua) and review of the literature","year":2012,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Endocrinology; Niacin; Ezetimibe; Cholesterol; Apolipoprotein B; Amino acid; Leucine; Fenofibrate; Glycine; Arginine; Biochemistry; Biology","score_opus":0.10466234383041302,"score_gpt":0.4262755057219348,"score_spread":0.3216131618915218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068685982","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002474352,0.9992694,0.000046845616,0.0001169265,0.00008068209,0.0000027909202,0.00002544529,0.0000030984372,0.0002073755],"genre_scores_gemma":[0.0011365219,0.9983341,0.0001381138,0.00015099082,0.0001061793,0.0000028666411,0.000036193134,6.126338e-7,0.00009438289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997156,0.00003436863,0.00010717548,0.000056004556,0.00006893087,0.000017902144],"domain_scores_gemma":[0.99928135,0.0004078414,0.00017874285,0.000013093772,0.0000872124,0.00003180778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005260166,0.000839964,0.00226984,0.0040115695,0.00024038512,0.0008896759,0.0010026103,0.00095388293,0.002282677],"category_scores_gemma":[0.0011944717,0.0002787561,0.00079039304,0.0033641208,0.00038294483,0.0011242352,0.00051021535,0.00083024957,0.0006321718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029582056,0.00009887141,0.0019543588,0.09780682,0.00068763195,0.0060008643,0.00011796402,0.00028524606,0.002201229,0.0010742553,0.026073081,0.86340386],"study_design_scores_gemma":[0.00015176418,0.00038807967,0.01462762,0.06821291,0.007127052,0.075836666,0.0006522439,0.00032032348,0.0019097816,0.0026970007,0.8279125,0.00016404221],"about_ca_topic_score_codex":0.0014690568,"about_ca_topic_score_gemma":0.0024090735,"teacher_disagreement_score":0.0040115695,"about_ca_system_score_codex":0.00036103892,"about_ca_system_score_gemma":0.0011398813,"threshold_uncertainty_score":0.0076363087},"labels":[],"label_agreement":null},{"id":"W2075673874","doi":"10.1016/j.jacl.2011.06.014","title":"A novel mutation of apolipoprotein B in a French Canadian family with homozygous hypobetalipoproteinemia","year":2011,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Apolipoprotein B; Mutation; Genetics; Apolipoprotein C2; Internal medicine; Gene; Cholesterol; Very low-density lipoprotein; Lipoprotein; Biology","score_opus":0.0900809625990871,"score_gpt":0.33612914707167874,"score_spread":0.24604818447259164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075673874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744718,0.0019060677,0.002650239,0.004627957,0.0006821557,0.00013299748,0.0007986561,0.00024068338,0.014489457],"genre_scores_gemma":[0.99348867,0.00043489574,0.0012953628,0.0006850493,0.0002227998,0.000014845467,0.00010758657,0.0000635601,0.0036873291],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9992409,0.000048099984,0.00006366369,0.00018428818,0.00018695353,0.0002762249],"domain_scores_gemma":[0.998401,0.0004949765,0.00018421563,0.000053331587,0.00021631514,0.000650238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003119629,0.003564319,0.0011476481,0.0040853005,0.008196755,0.0015883187,0.0027989913,0.005037901,0.005338881],"category_scores_gemma":[0.0028706286,0.0007462142,0.0016317655,0.0028240103,0.0032945322,0.000603994,0.0012357992,0.0024975736,0.00073296984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087320266,0.000053232827,0.0057838494,0.000021334707,0.000023791257,0.98619384,0.00051540486,0.00013625615,0.0047607534,0.0004888559,0.0005313116,0.0014041296],"study_design_scores_gemma":[0.00006129279,0.00007899333,0.019892817,0.00004445011,0.0001403888,0.9730601,0.00091322645,0.0009433118,0.002068672,0.00032497008,0.0023878787,0.00008385437],"about_ca_topic_score_codex":0.43323675,"about_ca_topic_score_gemma":0.3353386,"teacher_disagreement_score":0.5667633,"about_ca_system_score_codex":0.005433057,"about_ca_system_score_gemma":0.009700974,"threshold_uncertainty_score":0.86143005},"labels":[],"label_agreement":null},{"id":"W2079102359","doi":"10.1016/j.jacl.2011.05.004","title":"Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement","year":2011,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Medicine; Reliability (semiconductor); Cholesterol; Lipoprotein; Apolipoprotein C2; Internal medicine; High-density lipoprotein; Endocrinology; Very low-density lipoprotein","score_opus":0.10932544190154245,"score_gpt":0.382787442917427,"score_spread":0.2734620010158846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079102359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009096185,0.9980465,0.00030718488,0.0002293221,0.00011945893,0.000006471477,0.000045667926,0.000004747551,0.00033114027],"genre_scores_gemma":[0.011675094,0.98572296,0.0015011511,0.00032404493,0.00038648112,0.00001897972,0.000147913,0.0000062662352,0.00021706271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939545,0.0016847365,0.00090068724,0.0011767078,0.002168158,0.0001154039],"domain_scores_gemma":[0.9739499,0.017673455,0.0029817673,0.0005571142,0.004637156,0.00020059515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01239396,0.0016733961,0.00585388,0.0033806844,0.00023407488,0.0017546503,0.0029767558,0.0020020849,0.00083894696],"category_scores_gemma":[0.019730069,0.0010215888,0.0014891608,0.003122118,0.0013941646,0.0015188233,0.0009025696,0.0014724958,0.0007625271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045229832,0.000070581154,0.017286101,0.018711876,0.0013704166,0.00011180918,0.00009908806,0.00029681504,0.00070655136,0.0008554655,0.0063710054,0.95366806],"study_design_scores_gemma":[0.0006263159,0.0019920238,0.34497842,0.06564843,0.018208608,0.014278021,0.001531199,0.0037119724,0.010798482,0.010311653,0.52708036,0.00083454454],"about_ca_topic_score_codex":0.004037071,"about_ca_topic_score_gemma":0.0049407934,"teacher_disagreement_score":0.01239396,"about_ca_system_score_codex":0.0010691864,"about_ca_system_score_gemma":0.0022814057,"threshold_uncertainty_score":0.065546334},"labels":[],"label_agreement":null},{"id":"W2081834793","doi":"10.1016/j.jacl.2007.07.006","title":"Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B","year":2007,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval; Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Medicine; Internal medicine; Triglyceride; Lipoprotein; Cholesterol; Endocrinology; Gastroenterology","score_opus":0.04868595796761922,"score_gpt":0.36678412956928524,"score_spread":0.31809817160166604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081834793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877971,0.0012198362,0.0024368577,0.0012434406,0.00022177496,0.00013169678,0.00017834347,0.0000438645,0.006727032],"genre_scores_gemma":[0.99712676,0.0004010677,0.0010229776,0.0004116383,0.00019008882,0.000021303467,0.00019441078,0.000006223583,0.0006254944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968493,0.000059309623,0.000054143216,0.000034228626,0.00009575553,0.00007164279],"domain_scores_gemma":[0.9991966,0.00027285854,0.00007594992,0.000044670975,0.00014119875,0.00026874043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070149556,0.0007909287,0.0006704103,0.0012603507,0.00072985305,0.0005273095,0.0006409644,0.0013406472,0.0021349844],"category_scores_gemma":[0.0022227322,0.00039070926,0.00052367634,0.0005488992,0.00067577616,0.0005271457,0.00043647044,0.0013292758,0.00055063365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001034826,0.00022535028,0.9344873,0.000045082048,0.000046804966,0.05031903,0.000094937066,0.00008689022,0.0053122123,0.00024717336,0.0010074512,0.0070928894],"study_design_scores_gemma":[0.00022665052,0.0012723749,0.73477757,0.00009410789,0.00016604719,0.25221723,0.00082553667,0.0028856506,0.0045323446,0.0011684177,0.001793987,0.000040069306],"about_ca_topic_score_codex":0.002178759,"about_ca_topic_score_gemma":0.002772625,"teacher_disagreement_score":0.002178759,"about_ca_system_score_codex":0.0004186139,"about_ca_system_score_gemma":0.0010305287,"threshold_uncertainty_score":0.007142186},"labels":[],"label_agreement":null},{"id":"W2087386731","doi":"10.1016/j.jacl.2010.11.004","title":"Etiology and risk of lactescent plasma and severe hypertriglyceridemia","year":2010,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hypertriglyceridemia; Etiology; Intensive care medicine; Internal medicine; Triglyceride; Cholesterol","score_opus":0.029268728936129498,"score_gpt":0.35950293919097487,"score_spread":0.3302342102548454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087386731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828076,0.00043484356,0.000085876876,0.00012658574,0.000010731923,0.0000030310152,0.00007684128,0.000008530489,0.0009728777],"genre_scores_gemma":[0.9994149,0.00017113214,0.00007134761,0.00002398037,0.000025514753,0.0000016330275,0.000067144516,0.0000029427536,0.00022145131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997222,0.000103479564,0.000029782877,0.00003396825,0.00004556917,0.00006507437],"domain_scores_gemma":[0.9983381,0.0004099455,0.0006441062,0.00011497387,0.000080803315,0.00041205698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003560428,0.00045563807,0.0004015771,0.00122806,0.0005533976,0.0007889956,0.00034853313,0.00088127685,0.0032139001],"category_scores_gemma":[0.0027274862,0.00041557342,0.00042168322,0.0009638503,0.00041555043,0.00041738778,0.0005336814,0.0011360002,0.0003197762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006249227,0.00007495612,0.9963123,0.000007061128,0.000047994705,0.0009239129,0.000044643497,0.00003130858,0.00060916005,0.00007135085,0.00005538531,0.0011969733],"study_design_scores_gemma":[0.000022370174,0.00021426546,0.9917949,0.000010044732,0.000076735254,0.006212432,0.00032656844,0.00057528255,0.00026011316,0.00029831563,0.00019645815,0.000012593955],"about_ca_topic_score_codex":0.0017957815,"about_ca_topic_score_gemma":0.0012191195,"teacher_disagreement_score":0.0032139001,"about_ca_system_score_codex":0.00020884543,"about_ca_system_score_gemma":0.000392658,"threshold_uncertainty_score":0.010751605},"labels":[],"label_agreement":null},{"id":"W2096331435","doi":"10.1016/j.jacl.2013.01.007","title":"Point: Why statins have failed to reduce mortality in just about anybody","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Scopus; Medicine; Statin; Cholesterol; Event (particle physics); Meta-analysis; Clinical trial; Internal medicine; MEDLINE","score_opus":0.11087970980585737,"score_gpt":0.4464494420404469,"score_spread":0.3355697322345895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096331435","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052792585,0.0021479875,0.00023247353,0.9873439,0.008476845,0.0000045227453,0.00003834974,0.000022683775,0.001205283],"genre_scores_gemma":[0.018644925,0.0028363077,0.0006759194,0.9526949,0.020305961,0.000015688198,0.00004811208,0.000043200005,0.0047351094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99436754,0.0016437626,0.0006025236,0.0008706834,0.0019200266,0.0005953495],"domain_scores_gemma":[0.96514165,0.017562509,0.0027441448,0.0013735249,0.01027498,0.002903136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008047845,0.0008612752,0.0011383176,0.0008686089,0.0023473708,0.0040833782,0.0019768924,0.022388255,0.019673025],"category_scores_gemma":[0.062343467,0.00037829878,0.0013731747,0.00063837535,0.0059468145,0.0055534607,0.0024333156,0.028236756,0.009886869],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037008224,0.00009191962,0.0034692155,0.0003087612,0.00031781266,0.0006414937,0.0007586703,0.00011488287,0.0004859905,0.017749455,0.93702286,0.038668826],"study_design_scores_gemma":[0.0007291539,0.0002565615,0.006951,0.0021273121,0.0006705382,0.0019659868,0.004816842,0.0006020286,0.0013927405,0.1530599,0.82713026,0.0002976497],"about_ca_topic_score_codex":0.0059759268,"about_ca_topic_score_gemma":0.008609864,"teacher_disagreement_score":0.022388255,"about_ca_system_score_codex":0.0024897452,"about_ca_system_score_gemma":0.0058834753,"threshold_uncertainty_score":0.065812826},"labels":[],"label_agreement":null},{"id":"W2107166924","doi":"10.1016/j.jacl.2014.06.004","title":"Changes in total and central fat mass after a hypocaloric diet associate with changes of apoC-I in postmenopausal obese women","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montfort Hospital; University of Ottawa; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Internal medicine; Endocrinology; Medicine; Apolipoprotein B; Overweight; Body mass index; Insulin resistance; Obesity; Adipose tissue; Weight loss; Cholesterol","score_opus":0.019442322187210204,"score_gpt":0.29370596401768506,"score_spread":0.27426364183047486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107166924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994067,0.00024386244,0.000024267958,0.000024827137,0.000009108976,0.0000060599814,0.00006327503,0.0000025173451,0.00021939867],"genre_scores_gemma":[0.99914145,0.00013864045,0.00005118653,0.00003902125,0.00001678853,0.000007933199,0.0001472464,0.000002152558,0.000455563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991524,0.00001798815,0.0000097466345,0.000020540016,0.000012960048,0.000023449582],"domain_scores_gemma":[0.99949086,0.00009212992,0.00018074289,0.00004754678,0.00003504138,0.00015368311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031374893,0.00034672086,0.0005011098,0.0006583086,0.0004153326,0.00047845978,0.00022189973,0.0006527123,0.0011296344],"category_scores_gemma":[0.0010954791,0.00046548052,0.00044747343,0.0008126349,0.00033723383,0.00028062242,0.00030772487,0.00076735165,0.00016836965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013462771,0.00071326224,0.97211075,0.000043943837,0.00037215723,0.0004950828,0.0002485325,0.00006648186,0.0077059693,0.000033841752,0.000085832806,0.0046612914],"study_design_scores_gemma":[0.00003661856,0.00030964095,0.99919266,0.0000019253123,0.00007554135,0.00011266023,0.000072730865,0.000053963802,0.00007846709,0.00001426511,0.000048232938,0.000003241848],"about_ca_topic_score_codex":0.00489419,"about_ca_topic_score_gemma":0.005375081,"teacher_disagreement_score":0.00489419,"about_ca_system_score_codex":0.0002229397,"about_ca_system_score_gemma":0.00023010181,"threshold_uncertainty_score":0.009731412},"labels":[],"label_agreement":null},{"id":"W2112283571","doi":"10.1016/j.jacl.2015.03.005","title":"Successful reintroduction of statin therapy after statin-associated rhabdomyolysis","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Rhabdomyolysis; Medicine; Statin; Adverse effect; Incidence (geometry); Internal medicine; Intensive care medicine; Physical therapy","score_opus":0.09571902363080367,"score_gpt":0.41072969575694734,"score_spread":0.31501067212614364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112283571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745341,0.005227018,0.0059027076,0.003397044,0.0014939675,0.00043202966,0.00023862321,0.00034751024,0.008427127],"genre_scores_gemma":[0.9937283,0.0010670088,0.0012116863,0.0013545527,0.00021015826,0.00007537553,0.00022920672,0.000029127415,0.0020946057],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996997,0.00004781493,0.00004602573,0.000033292392,0.000059010235,0.00011425259],"domain_scores_gemma":[0.9995408,0.00008829786,0.000048725426,0.00009605065,0.000058718677,0.00016743642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032376844,0.00060642726,0.00095568766,0.00060914236,0.00084552413,0.0004996241,0.00066960056,0.0011912833,0.00068176014],"category_scores_gemma":[0.0014837458,0.00014462981,0.0011154243,0.00025606647,0.0004993113,0.00032487538,0.000702561,0.0014391869,0.0005359356],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012939573,0.005221636,0.076801226,0.0006058489,0.0007226396,0.47310972,0.0011905942,0.007127675,0.084300786,0.0023520254,0.0077798883,0.3278484],"study_design_scores_gemma":[0.003155099,0.031681348,0.47060007,0.0021608328,0.0010895487,0.3259783,0.0018186955,0.019836534,0.083906695,0.004947759,0.05419691,0.00062817434],"about_ca_topic_score_codex":0.001893323,"about_ca_topic_score_gemma":0.004847981,"teacher_disagreement_score":0.001893323,"about_ca_system_score_codex":0.00060139614,"about_ca_system_score_gemma":0.0010357009,"threshold_uncertainty_score":0.004363477},"labels":[],"label_agreement":null},{"id":"W2115261928","doi":"10.1016/j.jacl.2013.11.005","title":"A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Proband; Internal medicine; Endocrinology; Tangier disease; Cholesterol; Apolipoprotein B; High-density lipoprotein; Lipoprotein; Familial hypercholesterolemia; Mutation; Genetics; Gene; Biology","score_opus":0.036607715937194175,"score_gpt":0.32325980414142286,"score_spread":0.28665208820422866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115261928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799499,0.0012195776,0.0028622642,0.005523165,0.0005663987,0.00016395222,0.0005791096,0.00013859867,0.008997088],"genre_scores_gemma":[0.9938082,0.0005398618,0.0011071814,0.0008078789,0.00037388515,0.000030114601,0.00011328092,0.000045340963,0.0031741725],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993475,0.00008363567,0.000111237794,0.00016817419,0.00015606808,0.00013338329],"domain_scores_gemma":[0.99783427,0.00093107444,0.00025851157,0.00013491425,0.00017910246,0.0006621602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006919984,0.003676332,0.0013626796,0.0024273724,0.0039317696,0.000967531,0.0012145963,0.0027241898,0.0044305627],"category_scores_gemma":[0.004122782,0.0011321041,0.0013602575,0.0016171433,0.002408126,0.0010825018,0.0017406084,0.0019894606,0.00064997317],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017576269,0.00009425024,0.016579177,0.0000263204,0.000033729862,0.9787717,0.00057269883,0.00007563482,0.0017502494,0.0003662835,0.00041482522,0.0011393968],"study_design_scores_gemma":[0.0000802546,0.0002654383,0.02590605,0.000031518826,0.000079404446,0.9701099,0.00055543624,0.00033920887,0.00076309475,0.0005701134,0.0012575572,0.00004197822],"about_ca_topic_score_codex":0.008830216,"about_ca_topic_score_gemma":0.006284346,"teacher_disagreement_score":0.008830216,"about_ca_system_score_codex":0.0011814827,"about_ca_system_score_gemma":0.0012082965,"threshold_uncertainty_score":0.017557621},"labels":[],"label_agreement":null},{"id":"W2117730865","doi":"10.1016/j.jacl.2014.11.008","title":"Familial hypercholesterolemia mutations in the Middle Eastern and North African region: A need for a national registry","year":2014,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Saint Joseph University","keywords":"Medicine; Middle East; Mendelian inheritance; Disease; Familial hypercholesterolemia; Environmental health; Demography; Internal medicine; Genetics; Geography; Gene","score_opus":0.2850544005155663,"score_gpt":0.44188718749210476,"score_spread":0.15683278697653846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117730865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028267421,0.9917549,0.00042455108,0.0034784428,0.00032699187,0.000026340105,0.00020409774,0.000019938456,0.0009379573],"genre_scores_gemma":[0.016121998,0.97899467,0.0019432734,0.0015391937,0.00050289894,0.000053390297,0.00057823455,0.000005193431,0.0002612211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927336,0.00018168369,0.00020884081,0.00010618274,0.00016542393,0.000064452],"domain_scores_gemma":[0.9975575,0.0009992336,0.00058789883,0.00008918081,0.0005643603,0.0002016863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024679957,0.00045265575,0.0024633314,0.0024308087,0.0003065586,0.0011384208,0.0012276085,0.001106517,0.0013011086],"category_scores_gemma":[0.0037962694,0.00022001505,0.00082852825,0.0024440424,0.00031734962,0.0015500549,0.0007212163,0.0014211093,0.00025794934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023694205,0.00015911437,0.030088894,0.01629823,0.0006980828,0.0010778853,0.00022757938,0.00029561605,0.00082441873,0.0030716888,0.037616227,0.9094053],"study_design_scores_gemma":[0.00051113294,0.00026782393,0.19914028,0.08211498,0.005799661,0.011429944,0.0020968192,0.0010079006,0.0007370383,0.005105476,0.691586,0.00020296776],"about_ca_topic_score_codex":0.005639833,"about_ca_topic_score_gemma":0.008277009,"teacher_disagreement_score":0.005639833,"about_ca_system_score_codex":0.00065287563,"about_ca_system_score_gemma":0.004080106,"threshold_uncertainty_score":0.013052106},"labels":[],"label_agreement":null},{"id":"W2123303862","doi":"10.1016/j.jacl.2010.03.005","title":"Why is non−high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?","year":2010,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Medicine; Internal medicine; Cholesterol; Lipoprotein; Triglyceride; Endocrinology; Apolipoprotein C2; High-density lipoprotein; Intermediate-density lipoprotein; Very low-density lipoprotein","score_opus":0.035347692485231653,"score_gpt":0.3470390448419356,"score_spread":0.3116913523567039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123303862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006802453,0.9987105,0.00006197952,0.00070081634,0.00029117544,0.0000014702844,0.0000151946315,0.0000025803065,0.00014835907],"genre_scores_gemma":[0.00039664825,0.9982608,0.00016420265,0.0006307667,0.0003692811,0.0000030940525,0.000022205273,0.000001370518,0.00015170325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994537,0.000113530616,0.00011679114,0.000116481686,0.00016712336,0.000032392316],"domain_scores_gemma":[0.99820733,0.0010091246,0.00019347151,0.00004539298,0.0004722397,0.000072387746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002396032,0.0011125861,0.004708442,0.002073198,0.00032361445,0.0016156804,0.0017416286,0.0023569649,0.0022495717],"category_scores_gemma":[0.0030113296,0.00056534813,0.0010227915,0.0029516066,0.0012480891,0.0028345035,0.00069054833,0.003712544,0.0021970859],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024589844,0.000071648006,0.0008595641,0.02830088,0.0006106737,0.00017041418,0.00005838595,0.00017065553,0.0010478243,0.0045937733,0.044081032,0.9197893],"study_design_scores_gemma":[0.00019010849,0.00020930193,0.0064470395,0.017406076,0.0014879704,0.002211484,0.00023161004,0.00018250206,0.0006619946,0.007875426,0.96298504,0.000111516805],"about_ca_topic_score_codex":0.0033994368,"about_ca_topic_score_gemma":0.004895925,"teacher_disagreement_score":0.004708442,"about_ca_system_score_codex":0.00085263734,"about_ca_system_score_gemma":0.0017352741,"threshold_uncertainty_score":0.01267159},"labels":[],"label_agreement":null},{"id":"W2124766845","doi":"10.1016/j.jacl.2008.08.446","title":"Familial hypobetalipoproteinemia due to a novel early stop mutation","year":2008,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Very low-density lipoprotein; Proband; Apolipoprotein B; Endocrinology; Internal medicine; Lipoprotein; Catabolism; Mutation; Medicine; Intermediate-density lipoprotein; Cholesterol; Biology; Genetics; Metabolism; Gene","score_opus":0.08678801864790905,"score_gpt":0.364374144186582,"score_spread":0.2775861255386729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124766845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907555,0.0006403691,0.0036450825,0.0011560475,0.0004305137,0.00006379288,0.0002915704,0.00017129429,0.002845911],"genre_scores_gemma":[0.9970036,0.0001383248,0.00087532384,0.00035093148,0.0003132877,0.000017694854,0.00012463793,0.0000366938,0.0011395538],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996216,0.00007524548,0.000057579702,0.00009707577,0.0000683577,0.00008007098],"domain_scores_gemma":[0.9984042,0.0007814141,0.00021669017,0.00008159047,0.00011744143,0.0003985949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042483013,0.0026681253,0.00088828773,0.0015777557,0.0012810328,0.00071938493,0.000875034,0.0040334756,0.002256478],"category_scores_gemma":[0.0021466692,0.0005354446,0.0011850919,0.00077611173,0.0014247334,0.0003561591,0.0006388537,0.0016862858,0.0008260821],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005430887,0.00013414233,0.011945885,0.0000365729,0.0000936636,0.9576032,0.00022590921,0.00021445045,0.025832633,0.00052152405,0.00059441035,0.0022544165],"study_design_scores_gemma":[0.00036483677,0.00056779746,0.042573504,0.000048967882,0.00021944082,0.9388928,0.00019724385,0.0021852287,0.011625885,0.00087942486,0.0023525879,0.00009240491],"about_ca_topic_score_codex":0.0016224942,"about_ca_topic_score_gemma":0.0011318668,"teacher_disagreement_score":0.0040334756,"about_ca_system_score_codex":0.0005933198,"about_ca_system_score_gemma":0.0005189775,"threshold_uncertainty_score":0.00754869},"labels":[],"label_agreement":null},{"id":"W2133043280","doi":"10.1016/j.jacl.2014.03.004","title":"An assessment by the Statin Muscle Safety Task Force: 2014 update","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":484,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; myalgia; Adverse effect; Statin; Muscle biopsy; Physical medicine and rehabilitation; Physical therapy; Referral; Intensive care medicine; Internal medicine; Biopsy; Family medicine","score_opus":0.02842061362033824,"score_gpt":0.4207495266566056,"score_spread":0.3923289130362673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133043280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02301233,0.40926754,0.013212116,0.35752624,0.059171073,0.002043951,0.089361124,0.0012093437,0.045196217],"genre_scores_gemma":[0.08979858,0.5155761,0.041199774,0.1328493,0.036648642,0.0055016256,0.15010758,0.00061275787,0.0277056],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885768,0.0017609147,0.0029586437,0.0005858438,0.0056025726,0.00051518105],"domain_scores_gemma":[0.9382664,0.009311378,0.009142938,0.0011496394,0.03914796,0.0029816774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026231522,0.0021477013,0.0025877785,0.0065610535,0.0008935026,0.0032273263,0.0032318714,0.004677378,0.0044948813],"category_scores_gemma":[0.0502504,0.00089980813,0.002874035,0.005898146,0.000695962,0.0029371865,0.003035781,0.004037247,0.004484662],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007626853,0.0002443687,0.022652755,0.003584083,0.00067090295,0.000098852404,0.00014373493,0.0006159021,0.00034097204,0.00068920036,0.6605697,0.3096269],"study_design_scores_gemma":[0.000975607,0.00047151078,0.08597207,0.019673647,0.0028797048,0.00053204707,0.00051362976,0.00093775266,0.0010741847,0.0013816678,0.8853873,0.00020085862],"about_ca_topic_score_codex":0.0388666,"about_ca_topic_score_gemma":0.0669302,"teacher_disagreement_score":0.0388666,"about_ca_system_score_codex":0.0038272822,"about_ca_system_score_gemma":0.01728666,"threshold_uncertainty_score":0.13872725},"labels":[],"label_agreement":null},{"id":"W2133612265","doi":"10.1016/j.jacl.2010.03.004","title":"Should we use apoB for risk assessment and as a target for treatment?","year":2010,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Apolipoprotein B; Component (thermodynamics); Cholesterol; Lipoprotein; Feeling; Ldl cholesterol; Clinical Practice; Risk assessment; Internal medicine; Family medicine; Computer science; Psychology; Social psychology","score_opus":0.17666316196760606,"score_gpt":0.49987003720800327,"score_spread":0.3232068752403972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133612265","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00822743,0.09370822,0.0031137639,0.8734559,0.014820644,0.000028818185,0.00011953193,0.0000787329,0.00644704],"genre_scores_gemma":[0.20128678,0.14803094,0.021265795,0.52068067,0.0956733,0.00025765502,0.00022189574,0.00019789983,0.012385085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963766,0.0017916911,0.0004588054,0.0003471689,0.0008357899,0.00018984656],"domain_scores_gemma":[0.9844679,0.00719468,0.0016070588,0.0011275881,0.003488649,0.0021140543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008855429,0.00071739027,0.0030653733,0.00096891983,0.0011729543,0.0039411834,0.0010898644,0.009092299,0.004676413],"category_scores_gemma":[0.037187472,0.00044489006,0.0010141892,0.00084687275,0.0034107408,0.0070606424,0.0014075534,0.011338145,0.0032923974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004140383,0.0013939354,0.03561539,0.0017416733,0.0011534819,0.0018117223,0.0008624687,0.00064074475,0.0028223705,0.026737161,0.27060086,0.6524798],"study_design_scores_gemma":[0.0028994374,0.0018807772,0.03668984,0.009140586,0.0019917015,0.0057221246,0.0044161314,0.003818209,0.0026960268,0.2931063,0.6370505,0.00058835495],"about_ca_topic_score_codex":0.00216401,"about_ca_topic_score_gemma":0.0035982686,"teacher_disagreement_score":0.009092299,"about_ca_system_score_codex":0.0010496171,"about_ca_system_score_gemma":0.0037382815,"threshold_uncertainty_score":0.04683256},"labels":[],"label_agreement":null},{"id":"W2138255384","doi":"10.1016/j.jacl.2010.06.004","title":"Proteinuria and severe mixed dyslipidemia associated with a novel APOAV gene mutation","year":2010,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"Manchester Biomedical Research Centre","keywords":"Dyslipidemia; Glomerulopathy; Medicine; Apolipoprotein B; Apolipoprotein E; Internal medicine; Kidney; Lipoprotein; Glomerulosclerosis; Proteinuria; Endocrinology; Cholesterol; Disease","score_opus":0.043807837595715854,"score_gpt":0.35926491862873866,"score_spread":0.31545708103302283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138255384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883299,0.0006419397,0.002134913,0.0017431611,0.00021512975,0.00007278874,0.00031474838,0.00023023094,0.006317138],"genre_scores_gemma":[0.99782467,0.00013190629,0.00077283726,0.00022261216,0.00022020757,0.000008159659,0.00008182058,0.000036924474,0.0007009707],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99939084,0.000082348546,0.00009083705,0.0001533632,0.00014573423,0.00013689366],"domain_scores_gemma":[0.9983199,0.00051819545,0.0002908604,0.00009763028,0.000104749895,0.000668617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037281698,0.0026859972,0.0011351731,0.0030291898,0.0015106882,0.0009321274,0.0016744647,0.0039753765,0.0029773645],"category_scores_gemma":[0.0025859948,0.000749475,0.001221752,0.0013463751,0.0016019111,0.0008372419,0.0010973513,0.0019133823,0.0004807161],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032197544,0.00012532697,0.0130982315,0.00003438642,0.000064891734,0.9762581,0.00008407013,0.00008717193,0.007937534,0.00028905325,0.00024216181,0.0014570254],"study_design_scores_gemma":[0.00010591483,0.00023089733,0.03119177,0.000013934309,0.00012947957,0.9625033,0.000090954665,0.0012520743,0.003376293,0.0005683827,0.0004934136,0.000043581716],"about_ca_topic_score_codex":0.0022862658,"about_ca_topic_score_gemma":0.0022857687,"teacher_disagreement_score":0.0039753765,"about_ca_system_score_codex":0.00067672646,"about_ca_system_score_gemma":0.0008258361,"threshold_uncertainty_score":0.009960294},"labels":[],"label_agreement":null},{"id":"W2147875519","doi":"10.1016/j.jacl.2014.02.090","title":"An Antisense Inhibitor of Apolipoprotein C-III Substantially Decreases Fasting Apolipoprotein C-III and Triglyceride Levels in LPL Deficiency","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Internal medicine; Triglyceride; Apolipoprotein B; Apolipoprotein C2; Endocrinology; Apolipoprotein E; Cholesterol; Very low-density lipoprotein; Lipoprotein; Disease","score_opus":0.056100484533087025,"score_gpt":0.3804990527894931,"score_spread":0.32439856825640606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147875519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802256,0.00038669232,0.0007831629,0.00011901952,0.000059311937,0.0000156834,0.00006297738,0.0000903811,0.0004601719],"genre_scores_gemma":[0.997509,0.0003300787,0.00094480027,0.000089865265,0.000031615848,0.000026814754,0.00013736311,0.000024452722,0.00090592075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999068,0.000018633073,0.000015128932,0.000015310903,0.000015328449,0.000028797802],"domain_scores_gemma":[0.9997974,0.000060635444,0.000038740345,0.00001748367,0.000011385905,0.00007434029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020934286,0.00041508008,0.00050878705,0.00019983808,0.0001743474,0.0003266453,0.0002866556,0.00034819372,0.0012325958],"category_scores_gemma":[0.00031686257,0.00026803502,0.00019924203,0.00012454881,0.0003897359,0.00020238612,0.00014219871,0.0008995214,0.0002137424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069045285,0.00059451774,0.00039558118,0.00003743418,0.000030901185,0.00011523569,0.00002142131,0.00010283748,0.9872984,0.000115439514,0.0001685868,0.0042149923],"study_design_scores_gemma":[0.004153016,0.020648986,0.01059972,0.000015549967,0.00022664471,0.0008674309,0.000110462555,0.0027032401,0.95822024,0.00020516086,0.0022223252,0.000027156764],"about_ca_topic_score_codex":0.00079107983,"about_ca_topic_score_gemma":0.001030596,"teacher_disagreement_score":0.0012325958,"about_ca_system_score_codex":0.00021345585,"about_ca_system_score_gemma":0.00031730242,"threshold_uncertainty_score":0.0041234493},"labels":[],"label_agreement":null},{"id":"W2155520947","doi":"10.1016/j.jacl.2009.02.006","title":"Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity","year":2009,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Ministry of Agriculture and Forestry; University of Alberta","funders":"","keywords":"Medicine; Postprandial; Overweight; Obesity; Chylomicron; Internal medicine; Childhood obesity; Disease; Endocrinology; Insulin resistance; Risk factor; Diabetes mellitus; Cholesterol; Lipoprotein; Very low-density lipoprotein","score_opus":0.036937830145695086,"score_gpt":0.3692504632505015,"score_spread":0.3323126331048064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155520947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833775,0.00072225183,0.00011120904,0.00008369855,0.000022684057,0.0000054019715,0.00013989731,0.000007339174,0.0005696986],"genre_scores_gemma":[0.99897385,0.00039702863,0.00022001841,0.000017798298,0.000026795728,0.0000067122915,0.00018233054,0.0000055464056,0.0001699441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996215,0.00013215237,0.00003557929,0.00004922906,0.00006471186,0.000096755684],"domain_scores_gemma":[0.99757093,0.00080832746,0.0008200235,0.00010959829,0.00013069336,0.0005603341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070420397,0.00070336723,0.00059741933,0.0011663146,0.00057643646,0.0011491254,0.00041754456,0.00095336227,0.0012230951],"category_scores_gemma":[0.002734174,0.00066533155,0.0008332006,0.0011660312,0.0004750979,0.00066524727,0.0005940277,0.0021958547,0.00018569171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031120793,0.00005177621,0.99768066,0.000012117673,0.000035959678,0.0002917573,0.000045626814,0.000057873236,0.0003730921,0.000027011394,0.000044112745,0.0010687275],"study_design_scores_gemma":[0.0000052114,0.00011517235,0.9986853,0.000009715948,0.000047383033,0.0005484827,0.00013324802,0.00023546592,0.00013856155,0.000021437503,0.00005473554,0.00000530006],"about_ca_topic_score_codex":0.005230062,"about_ca_topic_score_gemma":0.004840662,"teacher_disagreement_score":0.005230062,"about_ca_system_score_codex":0.00039207653,"about_ca_system_score_gemma":0.00070503965,"threshold_uncertainty_score":0.010399282},"labels":[],"label_agreement":null},{"id":"W2163570185","doi":"10.1016/j.jacl.2012.04.081","title":"Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein","year":2012,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Université Laval; Royal Victoria Hospital","funders":"","keywords":"Medicine; Hypertriglyceridemia; Phenotype; Internal medicine; Genetics; Gastroenterology; Cholesterol; Triglyceride; Gene","score_opus":0.04558916292302815,"score_gpt":0.35465696337060687,"score_spread":0.3090678004475787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163570185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957279,0.00022892139,0.0011044218,0.00017475165,0.000032661934,0.000045073124,0.00042068245,0.000058645943,0.0022069707],"genre_scores_gemma":[0.9986332,0.00009467608,0.00045923667,0.00006463154,0.000039312996,0.00001459717,0.00030305042,0.000023238441,0.00036807288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994838,0.00015262965,0.00008664721,0.00008402878,0.000100193625,0.00009267058],"domain_scores_gemma":[0.99905473,0.00022352346,0.00032919523,0.00008691814,0.00006967059,0.00023600049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029981005,0.001711406,0.00062168995,0.0016989844,0.0005439358,0.00051774306,0.000635395,0.00084570266,0.004355803],"category_scores_gemma":[0.0017315075,0.00040720418,0.0005337938,0.0008749077,0.0007950357,0.0003390712,0.0010763981,0.0006534082,0.00066824775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017331867,0.000988723,0.4272089,0.0002870006,0.00050472625,0.24760391,0.0010522543,0.0008004427,0.2825591,0.0024239097,0.0019405207,0.017298684],"study_design_scores_gemma":[0.00039527856,0.0017296124,0.60390943,0.00006313609,0.0003908508,0.373725,0.00071612775,0.0017483921,0.014237154,0.0015786582,0.0014199222,0.00008647681],"about_ca_topic_score_codex":0.00074462686,"about_ca_topic_score_gemma":0.0004861949,"teacher_disagreement_score":0.004355803,"about_ca_system_score_codex":0.0001460272,"about_ca_system_score_gemma":0.00018701333,"threshold_uncertainty_score":0.014571667},"labels":[],"label_agreement":null},{"id":"W2184482023","doi":"10.1016/j.jacl.2015.10.013","title":"A lipidologist perspective of global lipid guidelines and recommendations, part 1: Lipid treatment targets and risk assessment","year":2015,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amarin Corporation; Regeneron Pharmaceuticals; Sanofi; American Heart Association","keywords":"Medicine; Canadian Cardiovascular Society; Lipidology; Atherosclerotic cardiovascular disease; Perspective (graphical); Excellence; Internal medicine; Intensive care medicine; Family medicine; Cholesterol; Disease; Angina; Political science","score_opus":0.2637324996754211,"score_gpt":0.5382023141137132,"score_spread":0.2744698144382921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184482023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009103112,0.98787737,0.0003445008,0.00982666,0.0009281128,0.000012898578,0.00006653554,0.000008199593,0.00084469613],"genre_scores_gemma":[0.0012181667,0.98866177,0.0015907834,0.0070235897,0.0009983167,0.000024778965,0.000092878814,0.0000043365,0.00038533928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976375,0.0008065199,0.0005973922,0.00016595755,0.00067292916,0.000119697295],"domain_scores_gemma":[0.9928886,0.0039460175,0.0008434989,0.00010974772,0.0019566512,0.0002555893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007898233,0.0009458669,0.0028281654,0.0037870365,0.0004091612,0.0021165875,0.0016315605,0.0029497198,0.002620015],"category_scores_gemma":[0.01258435,0.0005434477,0.0013782261,0.0038260336,0.0008366343,0.0027619123,0.0012718036,0.0050852792,0.0011059595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024373516,0.00008690596,0.0006549139,0.039251857,0.00067609496,0.00026071127,0.00028384218,0.00048091734,0.0007303821,0.013458552,0.15257818,0.7912939],"study_design_scores_gemma":[0.0001034814,0.0001074537,0.0017185478,0.0531727,0.0009512842,0.0007154865,0.00027972134,0.00019849573,0.00022442438,0.005745684,0.9367366,0.000046203364],"about_ca_topic_score_codex":0.0057351715,"about_ca_topic_score_gemma":0.013405311,"teacher_disagreement_score":0.007898233,"about_ca_system_score_codex":0.0017018304,"about_ca_system_score_gemma":0.007456573,"threshold_uncertainty_score":0.04177034},"labels":[],"label_agreement":null},{"id":"W2188311092","doi":"10.1016/j.jacl.2015.11.006","title":"A lipidologist perspective of global lipid guidelines and recommendations, part 2: Lipid treatment goals","year":2015,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Nottingham; Amarin Corporation; Johnson and Johnson; Alnylam Pharmaceuticals; American Heart Association","keywords":"Medicine; Canadian Cardiovascular Society; Lipidology; Guideline; Position paper; Atherosclerotic cardiovascular disease; Excellence; National Cholesterol Education Program; Family medicine; Internal medicine; Intensive care medicine; Cholesterol; Disease; Pathology; Political science; Angina; Metabolic syndrome","score_opus":0.3604827061725882,"score_gpt":0.5472279023520266,"score_spread":0.18674519617943836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188311092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015563598,0.98213094,0.00048304014,0.014496546,0.0011373045,0.000020558975,0.00010296098,0.000013404427,0.0014596101],"genre_scores_gemma":[0.0018352373,0.98397833,0.0024576322,0.009818532,0.0011138476,0.000041512903,0.00016956263,0.000005657194,0.0005796852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980552,0.0005989238,0.0005421228,0.000140974,0.00055213115,0.000110553556],"domain_scores_gemma":[0.99541277,0.002249962,0.0006798026,0.00006633952,0.0013681436,0.00022289986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005875961,0.0009120269,0.002383567,0.003363168,0.0004502285,0.0019562915,0.0014493185,0.0027189958,0.002575308],"category_scores_gemma":[0.009494919,0.0005050809,0.0012735436,0.0032506476,0.00078772823,0.0025903028,0.0012797266,0.0049350737,0.0010500852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023003618,0.00010361059,0.00079759187,0.029182201,0.00042050303,0.00025974476,0.00028409765,0.00055463385,0.0007137424,0.013087524,0.17096145,0.7834048],"study_design_scores_gemma":[0.000104781866,0.00009940701,0.002081027,0.051046938,0.0006984915,0.0007683466,0.00030152797,0.00024525227,0.00025778537,0.0058452804,0.9385049,0.000046306915],"about_ca_topic_score_codex":0.005185028,"about_ca_topic_score_gemma":0.0110490015,"teacher_disagreement_score":0.005875961,"about_ca_system_score_codex":0.0017138615,"about_ca_system_score_gemma":0.0071383268,"threshold_uncertainty_score":0.031075418},"labels":[],"label_agreement":null},{"id":"W2196672055","doi":"10.1016/j.jacl.2015.03.065","title":"Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, Reduces Fasting Triglyceride Levels in Familial Chylomicronemia","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Triglyceride; Internal medicine; Endocrinology; Diacylglycerol kinase; Hypertriglyceridemia; Cholesterol; Biochemistry; Enzyme; Biology","score_opus":0.164553824003123,"score_gpt":0.4234010130512703,"score_spread":0.2588471890481473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196672055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536043,0.0017812068,0.0009145833,0.0002972878,0.00005035867,0.00003049995,0.00013369152,0.00036789876,0.0010639671],"genre_scores_gemma":[0.9974437,0.000738821,0.00076918694,0.00014652942,0.000031968655,0.000021575917,0.00018771862,0.000022927463,0.0006375215],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989593,0.000031932323,0.000010622918,0.000013749478,0.0000224016,0.000025327512],"domain_scores_gemma":[0.99987996,0.000028788354,0.000021361739,0.000007662714,0.0000071570676,0.000055138247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023506006,0.0006280976,0.00084258855,0.00036191955,0.00020075479,0.0002561268,0.000492059,0.0005486863,0.0010361015],"category_scores_gemma":[0.00036853921,0.00023822147,0.00030850832,0.00022391301,0.000257734,0.00023444922,0.0001914169,0.00078058726,0.0002554498],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11616026,0.0059632855,0.018959172,0.0005392604,0.00090364943,0.0027539064,0.00024710788,0.001912373,0.64670265,0.0005914816,0.0043036253,0.20096324],"study_design_scores_gemma":[0.081394956,0.13721925,0.37743422,0.0001661893,0.0039885757,0.014314839,0.0006037224,0.016280582,0.34690845,0.0017025048,0.019733202,0.00025353182],"about_ca_topic_score_codex":0.0011748306,"about_ca_topic_score_gemma":0.0019799673,"teacher_disagreement_score":0.0011748306,"about_ca_system_score_codex":0.00035991674,"about_ca_system_score_gemma":0.00027414213,"threshold_uncertainty_score":0.0034661293},"labels":[],"label_agreement":null},{"id":"W2265557238","doi":"10.1016/j.jacl.2016.01.003","title":"A tale of 2 cousins: An atypical and a typical case of abetalipoproteinemia","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University; Université de Montréal; Montreal Clinical Research Institute","funders":"Fondation Leducq","keywords":"Medicine; Proband; Penetrance; Asymptomatic; Malabsorption; Genetics; Mutation; Pediatrics; Internal medicine; Gastroenterology; Phenotype; Gene; Biology","score_opus":0.06026532529301246,"score_gpt":0.41704371102476556,"score_spread":0.3567783857317531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265557238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94982034,0.0046128915,0.0034176898,0.01539003,0.0013899418,0.00027226988,0.0004538007,0.00031505284,0.024327932],"genre_scores_gemma":[0.98649895,0.0011474201,0.0016551963,0.0033089325,0.0013122882,0.00002674039,0.000104053426,0.000096201395,0.0058501516],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99900144,0.00013540302,0.00009234019,0.0002864214,0.00018256264,0.00030185125],"domain_scores_gemma":[0.998073,0.0006502144,0.00024957303,0.00012197766,0.0001254682,0.00077971094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051742606,0.003079482,0.0020035687,0.0054772715,0.006172211,0.0023891907,0.0024420992,0.008480883,0.005424473],"category_scores_gemma":[0.00521644,0.0022242956,0.0021666929,0.0034319663,0.0028119294,0.0027782156,0.0027284913,0.0046084607,0.0011378353],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024931198,0.00004189249,0.001391746,0.000009487584,0.0000064422507,0.9973974,0.00022191371,0.000028541237,0.00021513701,0.0001046578,0.0001591998,0.000398555],"study_design_scores_gemma":[0.000009937802,0.000056089793,0.0032771833,0.000013283177,0.000017516513,0.9952064,0.00034535181,0.00019490227,0.00012342172,0.00022178232,0.00051653426,0.000017562781],"about_ca_topic_score_codex":0.008365908,"about_ca_topic_score_gemma":0.0069241733,"teacher_disagreement_score":0.008480883,"about_ca_system_score_codex":0.0015539016,"about_ca_system_score_gemma":0.00094453903,"threshold_uncertainty_score":0.018146634},"labels":[],"label_agreement":null},{"id":"W2358367767","doi":"10.1016/j.jacl.2016.05.001","title":"An unusual cause of Achilles tendon xanthoma","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; Montreal Clinical Research Institute; McGill University Health Centre","funders":"","keywords":"Xanthoma; Cerebrotendinous Xanthomatosis; Medicine; Pathognomonic; Achilles tendon; Dermatology; Disease; Chenodeoxycholic acid; Cholestanol; Pathology; Tendon; Internal medicine; Cholesterol; Sterol","score_opus":0.11020547284063553,"score_gpt":0.4686136746363564,"score_spread":0.35840820179572086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2358367767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609692,0.0063225334,0.0065376656,0.0048635956,0.00093159144,0.00022676274,0.00056260807,0.0006366946,0.01894919],"genre_scores_gemma":[0.99321234,0.0007125721,0.0018167165,0.000607287,0.0018831801,0.000045405697,0.00011097108,0.000045901863,0.0015655886],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979752,0.00029683788,0.00026535065,0.00046697597,0.00028532115,0.00071046944],"domain_scores_gemma":[0.99013394,0.00456562,0.0016157603,0.0014769821,0.00044746598,0.0017602403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007922265,0.0032897634,0.002308345,0.005394309,0.003635232,0.003664128,0.002825946,0.010526761,0.0047446727],"category_scores_gemma":[0.013957062,0.0023550258,0.001821477,0.0032979727,0.0025428447,0.0052300594,0.0034608622,0.004732109,0.0024665608],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004626442,0.000026148871,0.0022018047,0.000015448006,0.000004214306,0.99672854,0.000038425835,0.000032819997,0.0002867925,0.00011193049,0.00007340742,0.00043420927],"study_design_scores_gemma":[0.00002733414,0.000041633462,0.0018181012,0.000006028946,0.000008431291,0.99728453,0.000046258803,0.00020163207,0.0002728428,0.00016288784,0.00012220707,0.000008062629],"about_ca_topic_score_codex":0.00096688466,"about_ca_topic_score_gemma":0.00070348824,"teacher_disagreement_score":0.010526761,"about_ca_system_score_codex":0.00157119,"about_ca_system_score_gemma":0.0008774164,"threshold_uncertainty_score":0.015872538},"labels":[],"label_agreement":null},{"id":"W2396635029","doi":"10.1016/j.jacl.2016.03.038","title":"Environmental and Biological Markers of Survival in Septuagenarians and Octogenarians Carrying FH-Causing LDLR Gene Mutations*","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; LDL receptor; Gene; Gene mutation; Internal medicine; Genetics; Mutation; Cholesterol; Biology","score_opus":0.07337287944068112,"score_gpt":0.35197181323120424,"score_spread":0.27859893379052314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396635029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995915,0.00004970461,0.000015385527,0.000021787393,0.0000029391756,6.6182145e-7,0.00008898022,0.0000010016114,0.00022798081],"genre_scores_gemma":[0.9995685,0.00003273193,0.000023274097,0.000021842669,0.000008115415,0.0000015268714,0.00011502811,0.0000010357955,0.00022779846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998845,0.000024697752,0.000011976335,0.000020512995,0.0000125461365,0.0000458888],"domain_scores_gemma":[0.99957234,0.00008858354,0.00011611329,0.00002520452,0.000035861027,0.00016189385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015481768,0.00024889485,0.00019012758,0.0004916633,0.00042643768,0.00044093715,0.00016783012,0.00043524642,0.0016073197],"category_scores_gemma":[0.0009788153,0.00014553373,0.00027873163,0.00052772404,0.0002465742,0.00018311726,0.00027623083,0.00037200874,0.00022953998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070156204,0.000035774923,0.9974491,0.0000037130862,0.000034768284,0.00021405568,0.00013504532,0.0000277643,0.0004940606,0.000011163447,0.000056625067,0.00083624915],"study_design_scores_gemma":[0.0000066097587,0.00012589215,0.998872,0.0000016150309,0.0000295835,0.00028818814,0.00044604496,0.000077275945,0.000061000144,0.0000136225435,0.00007553597,0.000002733185],"about_ca_topic_score_codex":0.0163315,"about_ca_topic_score_gemma":0.013538637,"teacher_disagreement_score":0.0163315,"about_ca_system_score_codex":0.00024208278,"about_ca_system_score_gemma":0.00026675902,"threshold_uncertainty_score":0.03247285},"labels":[],"label_agreement":null},{"id":"W2397078167","doi":"10.1016/j.jacl.2016.03.039","title":"Association Between Frequent Gene-Smoking Interactions And Plama Apolipoprotein B Levels Among Low-Risk Individuals","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Apolipoprotein B; Association (psychology); Apolipoprotein E; Gene; Internal medicine; Genetics; Disease; Cholesterol","score_opus":0.06188792961069819,"score_gpt":0.37546896514250466,"score_spread":0.3135810355318065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397078167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998938,0.0002964074,0.00015495242,0.00008562673,0.000020514874,0.000003115814,0.000082207065,0.0000083617615,0.00041070327],"genre_scores_gemma":[0.99947256,0.00004145774,0.000089243345,0.00002344564,0.00002006575,0.0000026873652,0.00004173292,0.0000034700192,0.0003055505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995623,0.0001546057,0.000046699188,0.000118925294,0.000040816954,0.00007656325],"domain_scores_gemma":[0.99855417,0.0005358463,0.0003468326,0.00015826813,0.00011088057,0.0002939891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005484204,0.00045362505,0.00044412608,0.00057719543,0.00064597855,0.0007350312,0.00039871255,0.0010144671,0.0037274926],"category_scores_gemma":[0.0015533534,0.0004239577,0.0006989388,0.00056789996,0.00033363927,0.00037478097,0.00035351695,0.0011055961,0.00030097284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001800842,0.00019231185,0.98868203,0.000019448036,0.0006064765,0.00030113908,0.00012732258,0.0000697708,0.0055835657,0.00009609887,0.00012040515,0.0024005743],"study_design_scores_gemma":[0.000031013045,0.00022481188,0.99792993,0.000005391064,0.00030868244,0.00035189895,0.00012572222,0.0005169541,0.00024109342,0.00012730346,0.0001282613,0.000008956246],"about_ca_topic_score_codex":0.0028640043,"about_ca_topic_score_gemma":0.0039151213,"teacher_disagreement_score":0.0037274926,"about_ca_system_score_codex":0.00014926755,"about_ca_system_score_gemma":0.00019378161,"threshold_uncertainty_score":0.012469709},"labels":[],"label_agreement":null},{"id":"W2397520716","doi":"10.1016/j.jacl.2016.03.049","title":"Gene Expression Signature of Recurrent Acute Pancreatitis Risk in LPL Deficiency and Severe Hypertriglyceridemia","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Hypertriglyceridemia; Acute pancreatitis; Pancreatitis; Internal medicine; Gastroenterology; Triglyceride","score_opus":0.03048960272664635,"score_gpt":0.3533478882547323,"score_spread":0.32285828552808593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397520716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992912,0.00016218069,0.000100370926,0.000023036884,0.0000036835188,0.000004242705,0.00021247593,0.000004451315,0.0001983164],"genre_scores_gemma":[0.999044,0.000085073334,0.00018180507,0.000024719888,0.000013152255,0.000010599948,0.00034419016,0.0000029323903,0.0002934256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998406,0.00003123548,0.00001701924,0.000042492284,0.000028293278,0.000040352654],"domain_scores_gemma":[0.9996284,0.000079839636,0.0001558421,0.000018439805,0.000034107823,0.00008338279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017307996,0.0001731448,0.00036993297,0.0008067929,0.00020938778,0.00048038035,0.0001350882,0.00030527762,0.0010700704],"category_scores_gemma":[0.00047423615,0.00013614484,0.0003303262,0.0007081905,0.00021144823,0.00013145404,0.00026040807,0.00027857383,0.00022404372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034164784,0.000104430685,0.9070233,0.00005308976,0.00016689312,0.0010225438,0.00022605954,0.00017138322,0.08185495,0.00007200396,0.000168462,0.0057202913],"study_design_scores_gemma":[0.000013521648,0.00022528002,0.9952898,0.0000050770295,0.0000863512,0.0010381893,0.000271318,0.00057057926,0.002188516,0.00008061561,0.00022227205,0.0000084934445],"about_ca_topic_score_codex":0.0005764719,"about_ca_topic_score_gemma":0.0005528788,"teacher_disagreement_score":0.0010700704,"about_ca_system_score_codex":0.00014451388,"about_ca_system_score_gemma":0.00014613237,"threshold_uncertainty_score":0.0035797954},"labels":[],"label_agreement":null},{"id":"W2397746860","doi":"10.1016/j.jacl.2016.03.048","title":"Acute Pancreatitis is Highly Prevalent and Complications can be Fatal in Patients with Familial Chylomicronemia: Results From a Survey of Lipidologist","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Family medicine; Acute pancreatitis; Internal medicine","score_opus":0.05853100770492536,"score_gpt":0.34866427179230536,"score_spread":0.29013326408738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397746860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920183,0.00011165508,0.00003899779,0.00003776488,0.0000030802623,0.0000045163288,0.00014862766,0.0000016234876,0.00045191552],"genre_scores_gemma":[0.9993131,0.0001567765,0.00004390903,0.00005579647,0.0000068793042,0.000005884018,0.00021797087,0.0000015394692,0.0001981682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999526,0.0001408763,0.000071279086,0.000071679504,0.00007923507,0.00011100172],"domain_scores_gemma":[0.9990671,0.00014645989,0.00038598783,0.000056739213,0.0001266654,0.00021701175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000445721,0.00029741865,0.00029588232,0.0010066907,0.0007760312,0.0008732832,0.00019148205,0.00051817554,0.0019317165],"category_scores_gemma":[0.0017096106,0.00026626835,0.00047162978,0.0013178831,0.0002723924,0.0007011446,0.0006879,0.000387847,0.00044656306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024178597,0.00002074329,0.9990138,0.0000034315474,0.000012890136,0.00009646116,0.00016258004,0.0000042352303,0.00007465195,0.000003815688,0.000029082465,0.0005541375],"study_design_scores_gemma":[0.0000015806811,0.000070457805,0.99861324,0.0000038568405,0.00001313533,0.00040059714,0.0007291785,0.00001403946,0.000023281918,0.000006803156,0.0001212866,0.000002610722],"about_ca_topic_score_codex":0.004948939,"about_ca_topic_score_gemma":0.005856789,"teacher_disagreement_score":0.004948939,"about_ca_system_score_codex":0.00022345684,"about_ca_system_score_gemma":0.00028108325,"threshold_uncertainty_score":0.00984025},"labels":[],"label_agreement":null},{"id":"W2398489629","doi":"10.1016/j.jacl.2016.03.091","title":"Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia receiving concomitant lipid-lowering therapies","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Concomitant; Familial hypercholesterolemia; Monoclonal antibody; Monoclonal; Internal medicine; Antibody; Immunology; Pharmacology; Cholesterol","score_opus":0.02605880585477787,"score_gpt":0.34929665867763077,"score_spread":0.3232378528228529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398489629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603903,0.002887953,0.00015290761,0.00012591519,0.000030836516,0.000017239849,0.0000914893,0.0000096063795,0.0006450378],"genre_scores_gemma":[0.99892163,0.0004971308,0.000080861646,0.00013330141,0.00004928245,0.000017123872,0.00015158625,0.0000024124324,0.00014670374],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996699,0.000116211486,0.000038862912,0.00005716048,0.000059837148,0.000058081554],"domain_scores_gemma":[0.99938023,0.0002116079,0.0001533967,0.000043831937,0.00004746455,0.00016348205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006780286,0.0002915729,0.0010826549,0.0002323607,0.0002867696,0.00048608234,0.00020934646,0.00063562056,0.0005546916],"category_scores_gemma":[0.001329334,0.00016119682,0.00079852366,0.00021310791,0.00027421405,0.00040719952,0.00014328337,0.0010695476,0.00014998335],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43283865,0.0048298445,0.31710964,0.0005491638,0.0033963071,0.0027470684,0.00033002597,0.002136746,0.045868997,0.00044372317,0.0016259683,0.18812385],"study_design_scores_gemma":[0.053972684,0.10997278,0.797327,0.00021626102,0.005422135,0.0059205364,0.00030227995,0.007567568,0.011450872,0.0008394972,0.0068848454,0.00012361127],"about_ca_topic_score_codex":0.00041531184,"about_ca_topic_score_gemma":0.00068163476,"teacher_disagreement_score":0.0010826549,"about_ca_system_score_codex":0.0004228173,"about_ca_system_score_gemma":0.00039737747,"threshold_uncertainty_score":0.0035858154},"labels":[],"label_agreement":null},{"id":"W2407973833","doi":"10.1016/j.jacl.2016.03.028","title":"Genetic and Functional investigation of LPL Independent Pathways of TG-Rich Lipoproteins Catabolism in Severe Hypertriglyceridemia and Chylomicronemia","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Hypertriglyceridemia; Medicine; Catabolism; Genetics; Internal medicine; Lipoprotein lipase; Chylomicron; Endocrinology; Bioinformatics; Triglyceride; Very low-density lipoprotein; Lipoprotein; Metabolism; Cholesterol; Biology","score_opus":0.05027855709036005,"score_gpt":0.30511652978273623,"score_spread":0.2548379726923762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407973833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99836844,0.00013630261,0.0010182821,0.00005742438,0.0000044639633,0.000011979703,0.00013272767,0.000010241615,0.0002601754],"genre_scores_gemma":[0.9988254,0.00009340668,0.0006262579,0.000020231593,0.0000050442604,0.000013164233,0.000094193696,0.0000069144876,0.00031542347],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99972576,0.00010967258,0.000041498155,0.000045777317,0.00004075847,0.00003651719],"domain_scores_gemma":[0.9995394,0.00018298611,0.00011098976,0.000041923322,0.000032929758,0.00009192253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033248126,0.0005783618,0.00025947718,0.00096045394,0.00031793196,0.00028595162,0.00030958612,0.00043887962,0.0019120958],"category_scores_gemma":[0.00049555954,0.00028696816,0.00042911337,0.00035962844,0.00076371065,0.00018419474,0.00042174716,0.00054879376,0.00016275984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068470556,0.00032308072,0.019261671,0.000090567766,0.00015164788,0.003407351,0.00020192824,0.0007328329,0.96398145,0.0013025003,0.0000591283,0.003640719],"study_design_scores_gemma":[0.0006759074,0.0025197363,0.40278038,0.000047064055,0.0008876914,0.018400447,0.000823353,0.013565916,0.5555655,0.00247078,0.0021799775,0.000083259096],"about_ca_topic_score_codex":0.0010624566,"about_ca_topic_score_gemma":0.000707526,"teacher_disagreement_score":0.0019120958,"about_ca_system_score_codex":0.0002800849,"about_ca_system_score_gemma":0.0002729222,"threshold_uncertainty_score":0.0063965917},"labels":[],"label_agreement":null},{"id":"W2471384323","doi":"10.1016/j.jacl.2016.06.008","title":"Management strategies in patients with statin-associated muscle symptoms: What is the best strategy?","year":2016,"lang":"en","type":"editorial","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Tolerability; Statin; Dosing; Intensive care medicine; Management strategy; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Adverse effect","score_opus":0.02202002240606705,"score_gpt":0.3560976123873917,"score_spread":0.33407758998132464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471384323","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011689153,0.0851993,0.00026291242,0.10169291,0.81108767,0.000035964717,0.00006691035,0.000051466403,0.0014860433],"genre_scores_gemma":[0.00075026945,0.054915592,0.00030323863,0.036407307,0.9059128,0.00003792322,0.00003573922,0.000015276142,0.0016218476],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963858,0.0008806987,0.0010412771,0.00034688506,0.0010887724,0.00025658982],"domain_scores_gemma":[0.975204,0.013880376,0.0015817719,0.00030752373,0.0066364687,0.0023899903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006845729,0.0029177386,0.007244685,0.0022679467,0.001838114,0.006221655,0.003137054,0.01694576,0.0044292593],"category_scores_gemma":[0.028911445,0.0009345658,0.0030470586,0.0014196694,0.0019004055,0.0054039517,0.0009562101,0.03155685,0.003824947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026241268,0.00006738712,0.00018098163,0.002351555,0.00018623647,0.00042229684,0.000037379563,0.00010774357,0.000092992355,0.0005661346,0.947632,0.048092887],"study_design_scores_gemma":[0.00070180383,0.00023812728,0.0015132661,0.011552746,0.00093475066,0.0013221732,0.00029887113,0.0006878078,0.00020569282,0.0028084312,0.97962403,0.00011231957],"about_ca_topic_score_codex":0.0018670114,"about_ca_topic_score_gemma":0.005627417,"teacher_disagreement_score":0.01694576,"about_ca_system_score_codex":0.0027072756,"about_ca_system_score_gemma":0.0032787714,"threshold_uncertainty_score":0.0362041},"labels":[],"label_agreement":null},{"id":"W2477001448","doi":"10.1016/j.jacl.2016.07.008","title":"An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Apolipoprotein B; Association (psychology); Internal medicine; Cholesterol; Psychotherapist","score_opus":0.13589605663529047,"score_gpt":0.43208053366636756,"score_spread":0.2961844770310771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477001448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04625462,0.6697428,0.013647021,0.1975258,0.010290613,0.012968094,0.01986769,0.00022410165,0.029479241],"genre_scores_gemma":[0.43198857,0.3052097,0.12253059,0.10964379,0.004576922,0.007964561,0.013977291,0.00017504882,0.0039335624],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9123456,0.041240424,0.020557452,0.0028495193,0.021522705,0.0014842075],"domain_scores_gemma":[0.75759387,0.16937728,0.028054554,0.0030340734,0.03760303,0.0043371725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10037976,0.0019239602,0.0045618354,0.010492006,0.0016535068,0.004987099,0.004828246,0.00721658,0.004511934],"category_scores_gemma":[0.21582134,0.0015026662,0.010849917,0.0070342715,0.0014673601,0.0018786186,0.0029331509,0.008650633,0.0010199803],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01797366,0.0016373844,0.06398858,0.19785574,0.094220676,0.0011647603,0.0018518289,0.004668898,0.002499131,0.009472697,0.0988403,0.50582635],"study_design_scores_gemma":[0.01666011,0.0027719752,0.11003201,0.400696,0.22681858,0.00095783465,0.0015450681,0.0040053623,0.0033583103,0.01036694,0.22229607,0.0004916427],"about_ca_topic_score_codex":0.01691435,"about_ca_topic_score_gemma":0.03724852,"teacher_disagreement_score":0.10037976,"about_ca_system_score_codex":0.009643011,"about_ca_system_score_gemma":0.027151499,"threshold_uncertainty_score":0.53086525},"labels":[],"label_agreement":null},{"id":"W2510502505","doi":"10.1016/j.jacl.2016.08.014","title":"Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"Canadian Institutes of Health Research; American Heart Association","keywords":"Medicine; PCSK9; Coronary artery disease; Internal medicine; Apolipoprotein B; Lipoprotein; Endocrinology; Cardiology; Cholesterol; LDL receptor","score_opus":0.037982505983665905,"score_gpt":0.3672439293652763,"score_spread":0.32926142338161035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510502505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983034,0.000556624,0.000040189494,0.00040216392,0.000105615836,0.00005638294,0.00009896449,0.000012850358,0.0004238912],"genre_scores_gemma":[0.9985324,0.00031354942,0.0001501796,0.00025781247,0.00010770216,0.000059295566,0.00019012892,0.0000020928485,0.00038670524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945885,0.00013551387,0.000045454748,0.00010527382,0.00005991307,0.00019492903],"domain_scores_gemma":[0.99920064,0.0001420543,0.00010645465,0.000043992477,0.00006347404,0.00044331577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074323744,0.0007952471,0.0017002311,0.0003418147,0.0007903912,0.0007615707,0.00053376355,0.0016434306,0.0017439662],"category_scores_gemma":[0.001812206,0.00038040878,0.001853661,0.00050988694,0.0003279527,0.0005894503,0.00070333306,0.001806577,0.00020349021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29273808,0.118537396,0.39716607,0.00066988444,0.006115956,0.00054150296,0.0006349507,0.0021644249,0.004641424,0.00016547432,0.0016510411,0.17497377],"study_design_scores_gemma":[0.013339945,0.043039925,0.93883765,0.00006620992,0.0023618066,0.000054342374,0.0002922932,0.0011891129,0.00025887397,0.00009130349,0.00043054722,0.00003791134],"about_ca_topic_score_codex":0.010624967,"about_ca_topic_score_gemma":0.016586667,"teacher_disagreement_score":0.010624967,"about_ca_system_score_codex":0.000753527,"about_ca_system_score_gemma":0.0014034442,"threshold_uncertainty_score":0.02112627},"labels":[],"label_agreement":null},{"id":"W2510811365","doi":"10.1016/j.jacl.2016.07.009","title":"Frameshift mutation in the APOA5 gene causing hypertriglyceridemia in a Pakistani family: Management and considerations for cardiovascular risk","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Cisco Systems Canada; Université Laval","keywords":"Medicine; Hypertriglyceridemia; Frameshift mutation; Family history; Internal medicine; Myocardial infarction; Pediatrics; Cardiology; Endocrinology; Mutation; Genetics; Gene; Triglyceride; Cholesterol","score_opus":0.08349122197677693,"score_gpt":0.37921960659042897,"score_spread":0.29572838461365203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510811365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006104,0.0011693285,0.0011596861,0.0041422388,0.00018613916,0.000035622612,0.00015859058,0.000031629246,0.003055637],"genre_scores_gemma":[0.9970182,0.00045133146,0.0010518931,0.0006399182,0.00021275823,0.000007481201,0.000046592013,0.000008431113,0.0005634753],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998035,0.000026272679,0.00003128992,0.000056407378,0.000031687363,0.00005086684],"domain_scores_gemma":[0.99960834,0.00015440093,0.00007605618,0.000013620552,0.000029244133,0.00011845128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019953746,0.0010322365,0.00037332217,0.0009482526,0.0018586064,0.0005834164,0.0007400079,0.0020326793,0.002121829],"category_scores_gemma":[0.001472646,0.00038943786,0.0005765406,0.000499979,0.00084930065,0.00067508774,0.00039883063,0.0013810298,0.00025164464],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006525345,0.000070831215,0.03574354,0.000013345064,0.00001425134,0.960145,0.00023933822,0.00016391501,0.0011800459,0.00025700004,0.0004931065,0.0016145128],"study_design_scores_gemma":[0.000019425048,0.00012542872,0.030345282,0.000043232692,0.000046963116,0.965722,0.0008811444,0.00086617615,0.0007504907,0.0004895854,0.00068410713,0.00002616193],"about_ca_topic_score_codex":0.006605642,"about_ca_topic_score_gemma":0.004317709,"teacher_disagreement_score":0.006605642,"about_ca_system_score_codex":0.00089356315,"about_ca_system_score_gemma":0.00077419344,"threshold_uncertainty_score":0.01313442},"labels":[],"label_agreement":null},{"id":"W2514472325","doi":"10.1016/j.jacl.2016.08.015","title":"Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ezetimibe; Medicine; Cohort; Internal medicine; Statin; Population; Cohort study; Environmental health","score_opus":0.1660314909023489,"score_gpt":0.42052369063993805,"score_spread":0.2544921997375892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514472325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530643,0.0007669955,0.00058138056,0.00022904215,0.000047283465,0.00007056297,0.0023975067,0.000035408448,0.00056521886],"genre_scores_gemma":[0.9943408,0.00025392658,0.00043693528,0.00020670741,0.00008740773,0.00014392598,0.0039480804,0.000020680825,0.00056154234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951025,0.0033367884,0.0001723076,0.00071170286,0.0002915367,0.00038505052],"domain_scores_gemma":[0.9917549,0.0033573483,0.0016479759,0.0016378715,0.00083185075,0.00077011576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062802914,0.0021598611,0.0029944403,0.0007777387,0.0007598103,0.002132705,0.0017925721,0.0023827336,0.0035086882],"category_scores_gemma":[0.0074087973,0.00083943945,0.0037380743,0.0009191714,0.00067591533,0.0012628568,0.0012111478,0.0017850184,0.0005879889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.108637,0.005475945,0.83963454,0.00039433435,0.02480512,0.0005701822,0.00059095066,0.0041571357,0.0013439686,0.00090536295,0.0047335383,0.008751894],"study_design_scores_gemma":[0.022398854,0.010992271,0.93772054,0.00013604564,0.010357458,0.00055003195,0.00080038875,0.0129429605,0.00034941445,0.0005417958,0.0030410013,0.000169235],"about_ca_topic_score_codex":0.03864703,"about_ca_topic_score_gemma":0.023489976,"teacher_disagreement_score":0.03864703,"about_ca_system_score_codex":0.0023906867,"about_ca_system_score_gemma":0.0021288441,"threshold_uncertainty_score":0.076844156},"labels":[],"label_agreement":null},{"id":"W2514504323","doi":"10.1016/j.jacl.2016.08.012","title":"Familial partial lipodystrophy presenting as metabolic syndrome","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Western University; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; LMNA; Hypertriglyceridemia; Lipodystrophy; Missense mutation; Metabolic syndrome; Type 2 Diabetes Mellitus; Disease; Bioinformatics; Diabetes mellitus; Internal medicine; Pediatrics; Endocrinology; Mutation; Genetics; Gene; Human immunodeficiency virus (HIV); Immunology; Cholesterol","score_opus":0.027159592289514707,"score_gpt":0.33802340923524044,"score_spread":0.31086381694572573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514504323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876673,0.00148914,0.0013709641,0.0010471899,0.00013381793,0.000055125245,0.0002944232,0.00016854818,0.0077733574],"genre_scores_gemma":[0.9975955,0.00040169078,0.00027758855,0.00017052323,0.00017489101,0.000014328176,0.0001242956,0.000020983969,0.0012201858],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99965155,0.000057990164,0.00003935796,0.00006691504,0.00005016716,0.00013401623],"domain_scores_gemma":[0.9991233,0.0003711366,0.00014221897,0.00006934379,0.000048078226,0.00024593796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029282598,0.0027937242,0.0010137246,0.0028938763,0.0015889012,0.0008211402,0.0008606001,0.0033043204,0.006087323],"category_scores_gemma":[0.0019028081,0.0010621606,0.0007692043,0.001740016,0.0015955945,0.0007280435,0.0012837034,0.0011521336,0.0009886002],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023438652,0.000020468282,0.008652105,0.000030152349,0.000018196588,0.986961,0.00008940254,0.00006713397,0.0027340278,0.00021996099,0.00014188996,0.0008312118],"study_design_scores_gemma":[0.000057908474,0.0000753471,0.013192987,0.000010318483,0.00005029386,0.9840941,0.00009962183,0.00026685547,0.0013496238,0.00023091707,0.0005586491,0.000013300213],"about_ca_topic_score_codex":0.001790103,"about_ca_topic_score_gemma":0.0010406283,"teacher_disagreement_score":0.006087323,"about_ca_system_score_codex":0.0006412245,"about_ca_system_score_gemma":0.0005508901,"threshold_uncertainty_score":0.020364165},"labels":[],"label_agreement":null},{"id":"W2528777031","doi":"10.1016/j.jacl.2016.09.013","title":"ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Endocrinology; Hyperinsulinemia; Type 2 diabetes; NEFA; Apolipoprotein B; White adipose tissue; Hypertriglyceridemia; Medicine; Insulin resistance; Postprandial; Insulin; Adipose tissue; Triglyceride; Diabetes mellitus; Cholesterol","score_opus":0.0611022772014886,"score_gpt":0.37361222532446525,"score_spread":0.31250994812297667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528777031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911965,0.006940296,0.0003676484,0.00021299806,0.00003759094,0.000006470177,0.00025868998,0.000010327448,0.0009694761],"genre_scores_gemma":[0.99725336,0.0015604618,0.00040883204,0.00008050334,0.00007331814,0.0000069891003,0.00018213129,0.0000044581016,0.0004298725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983764,0.000058038473,0.000018363266,0.00003283117,0.000030792333,0.00002232037],"domain_scores_gemma":[0.99933666,0.00016635837,0.00024571965,0.0000740371,0.00005137343,0.00012581745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040320202,0.000388203,0.00038737952,0.0007282218,0.00030948519,0.0010025817,0.00021021454,0.00065961905,0.0013251461],"category_scores_gemma":[0.0009864437,0.0004037328,0.000335835,0.0011439965,0.00024687368,0.00028617174,0.00029823894,0.0010809782,0.00020885939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002806033,0.00020772193,0.98405045,0.000059762897,0.0005204097,0.00035733584,0.00009596966,0.000107684384,0.0033954107,0.0002203696,0.0001288248,0.008050034],"study_design_scores_gemma":[0.00003313351,0.00020186645,0.99784696,0.000013701544,0.00020285202,0.0004884896,0.000089644265,0.00033493096,0.00026541424,0.00026442087,0.0002501911,0.000008413589],"about_ca_topic_score_codex":0.0013429052,"about_ca_topic_score_gemma":0.0013326902,"teacher_disagreement_score":0.0013429052,"about_ca_system_score_codex":0.00015384276,"about_ca_system_score_gemma":0.00018486899,"threshold_uncertainty_score":0.0044330955},"labels":[],"label_agreement":null},{"id":"W2529233490","doi":"10.1016/j.jacl.2016.09.015","title":"Predicting proprotein convertase subtilisin kexin type-9 loss of function mutations using plasma PCSK9 concentration","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; Genotyping; Subtilisin; Mutation; Medicine; LDL receptor; Genetics; Internal medicine; Biology; Lipoprotein; Gene; Genotype; Cholesterol; Biochemistry; Enzyme","score_opus":0.08100244998293878,"score_gpt":0.3805912096539901,"score_spread":0.29958875967105136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529233490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608445,0.00032448734,0.0016173811,0.00020665482,0.00005380317,0.000023052218,0.00048859266,0.00008322215,0.0011183721],"genre_scores_gemma":[0.9971961,0.000121219855,0.0019312868,0.00007429792,0.000021681397,0.0000069001017,0.000256834,0.000012189182,0.00037954398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995227,0.000065983426,0.00007793871,0.00011583369,0.00015658686,0.00006095647],"domain_scores_gemma":[0.99884903,0.0005564234,0.00020385768,0.000028664805,0.00018870643,0.00017326057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004481225,0.0011731829,0.00062334194,0.0019073162,0.00031778894,0.0010958142,0.0004978896,0.0012585842,0.0017418956],"category_scores_gemma":[0.002311356,0.0002836964,0.0006958505,0.0006886737,0.00039455848,0.00039836988,0.00036306068,0.0008651529,0.0007866424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021710147,0.00017614264,0.93805957,0.00003852219,0.000097006356,0.0042659743,0.00008104442,0.0014199446,0.038991954,0.00014764784,0.0006759424,0.013875094],"study_design_scores_gemma":[0.00016707956,0.0010194057,0.8374236,0.00008726464,0.0005033308,0.021946685,0.0005824082,0.057786398,0.07721412,0.00064216944,0.0025624852,0.00006503799],"about_ca_topic_score_codex":0.0017190294,"about_ca_topic_score_gemma":0.0014450634,"teacher_disagreement_score":0.0019073162,"about_ca_system_score_codex":0.00034843996,"about_ca_system_score_gemma":0.00029250982,"threshold_uncertainty_score":0.0058271885},"labels":[],"label_agreement":null},{"id":"W2530469753","doi":"10.1016/j.jacl.2016.10.004","title":"The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Cardiology; Cholesterol","score_opus":0.0650971866844904,"score_gpt":0.35441761803362604,"score_spread":0.28932043134913565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530469753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94148564,0.0065592993,0.00868271,0.0016116813,0.00046134242,0.0007527823,0.021191865,0.0007707736,0.018483758],"genre_scores_gemma":[0.96658397,0.0017347048,0.01264173,0.00030768514,0.0003385069,0.0007216128,0.011254779,0.000089806934,0.0063271793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922466,0.00015484942,0.000101881385,0.00011491903,0.0003043714,0.00009931755],"domain_scores_gemma":[0.9984806,0.00018403471,0.0005079884,0.0000488594,0.00048008809,0.0002984456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012149932,0.0021738168,0.001368613,0.0037001797,0.00059769157,0.0013279262,0.0015762637,0.0013838257,0.0029471922],"category_scores_gemma":[0.004428624,0.0003935418,0.0015673849,0.0013925205,0.00047353236,0.0013618732,0.0014085108,0.0009871225,0.0007485004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016343087,0.00015176502,0.94870037,0.00012788345,0.0014096344,0.00024448347,0.00007699884,0.0013591803,0.00084010104,0.00028724098,0.010190301,0.03497761],"study_design_scores_gemma":[0.00031252857,0.000288897,0.99053836,0.000038405044,0.00033544196,0.00042333247,0.00007028993,0.00472285,0.00025574822,0.0003577783,0.0025916572,0.00006472325],"about_ca_topic_score_codex":0.07935143,"about_ca_topic_score_gemma":0.10092883,"teacher_disagreement_score":0.07935143,"about_ca_system_score_codex":0.00211748,"about_ca_system_score_gemma":0.0018639526,"threshold_uncertainty_score":0.1577791},"labels":[],"label_agreement":null},{"id":"W2559607365","doi":"10.1016/j.jacl.2016.11.006","title":"Counterpoint: Soy protein","year":2016,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nutrition Society","funders":"","keywords":"Soy protein; Medicine; Plant protein; Cholesterol; Food science; Internal medicine; Biology; Pathology","score_opus":0.1191281873038474,"score_gpt":0.4720162893686848,"score_spread":0.3528881020648374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559607365","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004934398,0.0018052884,0.000057929574,0.9784017,0.016459825,0.0000060614884,0.000025136824,0.000014739471,0.0027359235],"genre_scores_gemma":[0.006787104,0.0018020555,0.00023203781,0.9115063,0.0716387,0.000021622394,0.000025399291,0.00001584885,0.007970989],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985702,0.00043701788,0.00019229905,0.00024302989,0.00034594772,0.00021150678],"domain_scores_gemma":[0.9948715,0.0029769745,0.00051579566,0.00022845528,0.00065977115,0.0007475884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001906846,0.0006498695,0.0013654571,0.0006039442,0.002905156,0.0029077828,0.0014620103,0.044860043,0.010168784],"category_scores_gemma":[0.020989493,0.00046751762,0.0011951881,0.0005288959,0.0029045856,0.0027844699,0.0016727813,0.0446673,0.006190904],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018166193,0.00006621193,0.0012115104,0.00012575496,0.000048339643,0.013043144,0.00017850028,0.00009997825,0.0004017749,0.0070681437,0.9559447,0.02163036],"study_design_scores_gemma":[0.00043894904,0.00023797271,0.002051042,0.0010031994,0.0001072224,0.012130781,0.0008252829,0.000583223,0.00050130463,0.029369345,0.9526742,0.000077502096],"about_ca_topic_score_codex":0.0027795897,"about_ca_topic_score_gemma":0.005086297,"teacher_disagreement_score":0.044860043,"about_ca_system_score_codex":0.0031312155,"about_ca_system_score_gemma":0.0023164162,"threshold_uncertainty_score":0.03401798},"labels":[],"label_agreement":null},{"id":"W2560906050","doi":"10.1016/j.jacl.2016.12.005","title":"Heterozygous familial hypercholesterolemia presenting as chylomicronemia syndrome","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Familial hypercholesterolemia; Presentation (obstetrics); LDL receptor; Internal medicine; Low-density lipoprotein; Endocrinology; Lipoprotein; Pediatrics; Cholesterol; Surgery","score_opus":0.054342531582068254,"score_gpt":0.3940626439381544,"score_spread":0.3397201123560861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560906050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845506,0.00078730285,0.0013849799,0.0011958138,0.0002502333,0.00008080615,0.00032678468,0.00013955621,0.007379353],"genre_scores_gemma":[0.9983311,0.0001638316,0.00029899232,0.00017307664,0.00021031199,0.00000943122,0.0001027063,0.000019065475,0.0006916117],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99948007,0.00007005364,0.000076770804,0.00010168686,0.00008956631,0.0001819375],"domain_scores_gemma":[0.9992999,0.00021107333,0.00014677118,0.000039817307,0.000050291186,0.00025220838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023260941,0.0027122407,0.0010574461,0.0028285081,0.0018149337,0.00091688614,0.0009557729,0.00280292,0.0057250303],"category_scores_gemma":[0.0017417397,0.0007067537,0.00094693125,0.0016316435,0.0011388633,0.00076768105,0.0010840121,0.001120125,0.0009913618],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001470636,0.00003254186,0.012866843,0.000013934242,0.000015374471,0.98241216,0.000081710656,0.00003378307,0.0034523285,0.00018185182,0.0001934911,0.0005689102],"study_design_scores_gemma":[0.000054834778,0.00013799522,0.023093015,0.0000099026975,0.00007289286,0.97375816,0.00020308064,0.0003987185,0.0015408022,0.00028730053,0.0004207154,0.000022664562],"about_ca_topic_score_codex":0.0022879285,"about_ca_topic_score_gemma":0.001466677,"teacher_disagreement_score":0.0057250303,"about_ca_system_score_codex":0.0004751205,"about_ca_system_score_gemma":0.000774026,"threshold_uncertainty_score":0.019152105},"labels":[],"label_agreement":null},{"id":"W2563466451","doi":"10.1016/j.jacl.2016.12.006","title":"Estrogen-associated severe hypertriglyceridemia with pancreatitis","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Robarts Clinical Trials; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Hypertriglyceridemia; Medicine; Pancreatitis; Acute pancreatitis; Internal medicine; Triglyceride; Gastroenterology; Fibrate; Estrogen; Complication; Endocrinology; Statin; Cholesterol","score_opus":0.04940313166546113,"score_gpt":0.3633876649732966,"score_spread":0.3139845333078355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563466451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98311967,0.0034251597,0.0007654815,0.0016076497,0.00024095517,0.000040330753,0.0001688271,0.000055396275,0.010576619],"genre_scores_gemma":[0.998135,0.0004928456,0.00009117819,0.00021764872,0.00022276804,0.0000031409127,0.000075182244,0.0000039818383,0.00075824495],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997292,0.00005886269,0.00004945762,0.000035857625,0.000052077343,0.00007446706],"domain_scores_gemma":[0.99941945,0.00018373597,0.0001507897,0.0000780141,0.000028140063,0.00013990978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033744882,0.0005119194,0.00037290936,0.0008138457,0.0004419056,0.00047609067,0.00034416022,0.0011474426,0.0028355198],"category_scores_gemma":[0.0018627617,0.00028725527,0.0005381602,0.0005369892,0.0005442491,0.00050693325,0.0005138534,0.001014933,0.00062335917],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017845707,0.00020681992,0.19081521,0.00008024685,0.00010344977,0.7897247,0.00014229487,0.00019938145,0.0063946405,0.00038877648,0.00061208755,0.009547792],"study_design_scores_gemma":[0.000102367056,0.00048701666,0.1610934,0.000031955435,0.00010567377,0.8315483,0.0002097385,0.0005348924,0.0024169516,0.0008954751,0.002552755,0.000021581709],"about_ca_topic_score_codex":0.0004904741,"about_ca_topic_score_gemma":0.0006741764,"teacher_disagreement_score":0.0028355198,"about_ca_system_score_codex":0.0003097275,"about_ca_system_score_gemma":0.00037538615,"threshold_uncertainty_score":0.009485722},"labels":[],"label_agreement":null},{"id":"W2583632013","doi":"10.1016/j.jacl.2017.01.012","title":"The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Université de Montréal; Population Health Research Institute; Hamilton Health Sciences; McGill University; Hamilton General Hospital; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; SNP; Familial hypercholesterolemia; Odds ratio; Dyslipidemia; Single-nucleotide polymorphism; Internal medicine; Allele; Confidence interval; Population; Locus (genetics); Genetics; Disease; Genotype; Cholesterol; Biology; Gene","score_opus":0.06037540104790643,"score_gpt":0.3881230423041327,"score_spread":0.32774764125622624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583632013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829763,0.0004037612,0.00022854263,0.00020987277,0.000020921141,0.0000056184895,0.00008765459,0.000014013971,0.00073195284],"genre_scores_gemma":[0.9993298,0.000087122935,0.00014204894,0.000025577823,0.000037279096,0.0000043640966,0.000049340168,0.0000051857664,0.00031924553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995759,0.00017425216,0.00004296367,0.000069561174,0.00009030698,0.0000469601],"domain_scores_gemma":[0.9992667,0.00024644213,0.00023902125,0.000044060173,0.000063564876,0.00014006648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004323536,0.0005961739,0.00035046466,0.0012146998,0.0006592171,0.00056188693,0.0003672545,0.0013289049,0.0027137797],"category_scores_gemma":[0.0020328253,0.00027473166,0.0004979463,0.0011290347,0.0003238061,0.00021108784,0.0003585923,0.0006345,0.00040194823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007356592,0.00035505518,0.92522293,0.000055429224,0.0005600866,0.011907437,0.0006524516,0.0005551522,0.039140753,0.00054139347,0.0006143527,0.013038273],"study_design_scores_gemma":[0.000112827445,0.00024802363,0.9893911,0.0000230086,0.0003008531,0.005954299,0.00015162728,0.00112417,0.0014889418,0.00060820614,0.000579734,0.000017178187],"about_ca_topic_score_codex":0.0026911665,"about_ca_topic_score_gemma":0.0017762673,"teacher_disagreement_score":0.0027137797,"about_ca_system_score_codex":0.00023491487,"about_ca_system_score_gemma":0.00018040724,"threshold_uncertainty_score":0.009078443},"labels":[],"label_agreement":null},{"id":"W2594242704","doi":"10.1016/j.jacl.2017.02.012","title":"Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Dyslipidemia; Lipoprotein; Apolipoprotein B; Endocrinology; Sleeve gastrectomy; Triglyceride; Obesity; High-density lipoprotein; Cholesterol; Surgery; Gastroenterology; Gastric bypass; Weight loss","score_opus":0.09786960224726281,"score_gpt":0.42416590843036056,"score_spread":0.32629630618309774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594242704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871683,0.0006462984,0.000026437727,0.00005136454,0.000018545468,0.0000029592122,0.00007127731,0.0000023033208,0.00046397664],"genre_scores_gemma":[0.99928194,0.00021732747,0.00003880554,0.000055393433,0.000020521818,0.0000030197343,0.000105785926,0.0000024603962,0.00027481074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983346,0.00005630647,0.000013314021,0.000027669366,0.000026883394,0.000042220454],"domain_scores_gemma":[0.9996191,0.000101013546,0.000081252634,0.00003916446,0.00002892853,0.0001304403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003089018,0.00032608648,0.00037446045,0.00034106264,0.00036053488,0.00060026743,0.00013398877,0.00047825347,0.0012198798],"category_scores_gemma":[0.0008469433,0.00022914332,0.00044469902,0.00039504247,0.0003193284,0.00020544503,0.00027848274,0.000629326,0.00017819347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020386646,0.0006728516,0.95446104,0.000063401574,0.00089312333,0.00085170096,0.00015954301,0.00010882783,0.013060984,0.00009234654,0.00020919058,0.009040351],"study_design_scores_gemma":[0.000030372828,0.00039147865,0.9990089,0.000002278314,0.00011151721,0.00010661149,0.00007093037,0.00005511812,0.0001201452,0.000020706368,0.00007765128,0.000004242688],"about_ca_topic_score_codex":0.0038144214,"about_ca_topic_score_gemma":0.0042430153,"teacher_disagreement_score":0.0038144214,"about_ca_system_score_codex":0.00024203015,"about_ca_system_score_gemma":0.0002700007,"threshold_uncertainty_score":0.0075844526},"labels":[],"label_agreement":null},{"id":"W2604231946","doi":"10.1016/j.jacl.2017.03.019","title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Institut universitaire de cardiologie et de pneumologie de Québec; McMaster University; Université de Montréal; Université Laval; Population Health Research Institute; Hamilton Health Sciences; McGill University; Hamilton General Hospital; Montreal Clinical Research Institute","funders":"Fondation Leducq; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Internal medicine; Disease; Framingham Risk Score; Polygenic risk score; Cholesterol; Genetics; Single-nucleotide polymorphism; Gene","score_opus":0.043091295056510166,"score_gpt":0.3318935463281696,"score_spread":0.2888022512716594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604231946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989256,0.0001826815,0.00017689557,0.00008122097,0.000014369669,0.0000030747624,0.0000948837,0.000006494081,0.0005146698],"genre_scores_gemma":[0.999627,0.00004037571,0.00007095084,0.000014886932,0.000015312284,0.0000020145026,0.00009587223,0.0000017414224,0.00013190771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941933,0.0002235513,0.000063815976,0.000112542846,0.00008229751,0.00009835774],"domain_scores_gemma":[0.997897,0.00058312126,0.0006977104,0.00021938211,0.00015264073,0.0004501566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007337784,0.00063279906,0.00051237654,0.0010560588,0.0008075121,0.0008483524,0.0003899225,0.0010352707,0.002572392],"category_scores_gemma":[0.0030249848,0.00035962553,0.0009621057,0.0010340642,0.00044773243,0.00057453424,0.0006108193,0.0010983722,0.00033062772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001831382,0.000044371252,0.9986563,0.0000027734018,0.00012788839,0.00010174384,0.000030087182,0.00005530034,0.00024741876,0.000025062804,0.000040156337,0.00048579305],"study_design_scores_gemma":[0.0000063232346,0.000080489415,0.99848914,0.0000029399687,0.00009790372,0.00033406666,0.00007398192,0.00075881387,0.000036233225,0.000071785595,0.0000432803,0.0000049581017],"about_ca_topic_score_codex":0.0045038112,"about_ca_topic_score_gemma":0.0045536207,"teacher_disagreement_score":0.0045038112,"about_ca_system_score_codex":0.00021871514,"about_ca_system_score_gemma":0.00037371332,"threshold_uncertainty_score":0.008955181},"labels":[],"label_agreement":null},{"id":"W2604950485","doi":"10.1016/j.jacl.2017.01.008","title":"Mortality in the Familial Atherosclerosis Treatment Study-Observational Study","year":2017,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"PCSK9; Medicine; Kexin; Proprotein convertase; Scopus; Internal medicine; Disease; Observational study; Coronary heart disease; Atherosclerotic cardiovascular disease; Cholesterol; Bioinformatics; MEDLINE; Lipoprotein; LDL receptor","score_opus":0.4816958245449386,"score_gpt":0.5051845335111509,"score_spread":0.0234887089662123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604950485","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4090072,0.021566702,0.0019286878,0.4706422,0.026196893,0.00016362185,0.019264042,0.00028793298,0.050942693],"genre_scores_gemma":[0.77580297,0.0047150776,0.002035718,0.15469873,0.04312881,0.00046264663,0.005487166,0.00008683005,0.013582096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833375,0.0008003026,0.00019539993,0.00017869365,0.00033735653,0.00015448518],"domain_scores_gemma":[0.9975452,0.00089662685,0.00047217068,0.00028348903,0.0003480665,0.0004544475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022071954,0.00038206164,0.0016319031,0.0004941009,0.0011114903,0.001496411,0.00061277533,0.006044502,0.0018793582],"category_scores_gemma":[0.005997521,0.0005914665,0.00057421206,0.0009651795,0.00036229033,0.0007752839,0.000570782,0.00518797,0.0010446879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029411654,0.00024308528,0.6025831,0.00020706316,0.00076644035,0.008524447,0.00027937483,0.00030855997,0.0008176856,0.0015362942,0.36169243,0.020100387],"study_design_scores_gemma":[0.0032720591,0.00043015718,0.9119574,0.00056994066,0.0012212365,0.011091948,0.00071392214,0.005148995,0.00051482016,0.0058854055,0.058978494,0.00021562539],"about_ca_topic_score_codex":0.0029911236,"about_ca_topic_score_gemma":0.007912021,"teacher_disagreement_score":0.006044502,"about_ca_system_score_codex":0.0006073464,"about_ca_system_score_gemma":0.0008656638,"threshold_uncertainty_score":0.011672854},"labels":[],"label_agreement":null},{"id":"W2607300795","doi":"10.1016/j.jacl.2017.04.001","title":"Can iPCSK9-induced hypocholesterolemia starve cancer cells?","year":2017,"lang":"en","type":"editorial","venue":"Journal of clinical lipidology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université Laval","funders":"","keywords":"Hypocholesterolemia; Medicine; Cancer; Cholesterol; Statin; Cancer cell; Cancer metastasis; Internal medicine; Metastasis; Cancer therapy; Cancer research; Oncology","score_opus":0.04627009749020652,"score_gpt":0.40141555227106457,"score_spread":0.35514545478085807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607300795","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014229654,0.008391386,0.00014120319,0.059920687,0.93020046,0.00002217614,0.000063716194,0.00005022861,0.0010677892],"genre_scores_gemma":[0.0014246802,0.014572943,0.00019001371,0.04981241,0.9217946,0.000047174315,0.00006724557,0.00004075812,0.012050238],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979062,0.000331047,0.00030634247,0.00021896024,0.0010458878,0.00019153683],"domain_scores_gemma":[0.9946826,0.0020005272,0.00038433107,0.00017277927,0.0018025885,0.00095725385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050864397,0.0023505061,0.001828136,0.001269391,0.001781484,0.004411755,0.0019456001,0.010652245,0.0053989002],"category_scores_gemma":[0.010125536,0.00074061466,0.0017838088,0.0005329867,0.0019256043,0.002894424,0.0016242431,0.021634804,0.0039620236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012894429,0.000024789219,0.00005330917,0.00030835636,0.000028291286,0.00023269547,0.000019193256,0.00002758352,0.0003583125,0.0006442237,0.988739,0.009435288],"study_design_scores_gemma":[0.0001361104,0.00006522781,0.0003522935,0.00025024844,0.00007273891,0.00022178903,0.00005170239,0.00010051803,0.0006204237,0.0010679013,0.9970386,0.00002245148],"about_ca_topic_score_codex":0.0008479212,"about_ca_topic_score_gemma":0.0025546593,"teacher_disagreement_score":0.010652245,"about_ca_system_score_codex":0.0025593648,"about_ca_system_score_gemma":0.0024272995,"threshold_uncertainty_score":0.026899993},"labels":[],"label_agreement":null},{"id":"W2612009195","doi":"10.1016/j.jacl.2017.04.076","title":"Familial Chylomicronemia Syndrome (FCS) Patients Recruited to the APPROACH Trial of Volanesorsen Therapy are Representative of Subjects with FCS","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Traditional medicine","score_opus":0.11160770638077137,"score_gpt":0.40701419771439334,"score_spread":0.29540649133362196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612009195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989309,0.00012197869,0.00013571083,0.000042332373,0.00000752136,0.000090365575,0.00018658994,0.0000041679823,0.00048042508],"genre_scores_gemma":[0.99847907,0.00008530674,0.00027300548,0.00010135848,0.000033775603,0.00012625362,0.0006123481,0.0000025188058,0.00028641633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996234,0.00013157932,0.000049233666,0.00008691456,0.000052988325,0.000055874134],"domain_scores_gemma":[0.9997485,0.00006444644,0.000060369206,0.000026429525,0.000024462739,0.00007570991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004424706,0.0004927459,0.000491174,0.0004869906,0.0007629058,0.00035958132,0.00022085135,0.00044387786,0.0030679898],"category_scores_gemma":[0.0009782643,0.00015643456,0.00024645575,0.00039583075,0.0003858478,0.00024410011,0.00033085851,0.00031632258,0.00028777393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056596242,0.0030577919,0.8525261,0.00023134597,0.00085821,0.0032458715,0.0017725829,0.0006011025,0.044399913,0.0015014821,0.0020969599,0.033112403],"study_design_scores_gemma":[0.005980396,0.014564614,0.96300757,0.000038540486,0.00041854996,0.005410455,0.002175906,0.0009969512,0.0024201244,0.00075534533,0.004191093,0.00004041524],"about_ca_topic_score_codex":0.0024346714,"about_ca_topic_score_gemma":0.0039124014,"teacher_disagreement_score":0.0030679898,"about_ca_system_score_codex":0.00017097955,"about_ca_system_score_gemma":0.0002952185,"threshold_uncertainty_score":0.010263503},"labels":[],"label_agreement":null},{"id":"W2612054286","doi":"10.1016/j.jacl.2017.04.039","title":"Gene Expression Signature of Platelet Count in Lipoprotein Lipase Deficiency","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aluminium Refining, Degassing and Filtering (Canada)","funders":"","keywords":"Medicine; Lipoprotein lipase; Gene; Lipase; Signature (topology); Platelet; Internal medicine; Genetics; Enzyme; Biochemistry; Biology","score_opus":0.06464443165236652,"score_gpt":0.40271622572061494,"score_spread":0.3380717940682484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612054286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987087,0.00026571643,0.00021523217,0.000028837647,0.0000072378775,0.000005741561,0.0004746696,0.000008082178,0.00028572074],"genre_scores_gemma":[0.99815243,0.00021728066,0.0003175033,0.000038978687,0.00001531538,0.000023394741,0.0007201794,0.0000051969155,0.00050958776],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988616,0.000017374517,0.00001038765,0.00002937975,0.000025950889,0.000030756284],"domain_scores_gemma":[0.9998375,0.000048966504,0.000054954748,0.000008962822,0.000017875667,0.000031726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009479007,0.00012686024,0.00028577255,0.0006829229,0.00014801041,0.0004139679,0.000103773134,0.00025460753,0.0010202262],"category_scores_gemma":[0.00027023273,0.000109622044,0.00018163635,0.0005936875,0.00018587291,0.00008840334,0.00017028642,0.0002618216,0.00019146015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048278077,0.000094833085,0.20437805,0.00009867779,0.00011471784,0.0012914616,0.0002350515,0.0002800678,0.77693236,0.00017393903,0.00030643895,0.011266489],"study_design_scores_gemma":[0.000032565757,0.00050466525,0.9592994,0.000012999886,0.00012056671,0.0018910684,0.00042672982,0.0012554679,0.035511233,0.00019884971,0.0007316329,0.000014721786],"about_ca_topic_score_codex":0.00034525682,"about_ca_topic_score_gemma":0.00035660042,"teacher_disagreement_score":0.0010202262,"about_ca_system_score_codex":0.00012381512,"about_ca_system_score_gemma":0.000120307974,"threshold_uncertainty_score":0.003412962},"labels":[],"label_agreement":null},{"id":"W2612430640","doi":"10.1016/j.jacl.2017.04.043","title":"Natural History (up to 15 years) of Platelet Count in 84 Patients with Familial Hyperchylomicronemia Due to Lipoprotein Lipase Deficiency","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Traditional medicine; Internal medicine","score_opus":0.03767277046023275,"score_gpt":0.33733918269028285,"score_spread":0.2996664122300501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612430640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912673,0.0003105319,0.000039798713,0.000040654642,0.000007654416,0.0000040773666,0.0000614732,0.0000028391082,0.00040627125],"genre_scores_gemma":[0.99946696,0.00010883307,0.000036218935,0.0000380613,0.00001499035,0.0000047834787,0.0001665237,0.0000016494363,0.00016197392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996748,0.00007526778,0.000049205777,0.00006367087,0.00006111296,0.000075909935],"domain_scores_gemma":[0.99864966,0.00039579516,0.00040681433,0.00007006469,0.00011038598,0.00036732954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036058368,0.00042673066,0.0005111792,0.0010279323,0.0009995326,0.0005608832,0.00030667492,0.00081650494,0.0008155035],"category_scores_gemma":[0.002282208,0.0003937499,0.00052388804,0.00072192185,0.0005890875,0.0006426858,0.0005412731,0.0008719915,0.0002029144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004899934,0.0001004201,0.9922889,0.000008142452,0.000035894816,0.004469304,0.00025986598,0.000048328107,0.00063315494,0.000021996533,0.000059341328,0.0015846373],"study_design_scores_gemma":[0.000021468031,0.00042655395,0.99064714,0.0000067579927,0.00004895152,0.008105452,0.0002660252,0.00012635873,0.000113939495,0.000040696992,0.00018544683,0.000011155678],"about_ca_topic_score_codex":0.0028831118,"about_ca_topic_score_gemma":0.002776162,"teacher_disagreement_score":0.0028831118,"about_ca_system_score_codex":0.00035040485,"about_ca_system_score_gemma":0.000267555,"threshold_uncertainty_score":0.005732715},"labels":[],"label_agreement":null},{"id":"W2612681726","doi":"10.1016/j.jacl.2018.03.093","title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec; Western University","funders":"Canadian Institutes of Health Research; Society for Endocrinology; Genome Canada; Heart and Stroke Foundation of Canada","keywords":"Chylomicron; Lipoprotein lipase; Medicine; Postprandial; Internal medicine; Endocrinology; Very low-density lipoprotein; Genetics; Familial hypercholesterolemia; Allele; Lipoprotein; Biology; Gene; Cholesterol; Insulin","score_opus":0.0427557181653299,"score_gpt":0.40568428603898055,"score_spread":0.36292856787365063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612681726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779713,0.00034377357,0.0001476934,0.000068943555,0.00000878519,0.000011867832,0.00010994771,0.00001007324,0.0015018298],"genre_scores_gemma":[0.99951327,0.00008883946,0.000116621675,0.000026071642,0.000021980251,0.0000057359857,0.00012272666,0.0000025099755,0.00010220962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995609,0.00009030278,0.0000799329,0.000089556466,0.000075315715,0.000103986844],"domain_scores_gemma":[0.99909604,0.00035045785,0.00018648415,0.000042177922,0.00006283432,0.00026198674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041136568,0.0010886431,0.00048736,0.0025481647,0.0005178963,0.0004993351,0.00047331123,0.0008881066,0.0029269394],"category_scores_gemma":[0.0021349764,0.0004130723,0.00055845274,0.0009619513,0.00085790147,0.0006036374,0.0006134982,0.0005068209,0.00025154054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035243926,0.00020967759,0.8993542,0.000047361318,0.00011380312,0.0759041,0.00040058908,0.0003081341,0.014849791,0.0004434275,0.00019658278,0.0046479474],"study_design_scores_gemma":[0.00008550133,0.0003361252,0.90382296,0.000018684017,0.000094303214,0.092962794,0.00041560485,0.00058993726,0.0009626196,0.00045865166,0.00022211921,0.00003063762],"about_ca_topic_score_codex":0.0012592983,"about_ca_topic_score_gemma":0.00072703295,"teacher_disagreement_score":0.0029269394,"about_ca_system_score_codex":0.00030369553,"about_ca_system_score_gemma":0.000294274,"threshold_uncertainty_score":0.009791613},"labels":[],"label_agreement":null},{"id":"W2612701632","doi":"10.1016/j.jacl.2017.04.106","title":"Safety and Efficacy of Evinacumab, A Monoclonal Antibody to ANGPTL3, In Homozygous Familial Hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Traditional medicine; Pharmacology","score_opus":0.06649787901129015,"score_gpt":0.44887980612413697,"score_spread":0.3823819271128468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612701632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967379,0.0020192247,0.0002548905,0.00013191362,0.000029405093,0.000020193142,0.00008579192,0.00002665904,0.0006941767],"genre_scores_gemma":[0.99908507,0.0003619997,0.000085536485,0.00009036082,0.000029022254,0.000015486878,0.00009192378,0.0000041975563,0.00023643274],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973947,0.00010462989,0.000024579094,0.000038431506,0.00004173141,0.000051231476],"domain_scores_gemma":[0.9996886,0.000088582856,0.00006135382,0.000033345914,0.000024034132,0.000104016595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005338419,0.00030048398,0.0008309259,0.0002022968,0.00023330798,0.00035128233,0.00022563609,0.0006446437,0.00056976476],"category_scores_gemma":[0.0007029494,0.00012778319,0.00050855096,0.00011915463,0.0003597795,0.00029903874,0.00010390483,0.001030753,0.00017588405],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48894235,0.011391208,0.031120943,0.00042808213,0.0013767807,0.0021821582,0.00024364462,0.0018175307,0.20713094,0.0006689626,0.0016505886,0.25304678],"study_design_scores_gemma":[0.14775689,0.44379848,0.273408,0.00021145558,0.0034200656,0.0074816532,0.00028294537,0.010718083,0.100371554,0.0012030597,0.011189871,0.00015791533],"about_ca_topic_score_codex":0.0005727335,"about_ca_topic_score_gemma":0.0007211655,"teacher_disagreement_score":0.0008309259,"about_ca_system_score_codex":0.0004965951,"about_ca_system_score_gemma":0.00034266288,"threshold_uncertainty_score":0.0036031008},"labels":[],"label_agreement":null},{"id":"W2613900028","doi":"10.1016/j.jacl.2017.04.018","title":"Predicting Cardiovascular Events in Familial Hypercholesterolemia: Validation of the Montreal-FH-SCORE","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Traditional medicine","score_opus":0.0830498208820497,"score_gpt":0.3756182711196162,"score_spread":0.2925684502375665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613900028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923746,0.0005337047,0.0012350975,0.00020503181,0.000047939513,0.00012253919,0.0020763145,0.00007294129,0.0033318058],"genre_scores_gemma":[0.99631387,0.00014239381,0.0013680448,0.00003697261,0.000032601933,0.00006549912,0.0012643378,0.000011347748,0.00076497806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922645,0.00026196797,0.000082187835,0.00014462846,0.00018913148,0.00009564026],"domain_scores_gemma":[0.99793696,0.00054361427,0.00049418013,0.00014452008,0.0005929517,0.00028779704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020963396,0.0010165708,0.0005846569,0.0019569471,0.00056100107,0.001041695,0.0009825919,0.0009853147,0.0025329082],"category_scores_gemma":[0.008535085,0.00024971872,0.00095844525,0.00067780085,0.0004074494,0.00075452,0.0010243796,0.0005118316,0.0004895866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056267425,0.00006386843,0.98741734,0.000021837293,0.00030684605,0.000039299783,0.00005710635,0.0006517174,0.00038920518,0.00010708902,0.00095324684,0.009429727],"study_design_scores_gemma":[0.00009423394,0.00023435608,0.99320775,0.000017900125,0.0001980996,0.00013330036,0.00007162332,0.0049052457,0.0002064441,0.00019397457,0.00071740424,0.000019562563],"about_ca_topic_score_codex":0.09053114,"about_ca_topic_score_gemma":0.11345514,"teacher_disagreement_score":0.09053114,"about_ca_system_score_codex":0.0011339892,"about_ca_system_score_gemma":0.0012844341,"threshold_uncertainty_score":0.18000835},"labels":[],"label_agreement":null},{"id":"W2614012162","doi":"10.1016/j.jacl.2017.04.071","title":"The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS)","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Traditional medicine","score_opus":0.0645473816067762,"score_gpt":0.39956486409463937,"score_spread":0.33501748248786317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614012162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988485,0.002458367,0.00095887616,0.00053889176,0.00035504042,0.0028924174,0.0008703628,0.00022870464,0.0018124208],"genre_scores_gemma":[0.9817583,0.0028257784,0.0027297079,0.0016722492,0.00050594396,0.0050937315,0.0012943891,0.000056285007,0.004063626],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99958915,0.00019553426,0.000022019707,0.00006629645,0.000037311253,0.0000896748],"domain_scores_gemma":[0.9994223,0.00014150217,0.000103424056,0.000042967233,0.00002863182,0.00026118534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011694981,0.0019059833,0.0035846105,0.0007057495,0.0005323424,0.0010052363,0.0010407607,0.0018517678,0.0058626113],"category_scores_gemma":[0.0010007065,0.00065903587,0.0017335502,0.00038356445,0.0013875087,0.0010608718,0.0004546454,0.0032198967,0.00095705956],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9698103,0.010577568,0.00047163435,0.0004368068,0.0005879781,0.000053762134,0.000074529155,0.0003236109,0.005724145,0.00017840226,0.00053007813,0.011231283],"study_design_scores_gemma":[0.94652075,0.05162318,0.00083984167,0.00001182682,0.00016173541,0.000018855493,0.000022376424,0.00018201525,0.00028273358,0.0000717009,0.00025401515,0.000010948111],"about_ca_topic_score_codex":0.0012552531,"about_ca_topic_score_gemma":0.0025888889,"teacher_disagreement_score":0.0058626113,"about_ca_system_score_codex":0.00050015707,"about_ca_system_score_gemma":0.0014429807,"threshold_uncertainty_score":0.019612432},"labels":[],"label_agreement":null},{"id":"W2624801309","doi":"10.1016/j.jacl.2017.06.005","title":"A case of hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function mutation and polymorphisms predisposing to nonalcoholic fatty liver disease","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Steatosis; Hypocholesterolemia; Nonalcoholic fatty liver disease; Fatty liver; Internal medicine; Loss function; Disease; Mutation; Gastroenterology; Genetics; Gene; Cholesterol; Phenotype; Biology","score_opus":0.06644746104700279,"score_gpt":0.3797804533995022,"score_spread":0.31333299235249945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624801309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823276,0.0012632932,0.0015228048,0.0060919253,0.0007590472,0.00015202821,0.00036656114,0.0001339743,0.0073828166],"genre_scores_gemma":[0.99497557,0.00040309207,0.000699814,0.0011026927,0.0009546518,0.000021270203,0.00010367955,0.000045447803,0.0016938003],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99916685,0.00008074092,0.000108344895,0.00024202293,0.000113540686,0.0002885001],"domain_scores_gemma":[0.99630404,0.0010824015,0.00051441,0.00025660446,0.0002097673,0.0016327886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045609655,0.0027308434,0.0015885896,0.0048093535,0.004129477,0.0018052136,0.0026018783,0.009928321,0.0045075733],"category_scores_gemma":[0.005732048,0.0017079186,0.0026973921,0.0020029682,0.0025367301,0.0022325793,0.0029643786,0.0044952976,0.0012800113],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004001189,0.000027125656,0.0022107542,0.000004756279,0.0000043109076,0.99717295,0.00006011379,0.000013894826,0.00024088987,0.000036272635,0.0000602728,0.00012868084],"study_design_scores_gemma":[0.000016879358,0.0000951767,0.004386571,0.0000061229716,0.000020706202,0.9947096,0.00013360613,0.0001552601,0.00020814849,0.000100460216,0.00015301534,0.000014425815],"about_ca_topic_score_codex":0.005770004,"about_ca_topic_score_gemma":0.003977093,"teacher_disagreement_score":0.009928321,"about_ca_system_score_codex":0.0016093442,"about_ca_system_score_gemma":0.001251287,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2656848837","doi":"10.1016/j.jacl.2017.06.008","title":"Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Insulin resistance; Hazard ratio; Internal medicine; Body mass index; Type 2 diabetes; Diabetes mellitus; Endocrinology; Framingham Risk Score; Proportional hazards model; Confidence interval; Lipoprotein; Cholesterol; Disease","score_opus":0.032328674968841405,"score_gpt":0.3456066635621577,"score_spread":0.3132779885933163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2656848837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958216,0.0011920962,0.00016253414,0.00012640597,0.000037728256,0.000028315213,0.002072416,0.000015917029,0.0005429471],"genre_scores_gemma":[0.99764735,0.00028462583,0.00011159934,0.00006207998,0.00003467022,0.000031879204,0.0014212126,0.0000051433553,0.00040135437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994209,0.00017288148,0.000056684654,0.00016733572,0.000082342,0.000099891855],"domain_scores_gemma":[0.9983822,0.00016114567,0.0006700983,0.0002618585,0.00012600816,0.00039873816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019405133,0.0006140425,0.00075367093,0.00072280574,0.00056437287,0.0009835374,0.0005945009,0.0009940147,0.0012249243],"category_scores_gemma":[0.0022572405,0.0007185812,0.0011511293,0.0014864964,0.00027729874,0.00069162983,0.000776519,0.0012878138,0.00031772107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000760992,0.0000622565,0.9975364,0.000013694928,0.00048565035,0.000040838277,0.000051629788,0.000055901986,0.00010614931,0.000020830537,0.00017946358,0.00068617554],"study_design_scores_gemma":[0.000067428824,0.00016410422,0.99898666,0.000007461181,0.00020985205,0.00006121294,0.00005537078,0.00018722103,0.00002623452,0.000023889033,0.00020432762,0.000006189171],"about_ca_topic_score_codex":0.008757604,"about_ca_topic_score_gemma":0.00904409,"teacher_disagreement_score":0.008757604,"about_ca_system_score_codex":0.0003350721,"about_ca_system_score_gemma":0.00038246505,"threshold_uncertainty_score":0.017413259},"labels":[],"label_agreement":null},{"id":"W2729521026","doi":"10.1016/j.jacl.2017.06.017","title":"Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Metabolic syndrome; Internal medicine; Post-hoc analysis; Dyslipidemia; Hazard ratio; Niacin; Diabetes mellitus; Disease; Atherosclerotic cardiovascular disease; Placebo; Confidence interval; Endocrinology; Obesity; Pathology","score_opus":0.02023938461424066,"score_gpt":0.2912122926738309,"score_spread":0.27097290805959023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729521026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590284,0.0015590547,0.00028778726,0.00046273312,0.000192787,0.00008417686,0.000664107,0.000032291548,0.000814243],"genre_scores_gemma":[0.9973556,0.0002782177,0.0003328896,0.0002466998,0.00033032583,0.000080680846,0.00091083755,0.00002681544,0.00043802982],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99645764,0.0022592496,0.00016014566,0.0005561929,0.00022308767,0.0003436462],"domain_scores_gemma":[0.9927821,0.003936669,0.00077186833,0.0013767392,0.00029835498,0.00083418126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063863206,0.0023182903,0.005070976,0.00034325517,0.00073860557,0.002943693,0.0017075895,0.0015063479,0.0031340832],"category_scores_gemma":[0.007889061,0.00080203696,0.005583059,0.00065624743,0.0013815634,0.0022233108,0.0013664132,0.003467481,0.000530686],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8732815,0.0012922932,0.08681005,0.00040409513,0.023661386,0.00021974712,0.0001498238,0.0009429216,0.0022444944,0.0003209459,0.0019708301,0.0087019205],"study_design_scores_gemma":[0.24126168,0.06762158,0.5749376,0.00021880755,0.09563037,0.0005548095,0.00064973295,0.009431403,0.0029921283,0.00274135,0.0036256842,0.00033486544],"about_ca_topic_score_codex":0.0010378062,"about_ca_topic_score_gemma":0.0026060813,"teacher_disagreement_score":0.0063863206,"about_ca_system_score_codex":0.00054078526,"about_ca_system_score_gemma":0.0011326035,"threshold_uncertainty_score":0.033774495},"labels":[],"label_agreement":null},{"id":"W2741564293","doi":"10.1016/j.jacl.2017.07.008","title":"Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Sanofi; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Disease; Internal medicine; Cholesterol","score_opus":0.08225324443632,"score_gpt":0.37062234136677635,"score_spread":0.28836909693045637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741564293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977532,0.001111787,0.0074063493,0.00043532084,0.00016949326,0.0006089488,0.004411459,0.00018791114,0.008136678],"genre_scores_gemma":[0.98863983,0.00028109306,0.0064128432,0.000085763044,0.000057497266,0.0003310301,0.0025814727,0.000039001254,0.001571424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974486,0.0009578167,0.0002895943,0.00041661205,0.0006978194,0.00018946377],"domain_scores_gemma":[0.99442154,0.0014465242,0.001057712,0.00048005767,0.0021792238,0.00041494725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061596236,0.0010851496,0.0007863044,0.0025960922,0.00082532875,0.0013201582,0.0016810218,0.0010502177,0.0020098274],"category_scores_gemma":[0.01678482,0.00032336096,0.001487929,0.0009655309,0.0005913495,0.0011207552,0.0015786302,0.0007150995,0.000489275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052285916,0.00009515228,0.97615415,0.000062362655,0.0005983433,0.00004999338,0.00015936044,0.0010166666,0.00054310093,0.00035650816,0.0018801134,0.018561453],"study_design_scores_gemma":[0.00010869343,0.0002685131,0.9917201,0.00003561768,0.00025938833,0.00013222899,0.00012868615,0.0048457575,0.0003292817,0.00038345126,0.0017589657,0.000029372552],"about_ca_topic_score_codex":0.10754377,"about_ca_topic_score_gemma":0.1474234,"teacher_disagreement_score":0.10754377,"about_ca_system_score_codex":0.0017842359,"about_ca_system_score_gemma":0.0023271414,"threshold_uncertainty_score":0.2138356},"labels":[],"label_agreement":null},{"id":"W2763903839","doi":"10.1016/j.jacl.2017.10.001","title":"Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Pfizer; European Commission; Ionis Pharmaceuticals; Agence Nationale de la Recherche","keywords":"Medicine; Kexin; Subtilisin; Atorvastatin; Type 2 Diabetes Mellitus; Proprotein convertase; Cholesterylester transfer protein; Internal medicine; PCSK9; Endocrinology; Diabetes mellitus; Cholesterol; Lipoprotein; Pharmacology; LDL receptor; Biochemistry; Enzyme","score_opus":0.030036964991493567,"score_gpt":0.32477968899625503,"score_spread":0.2947427240047615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763903839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969013,0.001862349,0.000046407316,0.00014154208,0.000090442074,0.000028803499,0.00010851331,0.0000095805,0.00081109535],"genre_scores_gemma":[0.9978536,0.0008503284,0.00014084259,0.00016135583,0.00014271156,0.000034997363,0.00021805224,0.000003029149,0.00059497415],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994861,0.00017371352,0.00006054833,0.000067057204,0.000045559842,0.00016702137],"domain_scores_gemma":[0.9987483,0.00047574728,0.00012244552,0.000063003834,0.00004530359,0.0005451422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009493071,0.00064383255,0.0020545549,0.0002740363,0.00045523452,0.00063326303,0.00034311265,0.00089945673,0.0028010975],"category_scores_gemma":[0.0020730253,0.00046364364,0.0015030755,0.00044078648,0.0005367274,0.0008072489,0.00043654616,0.0017822456,0.00029520752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.884555,0.0103997765,0.05909222,0.00023787736,0.0023963586,0.000513399,0.000181067,0.0005336344,0.008952459,0.00015621043,0.0006413196,0.032340676],"study_design_scores_gemma":[0.088273,0.21878047,0.67444956,0.00008553905,0.0061134156,0.0008007563,0.0005719487,0.0028899773,0.0052504693,0.0004802181,0.0021388067,0.00016585815],"about_ca_topic_score_codex":0.0018383852,"about_ca_topic_score_gemma":0.003658259,"teacher_disagreement_score":0.0028010975,"about_ca_system_score_codex":0.00048777362,"about_ca_system_score_gemma":0.00082075765,"threshold_uncertainty_score":0.009370565},"labels":[],"label_agreement":null},{"id":"W2765603577","doi":"10.1016/j.jacl.2017.10.013","title":"The association between hypercholesterolemia and sitosterolemia, and report of a sitosterolemia kindred","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Genome Canada","keywords":"Ezetimibe; Familial hypercholesterolemia; Internal medicine; Medicine; Endocrinology; Cholesterol; Sterol; Compound heterozygosity; Population; Gastroenterology; Chemistry; Biochemistry; Allele","score_opus":0.06579431383935343,"score_gpt":0.4130617408795349,"score_spread":0.3472674270401815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765603577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914335,0.0007460027,0.0005483102,0.0017355673,0.00020907613,0.00005161389,0.00034506762,0.00005023458,0.0048805345],"genre_scores_gemma":[0.9973475,0.00037128534,0.00034421263,0.0005038475,0.00043718785,0.000013258492,0.00016024084,0.000022875916,0.0007995772],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9991466,0.00011774506,0.00018154529,0.00022793606,0.00014929679,0.00017701673],"domain_scores_gemma":[0.99720687,0.0010265821,0.0003572858,0.00021009879,0.00024693203,0.00095217983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006667312,0.002047252,0.0008852809,0.004097253,0.003432418,0.000853789,0.0019199785,0.0035080097,0.0033047963],"category_scores_gemma":[0.005485358,0.0010495606,0.001434749,0.0018079652,0.0021815256,0.0015608848,0.001153776,0.0021745109,0.00076424755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021896204,0.00012412532,0.10262052,0.00002766041,0.00003525887,0.8921359,0.0007123863,0.000067337955,0.0025627753,0.00019065035,0.00036080313,0.00094348134],"study_design_scores_gemma":[0.00002368283,0.00026473714,0.08552416,0.000016885951,0.00008034347,0.9114578,0.0006858637,0.00021255294,0.00074275915,0.00024365787,0.0007095025,0.000038064765],"about_ca_topic_score_codex":0.005538444,"about_ca_topic_score_gemma":0.0029701625,"teacher_disagreement_score":0.005538444,"about_ca_system_score_codex":0.0007245758,"about_ca_system_score_gemma":0.001043058,"threshold_uncertainty_score":0.011055708},"labels":[],"label_agreement":null},{"id":"W2765980655","doi":"10.1016/j.jacl.2017.10.012","title":"Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Medicine; Hypertriglyceridemia; Randomized controlled trial; Placebo; Omega; Internal medicine; Alternative medicine; Triglyceride; Pathology; Cholesterol","score_opus":0.03300951902729328,"score_gpt":0.35718030756859076,"score_spread":0.3241707885412975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765980655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97727215,0.012713598,0.0006350158,0.0008590342,0.0006631015,0.004262502,0.0013343726,0.00018849343,0.002071736],"genre_scores_gemma":[0.9732228,0.01004766,0.0021208972,0.002229091,0.0008296948,0.0051535545,0.0019751487,0.000043936117,0.0043773223],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99952173,0.0002328052,0.00004282243,0.00008659737,0.000041788266,0.00007426155],"domain_scores_gemma":[0.9993154,0.00015020593,0.00017917818,0.000056704514,0.00006322818,0.0002352494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014446052,0.0015585093,0.0037098303,0.00045997737,0.0004788992,0.0012313015,0.0007531142,0.0020982418,0.0057079964],"category_scores_gemma":[0.001529846,0.00074126356,0.0020297996,0.00045962323,0.0008614697,0.0009236883,0.00036289543,0.0020529637,0.00082583376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9842754,0.0033208095,0.00050482457,0.0007279606,0.0008638355,0.0000368174,0.000034952354,0.00013835255,0.0024275687,0.00005276556,0.00047490298,0.00714185],"study_design_scores_gemma":[0.9826643,0.015578098,0.0009215227,0.000027676002,0.00026712622,0.000014058002,0.000010203566,0.00011306102,0.00012882195,0.00003465943,0.00023443192,0.000006045741],"about_ca_topic_score_codex":0.0012353655,"about_ca_topic_score_gemma":0.002395746,"teacher_disagreement_score":0.0057079964,"about_ca_system_score_codex":0.0007271684,"about_ca_system_score_gemma":0.0012147889,"threshold_uncertainty_score":0.019095182},"labels":[],"label_agreement":null},{"id":"W2766188269","doi":"10.1016/j.jacl.2017.10.020","title":"A common variant in ARHGEF10 alters delta-6 desaturase activity and influence susceptibility to hypertriglyceridemia","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"FADS2; Single-nucleotide polymorphism; Fatty acid desaturase; Linoleic acid; Genetics; SNP; Locus (genetics); Biology; Fatty acid; Medicine; Biochemistry; Gene; Docosahexaenoic acid; Polyunsaturated fatty acid; Genotype","score_opus":0.1096407545476103,"score_gpt":0.4709554977455135,"score_spread":0.3613147431979032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766188269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996443,0.00042016513,0.0007367649,0.00032460288,0.00015418319,0.000017440172,0.00067885005,0.000053005533,0.0011720387],"genre_scores_gemma":[0.99766964,0.000090141635,0.0005125986,0.00017551557,0.00005167062,0.000008156618,0.00029909494,0.000024287197,0.00116894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994816,0.00014064413,0.00005657619,0.00016516642,0.00008101917,0.000074985095],"domain_scores_gemma":[0.99909556,0.00041699066,0.00019730446,0.00006921845,0.000071833856,0.00014907018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035566202,0.0014436934,0.000576952,0.0010192625,0.0006214722,0.00056375004,0.0005318388,0.0014132923,0.006195597],"category_scores_gemma":[0.0016255868,0.00023562978,0.0008655335,0.00093199604,0.0004957516,0.00036371453,0.00031525653,0.00073939643,0.0007639341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010416498,0.0012010454,0.6828862,0.0002580178,0.002143432,0.055498477,0.00153528,0.001284867,0.20190457,0.0025572744,0.003724199,0.036590155],"study_design_scores_gemma":[0.0006440991,0.0021242483,0.9070405,0.00016882383,0.0018055119,0.053982683,0.0011420812,0.0039158887,0.017341899,0.002332045,0.009322315,0.000179942],"about_ca_topic_score_codex":0.0028898339,"about_ca_topic_score_gemma":0.002850617,"teacher_disagreement_score":0.006195597,"about_ca_system_score_codex":0.00030680417,"about_ca_system_score_gemma":0.00024458257,"threshold_uncertainty_score":0.020726383},"labels":[],"label_agreement":null},{"id":"W2768145636","doi":"10.1016/j.jacl.2017.10.010","title":"Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"ABCA1; Medicine; Subclinical infection; Tangier disease; Mutation; Internal medicine; Cholesterol; Gastroenterology; Genetics; Biology; Gene; Transporter","score_opus":0.11176871739042661,"score_gpt":0.43571536226866253,"score_spread":0.32394664487823593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768145636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984901,0.00044419078,0.00015261657,0.00009177753,0.000022685314,0.0000031234024,0.0001493879,0.000013820517,0.0006322481],"genre_scores_gemma":[0.9993273,0.00011792853,0.00008067199,0.000047339396,0.000040987903,0.0000039820884,0.00014873368,0.0000050029103,0.0002280621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995197,0.00011286802,0.00007090237,0.0001311475,0.000083960505,0.00008139508],"domain_scores_gemma":[0.9980399,0.0005080473,0.0008211557,0.00015665921,0.00017315375,0.00030111903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040683325,0.0005399722,0.00077001535,0.0012333203,0.0007001811,0.0008127406,0.00040351864,0.00122104,0.0051861224],"category_scores_gemma":[0.0032603862,0.00036160243,0.0005581125,0.0010996812,0.00040062174,0.0005029157,0.00038672294,0.0010130221,0.0006211595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043700638,0.00005022936,0.9939593,0.000024755736,0.00009477263,0.00095261727,0.000091460104,0.000028052698,0.0018612116,0.00004528731,0.00015313501,0.0023022164],"study_design_scores_gemma":[0.00001932238,0.00017605422,0.99117917,0.000008990147,0.00014444307,0.0074291048,0.00017947453,0.00024050978,0.00021604067,0.0001432519,0.00025281933,0.000010794681],"about_ca_topic_score_codex":0.0008216665,"about_ca_topic_score_gemma":0.0007030637,"teacher_disagreement_score":0.0051861224,"about_ca_system_score_codex":0.00013859807,"about_ca_system_score_gemma":0.00021520167,"threshold_uncertainty_score":0.017349243},"labels":[],"label_agreement":null},{"id":"W2774655289","doi":"10.1016/j.jacl.2017.12.001","title":"ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Amgen Canada; Sanofi; Pfizer; Amgen","keywords":"Medicine; ABO blood group system; Familial hypercholesterolemia; Risk factor; Internal medicine; Cardiology; Gastroenterology; Cholesterol","score_opus":0.03773443261635068,"score_gpt":0.33092926288322705,"score_spread":0.29319483026687637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774655289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978588,0.00062635046,0.00007343538,0.00018340236,0.00003075959,0.0000033451163,0.000092468224,0.000005697272,0.0011256711],"genre_scores_gemma":[0.99928445,0.00017090367,0.00008008428,0.00006606,0.000053998825,0.0000035056355,0.0000950961,0.0000018602049,0.00024411813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996786,0.000086222055,0.00004378118,0.000055668293,0.000069095164,0.00006669616],"domain_scores_gemma":[0.9991721,0.00023776079,0.00028317064,0.000050748495,0.00005752873,0.00019882621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003090656,0.0004893519,0.0006017599,0.0011318469,0.00086216157,0.00073437934,0.0003112514,0.0009693852,0.0025260479],"category_scores_gemma":[0.0019121653,0.0003317328,0.00054526463,0.0013619168,0.00035999928,0.0005622617,0.0003192173,0.00104585,0.0002742512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031380865,0.00006959318,0.9967719,0.0000095686555,0.00006812098,0.00076091074,0.00008134094,0.000022012431,0.0005707688,0.00003543749,0.00011172111,0.0011848082],"study_design_scores_gemma":[0.000016905002,0.00012601903,0.99670935,0.000009378171,0.00012726228,0.0021086654,0.00024826752,0.00026682808,0.000077634526,0.000116588795,0.000185022,0.000008128571],"about_ca_topic_score_codex":0.0037432094,"about_ca_topic_score_gemma":0.0042799395,"teacher_disagreement_score":0.0037432094,"about_ca_system_score_codex":0.00022954041,"about_ca_system_score_gemma":0.00029220464,"threshold_uncertainty_score":0.0084504485},"labels":[],"label_agreement":null},{"id":"W2785671951","doi":"10.1016/j.jacl.2018.01.011","title":"A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McGill University; Hamilton General Hospital; Western University; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Medicines Company; Cisco Systems; Eli Lilly and Company","keywords":"Medicine; Lipoprotein lipase; Mutation; Genetics; Gene; Bioinformatics; Endocrinology; Biology","score_opus":0.07324506441496603,"score_gpt":0.4112919027799929,"score_spread":0.33804683836502686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785671951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994385,0.0006628287,0.0014352404,0.0007806836,0.00017261246,0.0000386804,0.0002545137,0.00011193835,0.002158441],"genre_scores_gemma":[0.9989429,0.00009300484,0.00039861735,0.00007822209,0.00008666599,0.000008725585,0.00006929947,0.000011854725,0.00031063467],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997321,0.00004178638,0.00003460923,0.00007521024,0.00006280025,0.000053603526],"domain_scores_gemma":[0.9992618,0.00035253481,0.00013379224,0.000027669137,0.000034624572,0.00018956632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000213838,0.0023233648,0.00059361564,0.0018045746,0.0009046558,0.0005844574,0.00089458714,0.0030231732,0.0030426043],"category_scores_gemma":[0.0016494689,0.00038740097,0.000731195,0.0010179931,0.0009554546,0.0004380358,0.00082432816,0.00094430905,0.00073204556],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030914482,0.000044102253,0.011605371,0.00005944962,0.00006318345,0.94708323,0.0002858348,0.00025614956,0.036467656,0.00049099897,0.00052416493,0.0028106086],"study_design_scores_gemma":[0.000243691,0.00028685512,0.047195658,0.000059490078,0.00026707794,0.9237075,0.0003368151,0.00321929,0.020609358,0.0012151941,0.0027823339,0.00007671076],"about_ca_topic_score_codex":0.0009015752,"about_ca_topic_score_gemma":0.00051627576,"teacher_disagreement_score":0.0030426043,"about_ca_system_score_codex":0.0004884867,"about_ca_system_score_gemma":0.0002654881,"threshold_uncertainty_score":0.010178566},"labels":[],"label_agreement":null},{"id":"W2787480145","doi":"10.1016/j.jacl.2018.01.013","title":"Alirocumab in high-risk patients: Observations from the open-label expanded use program","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Familial hypercholesterolemia; PCSK9; Statin; Internal medicine; Evolocumab; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.2118351454886508,"score_gpt":0.4463498752314411,"score_spread":0.2345147297427903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787480145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967129,0.0006408376,0.00012399345,0.00021807505,0.000012291588,0.000053891566,0.00035263246,0.000009158356,0.001876311],"genre_scores_gemma":[0.99862635,0.00032750436,0.000117524265,0.00023155466,0.000033704127,0.000023389603,0.00033352428,0.0000044983863,0.00030204628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990307,0.0004469537,0.000060561335,0.00010567534,0.00019401853,0.00016207392],"domain_scores_gemma":[0.9945927,0.0021738703,0.0015352098,0.00061033387,0.00046820406,0.0006196825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017440767,0.0002514427,0.0006408005,0.00025009373,0.00041360914,0.00092931016,0.0002702812,0.00063067395,0.0016526498],"category_scores_gemma":[0.007291434,0.00015450768,0.0005294477,0.00053868734,0.00037140652,0.0011519558,0.0004862301,0.0013159247,0.00026492498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.103401564,0.010485096,0.6979191,0.00019414816,0.0007098273,0.00062278146,0.00083523866,0.00076272653,0.0068494366,0.00039382663,0.0031084213,0.17471781],"study_design_scores_gemma":[0.0030468274,0.016845245,0.9727188,0.000052085437,0.0006144049,0.00048960035,0.00046232273,0.0010839426,0.0011491119,0.00027992352,0.003224747,0.000033038414],"about_ca_topic_score_codex":0.002310738,"about_ca_topic_score_gemma":0.0026309395,"teacher_disagreement_score":0.002310738,"about_ca_system_score_codex":0.00048047653,"about_ca_system_score_gemma":0.0006120419,"threshold_uncertainty_score":0.00922364},"labels":[],"label_agreement":null},{"id":"W2787971106","doi":"10.1016/j.jacl.2018.02.018","title":"Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management","year":2018,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Etiology; Chylomicron; Acute pancreatitis; Pancreatitis; Penetrance; Psychosocial; Diabetes mellitus; Pediatrics; Internal medicine; Psychiatry; Cholesterol; Endocrinology; Very low-density lipoprotein; Genetics; Lipoprotein; Gene","score_opus":0.14526179954237523,"score_gpt":0.4576355772784412,"score_spread":0.31237377773606595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787971106","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052786234,0.81474817,0.0010863959,0.089480355,0.08751647,0.000063555344,0.00039126386,0.00018009006,0.0060058106],"genre_scores_gemma":[0.005667156,0.7328054,0.0018278684,0.09393231,0.1559765,0.00009076022,0.001178283,0.000040376442,0.008481328],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939656,0.00012451384,0.00013306242,0.00008441097,0.0001905037,0.00007094125],"domain_scores_gemma":[0.9978836,0.00082637393,0.00040134127,0.000059921756,0.00057617755,0.00025249497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010134238,0.0011179993,0.0017250914,0.0024135744,0.00052643544,0.0014787653,0.001493743,0.0056946618,0.01165679],"category_scores_gemma":[0.005242891,0.000323971,0.00091774797,0.0013926399,0.0005477828,0.0034605411,0.0017812855,0.0038275858,0.005843533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009224757,0.000030312462,0.0004889278,0.0038582103,0.00006468768,0.0032523212,0.000051513984,0.00021982729,0.00043876382,0.0011730082,0.77598363,0.21434656],"study_design_scores_gemma":[0.00008432616,0.0000661032,0.0012448048,0.009271187,0.00018175114,0.016310476,0.00014568766,0.0001836216,0.00019254979,0.0045901723,0.9676678,0.00006147211],"about_ca_topic_score_codex":0.0007507277,"about_ca_topic_score_gemma":0.0016827536,"teacher_disagreement_score":0.01165679,"about_ca_system_score_codex":0.00071413245,"about_ca_system_score_gemma":0.0015329103,"threshold_uncertainty_score":0.038995862},"labels":[],"label_agreement":null},{"id":"W2795629913","doi":"10.1016/j.jacl.2018.03.087","title":"Severe xanthomatosis in heterozygous familial hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Pediatrics; Internal medicine; Cholesterol","score_opus":0.07083815891387707,"score_gpt":0.40579267028163213,"score_spread":0.33495451136775506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795629913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997431,0.00026320934,0.00037648785,0.0001993687,0.000029312612,0.000018147837,0.00006652628,0.00003556252,0.0015803606],"genre_scores_gemma":[0.99943215,0.000058550195,0.00012467238,0.00004029511,0.000049429436,0.0000031748948,0.0000429407,0.000007974608,0.00024082071],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99947053,0.000115319745,0.00008519086,0.00008496887,0.00011022583,0.00013385554],"domain_scores_gemma":[0.999134,0.00029711289,0.00022219917,0.000048590722,0.000046109526,0.00025198504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042305194,0.0013935886,0.0007332919,0.0018587984,0.0010179718,0.00068504206,0.0005197545,0.0017779674,0.0038296063],"category_scores_gemma":[0.0028640195,0.00066316343,0.000551262,0.0007608461,0.0009796083,0.0005932686,0.0008843388,0.0008741074,0.00047926247],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028609643,0.00020445746,0.17055896,0.000102884944,0.00015102801,0.79464686,0.00061905594,0.00024281915,0.024151212,0.0005442108,0.00043634415,0.005481235],"study_design_scores_gemma":[0.00020652826,0.000535065,0.29510027,0.000028610633,0.00022642167,0.6989978,0.00044280867,0.00084159966,0.0025264237,0.0005681686,0.00048321031,0.000043120213],"about_ca_topic_score_codex":0.0016068254,"about_ca_topic_score_gemma":0.0015753087,"teacher_disagreement_score":0.0038296063,"about_ca_system_score_codex":0.0002535668,"about_ca_system_score_gemma":0.00032224966,"threshold_uncertainty_score":0.012811303},"labels":[],"label_agreement":null},{"id":"W2796014911","doi":"10.1016/j.jacl.2018.03.088","title":"Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Pfizer","keywords":"Medicine; PCSK9; Placebo; Internal medicine; Familial hypercholesterolemia; Adverse effect; Randomized controlled trial; Evolocumab; Alirocumab; Myocardial infarction; Stroke (engine); Cardiology; Placebo-controlled study; Cholesterol; Lipoprotein; Double blind; LDL receptor; Pathology","score_opus":0.05984281726075641,"score_gpt":0.3525676212761616,"score_spread":0.2927248040154052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796014911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882699,0.008200115,0.0002730361,0.0007486092,0.00025185765,0.00024294361,0.0006204783,0.000051375453,0.0013416782],"genre_scores_gemma":[0.99332666,0.0034260175,0.00047425757,0.00066283555,0.00023839665,0.00024284393,0.0007739606,0.000014596533,0.0008405474],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992797,0.00034373943,0.000067745976,0.0001418143,0.00006649594,0.00010051643],"domain_scores_gemma":[0.99938774,0.0001885901,0.00017287905,0.00006396653,0.000046952693,0.00013989935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014838779,0.0011605053,0.0030374206,0.00033045563,0.00033859897,0.0010134663,0.00053660595,0.001144215,0.0039277417],"category_scores_gemma":[0.0016962731,0.0006783789,0.0029923765,0.00039806147,0.00081920065,0.0006982307,0.0004018672,0.0023725259,0.0005771481],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9606897,0.0017243188,0.0037222793,0.0008521422,0.007451182,0.00005295352,0.000051474406,0.00025807202,0.0034875693,0.00010805886,0.0009799425,0.020622164],"study_design_scores_gemma":[0.92708296,0.028985966,0.031397607,0.0001312422,0.009823074,0.00007882333,0.00009695279,0.0004121769,0.0006785769,0.00018769158,0.0010886773,0.000036239253],"about_ca_topic_score_codex":0.0015664593,"about_ca_topic_score_gemma":0.003854448,"teacher_disagreement_score":0.0039277417,"about_ca_system_score_codex":0.00068400736,"about_ca_system_score_gemma":0.00055901357,"threshold_uncertainty_score":0.0131396055},"labels":[],"label_agreement":null},{"id":"W2796183245","doi":"10.1016/j.jacl.2018.03.092","title":"Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Université de Montréal; Montreal Clinical Research Institute","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Fondation Leducq","keywords":"Kexin; Proprotein convertase; Subtilisin; Medicine; PCSK9; Proteomics; Bioinformatics; Computational biology; Internal medicine; Biochemistry; LDL receptor; Cholesterol; Lipoprotein; Enzyme; Gene; Biology","score_opus":0.05505515265896005,"score_gpt":0.39439821204186704,"score_spread":0.339343059382907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796183245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661726,0.0011790891,0.001185537,0.00010243586,0.000037233825,0.000014744567,0.00034574216,0.000012817475,0.0005051995],"genre_scores_gemma":[0.9955668,0.00086171966,0.0011463683,0.00008586471,0.000017157372,0.000025028432,0.00051991496,0.00000861009,0.0017684071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998658,0.000016586813,0.0000096454205,0.00003918197,0.000026203074,0.000042613392],"domain_scores_gemma":[0.9998965,0.000013564311,0.000039778133,0.000009364976,0.000018197226,0.000022483757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016416401,0.00021561529,0.00034806677,0.00019168646,0.00019081026,0.00039838944,0.00010759153,0.00035083204,0.00095491234],"category_scores_gemma":[0.00021074596,0.0001594638,0.00034203182,0.00020199978,0.00017754323,0.00022139317,0.00018284333,0.0005782827,0.00024413783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015920505,0.00004504793,0.0013468858,0.000039847502,0.000030542,0.00011770226,0.000026769934,0.000032836982,0.9945338,0.00008723638,0.000049656515,0.0020976816],"study_design_scores_gemma":[0.00012900053,0.0008633016,0.31527027,0.000022960137,0.0001470571,0.0013738343,0.00024390165,0.0021205556,0.6768238,0.00038664765,0.0025866407,0.00003204271],"about_ca_topic_score_codex":0.00040660778,"about_ca_topic_score_gemma":0.0005506586,"teacher_disagreement_score":0.00095491234,"about_ca_system_score_codex":0.00020140511,"about_ca_system_score_gemma":0.00017032573,"threshold_uncertainty_score":0.0031945705},"labels":[],"label_agreement":null},{"id":"W2801700336","doi":"10.1016/j.jacl.2018.04.012","title":"PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Amgen Canada; Fondation Leducq","keywords":"Medicine; Odds ratio; Coronary artery disease; Internal medicine; Familial hypercholesterolemia; Genotype; Confidence interval; Cohort; Logistic regression; Allele; Single-nucleotide polymorphism; Gastroenterology; Polymorphism (computer science); Endocrinology; Genetics; Cholesterol; Gene; Biology","score_opus":0.03517950720577244,"score_gpt":0.3370644296585654,"score_spread":0.30188492245279297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801700336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984061,0.00040954904,0.000096494194,0.00012860686,0.000027800266,0.000003675416,0.00012661879,0.000006374213,0.0007947493],"genre_scores_gemma":[0.999243,0.000107349195,0.00008436218,0.000049315706,0.000041800766,0.0000043473606,0.00017035018,0.0000035566682,0.00029583924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966335,0.00010349893,0.000041105748,0.00007361331,0.00005331089,0.0000651125],"domain_scores_gemma":[0.99892277,0.00038567194,0.00030712047,0.00007914278,0.00007251863,0.0002327092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039818615,0.0007239411,0.0006670821,0.000953241,0.0007314912,0.0008236655,0.00039762873,0.0012469508,0.0034429252],"category_scores_gemma":[0.0019825178,0.00043874848,0.0006984563,0.0008565031,0.00044851843,0.00044563197,0.0003449599,0.001025122,0.0005869908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006620348,0.00008599718,0.99535733,0.00001237969,0.00012710673,0.00091583864,0.00007704371,0.000053653002,0.001353867,0.000050399063,0.00015255746,0.0011517926],"study_design_scores_gemma":[0.000034469773,0.00014897881,0.9963542,0.000013004024,0.00018537776,0.0021934332,0.00019279768,0.00040730927,0.00017062742,0.000114385926,0.00017421506,0.000011169063],"about_ca_topic_score_codex":0.0019491053,"about_ca_topic_score_gemma":0.0025062715,"teacher_disagreement_score":0.0034429252,"about_ca_system_score_codex":0.00022154964,"about_ca_system_score_gemma":0.00024096385,"threshold_uncertainty_score":0.0115177035},"labels":[],"label_agreement":null},{"id":"W2804217240","doi":"10.1016/j.jacl.2018.05.010","title":"PCSK9 inhibitors in familial hypercholesterolemia: What is the evidence?","year":2018,"lang":"en","type":"editorial","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Familial hypercholesterolemia; PCSK9; Internal medicine; LDL receptor; Cholesterol; Lipoprotein","score_opus":0.0790981821848273,"score_gpt":0.4256803845327321,"score_spread":0.3465822023479048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804217240","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008777501,0.08212722,0.00010067142,0.042737484,0.8740624,0.000017250875,0.00005449415,0.000032646807,0.00077995606],"genre_scores_gemma":[0.0006795452,0.044743218,0.00010749455,0.0238713,0.928672,0.00002031111,0.000028672717,0.000015329495,0.0018621555],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956216,0.0010106778,0.0010649743,0.0004603821,0.001565067,0.0002772674],"domain_scores_gemma":[0.9699858,0.01779986,0.0017656465,0.00038159135,0.007599656,0.0024673813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008945679,0.0026843664,0.0071947793,0.0031586257,0.0018885388,0.0062193116,0.0038813616,0.015345709,0.005611686],"category_scores_gemma":[0.02948915,0.0010733048,0.0028168675,0.0017522715,0.0016883824,0.0038947987,0.0010022818,0.01849204,0.0036415379],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003317746,0.00004285726,0.00009667855,0.0031162822,0.00026016674,0.0002548064,0.000025658832,0.00004407119,0.00009176609,0.000372113,0.9691841,0.026179718],"study_design_scores_gemma":[0.00093259575,0.00023494619,0.0011286745,0.007554184,0.00149118,0.0009861359,0.00015200443,0.0003324914,0.00027624166,0.0015508306,0.9852755,0.000085131964],"about_ca_topic_score_codex":0.0016372739,"about_ca_topic_score_gemma":0.0040945495,"teacher_disagreement_score":0.015345709,"about_ca_system_score_codex":0.002417053,"about_ca_system_score_gemma":0.0031836517,"threshold_uncertainty_score":0.047309816},"labels":[],"label_agreement":null},{"id":"W2804373208","doi":"10.1016/j.jacl.2018.05.007","title":"Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Amgen Canada; REGENXBIO; Sanofi; Amgen","keywords":"Evolocumab; Medicine; Tolerability; Familial hypercholesterolemia; Alirocumab; Randomized controlled trial; PCSK9; Clinical endpoint; Placebo; Internal medicine; Kexin; Adverse effect; Lipoprotein; Cholesterol; Pathology; LDL receptor","score_opus":0.046588446418501024,"score_gpt":0.3418543693989348,"score_spread":0.2952659229804338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804373208","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274307,0.016655536,0.0049624215,0.0015002812,0.00043918527,0.042021897,0.0019438232,0.00006726904,0.00497884],"genre_scores_gemma":[0.9584225,0.0026725244,0.0073005813,0.0006820837,0.00035822814,0.029344354,0.0005024236,0.000014409504,0.00070300855],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98220706,0.013796712,0.0016760582,0.00087798527,0.0007908102,0.0006514374],"domain_scores_gemma":[0.9920216,0.0037170944,0.0019606755,0.0010086987,0.00063333195,0.0006585268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022862576,0.0018417535,0.0035939082,0.0005389392,0.0007885521,0.0012048424,0.00088270096,0.0023592736,0.0033715295],"category_scores_gemma":[0.019719258,0.00083901646,0.0032046838,0.00069160084,0.0022084024,0.0017789707,0.0009152731,0.002239831,0.0005721516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9233681,0.005506958,0.022429997,0.0038878599,0.008372615,0.00027390232,0.0005825908,0.0010731576,0.0032220164,0.0018376373,0.0006491651,0.028796112],"study_design_scores_gemma":[0.6788366,0.254057,0.038767833,0.0010176514,0.014260183,0.00039962892,0.00046097726,0.0010858369,0.0025965234,0.0018219429,0.006588381,0.00010742827],"about_ca_topic_score_codex":0.00042470073,"about_ca_topic_score_gemma":0.0009716377,"teacher_disagreement_score":0.022862576,"about_ca_system_score_codex":0.0010098375,"about_ca_system_score_gemma":0.0020027566,"threshold_uncertainty_score":0.12091029},"labels":[],"label_agreement":null},{"id":"W2804693147","doi":"10.1016/j.jacl.2018.05.009","title":"A failure of standardization or a failure of the process of standardization","year":2018,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Standardization; Medicine; Apolipoprotein B; Internal medicine; Library science; Political science; Computer science; Law; Cholesterol","score_opus":0.37979541957606666,"score_gpt":0.5165761117044605,"score_spread":0.13678069212839383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804693147","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056317635,0.00068234635,0.0024111564,0.989141,0.004648246,0.000023980689,0.000022671722,0.000017766835,0.0024896255],"genre_scores_gemma":[0.026894048,0.0009429972,0.0056608953,0.9323103,0.030910047,0.00018429151,0.000056546167,0.00006711829,0.0029737824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8372719,0.08341914,0.022903806,0.01113731,0.03807897,0.0071889022],"domain_scores_gemma":[0.62991226,0.25833243,0.026225975,0.033618648,0.040905308,0.011005389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15480888,0.00082057505,0.0027727291,0.0017785777,0.003975059,0.0089658545,0.004519402,0.055153076,0.004619099],"category_scores_gemma":[0.4206533,0.0011825379,0.0021960197,0.0022688587,0.026769904,0.015741194,0.010116617,0.08176547,0.0023198868],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011797667,0.00010545762,0.0025199507,0.0002793332,0.00012640814,0.0012077725,0.0026388706,0.00029800247,0.00022088227,0.38100344,0.5756408,0.03584121],"study_design_scores_gemma":[0.00032820436,0.000121758596,0.0020367939,0.0012948589,0.00007850373,0.0013341293,0.00163517,0.0020572841,0.0009454914,0.45406514,0.5358925,0.00021015499],"about_ca_topic_score_codex":0.0033164837,"about_ca_topic_score_gemma":0.0030116173,"teacher_disagreement_score":0.15480888,"about_ca_system_score_codex":0.00639408,"about_ca_system_score_gemma":0.01762335,"threshold_uncertainty_score":0.81871736},"labels":[],"label_agreement":null},{"id":"W2805336640","doi":"10.1016/j.jacl.2018.05.014","title":"Co-occurrence of heterozygous CREB3L3 and APOA5 nonsense variants and polygenic risk in a patient with severe hypertriglyceridemia exacerbated by estrogen administration","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Gemfibrozil; Hypertriglyceridemia; Internal medicine; Endocrinology; Pregnancy; Discontinuation; Triglyceride; Estrogen; Cholesterol; Genetics; Biology","score_opus":0.02601434852517547,"score_gpt":0.34822362099262305,"score_spread":0.32220927246744757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805336640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966372,0.000326718,0.00053841627,0.00060175767,0.00006419271,0.000024613766,0.00015923784,0.000035053345,0.0016127715],"genre_scores_gemma":[0.9991941,0.00008426004,0.00022725102,0.000118703836,0.00007106974,0.0000036041113,0.00005055152,0.0000072328503,0.00024316968],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99962914,0.00004913741,0.00007143699,0.00010107835,0.00006810327,0.0000811065],"domain_scores_gemma":[0.99922967,0.00027029155,0.00018203456,0.00005340671,0.000049665487,0.0002149833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021067384,0.001195688,0.00050381705,0.0018246485,0.0013636929,0.0005142243,0.0008077683,0.0022296358,0.002627737],"category_scores_gemma":[0.0016980141,0.00042729362,0.00090540986,0.00084580696,0.00077454955,0.00042751792,0.00056932506,0.0011048692,0.00042936622],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045063058,0.00011179635,0.08915008,0.00002307807,0.000059333604,0.90055376,0.000200692,0.00011274787,0.0072100516,0.00020417715,0.00024278848,0.0016807748],"study_design_scores_gemma":[0.000042450924,0.0002868367,0.074753076,0.000020911173,0.00019163468,0.9200804,0.00028980296,0.0010493242,0.0023144574,0.00034596404,0.00057807297,0.000047105274],"about_ca_topic_score_codex":0.0026198057,"about_ca_topic_score_gemma":0.0023219406,"teacher_disagreement_score":0.002627737,"about_ca_system_score_codex":0.00036155904,"about_ca_system_score_gemma":0.00042723538,"threshold_uncertainty_score":0.008790612},"labels":[],"label_agreement":null},{"id":"W2883133263","doi":"10.1016/j.jacl.2018.07.007","title":"Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohort","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"National Heart, Lung, and Blood Institute; AbbVie","keywords":"Medicine; Cohort; Internal medicine","score_opus":0.047101163675057414,"score_gpt":0.3535024443263426,"score_spread":0.3064012806512852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883133263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969258,0.0007321756,0.00013088452,0.00013834251,0.000050812323,0.000014783647,0.0014399351,0.000009835006,0.0005574098],"genre_scores_gemma":[0.99675083,0.00018463926,0.0000890033,0.000094008006,0.00011788019,0.00004084836,0.0022872135,0.000011258481,0.0004243452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984303,0.00043729955,0.000099408244,0.0004940043,0.00015918605,0.0003798603],"domain_scores_gemma":[0.9976337,0.00029516846,0.00061860314,0.00070221507,0.00020063751,0.0005496139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003115417,0.0008337624,0.0017919281,0.00047335977,0.0008418679,0.001995741,0.0009053382,0.0011532035,0.0014880934],"category_scores_gemma":[0.0036751234,0.0007141587,0.0020297195,0.0010352156,0.0003682328,0.0013117865,0.0015934343,0.0024273805,0.00034495365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029421268,0.00057127274,0.95681834,0.000083837745,0.0034600426,0.0006212466,0.0002819334,0.0004024745,0.0018346232,0.00024575807,0.002048404,0.004210825],"study_design_scores_gemma":[0.00065357157,0.000704425,0.99585295,0.000018137485,0.0013063013,0.00022534106,0.00017062845,0.0003780431,0.0001237934,0.00015791075,0.00037846228,0.00003052604],"about_ca_topic_score_codex":0.004214831,"about_ca_topic_score_gemma":0.0047748303,"teacher_disagreement_score":0.004214831,"about_ca_system_score_codex":0.00039500915,"about_ca_system_score_gemma":0.000655171,"threshold_uncertainty_score":0.016476095},"labels":[],"label_agreement":null},{"id":"W2883883908","doi":"10.1016/j.jacl.2018.06.014","title":"From the editor: O Canada! A tariff-free zone for scientific exchange","year":2018,"lang":"en","type":"editorial","venue":"Journal of clinical lipidology","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Opening ceremony; Ceremony; Tariff; Library science; Family medicine; Law; Archaeology; History; Political science","score_opus":0.03912090173526989,"score_gpt":0.3219838649301955,"score_spread":0.2828629631949256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883883908","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019061872,0.0019331113,0.000049692848,0.057295103,0.9395891,0.000009241203,0.000022760942,0.000024697603,0.0010572332],"genre_scores_gemma":[0.00047628995,0.002421683,0.000087931156,0.05407427,0.92973083,0.000018751733,0.000030023191,0.00004931776,0.013110885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925479,0.0010820098,0.0007044889,0.0007192248,0.0042409124,0.00070546847],"domain_scores_gemma":[0.96177596,0.008188378,0.0022438788,0.000757671,0.018322766,0.008711331],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.008059955,0.003009502,0.0028236047,0.0029688608,0.004041742,0.010119377,0.0032288837,0.016768437,0.024300065],"category_scores_gemma":[0.050087288,0.0008801675,0.0016081653,0.0012366658,0.0029527168,0.004496017,0.0020098637,0.02365148,0.017366532],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018804029,0.000006019777,0.000019298735,0.000053630258,0.0000057028683,0.00007400862,0.000009733432,0.000008329559,0.000018973318,0.00014565098,0.99777645,0.0018633982],"study_design_scores_gemma":[0.000048045717,0.000016706668,0.00018244526,0.00029442884,0.00002050412,0.00019670452,0.00008059069,0.000076480355,0.000067931374,0.00055742066,0.9984363,0.000022416776],"about_ca_topic_score_codex":0.004784,"about_ca_topic_score_gemma":0.019199397,"teacher_disagreement_score":0.9956935,"about_ca_system_score_codex":0.0043064915,"about_ca_system_score_gemma":0.008329167,"threshold_uncertainty_score":0.081291854},"labels":[],"label_agreement":null},{"id":"W2886894071","doi":"10.1016/j.jacl.2018.07.011","title":"Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Hospital for Sick Children; Institute for Clinical Evaluative Sciences; SickKids Foundation","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Hemodialysis; Internal medicine; Intensive care medicine","score_opus":0.021227848130782948,"score_gpt":0.3112593410833814,"score_spread":0.29003149295259845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886894071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893135,0.00036757227,0.00007858202,0.00003379716,0.000010227024,0.0000027792632,0.00013606793,0.000005624115,0.00043397362],"genre_scores_gemma":[0.99935716,0.00015976686,0.00008696237,0.000033596338,0.000018941299,0.0000043169193,0.00014851417,0.0000017256062,0.00018890311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981266,0.00004572139,0.000023712413,0.000040222392,0.00004259362,0.00003509779],"domain_scores_gemma":[0.99935037,0.00017506421,0.00020991363,0.00005505368,0.000049096074,0.0001605605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026800868,0.0002992826,0.0004569658,0.00051519426,0.0004243117,0.0008393955,0.00021711444,0.00070056424,0.0014891529],"category_scores_gemma":[0.0009974992,0.00035395636,0.00036197205,0.0008077914,0.00020584208,0.00042404438,0.00023736195,0.0011059749,0.00019112563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080901437,0.00013682233,0.9957105,0.000010001866,0.00013040261,0.00016235198,0.00006051361,0.000051612547,0.0009387707,0.000030867148,0.00006328504,0.0018959413],"study_design_scores_gemma":[0.000022621107,0.00018750704,0.998372,0.000005926787,0.00010144421,0.0004149589,0.00013738759,0.00032623837,0.00022232383,0.00007763798,0.00012417557,0.000007896277],"about_ca_topic_score_codex":0.0014845748,"about_ca_topic_score_gemma":0.0017710752,"teacher_disagreement_score":0.0014891529,"about_ca_system_score_codex":0.0002033052,"about_ca_system_score_gemma":0.000230018,"threshold_uncertainty_score":0.004981756},"labels":[],"label_agreement":null},{"id":"W2889173752","doi":"10.1016/j.jacl.2018.08.011","title":"Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; European Commission; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Dosing; Placebo; Familial hypercholesterolemia; Internal medicine; Open label study; Adverse effect; Clinical trial; Open label; Cholesterol; Lipoprotein; Alternative medicine","score_opus":0.0677263020277176,"score_gpt":0.39127738179474775,"score_spread":0.3235510797670301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889173752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997928,0.0011874285,0.00009998177,0.0000737678,0.000012445752,0.000009588565,0.0002567236,0.000013198896,0.00041881297],"genre_scores_gemma":[0.9990916,0.00018340719,0.00009049207,0.000086196334,0.000020620642,0.000010576935,0.00034802995,0.000005215396,0.00016385995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937135,0.00014461494,0.00010227954,0.00016259,0.000117878066,0.00010132248],"domain_scores_gemma":[0.998635,0.00039557804,0.0006430468,0.00008489258,0.00009179959,0.00014958394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057280366,0.00030747912,0.0009526192,0.000497154,0.00030184464,0.000630925,0.00021397648,0.0005964794,0.00091563124],"category_scores_gemma":[0.0026202106,0.00018768464,0.00081775786,0.00064209505,0.00020012486,0.0005537204,0.00021641051,0.0006543305,0.00024879188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034612067,0.00055458606,0.9017623,0.00013740215,0.00095759385,0.001013541,0.00031247138,0.0007301944,0.0077223554,0.00007870366,0.0008715541,0.05124719],"study_design_scores_gemma":[0.00029969725,0.0018905653,0.99431604,0.000020669626,0.00035790948,0.00090141624,0.00010537654,0.00074313424,0.00043776567,0.00007398873,0.0008292958,0.000024249824],"about_ca_topic_score_codex":0.0014794765,"about_ca_topic_score_gemma":0.002351806,"teacher_disagreement_score":0.0014794765,"about_ca_system_score_codex":0.00056519324,"about_ca_system_score_gemma":0.00031393114,"threshold_uncertainty_score":0.00410074},"labels":[],"label_agreement":null},{"id":"W2889778517","doi":"10.1016/j.jacl.2018.08.012","title":"Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal","year":2018,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Lipoprotein(a); Confounding; Population; Secondary prevention; Risk factor; Internal medicine; Disease; Critical appraisal; Coronary heart disease; Lipoprotein; Cholesterol; Pathology; Alternative medicine; Environmental health","score_opus":0.1484425562686993,"score_gpt":0.5066070700772614,"score_spread":0.35816451380856207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889778517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033427994,0.99961025,0.000017969425,0.00017895557,0.000095965115,0.00000306925,0.00000885953,0.0000012407373,0.00005027697],"genre_scores_gemma":[0.0006382167,0.9984376,0.00008226185,0.00045692225,0.00032772674,0.000007907979,0.000013773606,6.70422e-7,0.0000349184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988784,0.0002729772,0.00036463927,0.00016945452,0.00025439032,0.00006019237],"domain_scores_gemma":[0.99339163,0.004914023,0.00082340714,0.000092316164,0.0006465006,0.00013215057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036224583,0.0014233271,0.006579251,0.0027137566,0.00034023338,0.002043855,0.0021396931,0.0025291198,0.0055358945],"category_scores_gemma":[0.008227362,0.00066055893,0.0035180484,0.0022600591,0.00077780685,0.0017342881,0.0010502683,0.0030243937,0.0008559663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013844768,0.00018274352,0.0008835446,0.29705828,0.006981086,0.0003727413,0.00013859491,0.0003493917,0.0005003996,0.0020887528,0.030198874,0.65986115],"study_design_scores_gemma":[0.0020041852,0.0013588571,0.0072767437,0.35182118,0.057985824,0.0021763246,0.000348485,0.0005676093,0.0004932548,0.0050522196,0.5707401,0.0001751884],"about_ca_topic_score_codex":0.0026596817,"about_ca_topic_score_gemma":0.005816451,"teacher_disagreement_score":0.006579251,"about_ca_system_score_codex":0.0009225246,"about_ca_system_score_gemma":0.0032990372,"threshold_uncertainty_score":0.019157588},"labels":[],"label_agreement":null},{"id":"W2890580573","doi":"10.1016/j.jacl.2018.09.010","title":"In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstruction","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Cholesterol; Medicine; Feces; In vivo; Bile duct; Efflux; Gastroenterology; Internal medicine; Excretion; Clinical significance; Common bile duct; Reverse cholesterol transport; Endocrinology; Biochemistry; Chemistry; Biology; Microbiology","score_opus":0.13545972320848154,"score_gpt":0.42753946354282324,"score_spread":0.2920797403343417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890580573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984024,0.0006544264,0.0002802605,0.000063564854,0.000009082007,0.000005497851,0.000045424327,0.000008997265,0.0005304684],"genre_scores_gemma":[0.99960893,0.00011124186,0.00006563389,0.000023529392,0.000012659053,0.0000031704515,0.000076227305,0.0000026571586,0.00009599813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997191,0.00009897316,0.000034328226,0.000046646197,0.000049369137,0.00005156989],"domain_scores_gemma":[0.998719,0.0005483103,0.00027036323,0.00016696546,0.00008180758,0.00021364618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004313183,0.00037653683,0.0008758006,0.00058399973,0.00033665836,0.0009059622,0.00023742171,0.0006312218,0.002473429],"category_scores_gemma":[0.002062719,0.00021688499,0.0002693841,0.00039932976,0.0006636714,0.00047322622,0.00041968233,0.0007432313,0.00028151664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01934803,0.0005100257,0.8431931,0.00017736126,0.00026134044,0.01011627,0.00050224643,0.00020827193,0.11094422,0.00036495007,0.00021814143,0.0141560035],"study_design_scores_gemma":[0.00022590668,0.0037234067,0.94708,0.000022744442,0.00030103876,0.020345898,0.00080201775,0.00078692136,0.025416479,0.0002810816,0.0009934999,0.000020839669],"about_ca_topic_score_codex":0.000403277,"about_ca_topic_score_gemma":0.00019744897,"teacher_disagreement_score":0.002473429,"about_ca_system_score_codex":0.0001667569,"about_ca_system_score_gemma":0.00023024577,"threshold_uncertainty_score":0.008274496},"labels":[],"label_agreement":null},{"id":"W2890737184","doi":"10.1016/j.jacl.2018.09.006","title":"The spectrum of type III hyperlipoproteinemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Royal Victoria Hospital; McGill University Health Centre","funders":"Google; American Heart Association; Aetna Foundation","keywords":"Chylomicron; Hypertriglyceridemia; Internal medicine; Apolipoprotein B; Medicine; Triglyceride; Hyperlipidemia; Cholesterol; Lipoprotein; Very low-density lipoprotein; Endocrinology; Percentile; Diabetes mellitus","score_opus":0.05967622492712722,"score_gpt":0.39825411751260054,"score_spread":0.33857789258547333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890737184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569137,0.0044317613,0.0058612833,0.0018011022,0.00010201807,0.000070496964,0.0005294044,0.00014444458,0.030145833],"genre_scores_gemma":[0.99615663,0.0011977728,0.0012637032,0.00029341027,0.00007108341,0.000016955804,0.00024758663,0.000012214915,0.000740591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997919,0.000049839713,0.000029128274,0.000026076721,0.00005842917,0.000044662225],"domain_scores_gemma":[0.9996927,0.00007302254,0.000067148,0.000019131467,0.000048176928,0.0000999477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002749088,0.0006772094,0.00039425882,0.0009822386,0.00040293188,0.0004541951,0.00034846435,0.00034680814,0.0027694863],"category_scores_gemma":[0.00089148636,0.000100079655,0.00026353967,0.00058907794,0.0003457506,0.00029231663,0.0005479635,0.00054104126,0.00047717927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023206447,0.00028493136,0.6873163,0.00024516936,0.0002214819,0.063010685,0.0011268244,0.0007306057,0.08155172,0.008331991,0.004859326,0.15000033],"study_design_scores_gemma":[0.00009522742,0.0006965329,0.6599849,0.00031578675,0.00015704136,0.30186397,0.0019573332,0.0015244932,0.008140632,0.014478606,0.010744544,0.00004103613],"about_ca_topic_score_codex":0.0006414537,"about_ca_topic_score_gemma":0.00048930576,"teacher_disagreement_score":0.0027694863,"about_ca_system_score_codex":0.00019696986,"about_ca_system_score_gemma":0.00030848125,"threshold_uncertainty_score":0.009264886},"labels":[],"label_agreement":null},{"id":"W2890833213","doi":"10.1016/j.jacl.2018.09.008","title":"Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; Université de Montréal; Montreal Clinical Research Institute","funders":"Merck; Sanofi; AstraZeneca; Fondation Leducq; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Diabetes mellitus; Disease; Atherosclerotic cardiovascular disease; Internal medicine; Pediatrics; Endocrinology; Cholesterol","score_opus":0.025770732921513825,"score_gpt":0.30672280103424915,"score_spread":0.2809520681127353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890833213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970028,0.001197568,0.00016589103,0.00019519431,0.000047876045,0.0000041036224,0.00014206798,0.000011000689,0.0012334831],"genre_scores_gemma":[0.9989692,0.00027307417,0.00015186505,0.00009261483,0.00006335576,0.0000044785584,0.00016305629,0.0000030959293,0.00027939188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995216,0.000144916,0.00006835829,0.000091179645,0.000097239135,0.00007670704],"domain_scores_gemma":[0.9987174,0.0002739539,0.0005648635,0.000105961866,0.00009308642,0.00024466484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037292184,0.0004999097,0.0007341988,0.0010833963,0.0007899345,0.00087558036,0.00030198542,0.0009843581,0.0027391633],"category_scores_gemma":[0.0016659129,0.0004328631,0.000837981,0.0018270288,0.0003492133,0.0004543293,0.00036649642,0.0011510958,0.0002864873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032332094,0.00005512653,0.9971129,0.0000114137765,0.00016698558,0.0003111213,0.00003786389,0.000019594392,0.0005783305,0.000025226662,0.00007963948,0.0012785012],"study_design_scores_gemma":[0.00001350273,0.000071634575,0.9986041,0.000006568385,0.00013622663,0.0007719079,0.00006497829,0.00011388872,0.000047264955,0.00005292677,0.00011173726,0.0000052189594],"about_ca_topic_score_codex":0.003884565,"about_ca_topic_score_gemma":0.0046163397,"teacher_disagreement_score":0.003884565,"about_ca_system_score_codex":0.0002458247,"about_ca_system_score_gemma":0.0002954288,"threshold_uncertainty_score":0.00916338},"labels":[],"label_agreement":null},{"id":"W2891658580","doi":"10.1016/j.jacl.2018.09.007","title":"Extreme hypertriglyceridemia: Genetic diversity, pancreatitis, pregnancy, and prevalence","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Hypertriglyceridemia; Medicine; Missense mutation; Internal medicine; Endocrinology; Pancreatitis; Acute pancreatitis; Population; Triglyceride; Gastroenterology; Genetics; Mutation; Biology; Cholesterol; Gene","score_opus":0.10478142755902664,"score_gpt":0.3692251034765496,"score_spread":0.26444367591752294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891658580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855965,0.0005011201,0.00018306899,0.00008108745,0.0000047390063,0.0000028045433,0.00011247574,0.000003752518,0.00055131334],"genre_scores_gemma":[0.9993729,0.0003191159,0.00013798737,0.00001197779,0.000009814044,0.0000024455146,0.00006036143,0.0000022657941,0.000083155195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927825,0.00026483825,0.00010333255,0.00017119118,0.00009938987,0.0000831401],"domain_scores_gemma":[0.99859124,0.00047254682,0.00047287185,0.00014927087,0.00008035383,0.00023374254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000614262,0.00028350038,0.00031664272,0.0015702381,0.0004640916,0.0008481754,0.00040824097,0.0006878508,0.0026584843],"category_scores_gemma":[0.003431849,0.00025913698,0.00035868122,0.001585159,0.0005413386,0.0005490549,0.00082115387,0.0005549764,0.00020674571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026605045,0.000026494132,0.99332607,0.000009767471,0.00008882853,0.0009537247,0.00025724794,0.000037497684,0.0011421995,0.000113176626,0.000036163696,0.0037428017],"study_design_scores_gemma":[0.0000050923472,0.00007946097,0.9932179,0.000014129204,0.00004400573,0.005467122,0.00048099138,0.00012452419,0.00014988674,0.00027426652,0.00013409686,0.0000084346475],"about_ca_topic_score_codex":0.0014117615,"about_ca_topic_score_gemma":0.00093389023,"teacher_disagreement_score":0.0026584843,"about_ca_system_score_codex":0.00016181126,"about_ca_system_score_gemma":0.00019217032,"threshold_uncertainty_score":0.008893549},"labels":[],"label_agreement":null},{"id":"W2896745557","doi":"10.1016/j.jacl.2018.10.004","title":"GPIHBP1 autoantibody syndrome during interferon β1a treatment","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; Fondation Leducq","keywords":"Medicine; Autoantibody; Interferon γ; Interferon; Immunology; Antibody; Interferon gamma; Immune system","score_opus":0.07931617892183054,"score_gpt":0.44540675444355937,"score_spread":0.36609057552172886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896745557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790004,0.005037347,0.001336759,0.0026001183,0.00033085022,0.000070915194,0.00012253584,0.00007150806,0.01142954],"genre_scores_gemma":[0.9978098,0.00049930747,0.00011237778,0.000536017,0.00013788945,0.000012768698,0.00008289396,0.0000061689357,0.00080273155],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997409,0.00006912122,0.000033106044,0.00004000635,0.000043251654,0.000073518975],"domain_scores_gemma":[0.99931955,0.00031169507,0.00013172123,0.000045525932,0.000039094964,0.00015236624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030967614,0.0005281075,0.00050619163,0.00061399746,0.000638264,0.0005198021,0.00035495404,0.0015541494,0.0013732368],"category_scores_gemma":[0.002229169,0.00025296528,0.0006356085,0.00040473085,0.0003747697,0.0004577427,0.00028706365,0.0020121138,0.0003595916],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00546493,0.0003528641,0.080721505,0.00011608098,0.00022662968,0.8629559,0.00050199375,0.00039417372,0.021620855,0.0005527166,0.0012592117,0.025833085],"study_design_scores_gemma":[0.00046741657,0.0026616736,0.20291682,0.00013725884,0.0004806437,0.7738644,0.0004240034,0.0020175888,0.007922076,0.0014031627,0.007646384,0.00005860394],"about_ca_topic_score_codex":0.0011128151,"about_ca_topic_score_gemma":0.0008525898,"teacher_disagreement_score":0.0015541494,"about_ca_system_score_codex":0.0006336666,"about_ca_system_score_gemma":0.0003119067,"threshold_uncertainty_score":0.0045976043},"labels":[],"label_agreement":null},{"id":"W2897891567","doi":"10.1016/j.jacl.2018.10.006","title":"Severe hypertriglyceridemia is primarily polygenic","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Western University","funders":"Schulich School of Medicine and Dentistry; Genome Canada; Canadian Institutes of Health Research; University of California, San Francisco; Frank A. Campini Foundation; Heart and Stroke Foundation of Canada","keywords":"Medicine; Hypertriglyceridemia; Computational biology; Internal medicine; Triglyceride","score_opus":0.07239149790164767,"score_gpt":0.41521455521061934,"score_spread":0.34282305730897167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897891567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98437077,0.0013709508,0.0044431896,0.0005644302,0.000057068115,0.000035953162,0.00069657556,0.00022453077,0.0082365535],"genre_scores_gemma":[0.99679095,0.00058537256,0.00068095746,0.000101153724,0.000089308895,0.000009871975,0.00032666433,0.00003773633,0.0013779628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953604,0.0001651033,0.000049558297,0.000099834404,0.000081920436,0.000067460365],"domain_scores_gemma":[0.99913436,0.00026130286,0.0003258141,0.000098588855,0.000059521448,0.00012041289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002550925,0.0010420886,0.0005533601,0.001500612,0.00048955483,0.0004547917,0.00045440774,0.0006365066,0.0073014055],"category_scores_gemma":[0.0012281787,0.00027493,0.00044269106,0.0009948077,0.0006787951,0.0004493443,0.0007987432,0.0005444763,0.0010382878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034196943,0.00051345554,0.6302763,0.0003303028,0.0009200428,0.12559648,0.00058418437,0.0005341583,0.16640972,0.005426928,0.002311015,0.06367771],"study_design_scores_gemma":[0.000079253114,0.0006462549,0.79437155,0.00008948298,0.00054807024,0.18341598,0.00033432423,0.000896979,0.012288063,0.0032105364,0.0040617352,0.00005784104],"about_ca_topic_score_codex":0.0007040711,"about_ca_topic_score_gemma":0.0005592667,"teacher_disagreement_score":0.0073014055,"about_ca_system_score_codex":0.00009948431,"about_ca_system_score_gemma":0.00023532737,"threshold_uncertainty_score":0.024425685},"labels":[],"label_agreement":null},{"id":"W2900168942","doi":"10.1016/j.jacl.2018.10.012","title":"Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; McGill University; University of Toronto; Royal Victoria Hospital; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Heart and Stroke Foundation of Canada","keywords":"Medicine; Meta-analysis; Odds ratio; Internal medicine; Confidence interval; Diabetes mellitus; Family history; Body mass index; Cochrane Library; Disease; Relative risk; Endocrinology","score_opus":0.2202542433955947,"score_gpt":0.447504653023783,"score_spread":0.2272504096281883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900168942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008339441,0.99031585,0.00035251593,0.00013119525,0.0001253232,0.000114979026,0.00044359383,0.000024670897,0.00015243741],"genre_scores_gemma":[0.3009867,0.69267476,0.0027390523,0.0015003429,0.00031906864,0.00045479182,0.00080043863,0.000036035144,0.00048878667],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958664,0.0014538054,0.0014201092,0.00061062234,0.0003963317,0.0002528167],"domain_scores_gemma":[0.99245304,0.0049382355,0.0016079738,0.00033215262,0.0005153648,0.00015330478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006034912,0.002680477,0.014898629,0.004276155,0.000589894,0.0024701145,0.0021877466,0.0026363702,0.005028581],"category_scores_gemma":[0.014879667,0.0019373279,0.027119242,0.0049774423,0.00071456714,0.001748191,0.001903965,0.0018836501,0.00037017747],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021442294,0.00004793769,0.009433575,0.2762951,0.699696,0.0002666627,0.0001553494,0.00026300712,0.0003548019,0.00011773764,0.0007668776,0.010458659],"study_design_scores_gemma":[0.00058782124,0.00010954389,0.0054341643,0.010042639,0.9822881,0.00012804744,0.00006378521,0.00007963714,0.000049052913,0.00009360961,0.0010962975,0.00002724642],"about_ca_topic_score_codex":0.0077391365,"about_ca_topic_score_gemma":0.028199006,"teacher_disagreement_score":0.014898629,"about_ca_system_score_codex":0.0015891024,"about_ca_system_score_gemma":0.0023256538,"threshold_uncertainty_score":0.031916022},"labels":[],"label_agreement":null},{"id":"W2900309192","doi":"10.1016/j.jacl.2018.10.013","title":"Diagnostic accuracy of ultrasound and MRI for Achilles tendon xanthoma in people with familial hypercholesterolemia: A systematic review","year":2018,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Dermatological and Skeletal Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"British Cardiovascular Society","keywords":"Medicine; Achilles tendon; Magnetic resonance imaging; Cochrane Library; Xanthoma; Radiology; Tendon; MEDLINE; Physical therapy; Meta-analysis; Internal medicine; Pathology","score_opus":0.04341357851296342,"score_gpt":0.3932687097005524,"score_spread":0.349855131187589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900309192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017690589,0.99784076,0.000036910773,0.0000677684,0.00003503892,0.000015318075,0.00015709647,0.0000018014325,0.00007618324],"genre_scores_gemma":[0.03137783,0.9673419,0.0003741859,0.00044661865,0.000090102374,0.000036877256,0.00026255578,0.0000031654783,0.00006683336],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982784,0.00030072543,0.00081170397,0.00029409467,0.00024691204,0.0000681598],"domain_scores_gemma":[0.99173635,0.0060436702,0.001470797,0.00010338509,0.00056436285,0.00008135533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021913324,0.0008166373,0.0047254283,0.004620382,0.00028244604,0.0014068272,0.0013027732,0.0014295719,0.002112782],"category_scores_gemma":[0.012882374,0.0007797275,0.005170632,0.00410393,0.00048851094,0.0014541654,0.0008094083,0.0007090965,0.00016050863],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009688542,0.000068343346,0.029781705,0.76664835,0.060088262,0.00052486564,0.00039098668,0.00021927428,0.00064809533,0.00024543132,0.003963318,0.13645263],"study_design_scores_gemma":[0.0008272544,0.00046765065,0.07834297,0.3981716,0.48836303,0.0032572718,0.00090829254,0.0002511676,0.00047845746,0.00058810314,0.028139876,0.00020423657],"about_ca_topic_score_codex":0.0061060116,"about_ca_topic_score_gemma":0.019259872,"teacher_disagreement_score":0.0061060116,"about_ca_system_score_codex":0.0007216178,"about_ca_system_score_gemma":0.0021207016,"threshold_uncertainty_score":0.01214093},"labels":[],"label_agreement":null},{"id":"W2902745272","doi":"10.1016/j.jacl.2018.11.007","title":"Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Regeneron Pharmaceuticals; Sanofi; Mylan; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Alirocumab; Open label; Open label study; Ldl cholesterol; Internal medicine; Low-density lipoprotein; Lipoprotein; Endocrinology; Cholesterol; Clinical trial; Adverse effect","score_opus":0.11641847434220684,"score_gpt":0.41734076573286005,"score_spread":0.3009222913906532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902745272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977685,0.0009531524,0.00025637288,0.00019038793,0.00006424493,0.00011844939,0.0001925991,0.000029355771,0.00042684076],"genre_scores_gemma":[0.9971662,0.00048687405,0.00086326955,0.00034357948,0.00009014849,0.00021376816,0.00035905218,0.00000924032,0.00046784373],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993781,0.00029160443,0.00004012034,0.00011992992,0.00005639091,0.00011387638],"domain_scores_gemma":[0.9992086,0.00020794095,0.00014758276,0.000117324846,0.000062967796,0.0002555396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012753323,0.0009825485,0.0023630937,0.00019467314,0.00036663847,0.0010484158,0.00045661876,0.0007289227,0.002093677],"category_scores_gemma":[0.0016549039,0.00025723467,0.0017873487,0.00020668657,0.00072504196,0.00094894134,0.00047778146,0.0020057105,0.0003349846],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9492395,0.007361064,0.003118955,0.0002632547,0.0015566574,0.000058267055,0.00010798575,0.00047034936,0.003415701,0.00011298541,0.0004910706,0.033804294],"study_design_scores_gemma":[0.81444657,0.13305111,0.043132428,0.00008347382,0.0035177409,0.00016377193,0.00017612438,0.002573557,0.0010719202,0.00042938045,0.0012602736,0.00009366982],"about_ca_topic_score_codex":0.0011508996,"about_ca_topic_score_gemma":0.002067125,"teacher_disagreement_score":0.0023630937,"about_ca_system_score_codex":0.000813417,"about_ca_system_score_gemma":0.0006753178,"threshold_uncertainty_score":0.0070040226},"labels":[],"label_agreement":null},{"id":"W2904792752","doi":"10.1016/j.jacl.2018.11.003","title":"JCL roundtable—Lipoprotein(a): The emerging risk factor","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lipoprotein(a); Lipoprotein; Apolipoprotein B; Risk factor; Internal medicine; Apolipoprotein E; Cardiology; Cholesterol; Endocrinology; Bioinformatics; Biology; Disease","score_opus":0.09065624832823797,"score_gpt":0.42415623949223985,"score_spread":0.33349999116400186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904792752","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015606944,0.030865237,0.000933489,0.55118763,0.38245127,0.00027492302,0.0016657857,0.0005057897,0.030555151],"genre_scores_gemma":[0.009924595,0.025429456,0.0029987239,0.277706,0.57977486,0.00025168227,0.002660226,0.00040920888,0.100845225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692816,0.00050558936,0.00037349894,0.0003575837,0.0012885806,0.0005465536],"domain_scores_gemma":[0.97609484,0.00374793,0.0018625878,0.0013982636,0.008391895,0.008504584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046396563,0.0012911378,0.0015145174,0.0031014094,0.002139127,0.0069381227,0.0026272845,0.014334766,0.041209385],"category_scores_gemma":[0.012838371,0.00079044123,0.0011464576,0.0013453978,0.0016985857,0.004457372,0.004264126,0.013956242,0.020776853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011526448,0.000039372095,0.00038393823,0.000099957746,0.000011071686,0.0001237399,0.000010866491,0.000020947746,0.00021212903,0.00054972386,0.96622926,0.032203928],"study_design_scores_gemma":[0.00011338312,0.000113352304,0.003502357,0.00079761486,0.000035060162,0.00027522672,0.00008955693,0.00015029722,0.00036596402,0.0018384847,0.9926806,0.00003803575],"about_ca_topic_score_codex":0.0056344713,"about_ca_topic_score_gemma":0.012592386,"teacher_disagreement_score":0.041209385,"about_ca_system_score_codex":0.0033017916,"about_ca_system_score_gemma":0.007722059,"threshold_uncertainty_score":0.13785905},"labels":[],"label_agreement":null},{"id":"W2908761591","doi":"10.1016/j.jacl.2017.12.015","title":"Roundtable on etiology of familial chylomicronemia syndrome","year":2017,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Montréal","funders":"","keywords":"Medicine; Hypertriglyceridemia; Etiology; Chylomicron; Metabolic syndrome; Gerontology; Diabetes mellitus; Intensive care medicine; Internal medicine; Endocrinology; Cholesterol; Triglyceride; Very low-density lipoprotein","score_opus":0.4184189856747005,"score_gpt":0.5567361431717739,"score_spread":0.1383171574970734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908761591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020882185,0.9925034,0.00018787668,0.0023949353,0.0030902175,0.000008515897,0.00007353877,0.00002200383,0.001510657],"genre_scores_gemma":[0.0014193377,0.98811394,0.00033918358,0.0028600364,0.005663464,0.000006969478,0.0002102124,0.0000051401476,0.0013816932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997464,0.000038797527,0.00007074175,0.000048127255,0.00006846893,0.000027378966],"domain_scores_gemma":[0.99935955,0.00030765557,0.00011155189,0.000018260953,0.00014617966,0.000056900466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044567086,0.00079654396,0.0015242151,0.0031228054,0.0003009751,0.001027923,0.0011932061,0.0015648224,0.009352951],"category_scores_gemma":[0.0014099234,0.0002679604,0.00082472217,0.0019305054,0.00040455087,0.0024825528,0.0010071343,0.0018394521,0.0024307752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016428018,0.000056696717,0.0011216581,0.015037618,0.0002854175,0.0044012866,0.00009682553,0.00025694742,0.0012925809,0.0027590224,0.21233733,0.7621903],"study_design_scores_gemma":[0.00007270658,0.00009345954,0.0024382751,0.01551732,0.0007412206,0.016761946,0.00018592553,0.00011086535,0.0003878629,0.004807787,0.9588232,0.0000594082],"about_ca_topic_score_codex":0.0010262365,"about_ca_topic_score_gemma":0.0018614978,"teacher_disagreement_score":0.009352951,"about_ca_system_score_codex":0.0004427103,"about_ca_system_score_gemma":0.0010054532,"threshold_uncertainty_score":0.031288743},"labels":[],"label_agreement":null},{"id":"W2921299509","doi":"10.1016/j.jacl.2019.02.006","title":"Atypical familial dysbetalipoproteinemia associated with high polygenic cholesterol and triglyceride scores treated with ezetimibe and evolocumab","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Ezetimibe; Medicine; Evolocumab; Dyslipidemia; Internal medicine; Hyperlipidemia; Triglyceride; Familial hypercholesterolemia; Population; Endocrinology; Apolipoprotein E; Cholesterol; Gastroenterology; Diabetes mellitus; Apolipoprotein B; Disease","score_opus":0.020330219128774755,"score_gpt":0.3021754602368027,"score_spread":0.28184524110802794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921299509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910802,0.0011419251,0.00080622314,0.0012806022,0.00014674687,0.000049110608,0.00017117437,0.000050160867,0.005273819],"genre_scores_gemma":[0.9984629,0.00017568578,0.00036027966,0.00034953654,0.00011635811,0.00000849392,0.000112832044,0.000007213063,0.00040657635],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99971074,0.000055240485,0.000042166783,0.000066711145,0.000051658797,0.0000735298],"domain_scores_gemma":[0.99965096,0.000099677774,0.00006567208,0.0000209261,0.000023025515,0.00013981707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022095411,0.00094616745,0.0007738545,0.00049848406,0.00080902706,0.00053135975,0.00042986157,0.00090361043,0.0017899009],"category_scores_gemma":[0.0011059958,0.00020933987,0.0008082446,0.00051035546,0.0004410147,0.0003273745,0.0003250504,0.0010467641,0.00020356977],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007934833,0.00075293006,0.40349767,0.0001265467,0.00063579844,0.54414195,0.000221659,0.0006145974,0.01482732,0.0014418983,0.0022175848,0.02358721],"study_design_scores_gemma":[0.00088867004,0.00223357,0.41629273,0.0000863331,0.00080409937,0.5663528,0.00035883934,0.0045669037,0.0025330647,0.00251285,0.0032920958,0.00007802112],"about_ca_topic_score_codex":0.0014398408,"about_ca_topic_score_gemma":0.0022891697,"teacher_disagreement_score":0.0017899009,"about_ca_system_score_codex":0.00058626506,"about_ca_system_score_gemma":0.0005098439,"threshold_uncertainty_score":0.005987823},"labels":[],"label_agreement":null},{"id":"W2936127254","doi":"10.1016/j.jacl.2019.04.005","title":"PCSK9 inhibition in patients with and without prior myocardial infarction or ischemic stroke: A pooled analysis of nine randomized-controlled studies of alirocumab","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Pasteur; Manitoba Beekeepers' Association; Regeneron Pharmaceuticals","keywords":"Medicine; Alirocumab; Internal medicine; Myocardial infarction; Cardiology; PCSK9; Stroke (engine); Randomized controlled trial; Ischemic stroke; Ischemia; Cholesterol","score_opus":0.023303845832343253,"score_gpt":0.35291366836183347,"score_spread":0.3296098225294902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936127254","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43430132,0.55285454,0.0022050904,0.0005804984,0.0007551498,0.0023940573,0.0049307416,0.00015692564,0.0018216624],"genre_scores_gemma":[0.934627,0.058831893,0.0014653327,0.00064712146,0.00027996092,0.0013342573,0.0022144737,0.000038263257,0.0005616916],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99148446,0.0044327504,0.0020159867,0.0010519737,0.00070197595,0.0003127704],"domain_scores_gemma":[0.99322814,0.00286666,0.0024797097,0.0005535561,0.00061069883,0.0002613126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008950436,0.0022383917,0.009422514,0.0019235617,0.0004535781,0.0020585526,0.00084502035,0.0013705787,0.0028488475],"category_scores_gemma":[0.010576026,0.0011440237,0.02232575,0.0021902118,0.00060074654,0.0009238172,0.0011868417,0.0015483674,0.00025151367],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34488782,0.00023513072,0.00942043,0.030520516,0.5945212,0.000109908084,0.000075138814,0.0005602969,0.0013928668,0.00008143642,0.00080359273,0.017391624],"study_design_scores_gemma":[0.14915325,0.006007277,0.031536035,0.0016630624,0.80849135,0.00015969654,0.00007780183,0.00049065467,0.00055781845,0.0002112295,0.0015841805,0.000067608424],"about_ca_topic_score_codex":0.0021036572,"about_ca_topic_score_gemma":0.005942218,"teacher_disagreement_score":0.009422514,"about_ca_system_score_codex":0.0012142244,"about_ca_system_score_gemma":0.0011851811,"threshold_uncertainty_score":0.04733503},"labels":[],"label_agreement":null},{"id":"W2941018557","doi":"10.1016/j.jacl.2019.04.006","title":"LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal; Montreal Clinical Research Institute","funders":"Amgen Canada; Institut de Recherche Clinique De Montréal; Fondation Leducq","keywords":"Medicine; Familial hypercholesterolemia; Lipoprotein(a); Internal medicine; Odds ratio; Risk factor; Apolipoprotein B; Confidence interval; Population; Genotype; Cohort; Genotyping; Disease; Gastroenterology; Endocrinology; Cholesterol; Genetics; Gene; Biology","score_opus":0.03779753070997961,"score_gpt":0.33029809264641413,"score_spread":0.29250056193643453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941018557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985184,0.00033223303,0.0002814733,0.000100598794,0.000031711195,0.0000044747276,0.00009272997,0.000014936798,0.0006234505],"genre_scores_gemma":[0.9991768,0.00007229081,0.00023838831,0.000039155046,0.000041399293,0.0000052851447,0.0000893254,0.000008275091,0.00032904677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929,0.00029562044,0.00011261169,0.00011319765,0.00010584521,0.000082666455],"domain_scores_gemma":[0.9977724,0.0008066959,0.0006860692,0.00017588504,0.00015070954,0.00040820075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006461697,0.0010024962,0.00085351727,0.0019149072,0.0011874383,0.0009218016,0.0005543552,0.0017031247,0.003913236],"category_scores_gemma":[0.003212229,0.00061281415,0.0009835177,0.0016397584,0.00058332965,0.00043821955,0.0005349613,0.0012092337,0.0005913253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030113407,0.00025439635,0.97601193,0.00004741619,0.000525118,0.0051640794,0.00040721684,0.00013861556,0.010832472,0.00021166446,0.00020790489,0.0031877416],"study_design_scores_gemma":[0.000054727825,0.0002890649,0.9933122,0.000021768537,0.00030098495,0.0041176407,0.00018237041,0.00075057073,0.0004667485,0.00027799365,0.0002039225,0.000022053346],"about_ca_topic_score_codex":0.0025952947,"about_ca_topic_score_gemma":0.002324657,"teacher_disagreement_score":0.003913236,"about_ca_system_score_codex":0.0002233759,"about_ca_system_score_gemma":0.00026003493,"threshold_uncertainty_score":0.013091028},"labels":[],"label_agreement":null},{"id":"W2945006463","doi":"10.1016/j.jacl.2019.04.010","title":"Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":504,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Statement (logic); Biomarker; Association (psychology); Clinical Practice; Lipoprotein(a); Internal medicine; Family medicine; Lipoprotein; Cholesterol; Biochemistry; Law; Epistemology","score_opus":0.1747784884710103,"score_gpt":0.44304946973812026,"score_spread":0.26827098126710996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945006463","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096310704,0.06996342,0.00068362616,0.90117365,0.02566677,0.00001360645,0.00014325237,0.000028982031,0.00136359],"genre_scores_gemma":[0.059736963,0.25883013,0.017261341,0.55250984,0.10575867,0.00024817564,0.0007494041,0.00013660372,0.004768936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9624671,0.01193122,0.008316285,0.002050472,0.014056664,0.0011782268],"domain_scores_gemma":[0.7209987,0.13325621,0.030444497,0.0072160773,0.0873766,0.020707924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07672193,0.0011301258,0.0026115247,0.001998401,0.0024014818,0.010069699,0.001975445,0.019318238,0.0015580151],"category_scores_gemma":[0.14706886,0.00076847343,0.0012411582,0.0032795288,0.0079711415,0.008273526,0.003447745,0.023110537,0.002069608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009456049,0.000291872,0.02268299,0.0021305543,0.0002600602,0.00040429985,0.0008257011,0.00036457687,0.0024263302,0.01579991,0.6103533,0.3435148],"study_design_scores_gemma":[0.0003337769,0.0008190284,0.035914134,0.014144756,0.0004389781,0.001314956,0.0020795478,0.001247975,0.0023136926,0.028242229,0.9127505,0.0004003801],"about_ca_topic_score_codex":0.006109763,"about_ca_topic_score_gemma":0.009163156,"teacher_disagreement_score":0.07672193,"about_ca_system_score_codex":0.003543145,"about_ca_system_score_gemma":0.024245778,"threshold_uncertainty_score":0.4057492},"labels":[],"label_agreement":null},{"id":"W2945048855","doi":"10.1016/j.jacl.2019.05.006","title":"Low LDL cholesterol—Friend or foe?","year":2019,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Apolipoprotein B; Ldl cholesterol; Cholesterol; Internal medicine; Endocrinology","score_opus":0.10073003751435704,"score_gpt":0.41376267884036505,"score_spread":0.313032641326008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945048855","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079519703,0.0011017882,0.000048516533,0.97636783,0.01822772,0.000010704781,0.000032942244,0.000012573392,0.0034026995],"genre_scores_gemma":[0.00999376,0.0015578646,0.00024255396,0.91707,0.05991382,0.00003978579,0.000040069466,0.000028168419,0.011114004],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99773455,0.0005816529,0.00034799404,0.0003476598,0.00043676895,0.0005513708],"domain_scores_gemma":[0.9954941,0.0017896238,0.00043585847,0.00013371125,0.0005568072,0.001589834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020599873,0.0010722771,0.0016997148,0.0011639311,0.0062593524,0.00476913,0.0014036528,0.06627333,0.011252685],"category_scores_gemma":[0.021670213,0.0010062122,0.0013546713,0.0009801866,0.0028390165,0.0039580963,0.002092634,0.042566687,0.006593397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011876201,0.00010150167,0.0035990234,0.000079955,0.000047172733,0.02087754,0.00032937372,0.00007082992,0.00021355704,0.0037386203,0.9601449,0.010678754],"study_design_scores_gemma":[0.00052488677,0.00027321524,0.008315534,0.0017134907,0.00020753288,0.055244606,0.002921744,0.0017214805,0.0003703126,0.026735565,0.90174633,0.00022532512],"about_ca_topic_score_codex":0.0093057165,"about_ca_topic_score_gemma":0.013074076,"teacher_disagreement_score":0.06627333,"about_ca_system_score_codex":0.0052714637,"about_ca_system_score_gemma":0.0047172406,"threshold_uncertainty_score":0.038247347},"labels":[],"label_agreement":null},{"id":"W2946627926","doi":"10.1016/j.jacl.2019.04.011","title":"The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada; Amgen","keywords":"Medicine; Statin; Adverse effect; Diabetes mellitus; Disease; Stroke (engine); Physical therapy; Internal medicine; Intensive care medicine; Emergency medicine","score_opus":0.08136892810638283,"score_gpt":0.4271468875689741,"score_spread":0.34577795946259127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946627926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983253,0.00021208703,0.00005678274,0.00019575283,0.000009469766,0.000013897451,0.00032780116,0.000003665968,0.0008550352],"genre_scores_gemma":[0.9988961,0.0002250377,0.000081809376,0.00017075142,0.000021067288,0.000010915784,0.0003608907,0.0000019855834,0.00023140373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875987,0.00051966525,0.00022408618,0.000082175786,0.00025410944,0.00016018536],"domain_scores_gemma":[0.99444264,0.00086700794,0.002819412,0.00012892835,0.00064465654,0.0010974191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014641149,0.00015547987,0.00039898217,0.00083687657,0.00047435143,0.0007006831,0.00019617422,0.0005278911,0.0009977982],"category_scores_gemma":[0.0051362403,0.00014384078,0.00046968335,0.00076420757,0.00022944763,0.00056993857,0.00090290507,0.000499411,0.00016752473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010217964,0.00006522536,0.9954868,0.0000115501425,0.00003503239,0.00013032134,0.00054615625,0.000029182385,0.00013306517,0.0000106719635,0.00024383412,0.0032058528],"study_design_scores_gemma":[0.00000838014,0.00026018062,0.99622285,0.000013567278,0.000027717526,0.00066264806,0.0018390188,0.00015812495,0.00008331233,0.000008757789,0.0007044686,0.000011072846],"about_ca_topic_score_codex":0.0058267945,"about_ca_topic_score_gemma":0.0077190334,"teacher_disagreement_score":0.0058267945,"about_ca_system_score_codex":0.00044442932,"about_ca_system_score_gemma":0.0005360806,"threshold_uncertainty_score":0.011585772},"labels":[],"label_agreement":null},{"id":"W2950041590","doi":"10.1016/j.jacl.2019.04.046","title":"Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aluminium Refining, Degassing and Filtering (Canada)","funders":"","keywords":"Medicine; Lipoprotein lipase; Internal medicine; Heparin; Lipase; Gastroenterology; Biochemistry; Enzyme","score_opus":0.04079246440259054,"score_gpt":0.36664460334907767,"score_spread":0.3258521389464871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950041590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815255,0.0002611203,0.00016655978,0.00007453327,0.000023419743,0.000005585556,0.00017192005,0.00000781961,0.0011363466],"genre_scores_gemma":[0.99934095,0.000056551886,0.000073370444,0.000015297454,0.00001909226,0.0000039111783,0.00013419233,0.0000015134848,0.0003550986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957925,0.00010273472,0.00007274264,0.00007483446,0.000088773755,0.00008169943],"domain_scores_gemma":[0.99768066,0.00094987714,0.00066056673,0.00010350301,0.00021538576,0.00038993178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003980626,0.00038283056,0.00033678114,0.0011285706,0.00034586978,0.00075824396,0.00026766292,0.00065118785,0.0036873536],"category_scores_gemma":[0.0027489343,0.00028038627,0.00051525485,0.0008377427,0.0003667493,0.00044921073,0.0004016152,0.0009219816,0.0005668249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002312025,0.000036855807,0.99856925,0.0000046504006,0.000049503607,0.00012486959,0.000020188922,0.000026246402,0.00023780798,0.000014611151,0.00004028509,0.0006445304],"study_design_scores_gemma":[0.0000099642475,0.00018347017,0.99810696,0.000003991003,0.00005317908,0.00072163326,0.00011146999,0.00046180078,0.00019041054,0.000048968956,0.00010204371,0.0000060378725],"about_ca_topic_score_codex":0.0012304344,"about_ca_topic_score_gemma":0.0015588684,"teacher_disagreement_score":0.0036873536,"about_ca_system_score_codex":0.00024980443,"about_ca_system_score_gemma":0.0003449518,"threshold_uncertainty_score":0.01233542},"labels":[],"label_agreement":null},{"id":"W2950592118","doi":"10.1016/j.jacl.2019.04.047","title":"Free glycerol correlate with post-heparin lipoprotein lipase activity and contribute to differentiate familial vs. multifactorial chylomicronemia","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aluminium Refining, Degassing and Filtering (Canada)","funders":"","keywords":"Medicine; Lipoprotein lipase; Heparin; Lipase; Internal medicine; Endocrinology; Genetics; Biochemistry; Enzyme; Biology","score_opus":0.018024107368651926,"score_gpt":0.31557066550896723,"score_spread":0.2975465581403153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950592118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802667,0.0005189486,0.00049591105,0.00008864501,0.000021961983,0.0000061717355,0.000114783004,0.000021953001,0.00070497254],"genre_scores_gemma":[0.99940276,0.000056088727,0.0002547264,0.000019749192,0.000015028607,0.0000022946142,0.00008996763,0.000006968984,0.00015252313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952126,0.00010383616,0.00008589303,0.00008557766,0.00008608985,0.000117330885],"domain_scores_gemma":[0.9982469,0.00070663635,0.0005233632,0.00013683585,0.00015466854,0.0002316069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007526453,0.0010197525,0.00043621316,0.0026622808,0.00041377696,0.0012543477,0.000507254,0.0010316868,0.0028633468],"category_scores_gemma":[0.0030751561,0.0003410012,0.0004734166,0.0010474415,0.0005838895,0.00052175985,0.0006900162,0.0009134084,0.0006295618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001083314,0.00005071121,0.9812914,0.00001903808,0.00007489408,0.0020609028,0.00010897835,0.00010307861,0.011283278,0.0001661311,0.00009255129,0.0036656514],"study_design_scores_gemma":[0.00002882538,0.00017316568,0.9778546,0.000024097923,0.00010401675,0.012945365,0.00036213407,0.0020536557,0.0055392385,0.00063068024,0.0002659567,0.000018133722],"about_ca_topic_score_codex":0.0013317968,"about_ca_topic_score_gemma":0.0012956026,"teacher_disagreement_score":0.0028633468,"about_ca_system_score_codex":0.0003052357,"about_ca_system_score_gemma":0.00021494982,"threshold_uncertainty_score":0.009578824},"labels":[],"label_agreement":null},{"id":"W2952046919","doi":"10.1016/j.jacl.2019.05.010","title":"Did the ACC/AHA/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA cholesterol guidelines get apoB right?","year":2019,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Guideline; Apolipoprotein B; Cover (algebra); Family medicine; Cholesterol; Internal medicine; Pathology","score_opus":0.13927878760279444,"score_gpt":0.43701122338987664,"score_spread":0.2977324357870822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952046919","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046305414,0.00041261016,0.00005539633,0.9661579,0.024898801,0.00001910448,0.0001592138,0.00001676559,0.007817121],"genre_scores_gemma":[0.004717493,0.0008408673,0.00023747674,0.91890305,0.042577986,0.00006530193,0.00013090794,0.000036499703,0.03249046],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722594,0.0005101369,0.00038949322,0.00034558302,0.00072760944,0.0008012128],"domain_scores_gemma":[0.9955303,0.0015104719,0.00044783394,0.000110573055,0.0011129809,0.0012878105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002589091,0.0010471322,0.0014282839,0.0010923003,0.0047779763,0.005530067,0.0012632471,0.06876423,0.018533263],"category_scores_gemma":[0.022150962,0.0010141858,0.0017806462,0.0008853084,0.0021086743,0.0031904578,0.00161691,0.035894506,0.015259673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008599248,0.000077093086,0.0014523899,0.000051309584,0.000029236493,0.0034832868,0.00013405633,0.00006902965,0.00012381453,0.003231497,0.98595583,0.0053063324],"study_design_scores_gemma":[0.00044986643,0.000121032856,0.0036247375,0.00071675645,0.0000993839,0.0037984862,0.00067340524,0.0010509025,0.00027779065,0.01056848,0.9784983,0.000120861805],"about_ca_topic_score_codex":0.024582786,"about_ca_topic_score_gemma":0.03330358,"teacher_disagreement_score":0.06876423,"about_ca_system_score_codex":0.007955324,"about_ca_system_score_gemma":0.008072542,"threshold_uncertainty_score":0.061999917},"labels":[],"label_agreement":null},{"id":"W2955786349","doi":"10.1016/j.jacl.2019.06.006","title":"Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ironwood Pharmaceuticals, Incorporated; Manitoba Beekeepers' Association; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Pooled analysis; Randomized controlled trial; Internal medicine; Meta-analysis; Total cholesterol","score_opus":0.05460852246808687,"score_gpt":0.3953743566006576,"score_spread":0.3407658341325708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955786349","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2178419,0.7705414,0.0020222906,0.00053935644,0.0005952689,0.0016558769,0.0047379904,0.00017003859,0.0018958766],"genre_scores_gemma":[0.8658687,0.12315021,0.0022607853,0.0015894123,0.0003834744,0.0020334108,0.0032883536,0.00008092393,0.0013445904],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933295,0.0036688612,0.0014252607,0.0008424365,0.00047469785,0.00025924816],"domain_scores_gemma":[0.99393153,0.0031692411,0.0017562697,0.00041036188,0.00053677027,0.00019579612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008131905,0.0023768526,0.012059953,0.0017564661,0.0003532387,0.0018753151,0.00086539617,0.0016223467,0.0033586144],"category_scores_gemma":[0.010775262,0.0010785033,0.023306366,0.002190833,0.0006955429,0.001289165,0.0012831655,0.0016288217,0.00028011322],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24386318,0.000159684,0.0058562863,0.06585839,0.66226685,0.000104396844,0.00008457476,0.0009677094,0.0008723324,0.00011207509,0.0012610769,0.01859358],"study_design_scores_gemma":[0.09094086,0.0031354958,0.016670782,0.0026588347,0.88319284,0.00010937001,0.00006401393,0.00052597426,0.00035236252,0.00031507743,0.0019740814,0.000060325423],"about_ca_topic_score_codex":0.0038464004,"about_ca_topic_score_gemma":0.008663081,"teacher_disagreement_score":0.012059953,"about_ca_system_score_codex":0.0013159479,"about_ca_system_score_gemma":0.001205291,"threshold_uncertainty_score":0.043006122},"labels":[],"label_agreement":null},{"id":"W2979652387","doi":"10.1016/j.jacl.2019.10.002","title":"Measurement of lipid profiles in the early postpartum period after hypertensive disorders of pregnancy","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Preeclampsia; Postpartum period; Pregnancy; Gestational hypertension; Obstetrics; Lipid profile; Blood pressure; Triglyceride; Logistic regression; Internal medicine; Cholesterol","score_opus":0.05695134782104442,"score_gpt":0.33572239946854404,"score_spread":0.2787710516474996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979652387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980192,0.0008497546,0.000063892345,0.00004673385,0.000014542163,0.000024149434,0.00009560619,0.0000016727114,0.0008844126],"genre_scores_gemma":[0.9980527,0.0010033104,0.00014108891,0.000060155868,0.000018338334,0.000029673145,0.00010063821,0.0000011449615,0.0005930021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970573,0.000106207306,0.000028363804,0.00003985472,0.00005704854,0.00006277441],"domain_scores_gemma":[0.99939,0.0001885754,0.0001595918,0.000027671447,0.000098765995,0.00013534387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044918654,0.00027970437,0.000319807,0.0008069474,0.0004951785,0.0007017797,0.00023505939,0.00040014295,0.00054966094],"category_scores_gemma":[0.0021197745,0.00021254843,0.0001721881,0.0009741761,0.00016231286,0.00027867028,0.00025814815,0.00067300705,0.00014482827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029988727,0.0005183038,0.9714793,0.00008814202,0.00005753732,0.0012559465,0.0012540506,0.000023702049,0.0035619067,0.000059329395,0.00013275228,0.018570203],"study_design_scores_gemma":[0.000015076582,0.0010015374,0.99659216,0.00002103857,0.00004635029,0.00043734192,0.0008495209,0.000034973928,0.0006521023,0.00003474656,0.00031017986,0.0000049036244],"about_ca_topic_score_codex":0.004015475,"about_ca_topic_score_gemma":0.004464144,"teacher_disagreement_score":0.004015475,"about_ca_system_score_codex":0.00036144702,"about_ca_system_score_gemma":0.00041003706,"threshold_uncertainty_score":0.007984221},"labels":[],"label_agreement":null},{"id":"W2979874565","doi":"10.1016/j.jacl.2019.10.003","title":"Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Pharma; Miltenyi Biotec; Amgen","keywords":"Evolocumab; Medicine; Apheresis; Clinical endpoint; Randomized controlled trial; Internal medicine; Alirocumab; Gastroenterology; Urology; Lipoprotein; Cholesterol; Endocrinology","score_opus":0.06162361087302733,"score_gpt":0.4142984293133187,"score_spread":0.35267481844029136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979874565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939122,0.0031106558,0.00037653424,0.00037457925,0.00017483503,0.000642977,0.0005425489,0.0000356239,0.0008299481],"genre_scores_gemma":[0.9950964,0.0011005308,0.0008955012,0.00042337005,0.00025572555,0.0006613073,0.00045569014,0.00001246311,0.0010990163],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982187,0.0012487707,0.00009372254,0.00017165949,0.00014266864,0.00012439271],"domain_scores_gemma":[0.99739206,0.0011053253,0.00062252866,0.00022278784,0.00013095823,0.00052631967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026962096,0.000880548,0.00193805,0.00024226726,0.00027337662,0.00086350215,0.000655334,0.0011304617,0.0030047472],"category_scores_gemma":[0.002901647,0.00040172972,0.0019242025,0.00019575532,0.0008840384,0.0006896027,0.00037659804,0.0016799795,0.0003617066],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98266625,0.0036606858,0.0012051502,0.00023839842,0.000999086,0.000016602331,0.00002739918,0.00014838367,0.0013663018,0.00004705522,0.00024074849,0.009383876],"study_design_scores_gemma":[0.942216,0.04986777,0.005758727,0.000029347471,0.0007772862,0.000024216686,0.000014725822,0.00042569902,0.00039706426,0.000066947236,0.0004079349,0.000014416933],"about_ca_topic_score_codex":0.0007158861,"about_ca_topic_score_gemma":0.0016462816,"teacher_disagreement_score":0.0030047472,"about_ca_system_score_codex":0.0007030389,"about_ca_system_score_gemma":0.00083671237,"threshold_uncertainty_score":0.0142591},"labels":[],"label_agreement":null},{"id":"W2997233238","doi":"10.1016/j.jacl.2019.12.006","title":"Triglycerides, hypertension, and smoking predict cardiovascular disease in dysbetalipoproteinemia","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Population Health Research Institute; Université de Montréal; Montreal Clinical Research Institute","funders":"Fondation Leducq","keywords":"Medicine; Internal medicine; Coronary artery disease; Cohort; Cardiology; Disease; Population; Gastroenterology; Metabolic syndrome; Endocrinology; Obesity","score_opus":0.04018789559988161,"score_gpt":0.3087395869271026,"score_spread":0.268551691327221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997233238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976914,0.0005998871,0.00018454825,0.0001516714,0.00004368673,0.000010556845,0.00010578195,0.000008681522,0.0012038718],"genre_scores_gemma":[0.9991967,0.00012889109,0.00013253864,0.000055970733,0.000048176084,0.0000065135105,0.000096181175,0.0000035071264,0.00033162686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993962,0.00024941296,0.000072972754,0.00008028098,0.0001024246,0.000098575765],"domain_scores_gemma":[0.9969285,0.0012558834,0.00048105177,0.00016954327,0.0001479687,0.0010170584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014327782,0.00080895994,0.00062356866,0.00084160233,0.00073506025,0.001494125,0.00054740673,0.0015178727,0.002947065],"category_scores_gemma":[0.0038248033,0.0008158541,0.00097024214,0.00088387966,0.0005907031,0.0008143717,0.0007139814,0.0019136328,0.0006053947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046606912,0.00012740024,0.998102,0.000004587587,0.00009412036,0.00007672911,0.000037339436,0.000055764947,0.00016885437,0.00002295426,0.000049445727,0.00079467247],"study_design_scores_gemma":[0.000031926145,0.00016643162,0.99753296,0.000008976013,0.00017000448,0.00028056867,0.00017395041,0.001278513,0.00008719234,0.00015015554,0.00010974294,0.0000095404575],"about_ca_topic_score_codex":0.0028548369,"about_ca_topic_score_gemma":0.004727041,"teacher_disagreement_score":0.002947065,"about_ca_system_score_codex":0.00023250718,"about_ca_system_score_gemma":0.0005177532,"threshold_uncertainty_score":0.009858906},"labels":[],"label_agreement":null},{"id":"W2998950773","doi":"10.1016/j.jacl.2020.01.003","title":"The polygenic nature of mild-to-moderate hypertriglyceridemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Schulich School of Medicine and Dentistry; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Hypertriglyceridemia; Internal medicine; Computational biology; Triglyceride; Cholesterol","score_opus":0.07829803412451246,"score_gpt":0.4154142111271596,"score_spread":0.3371161770026471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998950773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968798,0.00040644474,0.0010962753,0.00024010906,0.00001542607,0.0000117926975,0.0001876898,0.000019439833,0.0011431434],"genre_scores_gemma":[0.9993362,0.000121507706,0.00022743946,0.000024684541,0.000019694988,0.0000033577328,0.000065759305,0.0000033251529,0.00019815708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996302,0.00018324498,0.000038712744,0.000058729416,0.000050417944,0.000038680046],"domain_scores_gemma":[0.9992306,0.00030744844,0.00019877055,0.00009564303,0.000047436042,0.000120030294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003801258,0.0004277505,0.00035484764,0.0009780574,0.00039329543,0.00043102895,0.00034938595,0.00046884312,0.0023122535],"category_scores_gemma":[0.0018129867,0.00020214794,0.00032715703,0.00054858875,0.000438833,0.00035016407,0.00047344549,0.00038617325,0.00017025282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030331593,0.0001837626,0.9096425,0.000086434724,0.00056416134,0.008739307,0.0003827948,0.00044451328,0.053574786,0.0031633445,0.00037914817,0.019806128],"study_design_scores_gemma":[0.000020743068,0.00021264148,0.9879502,0.000012836182,0.00014216999,0.0077783726,0.00014640218,0.00089098595,0.0010370936,0.0015263039,0.0002657443,0.000016616325],"about_ca_topic_score_codex":0.0022480171,"about_ca_topic_score_gemma":0.002355568,"teacher_disagreement_score":0.0023122535,"about_ca_system_score_codex":0.00012304244,"about_ca_system_score_gemma":0.00023142874,"threshold_uncertainty_score":0.0077352524},"labels":[],"label_agreement":null},{"id":"W3000263047","doi":"10.1016/j.jacl.2020.01.001","title":"Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Statin; Online transaction processing; Internal medicine; Ezetimibe; Atorvastatin; Cholesterol; Lipoprotein; Database","score_opus":0.1230577307056659,"score_gpt":0.42616008427213575,"score_spread":0.30310235356646986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000263047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333185,0.0026846877,0.00023008858,0.0003116354,0.00013160473,0.0010151627,0.00088283344,0.00003085008,0.0013812558],"genre_scores_gemma":[0.99447507,0.0006763028,0.00035955533,0.0006106118,0.00027070116,0.001568958,0.0011350579,0.000007769668,0.0008960903],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99841785,0.00077637436,0.00015886572,0.00027124537,0.00015977416,0.00021585306],"domain_scores_gemma":[0.9976059,0.0003915785,0.0009418261,0.00022049695,0.00016089235,0.0006792529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032128019,0.0010650839,0.0023937593,0.00030378008,0.0006869095,0.0012604713,0.00049196143,0.0015989618,0.0039493404],"category_scores_gemma":[0.0039114333,0.00042459148,0.002192855,0.0004351261,0.0007505024,0.0012732659,0.0006363419,0.002311336,0.0005289904],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9713112,0.0038690376,0.008292794,0.0002910374,0.0009980265,0.00004770592,0.000060099188,0.0001574598,0.0010550864,0.00006626495,0.00057163526,0.013279591],"study_design_scores_gemma":[0.809853,0.11664988,0.06610024,0.00012070016,0.0025600365,0.00016194608,0.00009174385,0.0010609685,0.0010058085,0.00031406587,0.002014611,0.00006697973],"about_ca_topic_score_codex":0.00062510686,"about_ca_topic_score_gemma":0.0010182555,"teacher_disagreement_score":0.0039493404,"about_ca_system_score_codex":0.00070952094,"about_ca_system_score_gemma":0.0008222869,"threshold_uncertainty_score":0.016991079},"labels":[],"label_agreement":null},{"id":"W3002437288","doi":"10.1016/j.jacl.2020.01.004","title":"Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"Medicines Company; University of Alabama; University of Alabama at Birmingham; Sanofi; Bayer Corporation; Amgen","keywords":"Medicine; Myocardial infarction; Internal medicine; Hazard ratio; Percutaneous coronary intervention; Diabetes mellitus; Population; Cardiology; Guideline; Heart failure; Emergency medicine; Confidence interval","score_opus":0.09486068985892704,"score_gpt":0.4406406638247928,"score_spread":0.34577997396586574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002437288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788034,0.00048748625,0.00006865443,0.00031525487,0.000023392557,0.000007812484,0.00017546325,0.0000070742317,0.0010345601],"genre_scores_gemma":[0.9991678,0.000097279175,0.000047816982,0.00005818219,0.00007269876,0.0000031062345,0.00034888333,0.0000020433833,0.00020220807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932694,0.0001378169,0.00007505647,0.00011168514,0.00008518106,0.0002633508],"domain_scores_gemma":[0.9970477,0.00058507285,0.00086123956,0.0003549738,0.00015268703,0.000998282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010793426,0.00034375375,0.00074546726,0.00044992083,0.0005179585,0.0010580724,0.00072754547,0.0009833295,0.0014377915],"category_scores_gemma":[0.0038516386,0.0002050939,0.00084815756,0.00055972027,0.0005171638,0.0008930516,0.0006830251,0.0018607626,0.000270408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053382004,0.0006576492,0.985881,0.00002197692,0.00026221346,0.0004915785,0.0001012936,0.00018101762,0.0009416644,0.00015480541,0.0002104462,0.0057581402],"study_design_scores_gemma":[0.000029623858,0.0003557147,0.9987772,0.0000054653433,0.000093511975,0.00012392376,0.00011437425,0.00020882413,0.00007301565,0.00012656984,0.000084289255,0.0000074296136],"about_ca_topic_score_codex":0.0049865264,"about_ca_topic_score_gemma":0.0070659965,"teacher_disagreement_score":0.0049865264,"about_ca_system_score_codex":0.0005031869,"about_ca_system_score_gemma":0.0009821497,"threshold_uncertainty_score":0.009914994},"labels":[],"label_agreement":null},{"id":"W3003487350","doi":"10.1016/j.jacl.2020.01.012","title":"Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Fondation Leducq","keywords":"Autoantibody; Medicine; Lipoprotein lipase; Internal medicine; Endocrinology; Pancreatitis; Etiology; Acute pancreatitis; Immunology; Antibody; Adipose tissue","score_opus":0.08342500298764088,"score_gpt":0.39507243265753256,"score_spread":0.3116474296698917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003487350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806918,0.003236977,0.0023015032,0.0017173267,0.00025547016,0.000081972525,0.00018938078,0.00019743312,0.0113282455],"genre_scores_gemma":[0.9983858,0.00031577874,0.00027258694,0.00021385822,0.00032501627,0.0000069469434,0.00005394625,0.000007337295,0.00041867592],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997062,0.000042083037,0.000033104578,0.000070468624,0.00004527678,0.00010274394],"domain_scores_gemma":[0.99912924,0.00034256905,0.00019263731,0.00007176786,0.000040216568,0.00022357616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021887326,0.0017409929,0.00075310987,0.0012997419,0.0007331368,0.0004470746,0.00069263077,0.0022131717,0.0026021602],"category_scores_gemma":[0.0017488194,0.00051815354,0.0006724643,0.00091702165,0.0006773275,0.0007132133,0.000586262,0.0017042917,0.00048916746],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002867586,0.0000582039,0.020290893,0.00005185389,0.000022151984,0.97317815,0.00007947424,0.000095993586,0.002698637,0.0001921019,0.0003730341,0.0026725836],"study_design_scores_gemma":[0.00007748828,0.0002756173,0.042722832,0.000020411871,0.000055444118,0.9541601,0.00006148557,0.0007714259,0.00093100185,0.00032093385,0.0005899618,0.000013223941],"about_ca_topic_score_codex":0.00094276015,"about_ca_topic_score_gemma":0.00060756353,"teacher_disagreement_score":0.0026021602,"about_ca_system_score_codex":0.00044006982,"about_ca_system_score_gemma":0.00023944202,"threshold_uncertainty_score":0.00870508},"labels":[],"label_agreement":null},{"id":"W3021549637","doi":"10.1016/j.jacl.2020.04.011","title":"Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Regeneron Pharmaceuticals","keywords":"Genetic testing; Medicine; Dyslipidemia; Familial hypercholesterolemia; Genetic counseling; Bioinformatics; Intensive care medicine; Genetics; Obesity; Pathology; Internal medicine; Biology; Cholesterol","score_opus":0.21956663925062728,"score_gpt":0.42650839433249316,"score_spread":0.20694175508186588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021549637","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005849468,0.01341827,0.0009991553,0.94013023,0.039598964,0.000025659649,0.00016469124,0.000038899492,0.005039134],"genre_scores_gemma":[0.012268796,0.020828055,0.004716178,0.8069331,0.15016353,0.00011596476,0.0004499513,0.00008090011,0.004443529],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97237927,0.007837204,0.004115414,0.0028448617,0.011378976,0.0014443115],"domain_scores_gemma":[0.8506823,0.08873352,0.007839871,0.00496843,0.031923283,0.015852623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045414887,0.0014210579,0.003126107,0.0030427752,0.0038342222,0.005346366,0.0030432267,0.04862379,0.00307893],"category_scores_gemma":[0.10234628,0.001094238,0.0021689713,0.002340392,0.0062334593,0.0032274474,0.0038396902,0.035635315,0.0032645622],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053914037,0.00022491462,0.0060634157,0.0004432856,0.00025991388,0.00141687,0.00017173804,0.00032188784,0.0010612928,0.011318405,0.90107584,0.07710321],"study_design_scores_gemma":[0.0007468751,0.00033606816,0.013692973,0.007112776,0.0006776422,0.0037012391,0.00031477786,0.0012626497,0.0012577169,0.031403188,0.93927974,0.00021432704],"about_ca_topic_score_codex":0.0031981464,"about_ca_topic_score_gemma":0.0045587462,"teacher_disagreement_score":0.04862379,"about_ca_system_score_codex":0.0018755043,"about_ca_system_score_gemma":0.010990648,"threshold_uncertainty_score":0.24017972},"labels":[],"label_agreement":null},{"id":"W3032256190","doi":"10.1016/j.jacl.2020.05.098","title":"High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia Hospital; St. Paul's Hospital; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Neurological Disorders and Stroke; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Medicine; Duchenne muscular dystrophy; Dyslipidemia; Wasting; Internal medicine; Muscular dystrophy; Dystrophin; Endocrinology; Obesity","score_opus":0.04933676721665461,"score_gpt":0.3246328304662323,"score_spread":0.2752960632495777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032256190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988411,0.00021042465,0.00021560318,0.000018520768,0.0000027918104,0.000003941656,0.00013922327,0.000013945693,0.00055456534],"genre_scores_gemma":[0.9993393,0.00008926643,0.00024700054,0.000011117169,0.0000056899335,0.0000025567515,0.0001700499,0.0000037294722,0.00013131354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997415,0.000042795506,0.000034071007,0.00007818181,0.000069068476,0.00003429748],"domain_scores_gemma":[0.9995609,0.00015016494,0.00013984207,0.00004074988,0.000037770307,0.0000704811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023863498,0.00034532827,0.0003257689,0.0024491118,0.0002640817,0.00040443157,0.00020010235,0.0005789652,0.0025643872],"category_scores_gemma":[0.0006693265,0.00018163791,0.00012819227,0.0008510931,0.00046401,0.00022989546,0.00029994905,0.00023442888,0.00023599603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026542735,0.00013676229,0.6635239,0.0001156093,0.00016231075,0.01141694,0.0005550755,0.00019605544,0.30716905,0.0005727976,0.00033518896,0.013161869],"study_design_scores_gemma":[0.00001673339,0.00027921877,0.96693325,0.000009476193,0.000074019285,0.022929832,0.00022691843,0.00033963186,0.008340001,0.00018913114,0.00064995827,0.000011767034],"about_ca_topic_score_codex":0.00045493065,"about_ca_topic_score_gemma":0.00063891493,"teacher_disagreement_score":0.0025643872,"about_ca_system_score_codex":0.00015196722,"about_ca_system_score_gemma":0.00009459873,"threshold_uncertainty_score":0.008578777},"labels":[],"label_agreement":null},{"id":"W3035228838","doi":"10.1016/j.jacl.2020.06.004","title":"A simplified diagnosis algorithm for dysbetalipoproteinemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal; Sanofi; Amgen","keywords":"Medicine; Dyslipidemia; Apolipoprotein B; Internal medicine; Lipoprotein; Apolipoprotein E; Cholesterol; Gastroenterology; Algorithm; Triglyceride; Endocrinology; Disease","score_opus":0.13423680595027532,"score_gpt":0.4076699965621666,"score_spread":0.2734331906118913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035228838","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036705386,0.0036500453,0.9314587,0.00415276,0.0009765135,0.002024798,0.0047881166,0.009301413,0.006942236],"genre_scores_gemma":[0.105040275,0.0011014625,0.8821443,0.00086817704,0.0003794364,0.0012541724,0.005154548,0.00026243742,0.0037952778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987012,0.00027753128,0.00023843147,0.00031879044,0.0003588765,0.000105175066],"domain_scores_gemma":[0.9985038,0.00042011155,0.00010389688,0.00009482102,0.0007716975,0.00010571252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014220101,0.0014617814,0.0016820744,0.0033592707,0.00097184035,0.0031727294,0.001757546,0.001417462,0.007842275],"category_scores_gemma":[0.005182426,0.0006621952,0.0014618594,0.0013182837,0.00024787534,0.0010092421,0.001735284,0.0020174752,0.0033417523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008214462,0.0003471066,0.0361562,0.0003141001,0.00032345994,0.0016988073,0.00017966468,0.02037233,0.005174382,0.0039841803,0.06310569,0.8675226],"study_design_scores_gemma":[0.0015736267,0.0010259288,0.056068793,0.0008803994,0.0011881386,0.022158341,0.0004681433,0.7627617,0.01664058,0.036940694,0.09988333,0.00041020344],"about_ca_topic_score_codex":0.01006947,"about_ca_topic_score_gemma":0.010407289,"teacher_disagreement_score":0.01006947,"about_ca_system_score_codex":0.0012009152,"about_ca_system_score_gemma":0.0026432264,"threshold_uncertainty_score":0.026235044},"labels":[],"label_agreement":null},{"id":"W3035497061","doi":"10.1016/j.jacl.2020.06.007","title":"A cautionary tale: Is this APOB whole-gene duplication actually pathogenic?","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Gene duplication; Apolipoprotein B; Medicine; Sanger sequencing; Familial hypercholesterolemia; Gene; LDL receptor; Genetics; Ldl cholesterol; Bioinformatics; Cholesterol; Lipoprotein; Internal medicine; Biology; Mutation","score_opus":0.08394923489520024,"score_gpt":0.3789151098864681,"score_spread":0.29496587499126786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035497061","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039549493,0.008121877,0.00513966,0.9311815,0.048272107,0.000031205367,0.0002176381,0.00032216217,0.0027588531],"genre_scores_gemma":[0.058052234,0.005894583,0.009859041,0.8081597,0.111729264,0.000058586193,0.00017787472,0.00014034529,0.005928423],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99552673,0.001289227,0.0006117538,0.0014233893,0.0008549442,0.0002939465],"domain_scores_gemma":[0.95108104,0.03745368,0.0019335977,0.003524563,0.0040337024,0.0019734076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012131382,0.001402127,0.0021091027,0.0016028488,0.0030697917,0.0039998144,0.005386808,0.022349898,0.006885711],"category_scores_gemma":[0.10298892,0.0006038253,0.0011554946,0.0010298633,0.010156787,0.0068349903,0.0032211198,0.033393875,0.005274457],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008139033,0.000077516495,0.011146026,0.00060481037,0.00054145977,0.04859939,0.0023305258,0.00040633755,0.0021149674,0.03080454,0.8312993,0.07126121],"study_design_scores_gemma":[0.0006540135,0.0002642699,0.009318772,0.0018397033,0.0006854561,0.09948551,0.005014581,0.0032748734,0.0023700923,0.28996637,0.5866108,0.00051559205],"about_ca_topic_score_codex":0.0023541967,"about_ca_topic_score_gemma":0.002273654,"teacher_disagreement_score":0.022349898,"about_ca_system_score_codex":0.00088024506,"about_ca_system_score_gemma":0.0018174656,"threshold_uncertainty_score":0.064157605},"labels":[],"label_agreement":null},{"id":"W3043909035","doi":"10.1016/j.jacl.2020.07.010","title":"Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; Missense mutation; PCSK9; Kexin; Proprotein convertase; Medicine; Locus (genetics); Genetics; Apolipoprotein B; Gene; LDL receptor; Lipoprotein; Internal medicine; Endocrinology; Cholesterol; Mutation; Biology","score_opus":0.10036274044262207,"score_gpt":0.381254003830548,"score_spread":0.28089126338792597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043909035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950459,0.0003397124,0.0013171727,0.00045395546,0.00019425167,0.000014799741,0.00040507538,0.00008013508,0.0021490722],"genre_scores_gemma":[0.99887043,0.000040120274,0.0003120498,0.00007692598,0.0000828851,0.0000047473036,0.00011055231,0.000016267248,0.00048610647],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99891245,0.00021540669,0.00020973202,0.0002713453,0.00022623889,0.00016479741],"domain_scores_gemma":[0.9970113,0.0014659426,0.0006128338,0.00032769362,0.00021060118,0.00037159902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005884615,0.0010346875,0.0006228241,0.0016717113,0.0008126182,0.0004359951,0.0008961099,0.0025606735,0.0072454843],"category_scores_gemma":[0.0038184968,0.0002653856,0.00083196966,0.00083467184,0.00070249505,0.00037018696,0.0005545304,0.0008710402,0.0014525723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003945782,0.00028613655,0.3083451,0.00012457055,0.0006001988,0.51505226,0.0007314662,0.00054430217,0.15278469,0.0012517899,0.0015293936,0.014804252],"study_design_scores_gemma":[0.00017400204,0.0011105486,0.29652557,0.00005092175,0.0005003139,0.6639461,0.0006752185,0.0027469269,0.029286526,0.00085862674,0.004028949,0.00009640808],"about_ca_topic_score_codex":0.0014155727,"about_ca_topic_score_gemma":0.000989058,"teacher_disagreement_score":0.0072454843,"about_ca_system_score_codex":0.00021469216,"about_ca_system_score_gemma":0.00029420725,"threshold_uncertainty_score":0.024238527},"labels":[],"label_agreement":null},{"id":"W3044130787","doi":"10.1016/j.jacl.2020.07.008","title":"The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal; Merck; Sanofi; Amgen; Fondation Leducq; AstraZeneca","keywords":"Medicine; Myocardial infarction; Familial hypercholesterolemia; Internal medicine; Genotype; Hazard ratio; Population; SNP; Genotyping; Confidence interval; Gastroenterology; Single-nucleotide polymorphism; Genetics; Cholesterol; Gene","score_opus":0.037728263471364924,"score_gpt":0.3222774633278502,"score_spread":0.28454919985648525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044130787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809843,0.00048368738,0.00011194396,0.00016101784,0.000021631879,0.0000042070214,0.00013861636,0.000007567644,0.0009729065],"genre_scores_gemma":[0.9991561,0.00014995375,0.00010094442,0.000046112527,0.00004511058,0.000004265694,0.00015997757,0.0000036500126,0.0003337015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996952,0.000089780944,0.00003487397,0.000057549296,0.00006243224,0.000060162933],"domain_scores_gemma":[0.9989918,0.00031327514,0.00037391513,0.00006619242,0.00005889067,0.00019580843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036070676,0.00066541275,0.00066314155,0.0011313672,0.0006323363,0.00076758384,0.00042533546,0.0010576361,0.0030503757],"category_scores_gemma":[0.0021896553,0.0004255591,0.0007170157,0.0010400093,0.00044362573,0.00037550658,0.00034907667,0.0011277341,0.0004944199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062936725,0.00007064558,0.99565,0.0000135619075,0.00014629215,0.0007228039,0.00006525205,0.000042003554,0.0011804368,0.000050278195,0.00013310439,0.0012962708],"study_design_scores_gemma":[0.000028898286,0.00012574685,0.99698776,0.000008274004,0.00016399888,0.0018620043,0.00013233584,0.0003248646,0.0001240339,0.000085687,0.00014819442,0.000008232195],"about_ca_topic_score_codex":0.0022440208,"about_ca_topic_score_gemma":0.0022410706,"teacher_disagreement_score":0.0030503757,"about_ca_system_score_codex":0.00021505519,"about_ca_system_score_gemma":0.00024105277,"threshold_uncertainty_score":0.010204554},"labels":[],"label_agreement":null},{"id":"W3082704660","doi":"10.1016/j.jacl.2020.08.009","title":"Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Abbott Vascular; National Institutes of Health; Novo Nordisk; Medicines Company; Valeant Pharmaceuticals International; Novartis; Eli Lilly and Company; AstraZeneca; Pfizer; NIHR Imperial Biomedical Research Centre; Amgen; Boehringer Ingelheim; Kowa Company; Meso Scale Diagnostics; Sanofi; Esperion Therapeutics; Merck; American Heart Association; American Diabetes Association","keywords":"Medicine; Placebo; Internal medicine; Discontinuation; Gastroenterology; Adverse effect; myalgia; Uric acid","score_opus":0.5493554365692096,"score_gpt":0.565551082466481,"score_spread":0.016195645897271405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082704660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7762377,0.1766419,0.018682655,0.0012148148,0.0009779122,0.007533443,0.010628792,0.00067389675,0.0074088294],"genre_scores_gemma":[0.96817356,0.016733585,0.0036235645,0.0012837821,0.00044707637,0.0026857757,0.005333647,0.00014710151,0.0015718865],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9894465,0.0068248105,0.0011536705,0.0009483953,0.0010952931,0.00053127506],"domain_scores_gemma":[0.9878164,0.0056594643,0.0033800893,0.0014704956,0.0011180339,0.00055551046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020159673,0.0027810335,0.008775951,0.001601774,0.00057320396,0.002491776,0.0008934193,0.0019457161,0.0034277171],"category_scores_gemma":[0.016481766,0.0008543257,0.012479522,0.0020487977,0.0010635792,0.0017764152,0.0010666018,0.0026154711,0.00055855874],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7530133,0.001446379,0.009166919,0.008615076,0.17513761,0.00015040979,0.0001445546,0.0025872367,0.0056660413,0.00019812709,0.0024679063,0.041406468],"study_design_scores_gemma":[0.4675737,0.09988651,0.06964548,0.0013930079,0.3424229,0.00053435005,0.00023653966,0.0021928179,0.00535971,0.0016556125,0.0088537345,0.0002455726],"about_ca_topic_score_codex":0.0006446888,"about_ca_topic_score_gemma":0.0015132531,"teacher_disagreement_score":0.020159673,"about_ca_system_score_codex":0.0011593925,"about_ca_system_score_gemma":0.0017536852,"threshold_uncertainty_score":0.10661584},"labels":[],"label_agreement":null},{"id":"W3089041414","doi":"10.1016/j.jacl.2020.09.006","title":"Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Université de Montréal; Ottawa Hospital; University of Ottawa","funders":"Department of Medicine, Ottawa Hospital","keywords":"Apolipoprotein B; Hypertriglyceridemia; Medicine; Internal medicine; Triglyceride; Cholesterol; Endocrinology; Lipid profile","score_opus":0.030464402648183113,"score_gpt":0.3313212701957954,"score_spread":0.30085686754761226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089041414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98235095,0.010509904,0.0017373206,0.00056045334,0.00021135023,0.000021288713,0.00039835836,0.00008842375,0.0041220495],"genre_scores_gemma":[0.9961339,0.00093533983,0.0007058491,0.00012003594,0.0003033854,0.000010741267,0.00019796357,0.000034991666,0.0015578008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959906,0.0029143435,0.00017765188,0.00040688427,0.00029459043,0.00021596543],"domain_scores_gemma":[0.9763861,0.018485708,0.0008548676,0.0022085048,0.00062194874,0.001442967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008698703,0.0010494846,0.0015735459,0.0010739573,0.00034067186,0.0013711465,0.0006011517,0.0011159016,0.003536597],"category_scores_gemma":[0.014756304,0.00074112904,0.0025086508,0.00062787643,0.0006766749,0.0011442302,0.000995156,0.0018324291,0.0005563685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15129328,0.00049253576,0.7677814,0.0004019074,0.015334286,0.0009315372,0.00028883474,0.0015992057,0.022300478,0.0008856977,0.00048892887,0.038201917],"study_design_scores_gemma":[0.0005359924,0.0032709816,0.975684,0.00002907701,0.010495003,0.0007169225,0.0002290548,0.004181064,0.002959842,0.00093621213,0.0009128827,0.00004892697],"about_ca_topic_score_codex":0.0015016297,"about_ca_topic_score_gemma":0.0014338489,"teacher_disagreement_score":0.008698703,"about_ca_system_score_codex":0.00023967934,"about_ca_system_score_gemma":0.0004623012,"threshold_uncertainty_score":0.0460037},"labels":[],"label_agreement":null},{"id":"W3094458672","doi":"10.1016/j.jacl.2020.09.011","title":"Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institutes of Health; Strålsäkerhetsmyndigheten; American Heart Association; Novo Nordisk; Sanofi; Quest Diagnostics; Aetna Foundation","keywords":"Medicine; Triglyceride; Apolipoprotein B; Cutoff; Internal medicine; Gastroenterology; Type 2 diabetes; Algorithm; Gold standard (test); Lipoprotein; Cholesterol; Predictive value; Endocrinology; Very low-density lipoprotein; Diabetes mellitus; Mathematics","score_opus":0.134640533330754,"score_gpt":0.3755043372432961,"score_spread":0.24086380391254214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094458672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93411046,0.0054192706,0.044152435,0.0035869987,0.0003990517,0.00025471664,0.0009010514,0.00035527005,0.010820658],"genre_scores_gemma":[0.9643444,0.0007066326,0.032682493,0.00046598515,0.00015413557,0.00007499884,0.00079358387,0.00007906882,0.0006986556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981831,0.00078156067,0.00025748866,0.00026954486,0.00042096828,0.000087343484],"domain_scores_gemma":[0.99727553,0.001306587,0.00029988377,0.00017443788,0.0006779099,0.00026579658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034945037,0.0009862399,0.0015132676,0.002023892,0.0005393832,0.0028917703,0.0009805298,0.0010831407,0.0012715625],"category_scores_gemma":[0.008873711,0.0002844748,0.0008524956,0.0008615535,0.00031564268,0.001106565,0.00096594123,0.0013580886,0.00073178957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038730337,0.0003439795,0.8745373,0.00012074586,0.000871163,0.00047168924,0.000082706065,0.0070000077,0.0034833327,0.0011923653,0.0028441902,0.105179444],"study_design_scores_gemma":[0.0011704307,0.0018774279,0.5653997,0.0005818868,0.0025199149,0.0065502804,0.00059082196,0.39228067,0.008184381,0.0113154575,0.009323499,0.00020550439],"about_ca_topic_score_codex":0.001337975,"about_ca_topic_score_gemma":0.0013126107,"teacher_disagreement_score":0.0034945037,"about_ca_system_score_codex":0.0003561467,"about_ca_system_score_gemma":0.0008094392,"threshold_uncertainty_score":0.018480897},"labels":[],"label_agreement":null},{"id":"W3097141469","doi":"10.1016/j.jacl.2020.10.005","title":"Ketogenic diets, not for everyone","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute","keywords":"Ketogenic diet; Medicine; Ezetimibe; Hyperlipidemia; Cholesterol; Internal medicine; Weight loss; Endocrinology; Familial hypercholesterolemia; Obesity; Diabetes mellitus; Epilepsy; Psychiatry","score_opus":0.2774389126729533,"score_gpt":0.4653276587630378,"score_spread":0.1878887460900845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097141469","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5580982,0.06108128,0.002129795,0.22439638,0.009992598,0.00008806363,0.00081911084,0.00016226292,0.14323233],"genre_scores_gemma":[0.89150566,0.026919229,0.0023724083,0.052284937,0.0025640465,0.00006911763,0.0003109564,0.00007884047,0.02389487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984981,0.00060633704,0.000120357094,0.00018281884,0.00036221856,0.00023017295],"domain_scores_gemma":[0.9958476,0.0014188564,0.0005533406,0.00074600184,0.00053108897,0.0009031009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020829798,0.00041052734,0.0010930108,0.00078980613,0.0022481799,0.0029188236,0.00035862104,0.002080133,0.0070800446],"category_scores_gemma":[0.008358003,0.00023618962,0.00039477786,0.0010941139,0.0017040377,0.0037716455,0.0017900781,0.0037139868,0.0015040876],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005466301,0.002583435,0.25554514,0.0034155652,0.0018335492,0.0026002084,0.015690517,0.00014751806,0.008806926,0.07382211,0.10843738,0.5216514],"study_design_scores_gemma":[0.00088249973,0.003493768,0.2876832,0.0073554767,0.0028359687,0.014622234,0.059163753,0.0002510851,0.007072489,0.13601562,0.48033363,0.000290278],"about_ca_topic_score_codex":0.0011626835,"about_ca_topic_score_gemma":0.0027829357,"teacher_disagreement_score":0.0070800446,"about_ca_system_score_codex":0.00045753876,"about_ca_system_score_gemma":0.0011333093,"threshold_uncertainty_score":0.023685098},"labels":[],"label_agreement":null},{"id":"W3106829925","doi":"10.1016/j.jacl.2020.11.007","title":"Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Single-nucleotide polymorphism; Hypertriglyceridemia; Ancestry-informative marker; Medicine; SNP; Genetics; Genetic genealogy; Genetic predisposition; Genome-wide association study; Internal medicine; Genotype; Biology; Triglyceride; Gene; Disease; Cholesterol; Population","score_opus":0.15878918396139746,"score_gpt":0.4071608414391785,"score_spread":0.24837165747778106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106829925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988494,0.00009990197,0.00019650575,0.000025552072,0.0000050734643,0.0000047117614,0.00014832833,0.0000048796564,0.00066564133],"genre_scores_gemma":[0.999321,0.000044444467,0.00014085614,0.0000112344605,0.0000075329776,0.0000027871115,0.00015995193,0.000008806583,0.00030347583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993755,0.00022354983,0.00006732955,0.0001558822,0.00006690767,0.00011083027],"domain_scores_gemma":[0.9988771,0.00023003863,0.0003961678,0.00014480889,0.000114016046,0.00023774455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041798226,0.00044217252,0.00043105503,0.001258607,0.0006645208,0.00073057436,0.00040165216,0.00062092574,0.004290163],"category_scores_gemma":[0.002138492,0.00024817922,0.00053485495,0.0012131257,0.0003896451,0.00038537302,0.0007925602,0.0005774832,0.00044190054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087373954,0.000061844476,0.98271203,0.000011001228,0.00027714684,0.00056768267,0.00043107237,0.000105044,0.011882278,0.00025917144,0.00008538388,0.0027335978],"study_design_scores_gemma":[0.0000045702095,0.00008849208,0.9982186,0.0000036275108,0.0000583984,0.000761702,0.00022747237,0.00016294635,0.00023293357,0.00012256208,0.00011203733,0.0000064445917],"about_ca_topic_score_codex":0.0026615947,"about_ca_topic_score_gemma":0.002950839,"teacher_disagreement_score":0.004290163,"about_ca_system_score_codex":0.00012878625,"about_ca_system_score_gemma":0.00020270476,"threshold_uncertainty_score":0.014352024},"labels":[],"label_agreement":null},{"id":"W3107261118","doi":"10.1016/j.jacl.2020.11.006","title":"Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Sanofi; HLS Therapeutics; Amgen; Pfizer; Heart and Stroke Foundation of Canada","keywords":"Hypertriglyceridemia; Hyperlipidemia; Odds ratio; Medicine; Internal medicine; Single-nucleotide polymorphism; Endocrinology; Triglyceride; Cholesterol; Genetics; Biology; Genotype; Gene; Diabetes mellitus","score_opus":0.10543542278113052,"score_gpt":0.4033601854879213,"score_spread":0.2979247627067908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107261118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156356,0.0003407097,0.00075378036,0.00039198357,0.000056271194,0.000045870136,0.0003299432,0.00007822151,0.0064397412],"genre_scores_gemma":[0.996309,0.00035296587,0.0009802748,0.00013208945,0.00015610276,0.000027357839,0.00032113094,0.00004572959,0.001675504],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99938226,0.00012498736,0.00008457091,0.00015908138,0.00013883584,0.00011029958],"domain_scores_gemma":[0.9989053,0.0003148497,0.00041441745,0.00008775548,0.00005690613,0.000220797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002502595,0.0018772503,0.00065768906,0.0026209373,0.00086265506,0.000722247,0.00078158383,0.0013394215,0.008735345],"category_scores_gemma":[0.0015760672,0.0005219797,0.00076603726,0.0017238263,0.001076392,0.00055972586,0.0011710894,0.0010814,0.0010763059],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005479121,0.0010186296,0.24609157,0.00021587052,0.0005040315,0.5299144,0.001003446,0.000392388,0.19690973,0.003688968,0.0011136999,0.013668204],"study_design_scores_gemma":[0.00022571885,0.0007093085,0.32827514,0.00009221289,0.0004932659,0.6535327,0.0006237982,0.00080211164,0.010452608,0.0018774247,0.002825631,0.00009009009],"about_ca_topic_score_codex":0.0014144093,"about_ca_topic_score_gemma":0.0011515651,"teacher_disagreement_score":0.008735345,"about_ca_system_score_codex":0.00035202038,"about_ca_system_score_gemma":0.0004744326,"threshold_uncertainty_score":0.029222667},"labels":[],"label_agreement":null},{"id":"W3116757469","doi":"10.1016/j.jacl.2020.12.010","title":"Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Takeda Pharmaceuticals North America","keywords":"Medicine; Interrogation; Internal medicine; Ldl cholesterol; Gene; Cholesterol; Gastroenterology; Genetics","score_opus":0.06257001355462245,"score_gpt":0.3458537780997901,"score_spread":0.2832837645451677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116757469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926,0.00020159612,0.00007637837,0.00003805759,0.000004420447,0.0000041526378,0.00010444445,0.0000029053438,0.0003080201],"genre_scores_gemma":[0.99958104,0.000046723897,0.00008109688,0.000032361273,0.000007574167,0.00000427927,0.00012976916,0.000001907765,0.0001150798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976593,0.00006066963,0.000034671422,0.00006137705,0.000035012104,0.000042299733],"domain_scores_gemma":[0.9994855,0.00021526794,0.00015492161,0.000029482693,0.000046898753,0.00006788314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026632805,0.0002687164,0.00037828903,0.000610494,0.00036330216,0.0005678329,0.00017874448,0.00037540495,0.0012270041],"category_scores_gemma":[0.0011821503,0.00013177608,0.0003080604,0.00067018985,0.00026529553,0.00020294863,0.00021176114,0.0003067021,0.00017576032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088141754,0.000045540226,0.9893884,0.000021982032,0.00007125542,0.0008093439,0.00012789403,0.000060610055,0.0054400405,0.000036422345,0.00007340668,0.0030437994],"study_design_scores_gemma":[0.000015572929,0.00019487439,0.99679166,0.000006549433,0.00008641217,0.0013315945,0.00028449777,0.0002022155,0.00077611767,0.00005922438,0.00024684946,0.00000445889],"about_ca_topic_score_codex":0.0008503631,"about_ca_topic_score_gemma":0.0011838744,"teacher_disagreement_score":0.0012270041,"about_ca_system_score_codex":0.00020242087,"about_ca_system_score_gemma":0.0001696081,"threshold_uncertainty_score":0.004104674},"labels":[],"label_agreement":null},{"id":"W3128325240","doi":"10.1016/j.jacl.2021.01.010","title":"Characteristics and trends of PCSK9 inhibitor prescription fills in the United States","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alirocumab; Evolocumab; Medicine; Medical prescription; Quarter (Canadian coin); Demography; PCSK9; Family medicine; Pharmacology; Internal medicine; Cholesterol; Total cholesterol; Geography; Lipoprotein","score_opus":0.06425957143169246,"score_gpt":0.3801233647856103,"score_spread":0.31586379335391784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128325240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901035,0.00055133016,0.00006838671,0.00015920689,0.000011764233,0.000008288269,0.007867892,0.000018066767,0.0012115708],"genre_scores_gemma":[0.9952538,0.00028217724,0.00006408924,0.00010054672,0.000011671874,0.000010427199,0.0037946263,0.000005177427,0.0004775206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943596,0.00006982298,0.000118600394,0.00015752208,0.00010208424,0.000115997624],"domain_scores_gemma":[0.99726176,0.0004654097,0.0014567256,0.00009537095,0.0003497986,0.00037104954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046155238,0.00019123884,0.00037271142,0.0015097837,0.00037327054,0.0007873005,0.000430677,0.00062048883,0.0028212334],"category_scores_gemma":[0.001879928,0.00029935624,0.0007568536,0.0031717434,0.0002354903,0.00073990464,0.00038909944,0.0006975214,0.0004155332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012629293,0.000044782737,0.9978046,0.000012949587,0.0000628204,0.000031877484,0.000043005246,0.00007544561,0.00010246668,0.000026214075,0.00048810005,0.0011815013],"study_design_scores_gemma":[0.000004577686,0.00004390727,0.9989729,0.000009180723,0.000020797705,0.00010080279,0.00020944548,0.00026614894,0.000038676142,0.0000124239705,0.00031629155,0.000004856906],"about_ca_topic_score_codex":0.048047476,"about_ca_topic_score_gemma":0.054250393,"teacher_disagreement_score":0.048047476,"about_ca_system_score_codex":0.0007143322,"about_ca_system_score_gemma":0.0009077443,"threshold_uncertainty_score":0.095535636},"labels":[],"label_agreement":null},{"id":"W3138612987","doi":"10.1016/j.jacl.2021.03.006","title":"Novel PPARG mutation in multiple family members with chylomicronemia","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novo Nordisk; Sanofi; Merck","keywords":"Peroxisome proliferator-activated receptor gamma; Hypertriglyceridemia; Genetics; Allele; Chylomicron; Gene; Phenotype; Mutation; Biology; Medicine; Internal medicine; Triglyceride; Cholesterol; Peroxisome proliferator-activated receptor; Very low-density lipoprotein; Lipoprotein","score_opus":0.08354346964574806,"score_gpt":0.3790552046089398,"score_spread":0.2955117349631918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138612987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883307,0.00095874834,0.0016180794,0.0024282616,0.00030069833,0.000057323643,0.00047826755,0.00014129945,0.0051843193],"genre_scores_gemma":[0.9974872,0.00019041196,0.00067270076,0.00030670658,0.00022916363,0.000015635034,0.00010631629,0.000020550337,0.0009713755],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9994598,0.00006691407,0.00007193456,0.00019153889,0.00009096287,0.00011886501],"domain_scores_gemma":[0.9989594,0.00040897253,0.00019084563,0.000049707916,0.00006673855,0.0003243435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027832825,0.0028520988,0.000897755,0.0034196023,0.0022791526,0.0008084595,0.0014912041,0.003430962,0.0071216715],"category_scores_gemma":[0.0022053628,0.00061540474,0.0013967933,0.0016269779,0.0014697704,0.00075421087,0.0011375801,0.0014847995,0.00081336935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012141044,0.000035946126,0.010470842,0.00001926518,0.00003128139,0.9835007,0.00012711383,0.00008447152,0.004313196,0.00015774916,0.00024123896,0.00089686725],"study_design_scores_gemma":[0.000046457164,0.00008526895,0.019561104,0.000027566595,0.00012546078,0.976082,0.00025523506,0.00062422757,0.0020764251,0.00028099268,0.00080734026,0.000027805067],"about_ca_topic_score_codex":0.0025068664,"about_ca_topic_score_gemma":0.002097575,"teacher_disagreement_score":0.0071216715,"about_ca_system_score_codex":0.00081214216,"about_ca_system_score_gemma":0.00072833593,"threshold_uncertainty_score":0.023824394},"labels":[],"label_agreement":null},{"id":"W3157811151","doi":"10.1016/j.jacl.2021.04.001","title":"Clinical reasoning and prevention of cardiovascular disease","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Servier; Novartis","keywords":"Medicine; Observational study; Clinical trial; Disease; Randomized controlled trial; Metric (unit); Intensive care medicine; Event (particle physics); Primary prevention; Pathology","score_opus":0.08588843561969628,"score_gpt":0.4219238485394571,"score_spread":0.3360354129197608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157811151","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26685897,0.067352064,0.08616297,0.34235576,0.0030889553,0.00046598952,0.0008018428,0.00062934536,0.23228414],"genre_scores_gemma":[0.9509012,0.0097092595,0.028063463,0.0074431375,0.00073211273,0.00007317734,0.00021965067,0.00003171631,0.0028262562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99213505,0.0060397317,0.00041547994,0.000393385,0.0007927029,0.00022367231],"domain_scores_gemma":[0.9568419,0.034281217,0.003180092,0.001338076,0.002931379,0.0014273367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011083114,0.000505954,0.0004936485,0.001961865,0.0008761479,0.0045305216,0.001475773,0.0020798321,0.0068535632],"category_scores_gemma":[0.06007483,0.00032452433,0.00074007496,0.0005831898,0.0027465576,0.0022718203,0.0011044419,0.0032633443,0.0005800096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012651171,0.0057976046,0.15247542,0.00218173,0.0007783119,0.002541579,0.0068547092,0.00882006,0.001382253,0.2571547,0.04743254,0.513316],"study_design_scores_gemma":[0.000969775,0.00057976495,0.059437376,0.0033256619,0.0008013462,0.0026705377,0.0039779968,0.022948632,0.0018643001,0.86840725,0.034828756,0.00018866816],"about_ca_topic_score_codex":0.006399702,"about_ca_topic_score_gemma":0.0039021573,"teacher_disagreement_score":0.011083114,"about_ca_system_score_codex":0.0020547926,"about_ca_system_score_gemma":0.0049370904,"threshold_uncertainty_score":0.058613777},"labels":[],"label_agreement":null},{"id":"W3167159721","doi":"10.1016/j.jacl.2021.05.005","title":"Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA)","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; National Institutes of Health; National Center for Advancing Translational Sciences; U.S. Department of Health and Human Services","keywords":"Medicine; Internal medicine; Heart failure; Ejection fraction; Cardiology; Natriuretic peptide; Proportional hazards model; Prospective cohort study; Body mass index; Left ventricular hypertrophy; Population; Incidence (geometry); Endocrinology; Blood pressure","score_opus":0.13556791381099145,"score_gpt":0.4059542328651024,"score_spread":0.2703863190541109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167159721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971227,0.00089927536,0.000111325666,0.00017953271,0.000052383053,0.000026373913,0.00080877496,0.000006897173,0.0007926036],"genre_scores_gemma":[0.99757963,0.00050993933,0.00023134638,0.00008864789,0.00011151527,0.000049717386,0.00075867603,0.0000074010504,0.0006630467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999127,0.00044293742,0.000095164294,0.00012099781,0.00011408732,0.00009984895],"domain_scores_gemma":[0.99846303,0.00026398676,0.00045077247,0.00021823289,0.00013086112,0.0004731499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020626003,0.0009812892,0.0011418641,0.0012748331,0.0015115681,0.001496845,0.00066062406,0.0015702851,0.0019380141],"category_scores_gemma":[0.002178561,0.0011789476,0.0012967205,0.0016725216,0.0003910955,0.0009728428,0.0014872546,0.0019252514,0.00036567278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010532277,0.00019507697,0.9957033,0.000024577688,0.0007547145,0.00014954674,0.000110125184,0.000076807075,0.00072131585,0.0000789382,0.00021659958,0.0009156887],"study_design_scores_gemma":[0.000054399283,0.00009098504,0.9990687,0.000007857869,0.0001810902,0.00012311261,0.0001223384,0.00012567412,0.000044985056,0.00004389829,0.00013025563,0.000006764927],"about_ca_topic_score_codex":0.006047181,"about_ca_topic_score_gemma":0.010820148,"teacher_disagreement_score":0.006047181,"about_ca_system_score_codex":0.0003244374,"about_ca_system_score_gemma":0.00046612724,"threshold_uncertainty_score":0.012023985},"labels":[],"label_agreement":null},{"id":"W3171018091","doi":"10.1016/j.jacl.2021.05.006","title":"ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal; Fondation Leducq; AstraZeneca; Amgen","keywords":"Mace; Medicine; Internal medicine; Myocardial infarction; Genotype; Coronary artery disease; Cohort; Unstable angina; Genome-wide association study; Genotyping; Population; Hazard ratio; Single-nucleotide polymorphism; Genetics; Confidence interval; Gene; Percutaneous coronary intervention; Biology","score_opus":0.03504758172690741,"score_gpt":0.3235173776024441,"score_spread":0.28846979587553667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171018091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874395,0.00030869362,0.00007386726,0.00011495075,0.000025571777,0.0000034171414,0.00012962255,0.000005794356,0.00059404783],"genre_scores_gemma":[0.9992481,0.000094759125,0.00007594167,0.000042380074,0.000042498217,0.000003973909,0.00017300432,0.0000032249009,0.00031606475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996356,0.00009560244,0.000058538546,0.0000821334,0.000056605633,0.000071534254],"domain_scores_gemma":[0.998835,0.0003329748,0.00040884558,0.00008484337,0.000092968374,0.00024534372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004313292,0.000764284,0.00075663434,0.00086428126,0.00082971726,0.00088153646,0.00043797438,0.00120529,0.0028593878],"category_scores_gemma":[0.0020356963,0.00048390948,0.00087602594,0.0009379194,0.0004723251,0.0005225796,0.0004107113,0.0012329438,0.00048413582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007045359,0.000078491306,0.9964897,0.000011746147,0.00015098765,0.0005065729,0.000059873502,0.000059063022,0.00075542444,0.000038451555,0.00016315524,0.0009820954],"study_design_scores_gemma":[0.000028969473,0.00011185691,0.9976762,0.000009059273,0.00016060873,0.0011097813,0.00013867643,0.00044653736,0.00008338487,0.000098021716,0.00012723941,0.000009622583],"about_ca_topic_score_codex":0.0031779741,"about_ca_topic_score_gemma":0.003673724,"teacher_disagreement_score":0.0031779741,"about_ca_system_score_codex":0.00027916062,"about_ca_system_score_gemma":0.00028624214,"threshold_uncertainty_score":0.009565592},"labels":[],"label_agreement":null},{"id":"W3183201089","doi":"10.1016/j.jacl.2021.07.004","title":"Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hypertriglyceridemia; Internal medicine; Interquartile range; Pancreatitis; Diabetes mellitus; Gastroenterology; Acute pancreatitis; Lipodystrophy; LMNA; Cohort; Triglyceride; Endocrinology; Cholesterol; Immunology","score_opus":0.02415010785697165,"score_gpt":0.3214490003786686,"score_spread":0.29729889252169694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183201089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99975437,0.00006922526,0.000023921693,0.000011364825,0.0000013217901,0.0000016713153,0.000036514026,0.0000019762106,0.00009967543],"genre_scores_gemma":[0.9997836,0.000045974615,0.000031019583,0.000010000919,0.0000046886103,0.0000019712986,0.0000803373,8.4460487e-7,0.000041730946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996877,0.00006106236,0.000049507846,0.00008941847,0.000067126726,0.000045317192],"domain_scores_gemma":[0.9994005,0.000097919474,0.0002791763,0.000037432288,0.000049233575,0.00013577747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027490983,0.00035036745,0.0004108715,0.00120287,0.0005424902,0.00051147846,0.00023002327,0.0004818166,0.0010280664],"category_scores_gemma":[0.0012588492,0.00030394984,0.000360703,0.000582531,0.00031088782,0.00029670354,0.0004397924,0.00032463574,0.00014553955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006996158,0.000009378161,0.9975261,0.0000042722363,0.000028560686,0.00078574935,0.00009651945,0.000021708149,0.00062319305,0.0000058911673,0.000038849383,0.0007897121],"study_design_scores_gemma":[0.0000046116907,0.000054014145,0.9948338,0.0000037091827,0.000018639465,0.004717834,0.0001327982,0.00007137357,0.000079679034,0.00001156907,0.00006804794,0.000003857315],"about_ca_topic_score_codex":0.0028268436,"about_ca_topic_score_gemma":0.002481626,"teacher_disagreement_score":0.0028268436,"about_ca_system_score_codex":0.00015004401,"about_ca_system_score_gemma":0.00013911883,"threshold_uncertainty_score":0.005620837},"labels":[],"label_agreement":null},{"id":"W4200272690","doi":"10.1016/j.jacl.2021.11.014","title":"Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Institute of Genetics; McGill University","keywords":"Medicine; Meta-analysis; MEDLINE; Psychosocial; Quality of life (healthcare); Systematic review; Physical therapy; Internal medicine; Psychiatry","score_opus":0.3462716066557222,"score_gpt":0.5105386654572085,"score_spread":0.1642670588014863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200272690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011113276,0.9876824,0.00032960283,0.00011516282,0.00011171336,0.000094553005,0.00038899475,0.000021745136,0.00014254167],"genre_scores_gemma":[0.319238,0.67609674,0.001957854,0.0009862167,0.00022107908,0.00036460624,0.0007243033,0.000028597826,0.00038258795],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969441,0.0011033285,0.0009563376,0.00048487805,0.00032021108,0.00019109066],"domain_scores_gemma":[0.99489033,0.0033457342,0.001047478,0.00020825143,0.0003841546,0.00012400349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004849099,0.0022523433,0.0145276785,0.003408568,0.00052258157,0.002333943,0.001569883,0.0019800023,0.0033753577],"category_scores_gemma":[0.010702362,0.0014050049,0.026644407,0.0045234603,0.0005889197,0.0013900733,0.0017435439,0.0019404257,0.00025728325],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002631436,0.000051612606,0.009718638,0.22950155,0.7431104,0.00016938591,0.00011175639,0.0003176587,0.00032615755,0.00008791699,0.0006225714,0.013350962],"study_design_scores_gemma":[0.000727243,0.00015870569,0.009701901,0.010505915,0.977422,0.00009213194,0.00006400187,0.0001333532,0.000060705708,0.000098410936,0.0010031546,0.00003249305],"about_ca_topic_score_codex":0.009144278,"about_ca_topic_score_gemma":0.028938502,"teacher_disagreement_score":0.0145276785,"about_ca_system_score_codex":0.0017324522,"about_ca_system_score_gemma":0.0018988575,"threshold_uncertainty_score":0.025644839},"labels":[],"label_agreement":null},{"id":"W4211096608","doi":"10.1016/j.jacl.2022.02.003","title":"Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Microsomal triglyceride transfer protein; Medicine; Apolipoprotein B; Internal medicine; Chylomicron; Endocrinology; Steatosis; Malabsorption; Gastroenterology; Very low-density lipoprotein; Cholesterol; Lipoprotein","score_opus":0.062120681918617464,"score_gpt":0.3306134127435129,"score_spread":0.26849273082489544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211096608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989907,0.00023053854,0.00011867357,0.00005135276,0.000018634672,0.0000086000555,0.000051214836,0.000007856027,0.000522405],"genre_scores_gemma":[0.99918383,0.00009362466,0.000058156827,0.000053960182,0.00002244655,0.0000065972727,0.00011684514,0.0000050829426,0.0004594956],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9995751,0.00005311913,0.00005516735,0.00007926057,0.000055781456,0.00018161726],"domain_scores_gemma":[0.9985257,0.0003967582,0.0002727705,0.00024530027,0.0001859947,0.0003734006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003665908,0.0006836317,0.000931798,0.000965324,0.002482893,0.00092653435,0.00059764314,0.0014135729,0.0015810236],"category_scores_gemma":[0.002246388,0.0006511975,0.0011948597,0.0006604204,0.0010180295,0.00055209885,0.0008571922,0.0012283822,0.00076159753],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029048084,0.0009154352,0.8317355,0.0000479858,0.00020856212,0.14679293,0.0035072241,0.00017876389,0.005765184,0.00011040413,0.00027096455,0.0075621856],"study_design_scores_gemma":[0.00014873274,0.0025543473,0.90315664,0.00001814327,0.00026826307,0.0888764,0.0018655594,0.00034642612,0.0013473494,0.00014916285,0.001191024,0.00007796923],"about_ca_topic_score_codex":0.0044016503,"about_ca_topic_score_gemma":0.0022122136,"teacher_disagreement_score":0.0044016503,"about_ca_system_score_codex":0.00041149254,"about_ca_system_score_gemma":0.00041846826,"threshold_uncertainty_score":0.008752048},"labels":[],"label_agreement":null},{"id":"W4220903911","doi":"10.1016/j.jacl.2022.03.001","title":"Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital; University of Toronto; St. Michael's Hospital","funders":"Daiichi Sankyo Europe; NIHR Imperial Biomedical Research Centre; Sanofi-Aventis Deutschland; Ministero della Salute; National Institute for Health and Care Research; Novartis; Esperion Therapeutics; Amgen","keywords":"Ezetimibe; Medicine; Tolerability; Statin; Placebo; Internal medicine; Concomitant; Adverse effect; Cohort; Gastroenterology; Population; Familial hypercholesterolemia; Cholesterol","score_opus":0.18603691046425694,"score_gpt":0.5038343641630217,"score_spread":0.3177974536987648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220903911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599525,0.034396842,0.0005082828,0.0012466778,0.0003299372,0.00065846025,0.000865597,0.00006437412,0.0019773035],"genre_scores_gemma":[0.98861164,0.007545418,0.0006595849,0.0007822548,0.00020819275,0.00057002204,0.0009148233,0.000016865117,0.0006912377],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99878114,0.0006951631,0.00012097888,0.00012890386,0.000105121515,0.00016873448],"domain_scores_gemma":[0.9982027,0.00057545304,0.0005223767,0.00011377564,0.00015427309,0.00043142398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026943563,0.0008402069,0.0037188453,0.00045417712,0.00043899802,0.0013290169,0.00050290633,0.0013672346,0.0020187718],"category_scores_gemma":[0.0030129622,0.00036817507,0.0018325443,0.00060006295,0.0007031414,0.00091722474,0.0003599519,0.0022853448,0.00034835012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9450195,0.0025942978,0.0038608026,0.0011197735,0.00268144,0.00008001152,0.00006472533,0.00040327088,0.005921345,0.00017725196,0.00088388595,0.037193794],"study_design_scores_gemma":[0.8134468,0.14772958,0.025037158,0.0003091324,0.0040639862,0.00019251279,0.0001065359,0.00082399393,0.0027447517,0.00056299905,0.004919797,0.00006270202],"about_ca_topic_score_codex":0.00045165967,"about_ca_topic_score_gemma":0.0011935333,"teacher_disagreement_score":0.0037188453,"about_ca_system_score_codex":0.0007717921,"about_ca_system_score_gemma":0.0011074081,"threshold_uncertainty_score":0.014249265},"labels":[],"label_agreement":null},{"id":"W4225680590","doi":"10.1016/j.jacl.2021.09.007","title":"Circulating Levels of PCSK9, ANGPTL3 and Lp(a) in Stage III Breast Cancers","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Montreal Clinical Research Institute","funders":"Fonds de Recherche du Québec - Santé; Centre Hospitalier Universitaire de Québec; Fondation du cancer du sein du Québec; Université Laval","keywords":"Medicine; Breast cancer; PCSK9; Internal medicine; Cancer; Oncology; Cholesterol; Stage (stratigraphy); Evolocumab; Apolipoprotein B; LDL receptor; Lipoprotein; Apolipoprotein A1","score_opus":0.05370306424862206,"score_gpt":0.3701809865328938,"score_spread":0.31647792228427174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225680590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832433,0.0005420536,0.000104526334,0.000036788897,0.000010364126,0.00000382153,0.0004290507,0.000008862279,0.0005403321],"genre_scores_gemma":[0.99888855,0.00013639338,0.00011118735,0.000024737144,0.0000114396,0.0000061356036,0.00028714328,0.0000033395813,0.00053105864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991715,0.000018142533,0.000010280782,0.000019153546,0.000018543902,0.000016719629],"domain_scores_gemma":[0.9996093,0.000089668494,0.00013692568,0.000022977352,0.000041590818,0.000099629804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014073042,0.00014284479,0.00028440187,0.0003613199,0.00019637223,0.000494814,0.00011365595,0.0002599137,0.0011045566],"category_scores_gemma":[0.0006994278,0.00017600233,0.00017240428,0.0004895096,0.0001189741,0.00015696244,0.00013566171,0.0005169011,0.00020447823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038777457,0.000080158025,0.9782973,0.000025890075,0.00011446771,0.00024066852,0.00012672305,0.00014659615,0.0102760075,0.000043918535,0.00027147125,0.006498971],"study_design_scores_gemma":[0.000017464536,0.000196291,0.9976655,0.000003823012,0.000049781494,0.0003422486,0.00012447825,0.0003184632,0.0009427945,0.000041332973,0.0002929386,0.000004815061],"about_ca_topic_score_codex":0.0024973382,"about_ca_topic_score_gemma":0.0029635346,"teacher_disagreement_score":0.0024973382,"about_ca_system_score_codex":0.00031413592,"about_ca_system_score_gemma":0.00020113472,"threshold_uncertainty_score":0.0049655437},"labels":[],"label_agreement":null},{"id":"W4232457061","doi":"10.1016/j.jacl.2007.08.009","title":"Thursday - Sunday Poster Session 3","year":2007,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Thursday; Medicine; Session (web analytics); World Wide Web; Theology","score_opus":0.09628509327030592,"score_gpt":0.5030452570642934,"score_spread":0.40676016379398744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232457061","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014218412,0.005073842,0.0021902188,0.027317515,0.1646077,0.003434946,0.0056347293,0.002863528,0.7746591],"genre_scores_gemma":[0.008534759,0.00094647415,0.0005830324,0.0031519083,0.013380083,0.0006895139,0.0016252709,0.0003022695,0.97078675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989814,0.00009530672,0.00003344726,0.00022994465,0.00020351772,0.0004563289],"domain_scores_gemma":[0.9983094,0.0000987006,0.00005554626,0.00006258381,0.0003311163,0.0011426312],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019562338,0.0032989539,0.0019181719,0.0012747997,0.005603999,0.0061245575,0.002060453,0.010227433,0.71403766],"category_scores_gemma":[0.0012582701,0.0011509007,0.0032710012,0.0006372168,0.00051408244,0.0018605686,0.005102783,0.0061574695,0.5056293],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019948422,0.0006817001,0.0004347003,0.00023132269,0.000026317108,0.00038702425,0.000074290336,0.000099899196,0.0016975624,0.000656319,0.97014564,0.023570316],"study_design_scores_gemma":[0.00074620754,0.0010270261,0.005993554,0.00027007246,0.000046341233,0.00023840334,0.00042333856,0.00031166692,0.00093103584,0.0012377442,0.98871875,0.000055887696],"about_ca_topic_score_codex":0.0016355802,"about_ca_topic_score_gemma":0.008814603,"teacher_disagreement_score":0.28596234,"about_ca_system_score_codex":0.0011846066,"about_ca_system_score_gemma":0.0013456893,"threshold_uncertainty_score":0.40789056},"labels":[],"label_agreement":null},{"id":"W4281257632","doi":"10.1016/j.jacl.2022.05.064","title":"Prevalence, severity and management of hypertriglyceridemia-associated pancreatitis; A 7-year retrospective cohort study at Canadian quaternary care hospitals","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Montreal Heart Institute; Montreal Clinical Research Institute; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Acute pancreatitis; Hypertriglyceridemia; Internal medicine; Pancreatitis; Retrospective cohort study; Cohort; Fibrate; Gastroenterology; Statin; Triglyceride","score_opus":0.02145565954673811,"score_gpt":0.3298710302229278,"score_spread":0.3084153706761897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281257632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969547,0.00036849364,0.000051286574,0.00014166582,0.000011308566,0.00002742841,0.0017234882,0.000005252616,0.0007163592],"genre_scores_gemma":[0.9985715,0.00020440287,0.00009226163,0.000082282924,0.000007931601,0.000012361033,0.00081460684,0.000003255616,0.0002113403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978975,0.00014576966,0.00015891867,0.00038484,0.0005688312,0.000844127],"domain_scores_gemma":[0.9967925,0.00012582047,0.0010372802,0.00012842666,0.0011456619,0.00077036384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010257566,0.00064667215,0.0006687715,0.002352324,0.004200642,0.0019542985,0.0020185201,0.0012135301,0.0020074628],"category_scores_gemma":[0.0027806393,0.00097165845,0.0012556734,0.0048435866,0.0011838102,0.0009277579,0.0014982969,0.001336581,0.00028083948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034724962,0.000019513987,0.9989825,0.00000803901,0.000037955873,0.00007753188,0.00022845679,0.000023579814,0.00005081538,0.0000200984,0.00021596237,0.00030088905],"study_design_scores_gemma":[0.0000035732028,0.000032082215,0.99833655,0.000016309163,0.000019449384,0.00013312034,0.0011501203,0.00008888376,0.000015998367,0.000009864358,0.00018353952,0.000010492075],"about_ca_topic_score_codex":0.92538047,"about_ca_topic_score_gemma":0.94510794,"teacher_disagreement_score":0.92538047,"about_ca_system_score_codex":0.018162744,"about_ca_system_score_gemma":0.022849845,"threshold_uncertainty_score":0.15011793},"labels":[],"label_agreement":null},{"id":"W4281848556","doi":"10.1016/j.jacl.2022.05.067","title":"Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT","year":2022,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"St. Jude Medical; Esperion Therapeutics; HLS Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Assistance publique-Hôpitaux de Paris; Pfizer; Moderna; Medicines Company; Regado Biosciences; Belvoir Media Group; MyoKardia; Novo Nordisk; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Duke Clinical Research Institute; Eisai; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; Novartis; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Residual risk; Hypertriglyceridemia; Myocardial infarction; Internal medicine; Cardiology; Revascularization; Clinical endpoint; Randomized controlled trial; Stroke (engine); Triglyceride; Cholesterol","score_opus":0.19410173038570255,"score_gpt":0.4499473697340759,"score_spread":0.25584563934837334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281848556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007309221,0.9995316,0.000036560174,0.00013633627,0.000072612405,0.000012111176,0.000025407126,0.000002419917,0.00010973173],"genre_scores_gemma":[0.00054709293,0.999005,0.00011760415,0.00019095521,0.000051036437,0.000017794526,0.00002268524,0.0000012733647,0.000046651076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994411,0.00012659747,0.00019111454,0.00008971986,0.00012339753,0.000028061131],"domain_scores_gemma":[0.9972306,0.0021492152,0.00027740287,0.000036782534,0.00025236173,0.00005367427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002337867,0.0010154529,0.0036800508,0.0024083813,0.00021318249,0.0011744894,0.0014181202,0.0010981545,0.0030380313],"category_scores_gemma":[0.0047738063,0.0004357693,0.0019878414,0.0024338516,0.00047101922,0.0010047915,0.0006158964,0.0015918647,0.00063618604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065667497,0.00008144221,0.00020812472,0.29737046,0.0017825302,0.00012487976,0.000095259544,0.00021873109,0.0007388485,0.001323705,0.014734883,0.68266445],"study_design_scores_gemma":[0.00077668735,0.0012097307,0.0042328537,0.25992447,0.014090217,0.0014210053,0.00026603747,0.0002562692,0.0011123081,0.0029511712,0.7136559,0.00010335654],"about_ca_topic_score_codex":0.0013032549,"about_ca_topic_score_gemma":0.002485942,"teacher_disagreement_score":0.0036800508,"about_ca_system_score_codex":0.0006805579,"about_ca_system_score_gemma":0.0018563706,"threshold_uncertainty_score":0.01236403},"labels":[],"label_agreement":null},{"id":"W4283319095","doi":"10.1016/j.jacl.2022.06.005","title":"Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Q & T Research; Université de Montréal; Montreal Heart Institute","funders":"Ionis Pharmaceuticals; AstraZeneca","keywords":"Hypertriglyceridemia; Apolipoprotein B; Internal medicine; Triglyceride; Medicine; Lipoprotein particle; Lipoprotein; Endocrinology; Placebo; Particle size; Cholesterol; Very low-density lipoprotein; Chemistry; Pathology","score_opus":0.013357184509076088,"score_gpt":0.3031930515250316,"score_spread":0.28983586701595554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283319095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875987,0.00065564667,0.000061922976,0.00003509164,0.000014457767,0.000042018106,0.000053530155,0.000015788813,0.00036165386],"genre_scores_gemma":[0.99896574,0.00030650516,0.00016796956,0.000059703656,0.000018432977,0.000031012332,0.00012899372,0.0000028823358,0.0003186864],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9998115,0.00007707537,0.00002474218,0.00003263869,0.00002301806,0.000031073832],"domain_scores_gemma":[0.9996513,0.00008964781,0.00008134379,0.00003087774,0.00002604028,0.00012061671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005075751,0.0005811412,0.0010636137,0.0002965214,0.00026613916,0.00030484106,0.00021553924,0.00052015524,0.0011121803],"category_scores_gemma":[0.000686243,0.00024428964,0.00074701145,0.00020467331,0.0002369066,0.00025850898,0.00016861867,0.00063257804,0.00020750586],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6546778,0.016337313,0.1414371,0.00043766949,0.0021544944,0.001211404,0.00034038114,0.0012975401,0.08132524,0.00009147283,0.00090168585,0.099787906],"study_design_scores_gemma":[0.038025502,0.32519853,0.6187015,0.00004439761,0.0017915177,0.0013157603,0.0003120682,0.0020443266,0.010597805,0.00012907111,0.0017700129,0.00006941813],"about_ca_topic_score_codex":0.0008243926,"about_ca_topic_score_gemma":0.0015115443,"teacher_disagreement_score":0.0011121803,"about_ca_system_score_codex":0.0002977117,"about_ca_system_score_gemma":0.00024912893,"threshold_uncertainty_score":0.0037206411},"labels":[],"label_agreement":null},{"id":"W4286516530","doi":"10.1016/j.jacl.2022.07.005","title":"Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Université Laval; Université du Québec à Chicoutimi; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Amgen","keywords":"Evolocumab; Medicine; Familial hypercholesterolemia; Placebo; Cognition; Cognitive test; Tolerability; Confidence interval; Internal medicine; Adverse effect; Lipoprotein; Psychiatry; Cholesterol","score_opus":0.049849199616764955,"score_gpt":0.3603224030052448,"score_spread":0.31047320338847983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286516530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685067,0.0024019608,0.00018137011,0.00009961149,0.000014477437,0.000037113095,0.000099791,0.000012104338,0.0003028822],"genre_scores_gemma":[0.9983741,0.00094250316,0.0003629173,0.00007407747,0.000019390647,0.000041750714,0.00011146517,0.0000025412685,0.000071125214],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995079,0.00022759159,0.000046377903,0.00006578014,0.00009258448,0.00005976022],"domain_scores_gemma":[0.99900466,0.00036572118,0.0003627879,0.000045411172,0.00009888791,0.00012260946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012624995,0.00048138766,0.0009822592,0.00022083134,0.00018667876,0.00026440946,0.00019632412,0.00025943588,0.00045480966],"category_scores_gemma":[0.0017041513,0.000094013034,0.00086794,0.0002727622,0.00025597712,0.00022945464,0.00017689739,0.0007367837,0.000060267823],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2087784,0.0106481975,0.34102434,0.002772795,0.0044732788,0.0028958812,0.0008199908,0.0053705378,0.029389478,0.00037465518,0.0030941642,0.3903584],"study_design_scores_gemma":[0.025110997,0.25755432,0.68452585,0.00035372906,0.0035798613,0.0044283555,0.00033537124,0.004844564,0.014707006,0.0003116251,0.0042040315,0.00004423531],"about_ca_topic_score_codex":0.0018240102,"about_ca_topic_score_gemma":0.0023198724,"teacher_disagreement_score":0.0018240102,"about_ca_system_score_codex":0.00069417147,"about_ca_system_score_gemma":0.00061995274,"threshold_uncertainty_score":0.006676793},"labels":[],"label_agreement":null},{"id":"W4292873515","doi":"10.1016/j.jacl.2022.08.004","title":"Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Cardiology; Internal medicine; Alirocumab; Red blood cell distribution width; Adverse effect","score_opus":0.01424211124210622,"score_gpt":0.30516559509339214,"score_spread":0.2909234838512859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292873515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297196,0.0051656407,0.00037730928,0.00012579566,0.000028379663,0.000026589209,0.00048423748,0.000017001634,0.0008031267],"genre_scores_gemma":[0.99859434,0.0005268664,0.00018794466,0.000055797453,0.00003726364,0.000016714861,0.0003404946,0.0000043831838,0.00023618796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991334,0.00034213348,0.00009556407,0.00017860906,0.00014093678,0.00010939895],"domain_scores_gemma":[0.9933287,0.0026408182,0.002181537,0.00088437065,0.00037643648,0.0005881817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025858644,0.00035372798,0.0008767391,0.0004619274,0.00019556277,0.000672095,0.00038282783,0.00051977707,0.0012409437],"category_scores_gemma":[0.0057055284,0.00023724,0.0014951328,0.00052234257,0.0002331165,0.00047918825,0.00037249652,0.001137929,0.00012586244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026508074,0.00037545044,0.948512,0.00017540625,0.0039924625,0.000111824054,0.000032917844,0.0011421326,0.0013663735,0.00014389706,0.0003358805,0.017303504],"study_design_scores_gemma":[0.00027701995,0.0016519845,0.99376017,0.000019440544,0.0010544284,0.00013801175,0.000021721211,0.0021981783,0.0003244599,0.00019357303,0.00034196896,0.000019007724],"about_ca_topic_score_codex":0.0015159162,"about_ca_topic_score_gemma":0.001242418,"teacher_disagreement_score":0.0025858644,"about_ca_system_score_codex":0.00030722097,"about_ca_system_score_gemma":0.00035109086,"threshold_uncertainty_score":0.013675511},"labels":[],"label_agreement":null},{"id":"W4294707281","doi":"10.1016/j.jacl.2022.08.007","title":"Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association","year":2022,"lang":"en","type":"erratum","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Statement (logic); Clinical Practice; Biomarker; Association (psychology); Family medicine; Medical physics; Internal medicine; Biochemistry; Epistemology","score_opus":0.19563533106437056,"score_gpt":0.4475313405418341,"score_spread":0.2518960094774635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294707281","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119123404,0.0071552647,0.00033521678,0.22280645,0.7669506,0.000018040637,0.0002777231,0.000054684442,0.002282932],"genre_scores_gemma":[0.004541078,0.037270933,0.0048437696,0.38162416,0.5333878,0.0001342801,0.00079878204,0.00023459549,0.03716456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923753,0.0014126956,0.0021415085,0.00053215236,0.0032448815,0.00029347828],"domain_scores_gemma":[0.921546,0.03819982,0.004593413,0.002556133,0.029717978,0.0033866295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010944954,0.002356922,0.0022539534,0.002697632,0.0031463623,0.0054605305,0.0025893778,0.017613934,0.0064489027],"category_scores_gemma":[0.0847731,0.0013386556,0.0014078934,0.0026734802,0.003502961,0.004086814,0.0016072807,0.02140196,0.01239811],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004822149,0.000013564979,0.0001996681,0.00016830456,0.000009352219,0.00024145789,0.000028987812,0.00002699566,0.000049727587,0.0009094281,0.9865963,0.011708066],"study_design_scores_gemma":[0.000079485086,0.000045756195,0.0019228599,0.0019069664,0.000062132414,0.0011996016,0.00020648111,0.00019500472,0.00029324697,0.0032971194,0.9907244,0.00006702182],"about_ca_topic_score_codex":0.01568792,"about_ca_topic_score_gemma":0.02467731,"teacher_disagreement_score":0.017613934,"about_ca_system_score_codex":0.0028595182,"about_ca_system_score_gemma":0.0084729595,"threshold_uncertainty_score":0.057883084},"labels":[],"label_agreement":null},{"id":"W4295221059","doi":"10.1016/j.jacl.2022.09.001","title":"Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GLS Industries (Canada)","funders":"","keywords":"Medicine; Statin; Discontinuation; Tolerability; Intensive care medicine; Physical therapy; Psychological intervention; Internal medicine; Adverse effect; Psychiatry","score_opus":0.07177615053071422,"score_gpt":0.44054462916167497,"score_spread":0.36876847863096074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295221059","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064173173,0.56973237,0.0013912871,0.40947247,0.002774463,0.00005645734,0.00007388052,0.000049186736,0.010032602],"genre_scores_gemma":[0.062408097,0.8350287,0.006477831,0.08333403,0.0103168925,0.00014564239,0.00016075623,0.000026446136,0.0021016703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731404,0.0012343302,0.00040647507,0.00025202375,0.00060825405,0.0001848153],"domain_scores_gemma":[0.9937761,0.0019745028,0.0005624988,0.00012259773,0.0023973547,0.0011669893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004592662,0.00059730915,0.0011182027,0.0012898841,0.0012772159,0.0026689959,0.0009188762,0.0036227475,0.0017126456],"category_scores_gemma":[0.009130305,0.00030418957,0.00060394563,0.0009953025,0.0014588486,0.0026181852,0.00218295,0.0072652604,0.0006834747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021936606,0.0005027439,0.016135966,0.0054088454,0.0001961618,0.0019701803,0.0032352165,0.00030078797,0.001265758,0.0061071063,0.15211718,0.81254065],"study_design_scores_gemma":[0.00033248618,0.0015031795,0.061865952,0.04350732,0.0006110652,0.014896891,0.012977639,0.001114829,0.00071005983,0.022024395,0.8401496,0.0003066348],"about_ca_topic_score_codex":0.0053824177,"about_ca_topic_score_gemma":0.011748824,"teacher_disagreement_score":0.0053824177,"about_ca_system_score_codex":0.0017596019,"about_ca_system_score_gemma":0.004916143,"threshold_uncertainty_score":0.024288595},"labels":[],"label_agreement":null},{"id":"W4297535916","doi":"10.1016/j.jacl.2022.08.009","title":"Guidance for the diagnosis and treatment of hypolipidemia disorders","year":2022,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Western University","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.28991388833509557,"score_gpt":0.5016598527501303,"score_spread":0.21174596441503468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297535916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011421609,0.9873652,0.0007252408,0.0034872815,0.0011860771,0.000036865415,0.00019777162,0.00007157822,0.006815837],"genre_scores_gemma":[0.0009750864,0.9891705,0.0023758241,0.0027223753,0.00072503334,0.00006828168,0.00048370945,0.000013845318,0.0034653507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993692,0.00015423655,0.0001305702,0.0000732691,0.00023139543,0.000041425163],"domain_scores_gemma":[0.9990275,0.0004568869,0.0001241769,0.000028538687,0.0003029224,0.000059862945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089442136,0.00094861817,0.0010684544,0.0033778483,0.00032753777,0.00080372166,0.0011499352,0.0018863686,0.011092426],"category_scores_gemma":[0.0024747057,0.00029834078,0.0009426749,0.0017346003,0.0004570492,0.000990606,0.0006284659,0.0028599575,0.008029077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004394536,0.00007635652,0.00013412877,0.010034588,0.00005790971,0.000359116,0.00006699493,0.00013792705,0.0006170803,0.002985201,0.2160772,0.76940954],"study_design_scores_gemma":[0.00002295265,0.000026936541,0.0005204273,0.0062731053,0.000056625693,0.001735096,0.000025067759,0.000034128807,0.00011345164,0.0012963192,0.98988473,0.0000112628195],"about_ca_topic_score_codex":0.003032074,"about_ca_topic_score_gemma":0.004844876,"teacher_disagreement_score":0.011092426,"about_ca_system_score_codex":0.00075990084,"about_ca_system_score_gemma":0.001683332,"threshold_uncertainty_score":0.037107885},"labels":[],"label_agreement":null},{"id":"W4298092349","doi":"10.1016/j.jacl.2022.09.006","title":"A mechanism-based operational definition and classification of hypercholesterolemia","year":2022,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Daiichi Sankyo Europe; Instituto de Salud Carlos III; Gobierno de Aragón; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Ministerio de Economía y Competitividad; Sanofi; Amgen","keywords":"Medicine; Mechanism (biology); Guideline; Intensive care medicine; Statement (logic); Familial hypercholesterolemia; Internal medicine; Cholesterol; Epistemology; Pathology","score_opus":0.3154252477381304,"score_gpt":0.4585147656570687,"score_spread":0.1430895179189383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298092349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030117916,0.9949992,0.0020098977,0.0013893466,0.00038151594,0.000033395423,0.000072531795,0.000017637836,0.00079533784],"genre_scores_gemma":[0.004384525,0.98801863,0.004683437,0.0012687454,0.0008008591,0.00006201712,0.00022654326,0.0000068262852,0.00054837356],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9986681,0.0002852868,0.00036098764,0.0002643713,0.0003398284,0.000081501435],"domain_scores_gemma":[0.99843425,0.00081489154,0.00029999434,0.000054895994,0.00033125974,0.00006478768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036795768,0.0024347005,0.005268556,0.007773799,0.0005152369,0.0033108944,0.0031358835,0.0021159572,0.0017144238],"category_scores_gemma":[0.0033420748,0.0007551253,0.0027760009,0.004051087,0.0034454507,0.0033381125,0.0018816601,0.005301163,0.000985665],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023011195,0.00016069766,0.002835805,0.03040896,0.00096604705,0.00047205098,0.00029154087,0.0011622807,0.0014712756,0.06901505,0.023522085,0.8694641],"study_design_scores_gemma":[0.00027901132,0.00053281814,0.013860099,0.03799489,0.0037866146,0.009139024,0.000821888,0.0029271538,0.0016080602,0.09938806,0.8293243,0.00033809344],"about_ca_topic_score_codex":0.003651966,"about_ca_topic_score_gemma":0.0036311771,"teacher_disagreement_score":0.007773799,"about_ca_system_score_codex":0.0027133618,"about_ca_system_score_gemma":0.004287249,"threshold_uncertainty_score":0.019686937},"labels":[],"label_agreement":null},{"id":"W4307862389","doi":"10.1016/j.jacl.2022.10.010","title":"Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research","year":2022,"lang":"en","type":"editorial","venue":"Journal of clinical lipidology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Ketogenic diet; Medicine; Cholesterol; Phenotype; Internal medicine; Lean body mass; Endocrinology; Carbohydrate; Biology; Biochemistry; Body weight; Gene; Psychiatry","score_opus":0.20261357246790512,"score_gpt":0.4791434404174547,"score_spread":0.2765298679495496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307862389","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053000556,0.0055224346,0.00008142923,0.03001392,0.9633384,0.000022518105,0.00006560005,0.000035767356,0.00086697214],"genre_scores_gemma":[0.00041732032,0.0050661885,0.00012377375,0.0254053,0.9650724,0.00003932158,0.000041948835,0.000021981306,0.003811833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961062,0.0008869175,0.00076991646,0.00036884178,0.0016288091,0.00023927676],"domain_scores_gemma":[0.9669222,0.016446792,0.0018639821,0.0007990992,0.010770965,0.0031969806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009638713,0.0039859978,0.0066692536,0.0031930974,0.0028169493,0.007182092,0.0031141113,0.015635112,0.009339918],"category_scores_gemma":[0.032933865,0.001529056,0.0029522213,0.0016952778,0.0016948598,0.003617828,0.0011318836,0.020750482,0.007901043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019203433,0.00003204555,0.000121066616,0.00070398394,0.00008505883,0.0001717536,0.000014376324,0.000017418377,0.000057260946,0.00015938056,0.9901698,0.008275639],"study_design_scores_gemma":[0.0008270811,0.00018126781,0.0027061512,0.0020397424,0.0008852032,0.00083902077,0.00014464807,0.00037528196,0.00025721177,0.0017107823,0.98996735,0.000066252134],"about_ca_topic_score_codex":0.0021597398,"about_ca_topic_score_gemma":0.0059357183,"teacher_disagreement_score":0.015635112,"about_ca_system_score_codex":0.0029447777,"about_ca_system_score_gemma":0.0029226048,"threshold_uncertainty_score":0.050974965},"labels":[],"label_agreement":null},{"id":"W4309726548","doi":"10.1016/j.jacl.2022.11.007","title":"The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Hypertriglyceridemia; Lipoprotein lipase; Internal medicine; Medicine; Phenotype; Triglyceride; Endocrinology; Compound heterozygosity; Loss of heterozygosity; Gastroenterology; Gene; Genetics; Biology; Allele; Cholesterol","score_opus":0.058829752242066186,"score_gpt":0.3699882632442022,"score_spread":0.311158511002136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309726548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964774,0.00006080801,0.00009297563,0.000015319554,0.0000027625301,0.000002879343,0.000031408304,0.000008004997,0.00013812394],"genre_scores_gemma":[0.9996563,0.000026843127,0.000124929,0.000019180716,0.0000070133215,0.0000032045573,0.0000841343,0.0000037925931,0.000074596675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977857,0.000030990417,0.000031164094,0.00006184654,0.00004611077,0.00005134515],"domain_scores_gemma":[0.9988715,0.00020454035,0.0004775767,0.000053808035,0.00009273003,0.00029972126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044558078,0.0005237819,0.00034221285,0.0006999156,0.0005763296,0.0005340801,0.00022309835,0.00048740255,0.0012027067],"category_scores_gemma":[0.0018506681,0.0003152481,0.0003486001,0.00040471696,0.0004535585,0.00035561674,0.00040915087,0.0005503469,0.00030592587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000719511,0.00011217406,0.9541842,0.000014759246,0.000038404192,0.021296978,0.00044104992,0.00009160288,0.018942097,0.000058375343,0.00014534147,0.003955522],"study_design_scores_gemma":[0.000057218644,0.0015654139,0.8904668,0.000017858381,0.000108899956,0.10382937,0.00040143635,0.0004894056,0.0025861373,0.000090221845,0.00035944476,0.000027658969],"about_ca_topic_score_codex":0.0015035312,"about_ca_topic_score_gemma":0.0018650176,"teacher_disagreement_score":0.0015035312,"about_ca_system_score_codex":0.000286943,"about_ca_system_score_gemma":0.00023344479,"threshold_uncertainty_score":0.0040234327},"labels":[],"label_agreement":null},{"id":"W4311275510","doi":"10.1016/j.jacl.2022.12.002","title":"Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Evolocumab; PCSK9; Confounding; Context (archaeology); Internal medicine; Gynecology; LDL receptor; Apolipoprotein B; Cholesterol; Lipoprotein","score_opus":0.09722973839030458,"score_gpt":0.41983529243998213,"score_spread":0.32260555404967756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311275510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988182,0.00018478258,0.00008297132,0.00011871057,0.000010057416,0.00000632635,0.000121446006,0.0000017085764,0.00065581437],"genre_scores_gemma":[0.9992298,0.00020936872,0.00006880828,0.00008999556,0.000020614782,0.0000060004504,0.00009508636,0.0000028545267,0.00027746608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965274,0.00015046184,0.00002175941,0.000058382553,0.00005503516,0.000061591265],"domain_scores_gemma":[0.9990594,0.00039693978,0.00016660032,0.00008200265,0.00011483758,0.00018024804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067659817,0.00015060847,0.0002665935,0.00021392548,0.0004145466,0.00047512434,0.00017080225,0.00045987283,0.0016869684],"category_scores_gemma":[0.0018213019,0.00010707924,0.00021211217,0.00032430072,0.00050208205,0.0003428792,0.00034497472,0.00052515516,0.00026581256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023508393,0.0009738668,0.9671765,0.00005041099,0.00011216649,0.0026383363,0.0038321535,0.000106290216,0.0017119398,0.0001837718,0.00088857004,0.019975187],"study_design_scores_gemma":[0.0000713509,0.0022457093,0.9862939,0.000019987632,0.00006248397,0.0027467725,0.005294315,0.0001789671,0.00044377992,0.00015775318,0.0024573572,0.000027599826],"about_ca_topic_score_codex":0.0021795148,"about_ca_topic_score_gemma":0.0021081765,"teacher_disagreement_score":0.0021795148,"about_ca_system_score_codex":0.00027707173,"about_ca_system_score_gemma":0.00022012877,"threshold_uncertainty_score":0.0056434274},"labels":[],"label_agreement":null},{"id":"W4353094265","doi":"10.1016/j.jacl.2023.03.008","title":"Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University; McGill University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal","keywords":"Medicine; Metabolic syndrome; Familial hypercholesterolemia; Internal medicine; Cardiology; Pediatrics; Cholesterol; Obesity","score_opus":0.07117254390978822,"score_gpt":0.37475913103348096,"score_spread":0.30358658712369274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353094265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819404,0.00044713359,0.00012815767,0.00012315567,0.000026914078,0.000004283075,0.00008684575,0.00000923222,0.0009803164],"genre_scores_gemma":[0.9992256,0.00011864115,0.00012314241,0.000041071104,0.00003965648,0.0000043648574,0.000098152326,0.000003316883,0.00034597758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995708,0.00015650214,0.00005577473,0.0000672374,0.00007872897,0.00007091465],"domain_scores_gemma":[0.9986766,0.0003882354,0.00037340578,0.00010627692,0.00008652911,0.00036890522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063679507,0.00097149564,0.00085675134,0.0013739164,0.0009642306,0.001074751,0.00044047297,0.0014337363,0.0029012123],"category_scores_gemma":[0.0025500827,0.0006986121,0.0009705861,0.001339313,0.0005484207,0.00062318717,0.0006041241,0.0014452953,0.00041016666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005205342,0.00007958337,0.9971527,0.00000740528,0.00015496176,0.00042147504,0.0000702211,0.000043837925,0.0005587734,0.000039607025,0.0000610987,0.00088982517],"study_design_scores_gemma":[0.000017539733,0.00009542005,0.99811304,0.000007042147,0.00015244896,0.000818917,0.000117089956,0.0004457764,0.00006661406,0.000083185594,0.00007551437,0.0000073715605],"about_ca_topic_score_codex":0.0054252394,"about_ca_topic_score_gemma":0.0081466995,"teacher_disagreement_score":0.0054252394,"about_ca_system_score_codex":0.0003327375,"about_ca_system_score_gemma":0.00035502427,"threshold_uncertainty_score":0.010787308},"labels":[],"label_agreement":null},{"id":"W4353094383","doi":"10.1016/j.jacl.2023.03.007","title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Akebia Therapeutics; Ionis Pharmaceuticals","keywords":"Medicine; Triglyceride; Acute pancreatitis; Pancreatitis; Internal medicine; Endocrinology; Gastroenterology; Bioinformatics; Cholesterol; Biology","score_opus":0.23782430457288045,"score_gpt":0.4607185338501627,"score_spread":0.22289422927728225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353094383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666613,0.0019922506,0.00014878986,0.00015220142,0.00007261445,0.00014234477,0.00036379785,0.000030923064,0.00043099557],"genre_scores_gemma":[0.99591064,0.0014117062,0.0003304603,0.00024975848,0.00013599065,0.00027020017,0.0009392227,0.000015108242,0.0007369109],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990231,0.0005482006,0.000068107176,0.00014513588,0.00007246598,0.00014305647],"domain_scores_gemma":[0.9984995,0.00048310228,0.00029338294,0.00015924535,0.000075564065,0.0004891376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023465336,0.0023915602,0.0032464343,0.00047000067,0.00045096592,0.00130606,0.00077178254,0.0017200239,0.0031649708],"category_scores_gemma":[0.0016023079,0.0005035107,0.0025517922,0.00044682578,0.0013800043,0.0014955307,0.00044698126,0.0028693432,0.00061682635],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9748775,0.003726179,0.0034726758,0.00024214634,0.0018861003,0.00012407744,0.000104608414,0.0004817787,0.003627036,0.000085530075,0.0003101683,0.011062258],"study_design_scores_gemma":[0.84598714,0.12914729,0.01889848,0.000056171535,0.0022503687,0.00019159754,0.00014872958,0.0009763123,0.0013323276,0.0002689708,0.00067662273,0.00006598847],"about_ca_topic_score_codex":0.0007114385,"about_ca_topic_score_gemma":0.0012652526,"teacher_disagreement_score":0.0032464343,"about_ca_system_score_codex":0.0005421405,"about_ca_system_score_gemma":0.00075479393,"threshold_uncertainty_score":0.012409806},"labels":[],"label_agreement":null},{"id":"W4367043598","doi":"10.1016/j.jacl.2023.04.009","title":"Effect of pharmacologic anti-atherosclerotic therapy on carotid intraplaque neovascularization: A systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Faculty of Health Sciences, Queen's University; Canadian Institutes of Health Research","keywords":"Medicine; Neovascularization; Internal medicine; Statin; Fibrous cap; Randomized controlled trial; Clinical trial; Cochrane Library; Cardiology; Radiology; Pathology; Angiogenesis","score_opus":0.1372180379754087,"score_gpt":0.48823396675024205,"score_spread":0.35101592877483334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367043598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012399382,0.998126,0.00008005372,0.00007351405,0.00006981896,0.00008890468,0.0001682901,0.000006049786,0.00014749063],"genre_scores_gemma":[0.016070224,0.98275614,0.00033746575,0.00044959766,0.00006819515,0.000093787035,0.00011293902,0.0000034043185,0.00010819021],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99870884,0.00034041205,0.0004761243,0.00018250916,0.00021809206,0.00007407545],"domain_scores_gemma":[0.99578035,0.0029529228,0.0008731358,0.000057599296,0.0002546935,0.000081284525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021609406,0.0011890376,0.008282981,0.0025174601,0.00035829656,0.0015800806,0.0015329008,0.0018352773,0.0059446213],"category_scores_gemma":[0.008042586,0.00075716735,0.007866336,0.0031475693,0.0005737749,0.0013087584,0.0009077806,0.0013901687,0.00035022615],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013402511,0.000057634414,0.0009689794,0.90846604,0.045444157,0.00011532859,0.000096827505,0.00014746109,0.00027417205,0.00013256451,0.0016316875,0.04132498],"study_design_scores_gemma":[0.0032554087,0.000920818,0.009608894,0.3490187,0.6163017,0.00044262386,0.00028256263,0.00021196574,0.00028999234,0.0003970399,0.019176558,0.00009370871],"about_ca_topic_score_codex":0.0059580235,"about_ca_topic_score_gemma":0.021155499,"teacher_disagreement_score":0.008282981,"about_ca_system_score_codex":0.0010987802,"about_ca_system_score_gemma":0.0026443063,"threshold_uncertainty_score":0.019886672},"labels":[],"label_agreement":null},{"id":"W4376276448","doi":"10.1016/j.jacl.2023.05.093","title":"Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Hypertriglyceridemia; Apolipoprotein B; Medicine; Internal medicine; Endocrinology; Cholesterol; Population; Ldl cholesterol; Cohort; Gastroenterology; Triglyceride","score_opus":0.11013821341279538,"score_gpt":0.407660213907391,"score_spread":0.2975220004945956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376276448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665573,0.016867638,0.004301943,0.0042159986,0.00093768677,0.000051874213,0.0005838265,0.00011573813,0.0063680476],"genre_scores_gemma":[0.9931716,0.0021646367,0.0020019142,0.00095261517,0.0009073539,0.000025269906,0.0002546195,0.00001738179,0.00050466415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997979,0.0005935487,0.00039575607,0.0002847916,0.0005652899,0.00018155167],"domain_scores_gemma":[0.9895837,0.004718653,0.002509486,0.0010881396,0.0016086079,0.0004913194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040626316,0.00074892706,0.0013379984,0.0017969462,0.00032535705,0.0016950348,0.0013621956,0.0028723422,0.0013526749],"category_scores_gemma":[0.017191324,0.0006639482,0.0005019043,0.0014506902,0.0014306912,0.0015469755,0.00041183396,0.0012615672,0.0012145112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094488944,0.000082672406,0.9750152,0.0001491879,0.00022640891,0.0009323221,0.00007300666,0.00008905272,0.00618874,0.00018557298,0.0008945526,0.015218413],"study_design_scores_gemma":[0.00010413532,0.00061252184,0.97733593,0.00018577941,0.00046965966,0.0074449875,0.00048057293,0.0026381095,0.0069159847,0.0010676215,0.0026932617,0.00005141315],"about_ca_topic_score_codex":0.0008215518,"about_ca_topic_score_gemma":0.0008925123,"teacher_disagreement_score":0.0040626316,"about_ca_system_score_codex":0.00019677107,"about_ca_system_score_gemma":0.000449215,"threshold_uncertainty_score":0.021485567},"labels":[],"label_agreement":null},{"id":"W4377141610","doi":"10.1016/j.jacl.2023.05.096","title":"Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes","year":2023,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Montreal Heart Institute; Montreal Clinical Research Institute; Université de Montréal","funders":"Institut de Recherche Clinique De Montréal","keywords":"Medicine; Fatty liver; Disease; Alcoholic liver disease; Gastroenterology; Internal medicine; Cirrhosis","score_opus":0.13005907169400824,"score_gpt":0.43210084919499553,"score_spread":0.30204177750098726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377141610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031193945,0.9989831,0.00007199982,0.00013286197,0.00008843292,0.0000025378085,0.000015060194,0.0000031085103,0.0003910033],"genre_scores_gemma":[0.0034201276,0.9955799,0.00020127285,0.00025426873,0.0002600224,0.000005758883,0.0000434179,8.660485e-7,0.00023424668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986017,0.000027033564,0.00004171981,0.000024573668,0.000033478307,0.0000129768705],"domain_scores_gemma":[0.9996462,0.0001986055,0.000082098246,0.0000056670265,0.000043263895,0.00002422105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003209102,0.0007150505,0.0016472255,0.0020073222,0.00014557135,0.00059401465,0.0004773647,0.00064815575,0.0018825784],"category_scores_gemma":[0.00084315956,0.00020166684,0.00054560753,0.0015854564,0.00022110078,0.00064375,0.00046635728,0.000887574,0.00059762946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033663376,0.00006621462,0.004176406,0.015845012,0.0004584915,0.0012660605,0.000050929993,0.00014584069,0.0007995124,0.00061528926,0.0113862725,0.9648534],"study_design_scores_gemma":[0.00061458,0.00059639895,0.051968515,0.04940496,0.0069353958,0.03528723,0.0004634213,0.0005440984,0.0012406217,0.0034036064,0.8493553,0.00018589839],"about_ca_topic_score_codex":0.0009955032,"about_ca_topic_score_gemma":0.0024808273,"teacher_disagreement_score":0.0020073222,"about_ca_system_score_codex":0.00020736225,"about_ca_system_score_gemma":0.00055235624,"threshold_uncertainty_score":0.0062978864},"labels":[],"label_agreement":null},{"id":"W4378195092","doi":"10.1016/j.jacl.2023.05.101","title":"Dietary recommendations for dysbetalipoproteinemia: A need for better evidence","year":2023,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Dysfunctional family; Disease; Atherosclerotic cardiovascular disease; Bioinformatics; Intensive care medicine; Internal medicine; Psychiatry; Biology","score_opus":0.5330082096861793,"score_gpt":0.5598871365897444,"score_spread":0.02687892690356508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378195092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006750045,0.9980242,0.000117141964,0.0013080233,0.00030908748,0.000007548277,0.000033754328,0.0000050224994,0.00012780477],"genre_scores_gemma":[0.00086694636,0.99608755,0.0008121579,0.0017935961,0.00027144613,0.000023425428,0.000051302453,0.000003182519,0.00009039826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981243,0.0005432411,0.00054098223,0.00027907544,0.0004303813,0.0000820183],"domain_scores_gemma":[0.9921634,0.0052653383,0.0010683227,0.000114819086,0.0012219613,0.00016601352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065403525,0.0018200782,0.00914841,0.0028136228,0.00048066594,0.0036644046,0.0026084376,0.0037013998,0.006077614],"category_scores_gemma":[0.0111460695,0.00087066356,0.00331083,0.0029614866,0.0010090123,0.003301732,0.0015947775,0.0067584715,0.0011316674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006206059,0.00016365928,0.0007069545,0.22654957,0.004405004,0.00016050728,0.00013537999,0.00035498256,0.0005569613,0.0028178305,0.029367339,0.7341612],"study_design_scores_gemma":[0.0010912516,0.00042276058,0.006149288,0.42533424,0.020288432,0.0005814067,0.0006092857,0.00051818753,0.00032892113,0.008361181,0.5361355,0.00017956873],"about_ca_topic_score_codex":0.006795324,"about_ca_topic_score_gemma":0.0124900285,"teacher_disagreement_score":0.00914841,"about_ca_system_score_codex":0.0017760609,"about_ca_system_score_gemma":0.0039455625,"threshold_uncertainty_score":0.03458911},"labels":[],"label_agreement":null},{"id":"W4380201181","doi":"10.1016/j.jacl.2023.06.001","title":"Incident CHD and ischemic stroke associated with lipoprotein(a) by levels of Factor VIII and inflammation","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"National Institutes of Health; American College of Cardiology Foundation; Amgen","keywords":"Medicine; Hazard ratio; Internal medicine; Lipoprotein(a); C-reactive protein; Risk factor; Stroke (engine); Inflammation; Lipoprotein; Cardiology; Proportional hazards model; Confidence interval; Cholesterol","score_opus":0.0809140172044631,"score_gpt":0.3546075892138175,"score_spread":0.2736935720093544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380201181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997159,0.0008431051,0.0002647698,0.00008306186,0.000022463724,0.000007887298,0.00025919074,0.00001233524,0.0013481391],"genre_scores_gemma":[0.99889463,0.00011890831,0.00016564249,0.000021477525,0.000045984976,0.000004814579,0.00016432337,0.000004277885,0.00058007275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992755,0.00028014655,0.00009099876,0.00013492386,0.00010129828,0.00011721705],"domain_scores_gemma":[0.9979202,0.0005206773,0.0007991278,0.00017877981,0.000119027514,0.00046209808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067636574,0.0005246231,0.00048186694,0.0010447641,0.00034096104,0.0011797588,0.00033454288,0.00093220244,0.0036661741],"category_scores_gemma":[0.0024511537,0.0005292958,0.0009796036,0.0012349131,0.0003702011,0.00067659427,0.000525802,0.0011958327,0.00048509592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015359707,0.0000860346,0.99564713,0.000009818982,0.00030187523,0.00012828546,0.00004712558,0.000050132592,0.00079301954,0.000049282175,0.000060531573,0.001290729],"study_design_scores_gemma":[0.000016781749,0.00015321039,0.9985322,0.000004524619,0.0001535912,0.00032575315,0.000075373864,0.00037289222,0.00012194315,0.00012213425,0.00011466681,0.0000069750095],"about_ca_topic_score_codex":0.0026955004,"about_ca_topic_score_gemma":0.0020215588,"teacher_disagreement_score":0.0036661741,"about_ca_system_score_codex":0.00025374745,"about_ca_system_score_gemma":0.00030274762,"threshold_uncertainty_score":0.01226455},"labels":[],"label_agreement":null},{"id":"W4385638453","doi":"10.1016/j.jacl.2023.08.003","title":"Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Hypertriglyceridemia; Phenotype; Medicine; Internal medicine; Loss of heterozygosity; Allele; Triglyceride; Compound heterozygosity; Endocrinology; Gastroenterology; Genetics; Biology; Cholesterol; Gene","score_opus":0.07813754064576188,"score_gpt":0.40210273496054444,"score_spread":0.32396519431478255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385638453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921,0.00006273024,0.00017861831,0.00002581837,0.0000066922457,0.0000028633121,0.0001480942,0.00001022542,0.00035492168],"genre_scores_gemma":[0.9995535,0.000021006994,0.00007234683,0.000013878634,0.00000702288,0.000003505643,0.00016402297,0.000006222959,0.00015850615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965394,0.00006650473,0.00004443727,0.00012361641,0.000054747725,0.000056815763],"domain_scores_gemma":[0.99889106,0.0004339708,0.0002990225,0.000099629164,0.00012388897,0.0001525022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036076436,0.00036307832,0.00033799812,0.00086176407,0.00046521972,0.00055624446,0.00036812556,0.0006028236,0.0020893915],"category_scores_gemma":[0.0026697891,0.00016484273,0.0002861019,0.00061261735,0.00025914513,0.00030983088,0.00034709572,0.0004205686,0.00044260497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001154178,0.00010524638,0.9754684,0.000009586406,0.00006370659,0.005170217,0.00045547742,0.0001520876,0.012060782,0.00015357923,0.0002033128,0.005003386],"study_design_scores_gemma":[0.00002295721,0.00027322865,0.9870711,0.000007574276,0.000052622694,0.009893488,0.00031686918,0.0007315416,0.0011070458,0.0001753058,0.0003290955,0.00001909339],"about_ca_topic_score_codex":0.001303109,"about_ca_topic_score_gemma":0.0007840224,"teacher_disagreement_score":0.0020893915,"about_ca_system_score_codex":0.00019280573,"about_ca_system_score_gemma":0.00019131179,"threshold_uncertainty_score":0.006989658},"labels":[],"label_agreement":null},{"id":"W4387574102","doi":"10.1016/j.jacl.2023.09.015","title":"Evaluation of apolipoprotein A5 variants: A cohort of patients with severe hypertriglyceridemia from Turkiye","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hypertriglyceridemia; Internal medicine; Apolipoprotein B; Cohort; Gastroenterology; Body mass index; Retrospective cohort study; Triglyceride; Diabetes mellitus; Endocrinology; Cholesterol","score_opus":0.06979258126549717,"score_gpt":0.38181628035681253,"score_spread":0.31202369909131533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387574102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994311,0.0000921774,0.00004506193,0.000030796367,0.000007262646,0.000009083339,0.00015664553,0.0000016122191,0.00022623788],"genre_scores_gemma":[0.9990565,0.00007139859,0.00008805104,0.000048002217,0.000014499901,0.00001536762,0.00047674356,0.0000036722026,0.00022577682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996489,0.000044268283,0.00005035416,0.00011294927,0.00004721628,0.00009620122],"domain_scores_gemma":[0.9997466,0.000043513628,0.000054678552,0.000023624736,0.000056552777,0.00007489054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002795175,0.00084838906,0.0006281584,0.0014349519,0.001665802,0.0010614238,0.00048995356,0.0006902184,0.0026722332],"category_scores_gemma":[0.0009849538,0.00043920652,0.000674598,0.0011282644,0.0004279157,0.00047787116,0.00067325594,0.0005502027,0.0004540951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036344505,0.00009387783,0.9926017,0.0000137073675,0.00007413115,0.0032495658,0.00039026988,0.000038377068,0.0015753179,0.000043338412,0.0001925091,0.0013638271],"study_design_scores_gemma":[0.0000374826,0.00022685608,0.99121034,0.000013437849,0.0000986956,0.005976819,0.001420208,0.0001643289,0.00021734693,0.00006008898,0.0005589679,0.00001536771],"about_ca_topic_score_codex":0.0060496465,"about_ca_topic_score_gemma":0.004355917,"teacher_disagreement_score":0.0060496465,"about_ca_system_score_codex":0.0004339776,"about_ca_system_score_gemma":0.00048574465,"threshold_uncertainty_score":0.012028813},"labels":[],"label_agreement":null},{"id":"W4387610908","doi":"10.1016/j.jacl.2023.09.010","title":"Corrigendum to “Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial” [Journal of Clinical Lipidology, Volume 17, Issue 3, May–June 2023, Pages 342–355]","year":2023,"lang":"en","type":"erratum","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Akebia Therapeutics; Ionis Pharmaceuticals","keywords":"Medicine; Regret; Extension (predicate logic); Term (time); Clinical trial; Open label; Internal medicine; Machine learning; Computer science","score_opus":0.24579528250032498,"score_gpt":0.46173567097247725,"score_spread":0.21594038847215227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387610908","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015776293,0.00261649,0.00017422908,0.112706274,0.8798468,0.00006149259,0.0006095609,0.00013675279,0.0036906395],"genre_scores_gemma":[0.004938063,0.0074206376,0.0009409765,0.32993877,0.513473,0.00024957804,0.001664183,0.00026530528,0.14110953],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765354,0.00045216814,0.00038145867,0.00029434706,0.0009247672,0.00029379653],"domain_scores_gemma":[0.98695636,0.004520052,0.00077137654,0.0005215703,0.006145943,0.001084782],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035331235,0.0020160214,0.0035200533,0.0020440891,0.0020315757,0.0029933068,0.0025531119,0.00808805,0.038077738],"category_scores_gemma":[0.024896387,0.0010411994,0.002532907,0.0014227037,0.0012063684,0.0010691126,0.0010189008,0.010424407,0.021883544],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000672193,0.000013418102,0.00005313095,0.00005325122,0.000017301121,0.00015623428,0.0000042201154,0.000016656932,0.000021370266,0.00007714709,0.99610955,0.0034104662],"study_design_scores_gemma":[0.0006527937,0.00018113063,0.0035892816,0.00052003865,0.000256287,0.00064975425,0.000042523385,0.00043069653,0.0003640992,0.00085043366,0.9923902,0.00007284102],"about_ca_topic_score_codex":0.022526093,"about_ca_topic_score_gemma":0.037078984,"teacher_disagreement_score":0.99191195,"about_ca_system_score_codex":0.0038568252,"about_ca_system_score_gemma":0.004635107,"threshold_uncertainty_score":0.12738276},"labels":[],"label_agreement":null},{"id":"W4387783720","doi":"10.1016/j.jacl.2023.10.007","title":"Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; McGill University Health Centre; Providence Health Care Research Institute; Canadian Heart Research Centre; Providence Health Care","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Atherosclerotic cardiovascular disease; Myocardial infarction; Disease; Male gender; Cholesterol; Demography","score_opus":0.09393370917370486,"score_gpt":0.3804061041598035,"score_spread":0.28647239498609867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387783720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895716,0.00016215257,0.000025697918,0.00008578563,0.0000070499514,0.0000011886837,0.000021237402,7.390135e-7,0.00073902874],"genre_scores_gemma":[0.999668,0.000045059158,0.000014240341,0.00002181372,0.000005320912,6.0990743e-7,0.00001234283,6.7309117e-7,0.00023191846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997452,0.00010090409,0.000018149845,0.000032719643,0.00004991405,0.00005309717],"domain_scores_gemma":[0.9989316,0.00039758038,0.00029548764,0.00005661515,0.000085953936,0.00023276317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004957594,0.00014565534,0.00018723583,0.00047207574,0.00032025186,0.0006976231,0.00012956842,0.00040796804,0.0025680207],"category_scores_gemma":[0.0029052803,0.00018492258,0.0002506619,0.00032034406,0.00029933368,0.00025151367,0.00028141547,0.0004114982,0.00017571576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072581717,0.00014226696,0.9897872,0.000009850668,0.00009027399,0.000248087,0.0024724826,0.000033311542,0.0015042754,0.00018917955,0.00009121355,0.004706079],"study_design_scores_gemma":[0.000009768449,0.00006682453,0.99876606,0.0000030368153,0.000010472272,0.00015523129,0.0007150336,0.000075052914,0.000037431797,0.00009252485,0.00006498076,0.000003626933],"about_ca_topic_score_codex":0.0065231733,"about_ca_topic_score_gemma":0.008206898,"teacher_disagreement_score":0.0065231733,"about_ca_system_score_codex":0.00021996933,"about_ca_system_score_gemma":0.0001749157,"threshold_uncertainty_score":0.012970388},"labels":[],"label_agreement":null},{"id":"W4387801059","doi":"10.1016/j.jacl.2023.10.008","title":"Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Chicoutimi; Université de Montréal; Université du Québec à Chicoutimi","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Familial hypercholesterolemia; Cohort; Internal medicine; Coronary heart disease; Cohort study; Population; Disease; Pediatrics; Cholesterol","score_opus":0.08296627937137133,"score_gpt":0.42355261912419123,"score_spread":0.34058633975281993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387801059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799156,0.0002959515,0.000048398713,0.00011658069,0.000010930305,0.000011093435,0.00092989363,0.000004315307,0.0005912858],"genre_scores_gemma":[0.99818367,0.00018588523,0.000064974476,0.000045179808,0.0000091907295,0.0000097599595,0.0011467035,0.000002796118,0.0003518607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875903,0.0001596624,0.000077920035,0.00029193677,0.00021585786,0.0004956932],"domain_scores_gemma":[0.9980161,0.00018745485,0.0004188655,0.00012442085,0.00078069407,0.00047234356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010723318,0.0009804566,0.00080253545,0.0033284368,0.0032600018,0.0018029183,0.0015762623,0.0016883397,0.002055344],"category_scores_gemma":[0.003147903,0.00056716026,0.0014935078,0.003613583,0.000913838,0.00060184626,0.0014091696,0.0008480836,0.0001971431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046268894,0.000039920244,0.99665713,0.000010711527,0.00024191214,0.00015964093,0.00057491096,0.000088305984,0.00023856081,0.00008634548,0.00024175578,0.0011981259],"study_design_scores_gemma":[0.0000125696115,0.000036517315,0.99880576,0.0000067411115,0.00004242985,0.00006799411,0.0007195757,0.00011555439,0.000015048734,0.000014820754,0.00015419781,0.00000887927],"about_ca_topic_score_codex":0.9365585,"about_ca_topic_score_gemma":0.92218256,"teacher_disagreement_score":0.063441515,"about_ca_system_score_codex":0.010348672,"about_ca_system_score_gemma":0.0075527295,"threshold_uncertainty_score":0.12763023},"labels":[],"label_agreement":null},{"id":"W4389010956","doi":"10.1016/j.jacl.2023.11.012","title":"Differential impacts of admission LDL-cholesterol on early vascular outcomes by ischemic stroke subtypes","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Korea Centers for Disease Control and Prevention; Chonnam National University","keywords":"Medicine; Ischemic stroke; Internal medicine; Stroke (engine); Cardiology; Cholesterol; Ischemia","score_opus":0.0448395041104672,"score_gpt":0.3806171166049463,"score_spread":0.33577761249447907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389010956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703383,0.000508982,0.00010419041,0.000234337,0.000031560976,0.000009803855,0.00033922633,0.000006681174,0.0017312766],"genre_scores_gemma":[0.9989273,0.00013972506,0.000053624924,0.000058302194,0.000055233322,0.0000049562154,0.00034810745,0.000006474279,0.00040623298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822825,0.00049087155,0.0001693901,0.00027931167,0.00020977914,0.0006225],"domain_scores_gemma":[0.9956006,0.0018980938,0.00084350305,0.00044417832,0.00031306973,0.0009005714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016712309,0.00064969726,0.0010406937,0.0008404796,0.0006823933,0.0019875038,0.00082319585,0.0011741045,0.0051275953],"category_scores_gemma":[0.008090067,0.00047490996,0.002296844,0.0010535362,0.0005986845,0.0011857077,0.0013361851,0.0019543152,0.00069963554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030167457,0.00016499555,0.9899721,0.000018432398,0.00053986243,0.00015088951,0.0001226606,0.0001276879,0.00040826743,0.00012012889,0.00021909094,0.0051391604],"study_design_scores_gemma":[0.000027041902,0.00016019146,0.99870646,0.00000991638,0.00016548752,0.000087160646,0.00023934926,0.00025030732,0.000071477305,0.0002025763,0.00006961476,0.000010413438],"about_ca_topic_score_codex":0.006109896,"about_ca_topic_score_gemma":0.009036188,"teacher_disagreement_score":0.006109896,"about_ca_system_score_codex":0.0005071827,"about_ca_system_score_gemma":0.00095620553,"threshold_uncertainty_score":0.017153561},"labels":[],"label_agreement":null},{"id":"W4389514421","doi":"10.1016/j.jacl.2023.12.001","title":"Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Medicine; Oligonucleotide; Antisense therapy; Cancer research; Computational biology; Internal medicine; Pharmacology; Gene; Genetics","score_opus":0.08858040563683543,"score_gpt":0.3995422971318891,"score_spread":0.31096189149505366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389514421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943679,0.00043649654,0.002746209,0.00021254912,0.00014821746,0.000068372596,0.00011814976,0.000104013045,0.0017981392],"genre_scores_gemma":[0.99611783,0.0003503466,0.00097366,0.000111321395,0.000028085322,0.00004817948,0.00011571532,0.000021169568,0.0022335802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999182,0.000015359426,0.000007481883,0.000017216858,0.000018061326,0.000023611154],"domain_scores_gemma":[0.9999167,0.000022182794,0.000020423939,0.000012429757,0.000007578278,0.000020719828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019225336,0.00042580097,0.000455857,0.0002049086,0.00018514381,0.0002523031,0.00015006674,0.00032871397,0.0016457527],"category_scores_gemma":[0.00015625075,0.0001651851,0.00027212218,0.00019916052,0.00051600044,0.00031594254,0.00011561708,0.0008677726,0.00024344328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013717237,0.0008508076,0.0005823582,0.00006440885,0.00004922571,0.00049918046,0.000043198364,0.00041557135,0.97060555,0.00026133494,0.00016912038,0.012742098],"study_design_scores_gemma":[0.0024915447,0.025235059,0.005812539,0.000012325492,0.00019422453,0.0012637901,0.00012663525,0.003514365,0.9567442,0.00034047634,0.0042366115,0.00002813745],"about_ca_topic_score_codex":0.00069858413,"about_ca_topic_score_gemma":0.001009111,"teacher_disagreement_score":0.0016457527,"about_ca_system_score_codex":0.00024750174,"about_ca_system_score_gemma":0.00028329933,"threshold_uncertainty_score":0.005505562},"labels":[],"label_agreement":null},{"id":"W4389795448","doi":"10.1016/j.jacl.2023.12.002","title":"No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Natural Sciences and Engineering Research Council of Canada; Université du Québec à Chicoutimi; Berger (Canada); Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Statin; Randomized controlled trial; Vitamin D and neurology; Physical therapy; Placebo; Internal medicine; Quality of life (healthcare); Creatine kinase; Visual analogue scale; Vitamin","score_opus":0.06858655021675897,"score_gpt":0.3989503130699474,"score_spread":0.3303637628531884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389795448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626313,0.028470164,0.0006874915,0.0013922248,0.0016672867,0.0023472877,0.0009874456,0.00010357627,0.0017132155],"genre_scores_gemma":[0.9870809,0.0067515285,0.0007437128,0.0011344085,0.0008188444,0.001331367,0.0006547448,0.000015276304,0.0014692101],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99859947,0.0006106181,0.00018666933,0.00030452522,0.00011074368,0.00018803922],"domain_scores_gemma":[0.9981573,0.00078039727,0.00038760636,0.0001550154,0.0001289754,0.00039067582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021899054,0.0020657405,0.0065481868,0.0005723379,0.0009922468,0.0017754236,0.0013388966,0.0041923225,0.006872367],"category_scores_gemma":[0.0036234376,0.001249084,0.004952599,0.0007658865,0.0019298759,0.0014195308,0.00074636925,0.0037795065,0.0007642789],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99018705,0.0013830472,0.0007181781,0.0010554865,0.003360193,0.000027227179,0.000023306258,0.00006358044,0.00048435593,0.000033270637,0.00015131255,0.0025129926],"study_design_scores_gemma":[0.97310984,0.019006219,0.0021297035,0.0001132209,0.0050068777,0.000019303685,0.00002435929,0.00014998805,0.00012309801,0.00010041957,0.00019981581,0.000017254866],"about_ca_topic_score_codex":0.0029473337,"about_ca_topic_score_gemma":0.004298304,"teacher_disagreement_score":0.006872367,"about_ca_system_score_codex":0.0010265675,"about_ca_system_score_gemma":0.0012396896,"threshold_uncertainty_score":0.022990346},"labels":[],"label_agreement":null},{"id":"W4390739000","doi":"10.1016/j.jacl.2023.12.005","title":"Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada); University of British Columbia","funders":"Esperion Therapeutics; Ministry of Health","keywords":"Medicine; Familial hypercholesterolemia; Clinical trial; Internal medicine; Pooled analysis; Pediatrics; Cholesterol; Meta-analysis","score_opus":0.2269201333166373,"score_gpt":0.48440037491288873,"score_spread":0.25748024159625144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390739000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636839,0.032476652,0.0012963795,0.00032848577,0.00011938826,0.00030837025,0.00090690696,0.000064277076,0.0008156801],"genre_scores_gemma":[0.9946795,0.003367122,0.00051169656,0.00022946311,0.000082717794,0.00013994184,0.0008313124,0.000013496253,0.00014467973],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965174,0.0023678865,0.0003259863,0.00032936025,0.00027508033,0.00018425043],"domain_scores_gemma":[0.99613875,0.0018418805,0.001147016,0.0003566243,0.00019543942,0.00032023236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00757747,0.0012310346,0.004851831,0.0008616943,0.00034936648,0.0014264596,0.0005669759,0.0011309163,0.0010145053],"category_scores_gemma":[0.005380177,0.00055835035,0.0043683755,0.0011131767,0.00089519157,0.0010621707,0.00048323788,0.0017007532,0.00014963708],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8728269,0.0014547389,0.023872418,0.0017648643,0.05521873,0.00010516659,0.00009149361,0.0025106957,0.0068001263,0.00016363566,0.0005868849,0.034604378],"study_design_scores_gemma":[0.57158506,0.14952813,0.17907055,0.00036505653,0.085131995,0.00049912825,0.00021684752,0.0045689247,0.004148419,0.0011916569,0.003488116,0.00020613738],"about_ca_topic_score_codex":0.00045440602,"about_ca_topic_score_gemma":0.0011392918,"teacher_disagreement_score":0.00757747,"about_ca_system_score_codex":0.00069189514,"about_ca_system_score_gemma":0.00073429814,"threshold_uncertainty_score":0.04007393},"labels":[],"label_agreement":null},{"id":"W4390860012","doi":"10.1016/j.jacl.2024.01.003","title":"Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Heart Institute; Dalhousie University; Western University; University of Toronto; Queen Elizabeth II Health Sciences Centre; BC Innovation Council; Université du Québec à Chicoutimi; Hospital for Sick Children; University of British Columbia; Université Laval; Providence Health Care Research Institute; University of Ottawa; McGill University Health Centre; Providence Health Care; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Familial hypercholesterolemia; Presentation (obstetrics); Pediatrics; Internal medicine; Obstetrics; Cholesterol","score_opus":0.057059282639016634,"score_gpt":0.3810474081197081,"score_spread":0.32398812548069145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390860012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822694,0.0006022463,0.00003780785,0.00008940677,0.000010436269,0.000004170153,0.00022480739,0.0000016521618,0.0008025389],"genre_scores_gemma":[0.99958616,0.00010817929,0.000013999085,0.000031943266,0.000010472789,0.0000029452542,0.00016112227,9.150584e-7,0.000084273255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997069,0.000049072954,0.000029991457,0.00006718861,0.0000723611,0.00007445346],"domain_scores_gemma":[0.999331,0.00014774816,0.0002862324,0.00003359421,0.00007131305,0.00013007566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036114856,0.00013324685,0.00024843632,0.0003359908,0.00028960395,0.00040646808,0.00016303912,0.00029210935,0.0018627439],"category_scores_gemma":[0.0020685222,0.00007742233,0.00025825202,0.00042163016,0.00018880106,0.00019663098,0.00017986499,0.00028985477,0.0002034514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022419405,0.000020919406,0.9973974,0.000004928241,0.000029100775,0.00022423253,0.00006543736,0.000019318875,0.00017729627,0.000025684405,0.00011887614,0.001692684],"study_design_scores_gemma":[0.000011685921,0.00007325815,0.9986482,0.000004947791,0.000013768002,0.00084640714,0.00012430544,0.000053598236,0.000027076683,0.00003951841,0.0001541998,0.0000030540677],"about_ca_topic_score_codex":0.0042981226,"about_ca_topic_score_gemma":0.004829527,"teacher_disagreement_score":0.0042981226,"about_ca_system_score_codex":0.00034032422,"about_ca_system_score_gemma":0.00037120897,"threshold_uncertainty_score":0.008546233},"labels":[],"label_agreement":null},{"id":"W4392095094","doi":"10.1016/j.jacl.2024.02.007","title":"Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Hypertriglyceridemia; Acute pancreatitis; Pancreatitis; Internal medicine; Metabolic syndrome; Gastroenterology; Triglyceride; Obesity; Cholesterol","score_opus":0.03172456883648937,"score_gpt":0.3464273692086079,"score_spread":0.3147028003721185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392095094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890804,0.00018329063,0.0003539935,0.00008198483,0.000013352931,0.0000055609175,0.00009694922,0.000009202945,0.00034764508],"genre_scores_gemma":[0.9995289,0.000044657074,0.00016248354,0.000011056985,0.000020041425,0.0000032899702,0.000114559814,0.0000027123015,0.00011236696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935156,0.00020173326,0.00010717569,0.00014164904,0.00009237969,0.00010555778],"domain_scores_gemma":[0.99830294,0.0003629333,0.00076866476,0.00011428342,0.00010524528,0.00034590362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045946665,0.0010674811,0.0005638204,0.0015613203,0.00070587633,0.0007365591,0.00058819185,0.0007042566,0.0036477437],"category_scores_gemma":[0.0023834456,0.0003727242,0.0013138477,0.0016449185,0.00043388805,0.00058076996,0.00087783585,0.00091827096,0.000249061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048849167,0.00004236624,0.9933436,0.00001022253,0.00023461468,0.0025192588,0.00006568555,0.00008703631,0.0019286366,0.000087254724,0.000059136983,0.0011337238],"study_design_scores_gemma":[0.000018771287,0.00010338821,0.99358577,0.000008116507,0.00023827425,0.004263369,0.00013395246,0.0010982272,0.0002064323,0.00023564407,0.0000932141,0.000014860758],"about_ca_topic_score_codex":0.0015570801,"about_ca_topic_score_gemma":0.001245622,"teacher_disagreement_score":0.0036477437,"about_ca_system_score_codex":0.00021568584,"about_ca_system_score_gemma":0.00038788837,"threshold_uncertainty_score":0.0122029185},"labels":[],"label_agreement":null},{"id":"W4393386912","doi":"10.1016/j.jacl.2024.03.001","title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","year":2024,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lipoprotein(a); Epidemiology; Risk factor; Lipoprotein; Internal medicine; Risk assessment; Cholesterol","score_opus":0.27786265928669474,"score_gpt":0.5351723513316866,"score_spread":0.2573096920449919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393386912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001478695,0.9522333,0.0002783227,0.029786667,0.0148719335,0.000037540216,0.00052306516,0.000043560085,0.0020776896],"genre_scores_gemma":[0.0010849333,0.95137715,0.0010360342,0.03567847,0.008688095,0.00006713873,0.0006200096,0.000018610266,0.001429623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965898,0.0008588202,0.00083977816,0.000257826,0.0012117418,0.00024193824],"domain_scores_gemma":[0.9778535,0.012947764,0.0025560332,0.00028106058,0.0055063087,0.00085536577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009384642,0.0011079494,0.0032727832,0.005788432,0.00052269216,0.002989159,0.0018879798,0.005427337,0.008317938],"category_scores_gemma":[0.022804199,0.00057265814,0.0027671892,0.003859895,0.0008839656,0.0025365057,0.0020280955,0.006693891,0.0039651426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003482111,0.000102049955,0.00029248427,0.047645826,0.00047973133,0.00015500684,0.00010432304,0.00013425961,0.00063608313,0.003945519,0.4539743,0.49218234],"study_design_scores_gemma":[0.00015109296,0.000101882666,0.0012688466,0.03740416,0.0008150574,0.00025456786,0.00004868425,0.000068373454,0.0001368764,0.0010642728,0.95864767,0.000038554084],"about_ca_topic_score_codex":0.0054961615,"about_ca_topic_score_gemma":0.012169517,"teacher_disagreement_score":0.009384642,"about_ca_system_score_codex":0.0029480052,"about_ca_system_score_gemma":0.011072102,"threshold_uncertainty_score":0.049631357},"labels":[],"label_agreement":null},{"id":"W4394676333","doi":"10.1016/j.jacl.2024.04.122","title":"Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; Sanofi (Canada); University of Alberta; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Acute coronary syndrome; Internal medicine; Cardiology; Lipoprotein; Cholesterol; Myocardial infarction","score_opus":0.04398494660573627,"score_gpt":0.3833615390995042,"score_spread":0.33937659249376795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394676333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92342776,0.056864556,0.0007371255,0.0018560686,0.000369868,0.00024895385,0.013293421,0.000039205603,0.0031631226],"genre_scores_gemma":[0.9775785,0.010064279,0.00046456317,0.00085189537,0.0006570994,0.00028020926,0.009457123,0.000016076146,0.0006302199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983015,0.000657333,0.0002411664,0.0002546661,0.00042148025,0.00012381739],"domain_scores_gemma":[0.99348676,0.0023125452,0.0022825513,0.00044827675,0.0008477857,0.0006221306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005263855,0.0007971609,0.0013820095,0.0006134777,0.00032278374,0.0011110097,0.00043211173,0.00071309606,0.0016423365],"category_scores_gemma":[0.0064413757,0.00035582905,0.002079545,0.001216114,0.00025942846,0.0004672768,0.0007671176,0.0012647099,0.00018481752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049170636,0.0007012129,0.8881616,0.0015305779,0.013183918,0.00016767,0.00020880843,0.00035339524,0.00048519517,0.00021030208,0.00660798,0.03921871],"study_design_scores_gemma":[0.009062893,0.0016100903,0.9785985,0.00016302094,0.0061727604,0.00017190812,0.00007643196,0.00034016688,0.0001947263,0.0001522737,0.003404174,0.000053070213],"about_ca_topic_score_codex":0.0033674126,"about_ca_topic_score_gemma":0.0043264744,"teacher_disagreement_score":0.005263855,"about_ca_system_score_codex":0.00039291993,"about_ca_system_score_gemma":0.00060871925,"threshold_uncertainty_score":0.02783823},"labels":[],"label_agreement":null},{"id":"W4395663253","doi":"10.1016/j.jacl.2024.04.132","title":"High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Montreal Heart Institute; Université de Montréal; Montreal Clinical Research Institute; Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Institut de Recherche Clinique De Montréal","keywords":"Medicine; Population; Environmental health","score_opus":0.07466491111625129,"score_gpt":0.3998574967821571,"score_spread":0.3251925856659058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395663253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955968,0.0004840238,0.00015941939,0.00036045862,0.000022504035,0.00002049766,0.00063147995,0.000013911006,0.0027109168],"genre_scores_gemma":[0.9980666,0.0003084622,0.00018306602,0.00009705452,0.000016484759,0.000006923964,0.00020876175,0.0000067295537,0.0011058745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991192,0.00008145618,0.00006495423,0.00019878572,0.00022004831,0.0003155072],"domain_scores_gemma":[0.99880064,0.00020482075,0.00016627707,0.000056468885,0.00043427764,0.000337505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007410774,0.0011734276,0.0007652631,0.0037756697,0.0058986046,0.0016545501,0.0018232161,0.0015474337,0.008689103],"category_scores_gemma":[0.0028881868,0.00055455364,0.0010510305,0.0039006153,0.001713793,0.0004922539,0.00073467713,0.00096033956,0.00044114105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006752945,0.00018264772,0.97463155,0.000057690504,0.00022257595,0.007794434,0.00430054,0.0001740397,0.0038431978,0.00081901666,0.0014230481,0.0058759213],"study_design_scores_gemma":[0.000056118293,0.00014883323,0.9839521,0.00005830061,0.00024072122,0.008039269,0.0045961468,0.00055590185,0.0002734026,0.0002124252,0.001793922,0.00007278394],"about_ca_topic_score_codex":0.94910675,"about_ca_topic_score_gemma":0.9078015,"teacher_disagreement_score":0.050893247,"about_ca_system_score_codex":0.005792813,"about_ca_system_score_gemma":0.007510087,"threshold_uncertainty_score":0.10238588},"labels":[],"label_agreement":null},{"id":"W4400258283","doi":"10.1016/j.jacl.2024.06.005","title":"What's next for lipoprotein(a)? A National Lipid Association report from an Expert Panel Discussion","year":2024,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Association (psychology); Lipoprotein(a); Family medicine; Lipoprotein; Internal medicine; Cholesterol; Epistemology","score_opus":0.28352666396005166,"score_gpt":0.5182416227121824,"score_spread":0.23471495875213078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400258283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049338967,0.9157115,0.0007185517,0.069495305,0.00806656,0.00016257235,0.00068245677,0.000032759046,0.004636952],"genre_scores_gemma":[0.0034188277,0.93621814,0.002089398,0.051907185,0.0033754315,0.00021766474,0.0006543511,0.000016258544,0.0021028453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975267,0.00068871025,0.0005492241,0.0002523731,0.0007629284,0.00021999197],"domain_scores_gemma":[0.99263376,0.003372769,0.0010092567,0.000111023786,0.0024324374,0.00044072344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011802683,0.0011738162,0.0022935802,0.0023539495,0.00066079374,0.0019663826,0.0018247858,0.0045938003,0.0040067635],"category_scores_gemma":[0.010082864,0.00060161395,0.003152028,0.0018619957,0.00063460553,0.0021919913,0.0016527679,0.0055916,0.0017983896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000541272,0.0000862588,0.0010257637,0.040363226,0.0014783123,0.00036816252,0.00019933059,0.00024452872,0.001248287,0.0029597646,0.37024608,0.581239],"study_design_scores_gemma":[0.00036193448,0.00013485376,0.0027941298,0.06915775,0.0044331504,0.00045087613,0.00017905749,0.00011089383,0.00061636214,0.002263977,0.91943616,0.000060803584],"about_ca_topic_score_codex":0.006422614,"about_ca_topic_score_gemma":0.018573856,"teacher_disagreement_score":0.011802683,"about_ca_system_score_codex":0.0023924182,"about_ca_system_score_gemma":0.009601011,"threshold_uncertainty_score":0.062419355},"labels":[],"label_agreement":null},{"id":"W4400959170","doi":"10.1016/j.jacl.2024.04.109","title":"Role and Expression of 15-Prostaglandin Dehydrogenase in Cartilage tissue","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QUAD Engineering (Canada)","funders":"","keywords":"Medicine; Prostaglandin; Cartilage; Expression (computer science); Cell biology; Computational biology; Internal medicine; Anatomy","score_opus":0.029202111942865823,"score_gpt":0.38617020208413166,"score_spread":0.35696809014126585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400959170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774304,0.01417115,0.0037681602,0.00017086187,0.000059898586,0.00004466636,0.0003855598,0.000029651443,0.0039395886],"genre_scores_gemma":[0.99023974,0.0019240933,0.0013033502,0.00003026885,0.000029683539,0.000023031302,0.00027629195,0.000004816559,0.006168756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977547,0.00004432543,0.000020521558,0.00003713594,0.00004633072,0.00007626212],"domain_scores_gemma":[0.9997104,0.000045119894,0.000059550766,0.000028474435,0.00006754958,0.000088819455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036201102,0.00021942574,0.00020292928,0.0008604493,0.00034895638,0.0006991549,0.00025678036,0.00032257824,0.0018638019],"category_scores_gemma":[0.0003263023,0.00022922285,0.0003671404,0.00032325555,0.00057715416,0.0004854961,0.0003832346,0.0003896434,0.00045502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012789674,0.000051540144,0.0066927667,0.00011811751,0.000028469523,0.0006210099,0.00022446467,0.00004832997,0.98417574,0.00092202204,0.000045723216,0.005792781],"study_design_scores_gemma":[0.00009463228,0.0013857638,0.17110722,0.00006339378,0.00013597243,0.0029343741,0.0019252613,0.0013822273,0.81273896,0.00085322297,0.007348267,0.000030692732],"about_ca_topic_score_codex":0.0021625771,"about_ca_topic_score_gemma":0.0017197455,"teacher_disagreement_score":0.0021625771,"about_ca_system_score_codex":0.00045209235,"about_ca_system_score_gemma":0.0005289982,"threshold_uncertainty_score":0.006235063},"labels":[],"label_agreement":null},{"id":"W4400959353","doi":"10.1016/j.jacl.2024.04.107","title":"†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QUAD Engineering (Canada)","funders":"","keywords":"Medicine; DNA methylation; Osteoarthritis; Lipoxygenase; Gene; Methylation; Gene expression; Genetics; Bioinformatics; Biochemistry; Pathology; Enzyme; Biology; Alternative medicine","score_opus":0.03560181435165663,"score_gpt":0.3732644004483992,"score_spread":0.3376625860967426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400959353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98153406,0.0077183675,0.0033069937,0.00058132084,0.00022769083,0.00004752489,0.0023466172,0.00007403758,0.004163409],"genre_scores_gemma":[0.9898011,0.0014613807,0.0011546591,0.00008420158,0.00003823067,0.000028432332,0.00079493725,0.0000135276,0.006623555],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990356,0.000018340603,0.000009691492,0.000025701496,0.00001655217,0.000026178835],"domain_scores_gemma":[0.9998628,0.000027620928,0.000034104465,0.000009502648,0.000027455528,0.000038529834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021193689,0.00022201634,0.0001978717,0.00040216037,0.00026316755,0.00019662066,0.00014967434,0.0002514928,0.004834294],"category_scores_gemma":[0.00030848157,0.00011543664,0.00019501553,0.00022974449,0.00020261125,0.00012996166,0.00014489623,0.0003347943,0.0005067936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00965657,0.00018497618,0.09414672,0.00053436344,0.0001852491,0.0006382776,0.00018510428,0.00032265956,0.81447494,0.0006006795,0.0021013715,0.07696907],"study_design_scores_gemma":[0.00018117284,0.0016244047,0.63874346,0.00006565664,0.00028578754,0.0020198815,0.0004661273,0.001250201,0.3443696,0.0005865736,0.010374311,0.000032739106],"about_ca_topic_score_codex":0.002750829,"about_ca_topic_score_gemma":0.0038173813,"teacher_disagreement_score":0.004834294,"about_ca_system_score_codex":0.00022312153,"about_ca_system_score_gemma":0.0002647803,"threshold_uncertainty_score":0.01617235},"labels":[],"label_agreement":null},{"id":"W4400959371","doi":"10.1016/j.jacl.2024.04.108","title":"†Role of Epigenetic Regulation and Sp1 Rranscription Factor on DP1 Receptor Expression in Osteoarthritis","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QUAD Engineering (Canada)","funders":"","keywords":"Medicine; Epigenetics; Osteoarthritis; Cancer research; Bioinformatics; Computational biology; Genetics; Gene; Pathology; Biology","score_opus":0.03456602513961439,"score_gpt":0.3577370621068378,"score_spread":0.32317103696722344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400959371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594368,0.014260597,0.011628613,0.0013148412,0.0008078404,0.000119450844,0.00213675,0.00024367857,0.010051526],"genre_scores_gemma":[0.98052305,0.0028706638,0.0032721662,0.00023280743,0.00011202975,0.000067048604,0.00093710696,0.0000344039,0.011950837],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997695,0.00003059812,0.000025944177,0.000060590224,0.0000493439,0.000064033455],"domain_scores_gemma":[0.9998196,0.000021830181,0.000054347314,0.000025698651,0.000034068144,0.000044489207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033884103,0.00033440738,0.00026284708,0.00033060787,0.0003250944,0.00030250812,0.00025433916,0.00033097243,0.0065690274],"category_scores_gemma":[0.00031156253,0.00016171749,0.00035816012,0.00015977674,0.00042265494,0.0003043825,0.00031433516,0.00078088004,0.00087841944],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022963146,0.0001296798,0.0059271604,0.00038090884,0.000058276215,0.0005320498,0.000111691865,0.00012951011,0.94865835,0.0012565965,0.0015999755,0.038919564],"study_design_scores_gemma":[0.0002017264,0.0014137549,0.14708045,0.00007420618,0.00017557175,0.0020396975,0.00055202027,0.0018414623,0.82585865,0.0007424516,0.01997541,0.000044588785],"about_ca_topic_score_codex":0.0011019743,"about_ca_topic_score_gemma":0.0015224395,"teacher_disagreement_score":0.0065690274,"about_ca_system_score_codex":0.00025570078,"about_ca_system_score_gemma":0.00029674426,"threshold_uncertainty_score":0.021975577},"labels":[],"label_agreement":null},{"id":"W4401502381","doi":"10.1016/j.jacl.2024.08.004","title":"Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Apolipoprotein B; Fibrinogen; Lipoprotein(a); Medicine; Internal medicine; Lipoprotein; Stepwise regression; Population; Endocrinology; Very low-density lipoprotein; Cholesterol","score_opus":0.08375584990417963,"score_gpt":0.3275323674809093,"score_spread":0.2437765175767297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401502381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993181,0.00037388428,0.00007125353,0.000037589893,0.0000024671938,0.0000023922762,0.000055275228,0.0000018743483,0.00013708332],"genre_scores_gemma":[0.99953675,0.00012504864,0.00009625824,0.000011794565,0.00000671284,0.000003162504,0.000047926693,0.0000016903111,0.00017069351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967515,0.00010629425,0.000028404787,0.0000621077,0.0000674639,0.00006069346],"domain_scores_gemma":[0.9989716,0.00024175835,0.0005213161,0.00007298558,0.000081746606,0.000110609384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056752766,0.00034624996,0.0002858494,0.0008990069,0.0004410513,0.00045108568,0.000188337,0.00050347927,0.0027660117],"category_scores_gemma":[0.0028007445,0.00031988966,0.00036919385,0.0009548291,0.00032379007,0.00026570586,0.0002898354,0.000464493,0.00018464614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035137622,0.00004188406,0.9950478,0.000021150416,0.0000846329,0.0001968568,0.00027541304,0.00003590869,0.001660942,0.000052636635,0.00006877431,0.0021626356],"study_design_scores_gemma":[0.0000061274654,0.000057688365,0.99905366,0.000008087399,0.000026116628,0.0003918367,0.00007983339,0.00014806383,0.00009166501,0.000046603636,0.000087838846,0.0000025105685],"about_ca_topic_score_codex":0.0053827167,"about_ca_topic_score_gemma":0.0030787631,"teacher_disagreement_score":0.0053827167,"about_ca_system_score_codex":0.00023301072,"about_ca_system_score_gemma":0.00018612121,"threshold_uncertainty_score":0.010702789},"labels":[],"label_agreement":null},{"id":"W4402280397","doi":"10.1016/j.jacl.2024.08.013","title":"Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; McGill University Health Centre","funders":"Genentech; Esperion Therapeutics; National Institutes of Health; HLS Therapeutics; Novo Nordisk; National Institute for Health and Care Research; Amarin Corporation; Ionis Pharmaceuticals; American Heart Association; Pharmavite; Amryt Pharma; U.S. Department of Veterans Affairs; Alnylam Pharmaceuticals; Gilead Sciences; Eli Lilly and Company; AstraZeneca; Pfizer; Amgen; Sanofi; Regeneron Pharmaceuticals","keywords":"Apolipoprotein B; Medicine; Dyslipidemia; Lipoprotein; Internal medicine; Population; Cholesterol; Endocrinology; Disease; Environmental health","score_opus":0.06827878713381341,"score_gpt":0.41151399817231343,"score_spread":0.3432352110385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402280397","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009319857,0.57707447,0.015167675,0.36484376,0.016742414,0.00048542404,0.00061225507,0.00026166567,0.0154925585],"genre_scores_gemma":[0.14521238,0.5468534,0.13442889,0.14357458,0.021465702,0.0013282682,0.0023844365,0.00027094045,0.0044814097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9851601,0.0039349035,0.004631948,0.0011197673,0.0045718807,0.00058137433],"domain_scores_gemma":[0.9532518,0.019430373,0.003840705,0.0011666731,0.0188855,0.0034250738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04783996,0.0012560477,0.00395952,0.0034514088,0.0019262176,0.004803384,0.0056000357,0.0066445298,0.00080882665],"category_scores_gemma":[0.04037763,0.0007394581,0.0026706795,0.002297832,0.0024581393,0.0024335391,0.002973484,0.014405247,0.0007601408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010425687,0.00055310474,0.017674614,0.008863367,0.0015995567,0.0009898031,0.0014924018,0.001874378,0.0019623614,0.009079051,0.17315054,0.7817182],"study_design_scores_gemma":[0.00206596,0.0008778605,0.062066246,0.08056323,0.005821937,0.0042182035,0.0034879341,0.006597896,0.0041177333,0.028698297,0.80096436,0.0005202426],"about_ca_topic_score_codex":0.0089576505,"about_ca_topic_score_gemma":0.0110190045,"teacher_disagreement_score":0.04783996,"about_ca_system_score_codex":0.0031055447,"about_ca_system_score_gemma":0.015231053,"threshold_uncertainty_score":0.2530049},"labels":[],"label_agreement":null},{"id":"W4403063378","doi":"10.1016/j.jacl.2024.09.009","title":"Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Very low-density lipoprotein; Triglyceride; Apolipoprotein B; Variance (accounting); Composition (language); Internal medicine; Lipoprotein; Cholesterol","score_opus":0.05056189460596554,"score_gpt":0.37969604415121094,"score_spread":0.3291341495452454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403063378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795204,0.0002553463,0.00127534,0.00002708272,0.000004943177,0.0000070942647,0.00016097365,0.000018422159,0.000298693],"genre_scores_gemma":[0.99907804,0.000036212852,0.0005564915,0.000009073838,0.0000055620285,0.0000058138385,0.00016455271,0.000005136016,0.00013911014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993445,0.00014804846,0.000063336964,0.00029126447,0.00011444609,0.0000382284],"domain_scores_gemma":[0.9985061,0.0006328251,0.000343806,0.00030435392,0.00012423124,0.00008864903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007352536,0.00020985228,0.00023297207,0.00068647653,0.00025178335,0.000516578,0.00026010582,0.00036198963,0.0013795116],"category_scores_gemma":[0.0028558837,0.00019862915,0.00031441878,0.0006650799,0.00038342847,0.00019888765,0.00025842767,0.00033634462,0.00025626723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000415965,0.000024216006,0.98497295,0.000016903801,0.00024082485,0.00007146522,0.00013205443,0.00025401145,0.009222603,0.00009466845,0.0000865816,0.004467651],"study_design_scores_gemma":[0.000010129299,0.00006436342,0.99779546,0.0000028695874,0.000047695372,0.0004113402,0.00005423103,0.00076067727,0.0005916741,0.00011607978,0.00014064797,0.0000049784862],"about_ca_topic_score_codex":0.0011711067,"about_ca_topic_score_gemma":0.0006592052,"teacher_disagreement_score":0.0013795116,"about_ca_system_score_codex":0.00015250825,"about_ca_system_score_gemma":0.00013874391,"threshold_uncertainty_score":0.004614949},"labels":[],"label_agreement":null},{"id":"W4403293231","doi":"10.1016/j.jacl.2024.09.010","title":"The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases","year":2024,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Clinical trial; Intensive care medicine; Environmental health; Internal medicine","score_opus":0.4416627691802851,"score_gpt":0.608386602339193,"score_spread":0.16672383315890787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403293231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082641505,0.9983407,0.00017806036,0.00078413874,0.00029273404,0.00004060937,0.000046700647,0.0000041233125,0.00023032814],"genre_scores_gemma":[0.002848378,0.9926006,0.0016868664,0.0021298786,0.00042682502,0.00011801008,0.00008818323,0.0000055757178,0.000095666874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9825582,0.009442573,0.003931452,0.0012716476,0.0024501213,0.00034603148],"domain_scores_gemma":[0.79245615,0.1882188,0.010175841,0.0019527759,0.0061525367,0.0010438899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.054903336,0.0019520452,0.012605479,0.004369473,0.0005229172,0.004830996,0.0039194915,0.0059313816,0.007945778],"category_scores_gemma":[0.095467865,0.001102453,0.0059344103,0.0041338364,0.0022847457,0.0056305802,0.0024792817,0.0062915054,0.0008707669],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015346585,0.0001446437,0.0007256833,0.3566787,0.00889834,0.00014146333,0.00018263346,0.0005503557,0.00044917266,0.0078977905,0.01005258,0.61274403],"study_design_scores_gemma":[0.0029223242,0.001126708,0.003334609,0.6100443,0.04000438,0.00043364867,0.00039051336,0.0007004166,0.0005009549,0.017454749,0.322961,0.00012651818],"about_ca_topic_score_codex":0.0028085045,"about_ca_topic_score_gemma":0.0058984705,"teacher_disagreement_score":0.054903336,"about_ca_system_score_codex":0.0024260427,"about_ca_system_score_gemma":0.008222087,"threshold_uncertainty_score":0.2903601},"labels":[],"label_agreement":null},{"id":"W4404109847","doi":"10.1016/j.jacl.2024.10.008","title":"Extreme LDL-C concentration is associated with increased cardiovascular disease in women with homozygous familial hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada); McGill University Health Centre; University of Ottawa; University of Toronto; Western University; Queen Elizabeth II Health Sciences Centre; Université Laval; University of British Columbia; Montreal Heart Institute; Montreal Clinical Research Institute; Hospital for Sick Children; Université du Québec à Chicoutimi; McMaster University; Providence Health Care; Providence Health Care Research Institute","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Internal medicine; Disease; Ldl cholesterol; Cardiology; Endocrinology; Gastroenterology; Cholesterol","score_opus":0.049798382642746546,"score_gpt":0.3232022719678083,"score_spread":0.27340388932506177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404109847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905103,0.00017136996,0.00010847377,0.00007333734,0.000013974002,0.0000028989248,0.00005601645,0.000007788272,0.0005152194],"genre_scores_gemma":[0.99950397,0.000054972003,0.00009551021,0.000032780576,0.000024912952,0.000003734308,0.000073127136,0.0000036709826,0.00020737079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996032,0.00014185115,0.000045172575,0.0000690669,0.00006448852,0.00007621525],"domain_scores_gemma":[0.998396,0.00058816635,0.00053008954,0.00012416682,0.00007350232,0.00028800988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003975944,0.00066262885,0.00073145493,0.0014743543,0.0010865186,0.00075932493,0.00048216514,0.0013378736,0.0028685753],"category_scores_gemma":[0.0025634908,0.0005491161,0.0007772001,0.0012104968,0.0007174542,0.00038871256,0.0005164079,0.0010761474,0.00037279614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012655401,0.00011865638,0.9910739,0.00001882713,0.00019253495,0.002540559,0.00019462884,0.00005984311,0.0029356664,0.00007961542,0.00010247928,0.0014179331],"study_design_scores_gemma":[0.000021475344,0.00019504906,0.9952637,0.000007722901,0.00015476308,0.0035035566,0.00021464872,0.00024955434,0.00017562746,0.00011509728,0.000086287364,0.000012546688],"about_ca_topic_score_codex":0.0030629595,"about_ca_topic_score_gemma":0.002959042,"teacher_disagreement_score":0.0030629595,"about_ca_system_score_codex":0.00019736521,"about_ca_system_score_gemma":0.00025658897,"threshold_uncertainty_score":0.009596288},"labels":[],"label_agreement":null},{"id":"W4404338689","doi":"10.1016/j.jacl.2024.09.008","title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Ionis Pharmaceuticals","keywords":"Medicine; Intensive care medicine; Pediatrics","score_opus":0.09260224992245723,"score_gpt":0.46339597548283895,"score_spread":0.3707937255603817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404338689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822505,0.00051694503,0.00413911,0.00059173774,0.000038362494,0.0016056197,0.00063577085,0.00004826239,0.010173648],"genre_scores_gemma":[0.98653424,0.00020914404,0.010676483,0.00017359812,0.000014061468,0.0010791944,0.0008539471,0.000010564497,0.00044862388],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945726,0.0028781365,0.0007620907,0.00041353976,0.001008139,0.0003655122],"domain_scores_gemma":[0.9817863,0.0054098265,0.0018505115,0.00066940475,0.009304824,0.0009791325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011728064,0.00044837393,0.00031131372,0.0030583474,0.0009376054,0.0005985441,0.00076674565,0.0005526588,0.0011651181],"category_scores_gemma":[0.025419852,0.00020698555,0.00043651747,0.001211786,0.0009137574,0.0004900939,0.0014752531,0.00037873842,0.00029976977],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035567273,0.00020133855,0.9368751,0.00014672775,0.000068294365,0.0005033313,0.006143564,0.00092934124,0.0026859494,0.0005175766,0.0037980564,0.04777513],"study_design_scores_gemma":[0.00010191862,0.00039306283,0.977394,0.00019078823,0.00004358205,0.0014905218,0.0060659237,0.0049136183,0.0011450291,0.00048026565,0.0077512944,0.00003002529],"about_ca_topic_score_codex":0.028959375,"about_ca_topic_score_gemma":0.042781677,"teacher_disagreement_score":0.028959375,"about_ca_system_score_codex":0.0020030872,"about_ca_system_score_gemma":0.0041862554,"threshold_uncertainty_score":0.062024653},"labels":[],"label_agreement":null},{"id":"W4405018482","doi":"10.1016/j.jacl.2024.11.008","title":"Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform size","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; York University; American Heart Association","keywords":"Medicine; Gene isoform; Apolipoprotein B; Lipoprotein(a); Variation (astronomy); Internal medicine; Lipoprotein; Endocrinology; Cholesterol; Genetics; Biology; Gene","score_opus":0.02845290030042194,"score_gpt":0.3635471249868875,"score_spread":0.33509422468646555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405018482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860483,0.0001973618,0.0005272401,0.000055275446,0.000019764313,0.0000044906596,0.00017248253,0.000010625646,0.0004079227],"genre_scores_gemma":[0.9991861,0.000040876796,0.00030263,0.00005031544,0.000014962631,0.000004276257,0.000091652415,0.00001821799,0.0002910431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990971,0.00033892554,0.000100894766,0.00028018147,0.00012310075,0.00005980235],"domain_scores_gemma":[0.998164,0.00084209,0.0003672528,0.0002746785,0.0001325501,0.00021943788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094062876,0.00038529042,0.00039207708,0.00057967496,0.00030808977,0.0005442994,0.00041759116,0.00069955416,0.0017774319],"category_scores_gemma":[0.0019385619,0.00021815386,0.00038475744,0.0005119145,0.00042876578,0.00035336363,0.0003467339,0.00067098485,0.00025679605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096813105,0.000351595,0.7388866,0.00007375784,0.0014574297,0.0012783724,0.00082999683,0.00054832327,0.22910012,0.001402746,0.0006635,0.015726296],"study_design_scores_gemma":[0.000046383295,0.00046530945,0.9937396,0.0000057583443,0.00013049993,0.0010512846,0.00009916339,0.0007599819,0.003011287,0.0003159694,0.00035475727,0.000019927738],"about_ca_topic_score_codex":0.0013295625,"about_ca_topic_score_gemma":0.0010829119,"teacher_disagreement_score":0.0017774319,"about_ca_system_score_codex":0.00015544532,"about_ca_system_score_gemma":0.00012808743,"threshold_uncertainty_score":0.0059461594},"labels":[],"label_agreement":null},{"id":"W4405414154","doi":"10.1016/j.jacl.2024.12.003","title":"Exploring the impact of insurance switching on the cost-effectiveness of population genetic screening for familial hypercholesterolemia to US payers","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; U.S. Department of Health and Human Services; Muscular Dystrophy Canada; National Institutes of Health; Bristol-Myers Squibb; AstraZeneca","keywords":"Medicine; Population; Actuarial science; Quality-adjusted life year; Life insurance; Cost effectiveness; Quality of life (healthcare); Genetic testing; Environmental health; Business; Risk analysis (engineering)","score_opus":0.2655037146005769,"score_gpt":0.4585594530722698,"score_spread":0.19305573847169288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405414154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430144,0.0006642917,0.00014865174,0.0024506694,0.000047965943,0.00003673134,0.0005439913,0.000008671436,0.0017975175],"genre_scores_gemma":[0.9991027,0.00013306517,0.000074753145,0.00027829706,0.00003109738,0.000012712561,0.00016710721,0.0000016272418,0.00019865377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962579,0.0023291232,0.00019850605,0.00023338081,0.0002498065,0.00073136034],"domain_scores_gemma":[0.9822812,0.013461011,0.0023112902,0.0005059866,0.00033923148,0.0011012357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051410766,0.0004206678,0.0006010543,0.0006463844,0.0005357693,0.0017308391,0.000874811,0.0016323436,0.0060285656],"category_scores_gemma":[0.032565128,0.00027014388,0.0027067775,0.0008725625,0.00066666194,0.001272227,0.0009124859,0.001834789,0.00019109137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034003954,0.0058298083,0.84637135,0.00034415803,0.0047231046,0.000682022,0.00064433954,0.030698992,0.00072128855,0.005201151,0.0032458527,0.06753409],"study_design_scores_gemma":[0.00257861,0.014781214,0.90254617,0.00024141108,0.006302298,0.00062136847,0.00441639,0.0573511,0.0008291012,0.006894686,0.0033285243,0.00010903084],"about_ca_topic_score_codex":0.02502113,"about_ca_topic_score_gemma":0.020931128,"teacher_disagreement_score":0.02502113,"about_ca_system_score_codex":0.0027096868,"about_ca_system_score_gemma":0.0019981586,"threshold_uncertainty_score":0.049750984},"labels":[],"label_agreement":null},{"id":"W4405663829","doi":"10.1016/j.jacl.2024.12.018","title":"Differential effects of volanesorsen on apoC-III, triglycerides, and pancreatitis in familial chylomicronemia syndrome diagnosed by genetic or nongenetic criteria","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ionis Pharmaceuticals","keywords":"Medicine; Pancreatitis; Hereditary pancreatitis; Differential diagnosis; Pediatrics; Genetics; Internal medicine; Bioinformatics; Pathology; Biochemistry","score_opus":0.019491641286582564,"score_gpt":0.3511823041864319,"score_spread":0.3316906628998494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405663829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851376,0.0006521878,0.00007470145,0.000055687593,0.000012707078,0.0000036572658,0.000042123484,0.0000080224745,0.0006371506],"genre_scores_gemma":[0.9996517,0.000078173,0.000061989434,0.000027221833,0.000011469386,0.0000013524896,0.00004676451,0.0000027053184,0.00011870407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937207,0.00026193797,0.00008863997,0.000105848245,0.00009651324,0.00007500549],"domain_scores_gemma":[0.99890125,0.00061550044,0.00013324048,0.000058200963,0.00004345478,0.00024832302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068755326,0.0008987491,0.00075728353,0.000996724,0.00038393706,0.00049839215,0.00034065775,0.00079540885,0.0014441347],"category_scores_gemma":[0.0023375612,0.00031969725,0.0007825363,0.00049398857,0.00053252105,0.00038594086,0.0003505183,0.00058583915,0.0001416921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025931079,0.00053480733,0.9002217,0.000054918135,0.0007977457,0.024479942,0.00035392254,0.0005426473,0.032128677,0.0002273226,0.00014531409,0.014581887],"study_design_scores_gemma":[0.00027644294,0.0031513665,0.9754249,0.000018992027,0.0007799443,0.012461681,0.00038840587,0.0015037518,0.005249809,0.00029525245,0.00041924795,0.000030235924],"about_ca_topic_score_codex":0.0011995375,"about_ca_topic_score_gemma":0.0014481092,"teacher_disagreement_score":0.0014441347,"about_ca_system_score_codex":0.00026372718,"about_ca_system_score_gemma":0.00027623164,"threshold_uncertainty_score":0.0048310757},"labels":[],"label_agreement":null},{"id":"W4407028321","doi":"10.1016/j.jacl.2025.01.004","title":"Polygenic risk score for coronary artery disease predicts atherosclerotic cardiovascular disease in familial hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia; Université de Sherbrooke; McGill University Health Centre; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Coronary artery disease; Atherosclerotic cardiovascular disease; Cardiology; Framingham Risk Score; Disease; Cholesterol","score_opus":0.05548483528757916,"score_gpt":0.34802454131983135,"score_spread":0.2925397060322522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407028321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987425,0.00012524347,0.00038797953,0.00008955777,0.000014811027,0.000003798671,0.00010342105,0.000010096264,0.0005226405],"genre_scores_gemma":[0.9994149,0.000034354,0.00015644653,0.00001378212,0.00001610525,0.0000029933256,0.00010575814,0.000003077548,0.00025257873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927133,0.00035500695,0.000065066735,0.000120815916,0.00008825983,0.00009949596],"domain_scores_gemma":[0.9981414,0.0005924299,0.00050420285,0.00022006874,0.00014225845,0.00039962865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094244536,0.00084501103,0.00048462872,0.0015101928,0.0009302598,0.00080630067,0.00050950266,0.0009406225,0.0034065489],"category_scores_gemma":[0.003144345,0.00033453142,0.0011283251,0.0012262014,0.00052177306,0.00049586507,0.00074811175,0.0008776506,0.00036033697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047581943,0.00008180561,0.99610955,0.0000064128776,0.0003622126,0.0003622219,0.00009254226,0.00014436814,0.0009274061,0.00010552161,0.00009116175,0.0012410409],"study_design_scores_gemma":[0.000011851172,0.00010351341,0.9972682,0.000004052818,0.0001592987,0.0004282095,0.000098851495,0.0016444037,0.000060584814,0.00015436094,0.000059770973,0.000007034905],"about_ca_topic_score_codex":0.006475977,"about_ca_topic_score_gemma":0.0067425524,"teacher_disagreement_score":0.006475977,"about_ca_system_score_codex":0.000260529,"about_ca_system_score_gemma":0.00038534403,"threshold_uncertainty_score":0.01287657},"labels":[],"label_agreement":null},{"id":"W4408735722","doi":"10.1016/j.jacl.2025.03.013","title":"Familial chylomicronemia syndrome: An expert clinical review from the National Lipid Association","year":2025,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Western University; Université du Québec à Chicoutimi; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Statement (logic); Expert opinion; Association (psychology); Family medicine; Pediatrics; Intensive care medicine; Psychotherapist; Law","score_opus":0.18537605402209392,"score_gpt":0.5255152880684374,"score_spread":0.3401392340463435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408735722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058286634,0.9989569,0.000064745596,0.00035395325,0.00027590367,0.000008657473,0.000028946364,0.0000054471348,0.00024710415],"genre_scores_gemma":[0.00029574812,0.99851054,0.00017447777,0.00054738723,0.00024472852,0.000010714378,0.00005834499,0.0000012210377,0.00015680962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952114,0.00006133032,0.00013649497,0.00008290042,0.00016119616,0.00003690994],"domain_scores_gemma":[0.99888545,0.00050903833,0.00021843078,0.000018256573,0.00026618072,0.000102693375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012507037,0.0012079979,0.0030427882,0.0046956213,0.0003458564,0.0015611679,0.0013294074,0.0018448435,0.003700415],"category_scores_gemma":[0.0019985114,0.00045813184,0.0012109937,0.003534452,0.00034480207,0.0016584378,0.0014415352,0.0018630569,0.0014838242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020690908,0.00009206357,0.00043214002,0.05873161,0.0004650562,0.00072500465,0.0000702171,0.00029244463,0.0011308581,0.0010651656,0.088121645,0.8486668],"study_design_scores_gemma":[0.0002784123,0.00018665801,0.0028062728,0.047168344,0.00222175,0.004397794,0.00012310015,0.00021732085,0.0003738681,0.0012997407,0.9408331,0.00009362376],"about_ca_topic_score_codex":0.0016516518,"about_ca_topic_score_gemma":0.0036777717,"teacher_disagreement_score":0.0046956213,"about_ca_system_score_codex":0.00079109607,"about_ca_system_score_gemma":0.002579617,"threshold_uncertainty_score":0.01237911},"labels":[],"label_agreement":null},{"id":"W4408971450","doi":"10.1016/j.jacl.2025.02.008","title":"Epidemiology and longitudinal course of chylomicronemia: Insights from NHANES and a large health care system","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Université du Québec à Chicoutimi","keywords":"Medicine; Epidemiology; Course (navigation); Life course approach; Environmental health; Gerontology; Pediatrics; Internal medicine","score_opus":0.04986690594713759,"score_gpt":0.4368519749211767,"score_spread":0.3869850689740391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408971450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398804,0.0007320053,0.00023791446,0.0006450606,0.000015005283,0.000029375333,0.0035989422,0.000010251076,0.0007433444],"genre_scores_gemma":[0.99468464,0.0005172315,0.00033359136,0.00022523045,0.000036322035,0.000046170386,0.004037064,0.0000058889364,0.00011388289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846387,0.00068235473,0.00017524888,0.00025682646,0.00020692733,0.00021479373],"domain_scores_gemma":[0.9961051,0.0006397871,0.0018221737,0.00033268632,0.00057182537,0.0005284472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026433482,0.0002811768,0.0003106111,0.0013621574,0.0005742008,0.0008673994,0.0005342237,0.00046283557,0.0010881366],"category_scores_gemma":[0.004654666,0.0002869717,0.0007899646,0.0029370289,0.00033696197,0.000813372,0.0015627533,0.00066191825,0.00018028756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028397193,0.00002167702,0.99851245,0.00001021007,0.00006364374,0.000025478372,0.00011752498,0.000034787994,0.000042025244,0.000027475853,0.00030723037,0.00080915674],"study_design_scores_gemma":[0.0000032638402,0.000014898646,0.9993475,0.000011096607,0.000020444226,0.000035769248,0.00021178751,0.00011218468,0.000010857298,0.0000198081,0.00020972274,0.000002708669],"about_ca_topic_score_codex":0.06631037,"about_ca_topic_score_gemma":0.07932857,"teacher_disagreement_score":0.06631037,"about_ca_system_score_codex":0.0009821174,"about_ca_system_score_gemma":0.0015374142,"threshold_uncertainty_score":0.13184881},"labels":[],"label_agreement":null},{"id":"W4409016107","doi":"10.1016/j.jacl.2025.03.012","title":"Recognition and management of persistent chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Public Health Agency of Canada; Université du Québec à Chicoutimi; Johns Hopkins University; American Heart Association","keywords":"Medicine; Association (psychology); Family medicine; Internal medicine; Intensive care medicine","score_opus":0.10141519007007915,"score_gpt":0.4095065633263908,"score_spread":0.30809137325631164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409016107","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047143637,0.44292632,0.02867618,0.47029966,0.030472716,0.0011057999,0.00082615396,0.0007983439,0.020180445],"genre_scores_gemma":[0.057315204,0.67139864,0.10868556,0.0916163,0.052407827,0.0029589257,0.0047729122,0.0004567615,0.010387862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99334407,0.0018678232,0.002015928,0.0006031567,0.0017199417,0.0004490589],"domain_scores_gemma":[0.98134595,0.003512902,0.0013840831,0.00052617874,0.010877825,0.0023531015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015393566,0.0014202455,0.003013045,0.0043672663,0.0016113251,0.0036009673,0.0060067545,0.007709938,0.0023742286],"category_scores_gemma":[0.022401286,0.0006443402,0.002513556,0.0022300666,0.0014001968,0.0028636681,0.0031445455,0.010599089,0.0028550092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015193882,0.00020024064,0.0050798818,0.003599082,0.00024557265,0.0012828051,0.0006370049,0.00088214857,0.00084059447,0.0027347384,0.34190556,0.6424403],"study_design_scores_gemma":[0.0003450187,0.0002519498,0.024633836,0.042666018,0.00085034035,0.010056242,0.0023267872,0.0043323357,0.00095173134,0.018962748,0.89437646,0.00024652825],"about_ca_topic_score_codex":0.0043105683,"about_ca_topic_score_gemma":0.0050329487,"teacher_disagreement_score":0.015393566,"about_ca_system_score_codex":0.0022459326,"about_ca_system_score_gemma":0.00858355,"threshold_uncertainty_score":0.08140993},"labels":[],"label_agreement":null},{"id":"W4410202650","doi":"10.1016/j.jacl.2025.04.196","title":"Characterization of familial chylomicronemia syndrome in a compound heterozygote for 2 APOA5 nonsense variants","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"NHLBI Division of Intramural Research; National Institutes of Health","keywords":"Medicine; Compound heterozygosity; Nonsense; Genetics; Heterozygote advantage; Nonsense mutation; Pediatrics; Allele; Mutation; Gene; Missense mutation; Biology","score_opus":0.04508355466936858,"score_gpt":0.38893125191902644,"score_spread":0.34384769724965786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410202650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984831,0.00013853285,0.0004907935,0.00008996786,0.000022563852,0.000015677952,0.00010696059,0.000024212373,0.0006280647],"genre_scores_gemma":[0.99928576,0.00003860025,0.00031345818,0.00003489608,0.000018371971,0.0000041566873,0.00008025596,0.000008083447,0.00021646492],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997217,0.00003121872,0.00005292182,0.0000849118,0.000060265367,0.000048932125],"domain_scores_gemma":[0.9995468,0.00019073253,0.00007373758,0.000020713189,0.00003755173,0.0001304591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021087039,0.0011348163,0.00044133683,0.0019517025,0.0006256889,0.00039614935,0.0004734798,0.0012184312,0.0028747416],"category_scores_gemma":[0.0011284439,0.00027882334,0.00064707873,0.0005437215,0.00053333206,0.00024075004,0.00047828586,0.00049222104,0.0004257703],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010557501,0.00012978143,0.11258841,0.000045558,0.00007639132,0.7097872,0.00064868125,0.00022584022,0.17064796,0.0004775569,0.0002570969,0.004059795],"study_design_scores_gemma":[0.00012990987,0.0009957226,0.25974214,0.000030834737,0.00022344067,0.7031672,0.0005473263,0.0032250476,0.029919634,0.00049881084,0.0014567173,0.00006329533],"about_ca_topic_score_codex":0.0013702268,"about_ca_topic_score_gemma":0.00081790047,"teacher_disagreement_score":0.0028747416,"about_ca_system_score_codex":0.00018444694,"about_ca_system_score_gemma":0.00023418941,"threshold_uncertainty_score":0.009616911},"labels":[],"label_agreement":null},{"id":"W4410849711","doi":"10.1016/j.jacl.2025.04.096","title":"Long-term monitoring of LPL gene replacement therapy: A lexicon of lessons for gene editing or oligonucleotide-based lipid lowering treatments","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Lexicon; Oligonucleotide; Genetic enhancement; Term (time); Gene; Computational biology; Bioinformatics; Genetics; Natural language processing; Biology; Computer science","score_opus":0.07044214352769199,"score_gpt":0.4555174260628346,"score_spread":0.38507528253514256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410849711","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023498109,0.77065164,0.10566708,0.07086422,0.004263002,0.00017853026,0.00067436206,0.0010593584,0.023143731],"genre_scores_gemma":[0.23341441,0.6318671,0.08158576,0.033130378,0.009427612,0.00047390975,0.0010616265,0.0005022359,0.008536964],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99877495,0.0003762283,0.00019151428,0.00020746829,0.00036462446,0.00008516999],"domain_scores_gemma":[0.9950368,0.0028000544,0.0003238874,0.00054717856,0.0010033521,0.0002886203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046418617,0.0006758367,0.0019417522,0.0011333579,0.00044941567,0.0032212974,0.0014089764,0.001612239,0.0014524215],"category_scores_gemma":[0.007262626,0.00024813853,0.0006013669,0.00067215355,0.002479823,0.0030542503,0.0011190638,0.0049643996,0.00076618657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067941716,0.00022671517,0.0029920456,0.0012171752,0.00012211928,0.0006917526,0.0002405138,0.0007199825,0.016599251,0.020143133,0.019567937,0.93679994],"study_design_scores_gemma":[0.00036672867,0.0021219538,0.009820843,0.0046175336,0.000533941,0.007089177,0.00066112843,0.0045707133,0.041089375,0.13434555,0.7945154,0.00026766778],"about_ca_topic_score_codex":0.0010556977,"about_ca_topic_score_gemma":0.001688396,"teacher_disagreement_score":0.0046418617,"about_ca_system_score_codex":0.0017010423,"about_ca_system_score_gemma":0.0015198786,"threshold_uncertainty_score":0.024548829},"labels":[],"label_agreement":null},{"id":"W4410850261","doi":"10.1016/j.jacl.2025.04.034","title":"Comparison of the performance of three diagnosis scoring systems in patients with persistent chylomicronemia of different causes","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.05587690142929894,"score_gpt":0.36266122781239013,"score_spread":0.30678432638309117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410850261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963833,0.0009548876,0.0008790866,0.00013916865,0.00006887095,0.000029179599,0.00040051207,0.00003509415,0.0011098175],"genre_scores_gemma":[0.99842775,0.00017720292,0.00069991336,0.000034617784,0.00003059108,0.000016130562,0.00046405406,0.000005956413,0.0001438619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813676,0.000724979,0.00026532682,0.00027246826,0.0003680541,0.00023235782],"domain_scores_gemma":[0.9913182,0.005449183,0.0010233537,0.00029529995,0.001324325,0.00058958214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031019154,0.0009642389,0.0011571925,0.0019358074,0.00049143087,0.0014984016,0.00060888694,0.0010812527,0.0010860292],"category_scores_gemma":[0.012523119,0.00024618683,0.0010734117,0.000985617,0.0004636534,0.0009228161,0.0010369963,0.0007219246,0.0003586607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004583975,0.00011187914,0.975686,0.000073016694,0.00033884073,0.00013593653,0.00020682787,0.0005574019,0.00069534226,0.00009649839,0.0004106974,0.017103551],"study_design_scores_gemma":[0.00034192658,0.0018247609,0.9831029,0.000054712844,0.0005483422,0.0007501742,0.0007505699,0.010330416,0.0013360681,0.00039345867,0.0005049652,0.00006163692],"about_ca_topic_score_codex":0.0022247795,"about_ca_topic_score_gemma":0.0020976488,"teacher_disagreement_score":0.0031019154,"about_ca_system_score_codex":0.0006602527,"about_ca_system_score_gemma":0.0005196646,"threshold_uncertainty_score":0.016404688},"labels":[],"label_agreement":null},{"id":"W4410946477","doi":"10.1016/j.jacl.2025.05.023","title":"Neurodegeneration in familial chylomicronemia syndrome","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Body mass index; Endocrinology; Triglyceride; Cholesterol; Cardiology","score_opus":0.03827739361307932,"score_gpt":0.4120400277464448,"score_spread":0.3737626341333655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410946477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990576,0.00039140816,0.00008213924,0.000024467501,0.000003767125,0.0000050443073,0.000028800632,0.00000390474,0.00040279163],"genre_scores_gemma":[0.99951065,0.00017702296,0.00013746205,0.000018913302,0.0000069023854,0.0000036792223,0.00004204219,8.444274e-7,0.00010246515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999858,0.000031397205,0.000015738155,0.000035523113,0.00003112398,0.000028171049],"domain_scores_gemma":[0.99976724,0.000047590685,0.000087466746,0.0000109581515,0.00003837639,0.000048313494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031355995,0.0004856715,0.00023262516,0.0009407153,0.00039971157,0.00025917677,0.00019868731,0.00031924286,0.0015032215],"category_scores_gemma":[0.00073444756,0.00012287442,0.00015199577,0.00046629482,0.00044003478,0.00018054595,0.00047757447,0.00021703291,0.00011093969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008385461,0.00006128195,0.9255754,0.00009347385,0.00007681137,0.03378031,0.0008051939,0.00014167994,0.023962647,0.00012075415,0.00026197595,0.014281941],"study_design_scores_gemma":[0.000019294188,0.00031470475,0.95259154,0.0000327339,0.000042602518,0.044086296,0.0004055989,0.00017966359,0.0016210501,0.00023266255,0.0004663182,0.0000075921234],"about_ca_topic_score_codex":0.0017250438,"about_ca_topic_score_gemma":0.0025361425,"teacher_disagreement_score":0.0017250438,"about_ca_system_score_codex":0.0002710205,"about_ca_system_score_gemma":0.00014964423,"threshold_uncertainty_score":0.0050287843},"labels":[],"label_agreement":null},{"id":"W4410979841","doi":"10.1016/j.jacl.2025.05.021","title":"Heterozygous pathogenic PPARG variants in patients with severe hypertriglyceridemia","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University","funders":"Ultragenyx Pharmaceutical; Regeneron Pharmaceuticals; Sanofi; HLS Therapeutics; Pfizer; Amgen","keywords":"Medicine; Hypertriglyceridemia; Peroxisome proliferator-activated receptor gamma; Internal medicine; Genetics; Triglyceride; Peroxisome proliferator-activated receptor; Cholesterol","score_opus":0.023730488244245247,"score_gpt":0.34428525665918974,"score_spread":0.3205547684149445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410979841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879587,0.00024540807,0.00018087888,0.000073423565,0.0000069946127,0.000008701084,0.00013758663,0.00001499894,0.0005360044],"genre_scores_gemma":[0.999534,0.00007966463,0.00016937891,0.00003960986,0.000012604967,0.0000036602278,0.00010433569,0.0000031171764,0.00005364082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981576,0.000023764556,0.000033327964,0.000059178612,0.000038406666,0.000029519899],"domain_scores_gemma":[0.99959,0.00011692497,0.00014950855,0.000028103825,0.000031166717,0.000084290616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021323371,0.00046906303,0.0003051484,0.00083238364,0.0004911888,0.00034690305,0.00024233286,0.0005849177,0.0019152318],"category_scores_gemma":[0.0010807938,0.00020465223,0.00025499548,0.00063490134,0.00034082666,0.00018813256,0.00035457156,0.00035363357,0.00030826163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000442568,0.000040591935,0.9617413,0.00003135523,0.000043144584,0.02399066,0.00021336386,0.00011375477,0.007889963,0.00007557696,0.00039840315,0.0050192974],"study_design_scores_gemma":[0.000059058482,0.00028248245,0.8098016,0.000034703033,0.00012005276,0.1846287,0.00032020386,0.0005673419,0.0028337329,0.00032125085,0.0010128862,0.000018018693],"about_ca_topic_score_codex":0.0008245225,"about_ca_topic_score_gemma":0.0009467621,"teacher_disagreement_score":0.0019152318,"about_ca_system_score_codex":0.00015696963,"about_ca_system_score_gemma":0.00020254056,"threshold_uncertainty_score":0.0064071417},"labels":[],"label_agreement":null},{"id":"W4411080977","doi":"10.1016/j.jacl.2025.05.024","title":"ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk","year":2025,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Servier; McGill University Health Centre","keywords":"Apolipoprotein B; Medicine; Residual risk; Internal medicine; Lipoprotein; Cholesterol; Disease; Percentile; Atherosclerotic cardiovascular disease; Cardiology; Statistics","score_opus":0.05410343209786662,"score_gpt":0.41408791428695924,"score_spread":0.3599844821890926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411080977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004150791,0.9997023,0.00002661697,0.00008084685,0.000058057023,0.0000016456838,0.000010446801,0.0000018206265,0.000076671604],"genre_scores_gemma":[0.0002642156,0.9994029,0.00007634749,0.00007966664,0.00008179477,0.0000035241799,0.00001618015,4.1664833e-7,0.000074919786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997156,0.0000607802,0.000056108107,0.000052580213,0.000095074545,0.000019718143],"domain_scores_gemma":[0.99927384,0.00041794538,0.00011271474,0.000015355225,0.00013846997,0.000041704894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013649539,0.0011987814,0.003123641,0.0025373648,0.00022282731,0.0011781956,0.001255635,0.0012763689,0.0027266198],"category_scores_gemma":[0.0017665025,0.00041848377,0.0010114411,0.0028090016,0.0005090737,0.0010673363,0.0007728971,0.0024961366,0.0011581894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003121827,0.00011066914,0.0006864218,0.041898936,0.0008231118,0.00010032173,0.000047250767,0.00032126124,0.00056055596,0.002131975,0.024413448,0.9285938],"study_design_scores_gemma":[0.00032086432,0.0004282814,0.009462705,0.040362127,0.0049702385,0.0015587115,0.00020077758,0.0004549776,0.0006004078,0.005486858,0.9360297,0.00012438325],"about_ca_topic_score_codex":0.0022231755,"about_ca_topic_score_gemma":0.0034917654,"teacher_disagreement_score":0.003123641,"about_ca_system_score_codex":0.0005828161,"about_ca_system_score_gemma":0.001331571,"threshold_uncertainty_score":0.009121418},"labels":[],"label_agreement":null},{"id":"W4411139941","doi":"10.1016/j.jacl.2025.05.016","title":"Age and effect of intensive statin in acute mild ischemic stroke or transient ischemic attack: Subgroup analysis of the INSPIRES trial","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Stroke (engine); Statin; Internal medicine; Logistic regression; Physical therapy; Confidence interval","score_opus":0.04793367315366384,"score_gpt":0.4119252579801245,"score_spread":0.36399158482646066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411139941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98325366,0.013066173,0.00034527015,0.00045130128,0.00031091995,0.0001415592,0.0010519706,0.000032208955,0.0013467381],"genre_scores_gemma":[0.99519616,0.0018378621,0.00024642964,0.00037993456,0.0003794714,0.00012191906,0.0011009714,0.0000155464,0.0007216223],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99874264,0.00054863695,0.00016465064,0.00023800539,0.000098485376,0.00020761359],"domain_scores_gemma":[0.9986217,0.0004395519,0.00031932854,0.00031605587,0.00008174113,0.00022162613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025009722,0.0016885744,0.005272291,0.00044136442,0.00037881517,0.0014374015,0.00084768527,0.0013999556,0.002344756],"category_scores_gemma":[0.0032158406,0.0006411108,0.007278965,0.0006448894,0.0005698655,0.0010538559,0.0009233834,0.0023944266,0.00027757697],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8265134,0.00081245287,0.07945026,0.0014658362,0.0688339,0.00027430497,0.00013747733,0.0014374802,0.003193313,0.00040764932,0.0020396984,0.015434189],"study_design_scores_gemma":[0.2652386,0.022611815,0.539112,0.00048933364,0.1591007,0.00037223753,0.0005177125,0.0045332597,0.0013759761,0.002904053,0.0034767007,0.0002676357],"about_ca_topic_score_codex":0.0023074206,"about_ca_topic_score_gemma":0.0049123704,"teacher_disagreement_score":0.005272291,"about_ca_system_score_codex":0.0005428908,"about_ca_system_score_gemma":0.00067738566,"threshold_uncertainty_score":0.013226509},"labels":[],"label_agreement":null},{"id":"W4411403814","doi":"10.1016/j.jacl.2025.06.014","title":"Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec; Montreal Clinical Research Institute","funders":"Ionis Pharmaceuticals","keywords":"Medicine; Clinical trial; Pediatrics; Physical therapy; Family medicine; Internal medicine","score_opus":0.11537348721790136,"score_gpt":0.47984714210392204,"score_spread":0.3644736548860207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411403814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98929673,0.0014652814,0.0016685697,0.0035192554,0.000100750585,0.0007269409,0.0002569711,0.00001991426,0.0029456362],"genre_scores_gemma":[0.9928347,0.0010354372,0.0015193193,0.0017960345,0.00004132526,0.0013531771,0.0001641624,0.000021600614,0.0012342811],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9672633,0.028584044,0.0008584408,0.0006892558,0.00095338427,0.0016515915],"domain_scores_gemma":[0.95139647,0.03869897,0.0036400855,0.00063858496,0.0022638196,0.0033621523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026591009,0.00059351267,0.0010778054,0.0008352598,0.004932517,0.0032704696,0.0020528252,0.0021906402,0.0026745778],"category_scores_gemma":[0.0522835,0.00062417844,0.0006231792,0.0011541003,0.0045549246,0.0032420643,0.0050252345,0.003877895,0.00034806778],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034645016,0.000110018016,0.003835382,0.00034530537,0.000016475238,0.00053244305,0.9867589,0.00006766718,0.0006525514,0.00032953024,0.0007001542,0.0063051214],"study_design_scores_gemma":[0.000047550016,0.00030197448,0.0025596793,0.00028686537,0.000014716787,0.0002037803,0.98992914,0.00014723687,0.00028750458,0.00023273351,0.005955424,0.00003335345],"about_ca_topic_score_codex":0.005287946,"about_ca_topic_score_gemma":0.008343638,"teacher_disagreement_score":0.026591009,"about_ca_system_score_codex":0.0043381248,"about_ca_system_score_gemma":0.0047301715,"threshold_uncertainty_score":0.14062834},"labels":[],"label_agreement":null},{"id":"W4411404471","doi":"10.1016/j.jacl.2025.06.013","title":"Patients’ and families’ virtual care experiences for hypercholesterolemia management during the COVID-19 pandemic","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; Hamilton Health Sciences; Hospital for Sick Children; SickKids Foundation","funders":"Sick Kids Foundation","keywords":"Medicine; Gee; Psychosocial; Generalized estimating equation; Pandemic; Family medicine; Ambulatory; Situational ethics; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Psychiatry","score_opus":0.09263748202664064,"score_gpt":0.4744769962974702,"score_spread":0.38183951427082957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411404471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98276454,0.00020515724,0.00023402448,0.0079851905,0.00018757988,0.000028960889,0.000115941584,0.000017381597,0.0084612155],"genre_scores_gemma":[0.9977817,0.00011325242,0.0001737699,0.00089906034,0.00002456406,0.000026858612,0.000037580307,0.000005782506,0.0009373482],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99691063,0.0020472372,0.00007388716,0.00012783527,0.00015907477,0.00068125036],"domain_scores_gemma":[0.9939224,0.0017858903,0.00052386883,0.0001610938,0.00036351828,0.0032431874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00294015,0.00020143048,0.00026562889,0.00024994952,0.0057427026,0.002701179,0.0005844741,0.0012382146,0.006454224],"category_scores_gemma":[0.011410096,0.00021942594,0.00037603927,0.00020681215,0.0016833585,0.0020389596,0.004553714,0.0023851322,0.00039099896],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011700736,0.0014905548,0.096400775,0.00017365141,0.000105693376,0.00376379,0.78836894,0.00059974217,0.00092538516,0.003769563,0.035371717,0.067860186],"study_design_scores_gemma":[0.00005724221,0.0006040194,0.037745684,0.00015156042,0.00003727202,0.0010986773,0.92805433,0.00041712666,0.0002425553,0.00085516373,0.030641695,0.00009466662],"about_ca_topic_score_codex":0.010358493,"about_ca_topic_score_gemma":0.01954168,"teacher_disagreement_score":0.010358493,"about_ca_system_score_codex":0.0022796916,"about_ca_system_score_gemma":0.0028111169,"threshold_uncertainty_score":0.021591544},"labels":[],"label_agreement":null},{"id":"W4412602895","doi":"10.1016/j.jacl.2025.07.008","title":"Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance study","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université du Québec à Chicoutimi","funders":"Ionis Pharmaceuticals","keywords":"Medicine; Concordance; Balance (ability); Pediatrics; Internal medicine; Physical therapy","score_opus":0.019777032667560212,"score_gpt":0.32394660483456184,"score_spread":0.30416957216700163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412602895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902017,0.00067700405,0.0010327825,0.0023199674,0.00067839934,0.000034126886,0.0008893984,0.000068875044,0.0052793375],"genre_scores_gemma":[0.99727327,0.00016375682,0.0005685286,0.00035218088,0.00054975547,0.00001157311,0.0004027127,0.000012996099,0.00066532695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990722,0.00021665676,0.00014700525,0.0001785678,0.00028780667,0.0000977442],"domain_scores_gemma":[0.99529856,0.0020970954,0.0012022151,0.00024969212,0.00067783054,0.00047460146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097319926,0.00028562493,0.00029058772,0.0012053174,0.0003443609,0.0004572268,0.00020454668,0.00078669155,0.0045110728],"category_scores_gemma":[0.008424808,0.00012283225,0.00015838335,0.0004949555,0.0003327403,0.00025303813,0.0004240543,0.00040642,0.0006632316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050022965,0.0000469621,0.96193993,0.00006621468,0.000060952832,0.008220358,0.00032084878,0.000093427894,0.002709255,0.0001273055,0.008717681,0.017196752],"study_design_scores_gemma":[0.000051080573,0.00034369164,0.92965376,0.00006734038,0.00006405431,0.061621502,0.00038289285,0.00069606956,0.0023213562,0.00037058338,0.0043847375,0.000042972133],"about_ca_topic_score_codex":0.0008249792,"about_ca_topic_score_gemma":0.0007911025,"teacher_disagreement_score":0.0045110728,"about_ca_system_score_codex":0.00015773649,"about_ca_system_score_gemma":0.0001809444,"threshold_uncertainty_score":0.015091002},"labels":[],"label_agreement":null},{"id":"W4413149501","doi":"10.1016/j.jacl.2025.08.009","title":"Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Lipoprotein(a); Internal medicine; Cardiology; Lipoprotein; Cholesterol","score_opus":0.08472779856806323,"score_gpt":0.3850927413615161,"score_spread":0.3003649427934529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413149501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741,0.0001390022,0.00063603674,0.0001660316,0.00004588437,0.000008842053,0.000113176866,0.000026064536,0.001455031],"genre_scores_gemma":[0.99905246,0.0000373031,0.00032353893,0.000068473564,0.000053884083,0.0000034150985,0.00006604497,0.000008157569,0.00038684942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996043,0.00011252235,0.00007659904,0.00007271054,0.00007774426,0.00005618383],"domain_scores_gemma":[0.9992361,0.00031274598,0.00018989781,0.000055051638,0.0000408631,0.00016535925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036691368,0.0009006891,0.00051231624,0.0013859153,0.0008530819,0.00060769235,0.00036452943,0.0015412971,0.005186007],"category_scores_gemma":[0.0020001496,0.00026505283,0.0005273535,0.0006255446,0.00058892195,0.0003854381,0.0006542678,0.0008203721,0.00052332703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022676017,0.0012943937,0.587135,0.00021278484,0.0009009795,0.14128092,0.0014244267,0.0005542273,0.2108207,0.0048695486,0.0012759932,0.027554918],"study_design_scores_gemma":[0.0004895208,0.0025796574,0.8150928,0.00008445639,0.00087278674,0.15602843,0.0012478578,0.003151215,0.014056306,0.0039854865,0.002275703,0.00013582461],"about_ca_topic_score_codex":0.0010139222,"about_ca_topic_score_gemma":0.00070889073,"teacher_disagreement_score":0.005186007,"about_ca_system_score_codex":0.00012030728,"about_ca_system_score_gemma":0.00012630042,"threshold_uncertainty_score":0.017348945},"labels":[],"label_agreement":null},{"id":"W4413367057","doi":"10.1016/j.jacl.2025.08.012","title":"Prevalence, incidence, and definition of severe hypertriglyceridemia: A comprehensive review and weighted summary","year":2025,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute; McGill University Health Centre","funders":"Ionis Pharmaceuticals","keywords":"Medicine; Hypertriglyceridemia; Incidence (geometry); Pediatrics; Internal medicine","score_opus":0.1010357896509984,"score_gpt":0.4274710209802382,"score_spread":0.3264352313292398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413367057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009017254,0.99746025,0.0001106931,0.00017993346,0.00005477099,0.000057011996,0.0010422622,0.000007864253,0.00018555346],"genre_scores_gemma":[0.0057878164,0.992861,0.00033418607,0.00019291598,0.000056640165,0.00010399595,0.00060546736,0.000004367471,0.000053554944],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9948631,0.0009699471,0.0025598288,0.00060745655,0.00082901726,0.00017076978],"domain_scores_gemma":[0.9852246,0.009264785,0.003328297,0.00023499879,0.0017955819,0.00015180552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055333013,0.0013982161,0.0060727396,0.023151767,0.00037027433,0.0022003404,0.0015257929,0.0011242668,0.0031992656],"category_scores_gemma":[0.018130064,0.0009892852,0.0076531707,0.025924573,0.00067762646,0.0020410488,0.0012955935,0.0009480778,0.00039467379],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026350401,0.000016942447,0.00577711,0.8783465,0.0111925155,0.00016085082,0.00028039402,0.00022176148,0.0002630852,0.0003824966,0.005852809,0.09724196],"study_design_scores_gemma":[0.00018127127,0.0002619888,0.038789272,0.7626056,0.12082785,0.0016200523,0.00057665195,0.00021772394,0.00033266508,0.000708398,0.073772006,0.000106520405],"about_ca_topic_score_codex":0.010582535,"about_ca_topic_score_gemma":0.018467635,"teacher_disagreement_score":0.023151767,"about_ca_system_score_codex":0.002315223,"about_ca_system_score_gemma":0.006611042,"threshold_uncertainty_score":0.029263258},"labels":[],"label_agreement":null},{"id":"W4414382211","doi":"10.1016/j.jacl.2025.05.018","title":"Hypertension in youth with metabolic syndrome","year":2025,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; McMaster University","funders":"","keywords":"Metabolic syndrome; Psychological intervention; Multidisciplinary approach; Pharmacotherapy; Intervention (counseling); Lifestyle modification","score_opus":0.2184463955226851,"score_gpt":0.4397767180079877,"score_spread":0.22133032248530257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414382211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017098508,0.99885225,0.0000348689,0.00032125995,0.00016079636,0.000003479915,0.00001898291,0.000003490874,0.00043394527],"genre_scores_gemma":[0.0022698876,0.99705243,0.000069022506,0.00022994645,0.00020005245,0.000006203719,0.000030364501,8.109549e-7,0.00014134958],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996755,0.0000913501,0.00007009675,0.00004624257,0.00009073218,0.000026183003],"domain_scores_gemma":[0.9993575,0.0003718974,0.00013216285,0.000011974704,0.000092982234,0.000033564935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005851979,0.0004504173,0.0011269598,0.0011832888,0.00019969886,0.00077960745,0.00040340866,0.0006377037,0.003222729],"category_scores_gemma":[0.0017062414,0.00012797218,0.00065737445,0.0012191108,0.00023674448,0.0005288926,0.00045175053,0.0010624861,0.0005236399],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016490048,0.00005456137,0.0019914217,0.06821256,0.00051990454,0.0003137937,0.00012655374,0.00015066053,0.00039654187,0.0020255782,0.028904697,0.8971388],"study_design_scores_gemma":[0.000158896,0.00027871056,0.018809557,0.13623384,0.0028842392,0.008943926,0.00042082235,0.00033313673,0.0007075929,0.004030328,0.82714367,0.00005527869],"about_ca_topic_score_codex":0.0019350888,"about_ca_topic_score_gemma":0.0036225235,"teacher_disagreement_score":0.003222729,"about_ca_system_score_codex":0.00029970263,"about_ca_system_score_gemma":0.0013585169,"threshold_uncertainty_score":0.010781109},"labels":[],"label_agreement":null},{"id":"W4414518231","doi":"10.1016/j.jacl.2025.09.029","title":"Implementation strategies to optimize the use of nonstatin add-on lipid-lowering therapies in individuals with dyslipidemia: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"Merck","keywords":"Health care; Healthcare system; MEDLINE; Disease; Precision medicine","score_opus":0.18304526005787433,"score_gpt":0.49081854047386564,"score_spread":0.3077732804159913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414518231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010024584,0.99735165,0.0002999653,0.00047297694,0.00016866387,0.0002780903,0.00018731467,0.0000145033455,0.00022441393],"genre_scores_gemma":[0.0143077,0.9827624,0.0015353421,0.00079470465,0.00008868075,0.00027863827,0.00012759022,0.0000054339444,0.000099592115],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99570507,0.0018273514,0.0013599714,0.00032285243,0.00062566256,0.00015921473],"domain_scores_gemma":[0.989971,0.0071640206,0.0018067142,0.00011432089,0.0007682212,0.00017572696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068626534,0.0014972128,0.0074593653,0.0036881857,0.00038782292,0.0022030503,0.0016778606,0.002017387,0.004894376],"category_scores_gemma":[0.024958968,0.00085189583,0.009189304,0.0033367912,0.0004322735,0.0019423456,0.0011377247,0.0020416763,0.00032893653],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088967313,0.00010460886,0.0010686325,0.81229055,0.033122845,0.00007966583,0.00016329772,0.00040995705,0.00022650292,0.00039693707,0.0026217755,0.14862555],"study_design_scores_gemma":[0.0028552283,0.0005228922,0.005401457,0.68673176,0.27792615,0.00019825959,0.0003529366,0.00048598277,0.00029513476,0.0008042911,0.02434071,0.000085287626],"about_ca_topic_score_codex":0.011157106,"about_ca_topic_score_gemma":0.031962402,"teacher_disagreement_score":0.011157106,"about_ca_system_score_codex":0.002511572,"about_ca_system_score_gemma":0.0090231225,"threshold_uncertainty_score":0.036293626},"labels":[],"label_agreement":null},{"id":"W4415103943","doi":"10.1016/j.jacl.2025.09.024","title":"JCL Roundtable: Novel therapies in lipid management","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cholesterylester transfer protein; Chylomicron; Atherosclerotic cardiovascular disease; Apolipoprotein B; Lipoprotein; Adverse effect","score_opus":0.07530817419162966,"score_gpt":0.4257603828759231,"score_spread":0.35045220868429344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415103943","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013844379,0.1521336,0.0019537916,0.32695445,0.437995,0.00066048966,0.001904996,0.0010129454,0.07600021],"genre_scores_gemma":[0.008416748,0.081414916,0.0058359345,0.27205727,0.48621157,0.00068410346,0.002241705,0.00067124027,0.14246644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960622,0.00095306995,0.00026545042,0.00033552665,0.0015539437,0.00082971103],"domain_scores_gemma":[0.9809022,0.0049882773,0.0017151447,0.0008112765,0.0048735165,0.0067095994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006598005,0.002285832,0.0020184633,0.0030236419,0.0022653867,0.008336319,0.003360968,0.017711129,0.08329298],"category_scores_gemma":[0.011775263,0.000955797,0.002096643,0.0015470329,0.0020939908,0.0066934125,0.0049913907,0.013044226,0.03510162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018711746,0.000055361263,0.00003486058,0.00022507887,0.0000145050935,0.0000825362,0.00000765418,0.00004007258,0.00016185097,0.0008693144,0.9596564,0.038665213],"study_design_scores_gemma":[0.00040653555,0.000318965,0.0006480247,0.001209319,0.00005987205,0.00019894812,0.000058946684,0.00025828605,0.0002966343,0.003159846,0.99333256,0.000051997704],"about_ca_topic_score_codex":0.0025358433,"about_ca_topic_score_gemma":0.00961832,"teacher_disagreement_score":0.08329298,"about_ca_system_score_codex":0.0035796068,"about_ca_system_score_gemma":0.0072702384,"threshold_uncertainty_score":0.27864283},"labels":[],"label_agreement":null},{"id":"W4416046482","doi":"10.1016/j.jacl.2025.11.005","title":"Application of the North American Familial Chylomicronemia Syndrome Score (NAFCS Score) in monogenic hypertriglyceridemia patients: A single-center Turkish cohort study","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Hypertriglyceridemia; Turkish; Cohort; Genetic diagnosis; Differential diagnosis","score_opus":0.02608861357617871,"score_gpt":0.32666286936656336,"score_spread":0.30057425579038466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416046482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993156,0.000110032306,0.0000966383,0.000026472406,0.000013521117,0.00001058721,0.00026709243,0.000003308885,0.00015664268],"genre_scores_gemma":[0.9991702,0.00006757299,0.00011220639,0.000019160898,0.000013963491,0.000014831944,0.00043833238,0.000003842928,0.00015997402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992872,0.00014598368,0.000061315375,0.00028801995,0.00007820279,0.00013928636],"domain_scores_gemma":[0.999426,0.00006785723,0.00015132327,0.0001037452,0.00012826177,0.00012282062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069998164,0.0009919524,0.0008406202,0.0010562198,0.0012217212,0.0011951574,0.00075471774,0.000958911,0.0017869992],"category_scores_gemma":[0.0015736229,0.000747387,0.001302903,0.0012134191,0.00042158473,0.0008051163,0.00066783844,0.0009354678,0.00031928974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005001467,0.000114134986,0.99653673,0.00000966342,0.0002680338,0.00033322242,0.0002014659,0.00007401112,0.0004983628,0.000043996915,0.00025296706,0.0011674066],"study_design_scores_gemma":[0.000047636426,0.00022760183,0.99734193,0.0000075809853,0.00021735842,0.00071460946,0.0005055027,0.0005067272,0.00009378643,0.000060076458,0.00025822737,0.00001884358],"about_ca_topic_score_codex":0.010496449,"about_ca_topic_score_gemma":0.0090049775,"teacher_disagreement_score":0.010496449,"about_ca_system_score_codex":0.00069979654,"about_ca_system_score_gemma":0.00072170724,"threshold_uncertainty_score":0.020870686},"labels":[],"label_agreement":null},{"id":"W4417067266","doi":"10.1016/j.jacl.2025.12.004","title":"Severe hypercholesterolemia in a pediatric cohort: Familial homozygous and autosomal recessive hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; Genetic diagnosis; Phenotype; Genetic testing; Compound heterozygosity","score_opus":0.030683388220998146,"score_gpt":0.36707533378041574,"score_spread":0.3363919455594176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417067266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993299,0.00005595423,0.00007830152,0.000041638163,0.000003902431,0.000005791655,0.00015805384,0.0000057243433,0.00032074883],"genre_scores_gemma":[0.9994043,0.000107064894,0.00010285035,0.0000206208,0.000013029162,0.0000066895013,0.00021392803,0.0000073646574,0.00012419223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994332,0.00010216791,0.0000574916,0.00014414515,0.00013745311,0.00012535483],"domain_scores_gemma":[0.99913126,0.00018048982,0.00025532275,0.00007235228,0.00010072555,0.0002597472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035757298,0.0010704319,0.00073386723,0.0016275768,0.0014691532,0.0010671873,0.0006832119,0.0008432893,0.0030414911],"category_scores_gemma":[0.0022824665,0.00068690034,0.00052262296,0.0014624811,0.000891384,0.0005846471,0.0009791356,0.0009114614,0.00045183944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016605068,0.00008227249,0.98324955,0.0000070640385,0.000032614134,0.013722739,0.0003836156,0.000052007465,0.0010625708,0.00007467209,0.00018542462,0.0009814969],"study_design_scores_gemma":[0.000025204825,0.0002685816,0.93096024,0.000015809957,0.000067479916,0.06558187,0.0019658718,0.0003503227,0.0002914125,0.00012065224,0.00033439885,0.00001820847],"about_ca_topic_score_codex":0.0064019617,"about_ca_topic_score_gemma":0.0045342846,"teacher_disagreement_score":0.0064019617,"about_ca_system_score_codex":0.00038798622,"about_ca_system_score_gemma":0.0007844929,"threshold_uncertainty_score":0.012729406},"labels":[],"label_agreement":null},{"id":"W7103654544","doi":"10.1016/j.jacl.2025.10.069","title":"The prevalence of carotid subclinical atherosclerosis according to age: A systematic review and meta-analysis of the young to middle-age","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Queen's University","funders":"Novo Nordisk Fonden","keywords":"Subclinical infection; Carotid arteries; Epidemiology; Young adult; MEDLINE","score_opus":0.1723094937350511,"score_gpt":0.4492909410693289,"score_spread":0.27698144733427776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7103654544","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031605095,0.96683973,0.00048981066,0.0001353861,0.00020734657,0.00006459467,0.00046764166,0.000023076353,0.00016729995],"genre_scores_gemma":[0.5878568,0.40742567,0.0017977809,0.0011342284,0.00037920097,0.00022662393,0.00085288327,0.000034997436,0.0002918238],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942583,0.0020037387,0.0019051617,0.0011126457,0.00047841272,0.00024176294],"domain_scores_gemma":[0.990721,0.006076867,0.0016551822,0.00065057137,0.00069661223,0.0001998071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074947835,0.0022529445,0.012941976,0.0038282315,0.0006429557,0.0025152876,0.0015834664,0.0026315877,0.0017231748],"category_scores_gemma":[0.015890859,0.0017232709,0.030157764,0.0044404506,0.00072057085,0.0019378113,0.0016982534,0.0017413533,0.00021681841],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040587136,0.000034565852,0.03654287,0.08108345,0.869342,0.00019267906,0.0001332004,0.0002863442,0.0003602722,0.00006667351,0.00037121697,0.0075281058],"study_design_scores_gemma":[0.0005075034,0.00018537376,0.024539253,0.0032955573,0.97031116,0.00012548952,0.00006696349,0.00012796922,0.00007917741,0.00009898516,0.0006361863,0.000026271868],"about_ca_topic_score_codex":0.006583451,"about_ca_topic_score_gemma":0.016153881,"teacher_disagreement_score":0.012941976,"about_ca_system_score_codex":0.000884627,"about_ca_system_score_gemma":0.0013296233,"threshold_uncertainty_score":0.03963667},"labels":[],"label_agreement":null}]}